
<html lang="en"     class="pb-page"  data-request-id="a2e867d6-b62e-42ba-8b96-99cb5763e6c4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b01071;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)" /></meta><meta name="dc.Creator" content="María  Méndez" /></meta><meta name="dc.Creator" content="Hans  Matter" /></meta><meta name="dc.Creator" content="Elisabeth  Defossa" /></meta><meta name="dc.Creator" content="Michael  Kurz" /></meta><meta name="dc.Creator" content="Sylvain  Lebreton" /></meta><meta name="dc.Creator" content="Ziyu  Li" /></meta><meta name="dc.Creator" content="Matthias  Lohmann" /></meta><meta name="dc.Creator" content="Matthias  Löhn" /></meta><meta name="dc.Creator" content="Hartmut  Mors" /></meta><meta name="dc.Creator" content="Michael  Podeschwa" /></meta><meta name="dc.Creator" content="Nils  Rackelmann" /></meta><meta name="dc.Creator" content="Jens  Riedel" /></meta><meta name="dc.Creator" content="Pavel  Safar" /></meta><meta name="dc.Creator" content="David S.  Thorpe" /></meta><meta name="dc.Creator" content="Matthias  Schäfer" /></meta><meta name="dc.Creator" content="Dietmar  Weitz" /></meta><meta name="dc.Creator" content="Kristin  Breitschopf" /></meta><meta name="dc.Description" content="The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1..." /></meta><meta name="Description" content="The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 9, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01071" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01071" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01071" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01071" /></link>
        
    
    

<title>Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01071" /></meta><meta property="og:title" content="Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0015.jpeg" /></meta><meta property="og:description" content="The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1 receptor (GLP-1R) as a well-validated target for T2DM. Here, the discovery and characterization of a potent and selective positive allosteric modulator (PAM) for GLP-1R based on a 3,4,5,6-tetrahydro-1H-1,5-epiminoazocino[4,5-b]indole scaffold is reported. Optimization of this series from HTS was supported by a GLP-1R ligand binding model. Biological in vitro testing revealed favorable ADME and pharmacological profiles for the best compound 19. Characterization by in vivo pharmacokinetic and pharmacological studies demonstrated that 19 activates GLP-1R as positive allosteric modulator (PAM) in the presence of the much less active endogenous degradation product GLP1(9–36)NH2 of the potent endogenous ligand GLP-1(7–36)NH2. While these data suggest the potential of small molecule GLP-1R PAMs for T2DM treatment, further optimization is still required towards a clinical candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01071"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01071">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01071&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01071&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01071&amp;href=/doi/10.1021/acs.jmedchem.9b01071" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2292-2307</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01044" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01112" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">María Méndez</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Méndez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>M.M.: phone, ++49-69-305-44713; e-mail, <a href="/cdn-cgi/l/email-protection#337e52415a521d7e565d57564963564156497340525d5c555a1d505c5e"><span class="__cf_email__" data-cfemail="9bd6fae9f2fab5d6fef5fffee1cbfee9fee1dbe8faf5f4fdf2b5f8f4f6">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++M%C3%A9ndez">María Méndez</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6832-2714" title="Orcid link">http://orcid.org/0000-0002-6832-2714</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hans Matter</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hans Matter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>H.M.: phone, ++49-69-305-84329; e-mail, <a href="/cdn-cgi/l/email-protection#d49cb5baa7fa99b5a0a0b1a694a7b5babbb2bdfab7bbb9"><span class="__cf_email__" data-cfemail="175f767964395a76636372655764767978717e3974787a">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hans++Matter">Hans Matter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabeth Defossa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabeth Defossa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++Defossa">Elisabeth Defossa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Kurz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Kurz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Kurz">Michael Kurz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sylvain Lebreton</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylvain Lebreton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylvain++Lebreton">Sylvain Lebreton</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ziyu Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ziyu Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ziyu++Li">Ziyu Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Lohmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Lohmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Lohmann">Matthias Lohmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Löhn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Löhn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++L%C3%B6hn">Matthias Löhn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hartmut Mors</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hartmut Mors</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hartmut++Mors">Hartmut Mors</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Podeschwa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Podeschwa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Podeschwa">Michael Podeschwa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nils Rackelmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nils Rackelmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nils++Rackelmann">Nils Rackelmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jens Riedel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jens Riedel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jens++Riedel">Jens Riedel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pavel Safar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pavel Safar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pavel++Safar">Pavel Safar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David S. Thorpe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David S. Thorpe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Thorpe">David S. Thorpe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Schäfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Schäfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Sch%C3%A4fer">Matthias Schäfer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dietmar Weitz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dietmar Weitz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dietmar++Weitz">Dietmar Weitz</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kristin Breitschopf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristin Breitschopf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Breitschopf">Kristin Breitschopf</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01071&amp;href=/doi/10.1021%2Facs.jmedchem.9b01071" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2292–2307</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 9, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 July 2019</li><li><span class="item_label"><b>Published</b> online</span>9 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01071" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01071</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2292%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMar%25C3%25ADa%2BM%25C3%25A9ndez%252C%2BHans%2BMatter%252C%2BElisabeth%2BDefossa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01071%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2BPotent%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BGlucagon-like%2BPeptide-1%2BReceptor%2B%2528GLP-1R%2529%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2307%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01071"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2568</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01071" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Méndez&quot;},{&quot;first_name&quot;:&quot;Hans&quot;,&quot;last_name&quot;:&quot;Matter&quot;},{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;Defossa&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Kurz&quot;},{&quot;first_name&quot;:&quot;Sylvain&quot;,&quot;last_name&quot;:&quot;Lebreton&quot;},{&quot;first_name&quot;:&quot;Ziyu&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Lohmann&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Löhn&quot;},{&quot;first_name&quot;:&quot;Hartmut&quot;,&quot;last_name&quot;:&quot;Mors&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Podeschwa&quot;},{&quot;first_name&quot;:&quot;Nils&quot;,&quot;last_name&quot;:&quot;Rackelmann&quot;},{&quot;first_name&quot;:&quot;Jens&quot;,&quot;last_name&quot;:&quot;Riedel&quot;},{&quot;first_name&quot;:&quot;Pavel&quot;,&quot;last_name&quot;:&quot;Safar&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Thorpe&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Schäfer&quot;},{&quot;first_name&quot;:&quot;Dietmar&quot;,&quot;last_name&quot;:&quot;Weitz&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Breitschopf&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2292-2307&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01071&quot;},&quot;abstract&quot;:&quot;The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1 receptor (GLP-1R) as a well-validated target for T2DM. Here, the discovery and characterization of a potent and selective positive allosteric modulator (PAM) for GLP-1R based on a 3,4,5,6-tetrahydro-1H-1,5-epiminoazocino[4,5-b]indole scaffold is reported. Optimization of this series from HTS was supported by a GLP-1R ligand binding model. Biological in vitro testing revealed favorable ADME and pharmacological profiles for the best compound 19. Characterization by in vivo pharmacokinetic and pharmacological studies demonstrated that 19 activates GLP-1R as positive allosteric modulator (PAM) in the presence of the much less active endogenous degradation product GLP1(9–36)NH2 of the potent endogenous ligand GLP-1(7–36)NH2. While these data suggest the potential of small molecule GLP-1R PAMs for T2DM treatment, further&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01071" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01071&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01071" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01071&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01071" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01071&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01071&amp;href=/doi/10.1021/acs.jmedchem.9b01071" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01071" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01071" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01071%26sid%3Dliteratum%253Aachs%26pmid%3D31596080%26genre%3Darticle%26aulast%3DM%25C3%25A9ndez%26date%3D2020%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPharmacological%2BEvaluation%2Bof%2BPotent%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BGlucagon-like%2BPeptide-1%2BReceptor%2B%2528GLP-1R%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2292%26epage%3D2307%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The therapeutic success of peptidic GLP-1 receptor agonists for treatment of type 2 diabetes mellitus (T2DM) motivated our search for orally bioavailable small molecules that can activate the GLP-1 receptor (GLP-1R) as a well-validated target for T2DM. Here, the discovery and characterization of a potent and selective positive allosteric modulator (PAM) for GLP-1R based on a 3,4,5,6-tetrahydro-1<i>H</i>-1,5-epiminoazocino[4,5-<i>b</i>]indole scaffold is reported. Optimization of this series from HTS was supported by a GLP-1R ligand binding model. Biological in vitro testing revealed favorable ADME and pharmacological profiles for the best compound <b>19</b>. Characterization by in vivo pharmacokinetic and pharmacological studies demonstrated that <b>19</b> activates GLP-1R as positive allosteric modulator (PAM) in the presence of the much less active endogenous degradation product GLP1(9–36)NH<sub>2</sub> of the potent endogenous ligand GLP-1(7–36)NH<sub>2</sub>. While these data suggest the potential of small molecule GLP-1R PAMs for T2DM treatment, further optimization is still required towards a clinical candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The glucagon-like-peptide-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR), is a well-validated target for the treatment of type 2 diabetes mellitus (T2DM).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Several peptidic GLP-1R agonists from the class of incretin mimetics, such as exenatide, liraglutide, lixisenatide, albiglutide, and dulaglutide, are approved today for treatment of T2DM.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> The therapeutic success of these injectable GLP-1 analogues prompted us and other groups to search for peptide variations or small molecules that act as GLP-1R agonist or positive allosteric modulators (PAMs) leading to similar pharmacodynamic effects. PAMs could have the potential for producing reduced side effects such as nausea and vomiting prevalent in injectable GLP-1R agonists, which in turn limits their maximal efficacy. Thus, orally administered PAMs would likely result in higher patient convenience and compliance with maximal therapeutic efficacy.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12">(7−12)</a></div><div class="NLM_p">The search for small molecular entities able to directly activate the GLP-1R is ongoing for many years since mimicking the large interaction surface area involved in endogenous peptide ligand binding to class B GPCRs is challenging. Two main approaches have been pursued for activation of GLP-1R with small molecules, namely, searching for direct agonists or for positive allosteric modulators (PAMs) able to enhance the activity of either the endogenous ligand GLP-1(7–36)NH<sub>2</sub> or its much less active degradation product GLP1(9–36)NH<sub>2</sub>, which lacks the first two amino acids His7 and Ala8.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> PAMs do not to interfere with endogenous peptide levels and are expected not to induce tachyphylaxis, which could be an advantage against full agonists.</div><div class="NLM_p">Some of the earlier reported small molecule GLP-1R direct agonists suffer from non-drug-like properties, such as high lipophilicity and molecular weight, which causes low plasma exposure after oral administration.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> The most advanced compound is TTP273 from vTv Therapeutics, which is to our knowledge in clinical development for treatment of T2DM (phase 2 completed).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Although the chemical structure of TTP273 has not been disclosed, dioxino-2,3-isoquinoline derivatives such as <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have been disclosed by Transtec (now vTv-Therapeutics) in the patent literature.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> As expected for a small molecule with these mentioned characteristics, considerable formulation efforts and high doses of TTP273 were necessary to conduct clinical trials.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> More recently, Pfizer and Lilly have also disclosed having small molecule GLP-1R agonists in clinical development (PF-06882961<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and OWL833<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> in-licensed from Chugai). Although structures have not yet been reported, they might be related to those disclosed in the patent literature (compounds <b>7</b> and <b>8</b>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Current data suggest that some of the drawbacks from earlier molecules might have been overcome.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small molecule GLP-1R agonists and allosteric modulators in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The best-characterized GLP-1R PAMs (BETP (<b>2</b>) and compound 2 (<b>3</b>), <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) act by covalently modifying a cysteine side chain in the GLP-1R, inducing thereby a conformational change of the receptor which is able to trigger the GPCR signal cascade upon addition of less active GLP1(9–36)NH<sub>2</sub>.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> However, the presence of reactive chemical functionalities in both molecules <b>2</b> and <b>3</b>, and the fact that these two compounds besides their PAM effect also show direct agonistic activity on their own (they are allo-agonists),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> precludes them from being good in vivo tools for validating the potential of the solely positive modulation approach in a T2DM-relevant disease context. Although several noncovalent compounds have been reported as PAMs for the GLP-1R (compounds <b>4</b>, <b>5</b>, and <b>6</b> in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), only limited information about their in vivo pharmacology in T2DM disease-models is currently available.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33">(30−33)</a> Given that GLP1(9–36)NH<sub>2</sub> accounts for approximately 80–90% of the postprandrial GLP-1 total concentration in humans<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and that its half live in vivo is approximately 5 times higher than the active GLP1(7–36)NH<sub>2</sub> counterpart, we hypothesized that enhancing the activity of the peptide ligand GLP1(9–36)NH<sub>2</sub> could result in a therapeutic valuable approach. In order to increase our success chances, we conducted a HTS campaign with two different experimental settings with the aim to identify both small molecule direct agonists and PAMs for the GLP-1R. Unfortunately, this approach did not yield interesting starting points as small molecule direct agonists which would justify a chemical optimization program.</div><div class="NLM_p">However, the HTS outcome analysis led to the discovery and characterization of a potent and selective positive allosteric GLP-1R modulator based on a 3,4,5,6-tetrahydro-1<i>H</i>-1,5-epiminoazocino[4,5-<i>b</i>]indole scaffold (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This promising series was then chemically optimized, and we were able to show that the most potent compound and its analogues indeed activate the GLP-1R as PAMs in combination with the endogenous ligand GLP1(9–36)NH<sub>2</sub>.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of HTS hit (<b>8</b>) and advanced hit (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Discovery of GLP-1R PAMs</h3><div class="NLM_p">We performed a HTS of the Sanofi compound collection to identify positive allosteric modulators for the endogenous ligand GLP1(9–36)NH<sub>2</sub> to interact with the GLP-1R. This was done using an HTRF cAMP assay in a HEK293 cell line overexpressing the human GLP-1R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). In this assay, both GLP-1(7–36)NH<sub>2</sub> and GLP1(9–36)NH<sub>2</sub> peptides activate the GLP-1 receptor, albeit with significantly different potencies. The EC<sub>50</sub> value of the GLP-1(7–36)NH<sub>2</sub> is approximately 10 000-fold better than the EC<sub>50</sub> value for the GLP1(9–36)NH<sub>2</sub>. When the screening assay was performed, all compounds were tested at the EC<sub>20</sub> concentration of the orthosteric ligand GLP1(9–36)NH<sub>2</sub> to better assess the potentiation of putative HTS hits. Subsequently, compounds were tested for their ability to shift the EC<sub>50</sub> value of the endogenous GLP1(9–36)NH<sub>2</sub> at fixed compound concentrations of 10 and 3 μM, thereby aiming to demonstrate improved biological action of the less active endogenous peptide. Among the several active compounds from HTS, there were many with potentially reactive chemical functionalities (not shown). Consequently, a glutathione (GSH) stability assay served to focus on chemotypes able to activate GLP-1R in a noncovalent manner. Such a stability assay is used as counterscreen to detect substances with electrophilic moieties leading to covalent modification of nucleophiles.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curves from functional in vitro assay data for cAMP response of GLP-1(7–36)NH<sub>2</sub> and GLP1(9–36)NH<sub>2</sub> with or without test compounds in PSC-HEK293 cells overexpressing GLP-1R using the shift assay format. Left: 10 μM compound concentration. Right: 3 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One chemical series based on the 3,4,5,6-tetrahydro-1<i>H</i>-1,5-epiminoazocino[4,5-<i>b</i>]indole scaffold showed a particularly high activity in our HTS assay (compound <b>8</b>, PAM EC<sub>50</sub> 600 nM/100% efficacy, see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The best compound exhibited a very significant effect in enhancing (shifting) the EC<sub>50</sub> value of GLP1(9–36)NH<sub>2</sub> (>500 times at 10 μM). In the orthologue mouse receptor assay, which served as in vitro surrogate for our in vivo model, the biological activity was similar or slightly improved (PAM EC<sub>50</sub> 300 nM/100%). This chemical series originated from a synthesized chemical library based on natural-product-like scaffold using a Pictet–Spengler intramolecular cyclization.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This origin allowed for rapid structure–activity-relationship (SAR) evaluation due to the internal availability of numerous analogues plus a reasonable access to new derivatives by parallel-synthesis chemistry for further exploring the SAR. Although the hit structure <b>8</b> is clearly outside of the property range commonly assigned to lead-like structures from HTS (MW = 585.6),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> its robust biological activity encouraged us to optimize this motif. Hit structures were always obtained as single enantiomers, and we could rapidly determine that the <i>S</i>,<i>S</i> stereochemistry at the bridgehead carbon atoms is necessary for high GLP-1R activity in our primary assay. The corresponding R,R isomers provided minor 2–4 EC<sub>50</sub> shifts for GLP1(9–36)NH<sub>2</sub>. Other isomers were not tested.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Summary of in Vitro Data for Compounds <b>8</b>–<b>19</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">EC<sub>50</sub> shift<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">PAM EC<sub>50</sub> [μM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>/<i>E</i><sub>max</sub> [%]</th><th class="colsep0 rowsep0" align="center">10 μM</th><th class="colsep0 rowsep0" align="center">3 μM</th><th class="colsep0 rowsep0" align="center">1.1B4 cells PAM EC<sub>50</sub> [μM]<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a>/<i>E</i><sub>max</sub> [%]</th><th class="colsep0 rowsep0" align="center">fold change Ca<sup>2+</sup> influx<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">selectivity<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">0.6/91</td><td class="colsep0 rowsep0" align="left">1681</td><td class="colsep0 rowsep0" align="left">nda</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">0.005/99</td><td class="colsep0 rowsep0" align="left">3795</td><td class="colsep0 rowsep0" align="left">nda</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">0.0015/100</td><td class="colsep0 rowsep0" align="left">3143</td><td class="colsep0 rowsep0" align="left">526</td><td class="colsep0 rowsep0" align="left">0.04/100</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">OK</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">0.005/100</td><td class="colsep0 rowsep0" align="left">8188</td><td class="colsep0 rowsep0" align="left">2215</td><td class="colsep0 rowsep0" align="left">0.130/102</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">OK</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Compound EC<sub>50</sub> at EC<sub>20</sub> of GLP1(9–36)NH<sub>2</sub> in the cAMP response assay in PSC-HEK293 cells.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Shift factors of GLP1(9–36)NH<sub>2</sub> EC<sub>50</sub> for compound concentrations of 10 and 3 μM in cAMP response assay in the PSC-HEK293.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Compound EC<sub>50</sub> at EC<sub>20</sub> of GLP1(9–36)NH<sub>2</sub> in the cAMP response assay in 1.1B4 cells.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Compound effect on high glucose-mediated Ca<sup>2+</sup> influx in Min6 β-cells at 10 μM vs HG control (FLIPR assay).</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">OK = no direct effect on cAMP in parental HEK293 cells, HEK293 cells overexpressing GLP-1R, GCGR, VIPR, or GIPR; no modulation of cAMP response to GLP-1(7–36)NH<sub>2</sub> or oxyntomodulin in GLP1R overexpressing HEK293 cells or to GLP-1(9–36)NH<sub>2</sub> in GCGR overexpressing HEK293 cells.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Synthesis of these compounds starts with the amide coupling of Z-protected <i>N</i>-Boc <span class="smallcaps smallerCapital">l</span>-tryptophan <b>9a</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and a diacetal-containing amine of the type <b>10</b> under standard EDC-coupling conditions. The subsequent stereospecific Pictet–Spengler intramolecular cyclization in the presence of formic acid then delivered the polycyclic scaffold <b>12</b>, mostly with partial deprotection of the Boc-group at the indole-N1 moiety. A two-step protection/deprotection protocol was established with crude mixtures to deliver the mono-Boc-protected intermediate <b>12</b>, which was then submitted to standard deprotection conditions of the Z-group. Final amide coupling reaction with 2-(4,4-difluorocyclohexyl)acetic acid rendered compound <b>9</b> in good yields and as single (<i>S</i>,<i>S</i>) enantiomer. Subsequent functionalization of the amide nitrogen of compound <b>9</b> was performed via a Michael addition with acrolein and subsequent addition of MeMgBr, which delivered compound <b>14</b> as a 1:1 mixture of two diastereomers.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b> and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDC, oxyma, DMAP, <i>N</i>-methylmorpholine, DMF, rt, 74%; then DMAP, Boc<sub>2</sub>O, MeCN, 45%; (b) HCO<sub>2</sub>H, rt, 80%; (c) Boc<sub>2</sub>O, CH<sub>3</sub>CN, DMAP, rt; (d) HCO<sub>2</sub>H, rt; (e) H<sub>2</sub>, Pd/C, MeOH, rt, 90%; (f) R<sub>2</sub>CO<sub>2</sub>H, EDC, oxyma, DMAP, <i>N</i>-methylmorpholine, DMF, rt, 75%; (g) acrolein, NaOH, THF; (h) MeMgBr, THF, 27% over two steps, dr 1:1.</p></p></figure><div class="NLM_p">For the synthesis of compound <b>19</b>, a slightly modified synthesis was employed as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Starting from the Fmoc-protected tryptophan <b>9b</b> and the amine building block <b>15</b>,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> intermediate <b>16</b> was obtained via HATU coupling. Oxidation of the alcohol with Dess–Martin periodinane and subsequent in situ cyclization of the crude reaction mixture led to polycyclic intermediate <b>17</b>, which was submitted to Fmoc-deprotection using MeNH<sub>2</sub> to render intermediate <b>18</b> as a mixture of diastereomeres, which could be separated at this stage via HPLC. Final coupling with 2-(4,4-difluorocyclohexyl)acetic acid and subsequent ester hydrolysis delivered compound <b>19</b> as a single enantiomer. The relative stereochemistry of <b>19</b> could be unambiguously assigned by characterization and complete structure elucidation of intermediate <b>18</b> by NMR spectroscopy (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HATU, DIPEA, THF, rt, 37%; (b) Dess–Martin, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40%; (c) H<sub>2</sub>CO<sub>2</sub>H, rt, 45%; (d) Me<sub>2</sub>NH, THF, rt, 72%; (e) 2-(4,4-difluorocyclohexyl)acetic acid, HATU, DIPEA, THF, rt; (f) LiOH, MeOH/H<sub>2</sub>O, rt (38% over two steps).</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Molecular Pharmacology</h3><div class="NLM_p">Starting from the HTS hit <b>8</b>, we first aimed to identify a simplified chemical analogue retaining biological activity in our assay, which led to identification of compound <b>9</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This new molecule lacks the non-drug-like basic side chain but was more active in the primary PAM assay (EC<sub>50</sub>/<i>E</i><sub>max</sub> 5 nM/100%). Furthermore, it shifted the EC<sub>50</sub> value from GLP1(9–36)NH<sub>2</sub> by a factor of 3791 at 10 μM and 1183 at 3 μM, maintaining full agonistic efficacy (<i>E</i><sub>max</sub> 100%). For this and other compounds in this study, relevant data are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Compound <b>9</b> is a specific ligand for GLP-1R without significant activity in the cAMP accumulation assay with the parental, GIP-receptor (gastric inhibitory polypeptide), human VIPR2 (vasoactive intestinal peptide receptor 2), or glucagon receptor overexpressing cell lines, and it was also found to be highly stable in the GSH assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro and in Vivo Profiling Data for Compound <b>19</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">physicochemical data</th><th class="colsep0 rowsep0" align="center">value</th><th class="colsep0 rowsep0" align="center">unit</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW</td><td class="colsep0 rowsep0" align="left">585.64</td><td class="colsep0 rowsep0" align="left">Da</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i> (pH 7.4, 25 °C)</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clogP</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (pH 7.4)</td><td class="colsep0 rowsep0" align="left">>853</td><td class="colsep0 rowsep0" align="left">μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chemical stability (pH 1.1)</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chemical stability (pH 7.4)</td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">chemical stability (GSH)</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">%</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">in vitro ADME data</th><th class="colsep0 rowsep0" align="center">value</th><th class="colsep0 rowsep0" align="center">unit</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolic lability in microsomes (human)</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">metabolic lability in microsomes (mouse)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 inhib (IC<sub>50</sub>, substrate midazolam)</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 inhib (IC<sub>50</sub>, substrate testosterone)</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 <i>P</i><sub>app</sub></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">10<sup>–7</sup> cm/s</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition (IC<sub>50</sub>, patch clamp)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatic clearance (human)</td><td class="colsep0 rowsep0" align="left">0.184</td><td class="colsep0 rowsep0" align="left">(mL/h)/10<sup>6</sup> cells</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatic clearance (mouse)</td><td class="colsep0 rowsep0" align="left">0.145</td><td class="colsep0 rowsep0" align="left">(mL/h)/10<sup>6</sup> cells</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma stability (mouse)</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">%</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">In Vivo Pharmacokinetic Data. Treatment: 3 mg/kg iv/10 mg/kg po</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">rat + rifampicin</th><th class="colsep0 rowsep0" align="center">unit</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (po)</td><td class="colsep0 rowsep0" align="left">227</td><td class="colsep0 rowsep0" align="left">106</td><td class="colsep0 rowsep0" align="left">1130</td><td class="colsep0 rowsep0" align="left">ng/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (bioavailability)</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (po)</td><td class="colsep0 rowsep0" align="left">109</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">7340</td><td class="colsep0 rowsep0" align="left">h·ng/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>diss</sub> (iv)</td><td class="colsep0 rowsep0" align="left">0.934</td><td class="colsep0 rowsep0" align="left">2.29</td><td class="colsep0 rowsep0" align="left">0.815</td><td class="colsep0 rowsep0" align="left">L/kg</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance (iv)</td><td class="colsep0 rowsep0" align="left">6.52</td><td class="colsep0 rowsep0" align="left">7.06</td><td class="colsep0 rowsep0" align="left">1.15</td><td class="colsep0 rowsep0" align="left">L h<sup>–1</sup> kg<sup>–1</sup></td></tr></tbody></table></div></div><div class="NLM_p">It is also a selective potentiator of GLP-1R in the presence of the GLP1(9–36)NH<sub>2</sub> since it neither induced a cAMP signal in the corresponding recombinant cell line when tested alone nor in the presence of 10 nM GLP-1(7–36)NH<sub>2</sub> or oxyntomodulin (data not shown). Furthermore, in a radioactive ligand binding assay, compound <b>9</b> was not able to displace the radioactive labeled peptide GLP-1(7–36)NH<sub>2</sub>, thus supporting our presumed allosteric mode of action. Compound <b>9</b> was also selective against other common channels and receptors. When investigating in a standard receptor (CEREP-33) panel<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and ion channel antitarget panel, only moderate agonistic effects on the K<sub>ATP</sub> channel (EC<sub>50</sub> 2.67 μM) and minor effects on ion channels such as Na<sub>v</sub>1.2 and Na<sub>v</sub>1.5 were observed.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">However, when testing this compound for its ability to shift the EC<sub>50</sub> value of GLP1(9–36)NH<sub>2</sub> in the human pancreatic 1.1B4 β-cell line, which endogenously expresses the GLP-1 receptor, no EC<sub>50</sub> value shift was observed. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, the ligand GLP1(9–36)NH<sub>2</sub> alone does not exhibit any activity on the endogenously expressed GLP-1R, whereas GLP-1(7–36)NH<sub>2</sub> clearly activates its natural receptor.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curves from functional in vitro assay for cAMP response of GLP-1(7–36)NH<sub>2</sub> and GLP1(9–36)NH<sub>2</sub> with or without test compounds in human pancreatic 1.1B4 cells using the shift assay format.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further optimization of the HTS hits led to analogues <b>14</b> and <b>19</b>, bearing both a polar substituent at the amide nitrogen. Our model (see below) suggested that a potential polar interaction to Lys190 might be beneficial for potency. Interestingly, these compounds could clearly potentiate GLP1(9–36)NH<sub>2</sub> in our in vitro assay (see <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In this primary PAM assay, both compounds showed a similar potency (EC<sub>50</sub>/<i>E</i><sub>max</sub> 1.5 nM/100% for compound <b>14</b> and 5 nM/100% for compound <b>19</b>). However, <b>19</b> showed superior activity in the primary assay by shifting the EC<sub>50</sub> value of GLP1(9–36)NH<sub>2</sub> compared to <b>14</b> (8188/2215 fold at 10 and 3 μM for <b>19</b> versus 3143/526 fold at 10 and 3 μM for <b>14</b>). To our knowledge, this is the best potentiation ability described for a noncovalent PAM of the GLP-1R reported so far.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Moreover, in the endogenous human pancreatic β-cell line 1.1B4, both compounds <b>14</b> and <b>19</b> showed robust PAM efficacy, although the difference between these two compounds was not as pronounced as observed previously in the overexpressing cell line (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_p">Both compounds <b>14</b> and <b>19</b> also proved to be selective potentiators of GLP1(9–36)NH<sub>2</sub>. They did not alter the biological responses of GLP-1(7–36)NH<sub>2</sub> or of oxyntomodulin in the recombinant cell line system (data not shown). Furthermore, they had no effect on cAMP accumulation, when tested alone in HEK293 cells overexpressing the GLP-1R, in the parental cell line or in HEK293 cells overexpressing the glucagon receptor either alone or in the presence of GLP1(9–36)NH<sub>2</sub>. Additional assays were performed using cells overexpressing the human GIP-receptor and the human VIPR2. Both compounds were found inactive when tested tested for agonistic activity and for their effect as allosteric modulator using GLP1(9–36)NH<sub>2</sub> or GIP.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">The good selectivity displayed by both compounds in our standard receptor and ion channel panels and against other typical diabetes-relevant GPCRs, such as TGR5 or GPR119 (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a> for full data), prompted us to investigate these compounds in relevant functional assays like the glucose-stimulated insulin secretion (GSIS) assay in dispersed rat and mouse pancreatic islets.</div><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, compound <b>14</b> significantly improved the GLP1(9–36)NH<sub>2</sub>-mediated glucose-stimulated insulin secretion in dispersed rat pancreatic islets. This GSIS potentiation effect was much more pronounced at higher concentrations of the peptide ligand. However, when higher concentrations (10 μM) of compound <b>14</b> were tested, its ability to potentiate the effect of 10 nM GLP1(9–36)NH<sub>2</sub> vanished and even turned into an inhibitory effect in the absence of the peptide ligand GLP1(9–36)NH<sub>2</sub> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In contrast, compound <b>19</b> showed a distinct behavior in this assay. It robustly stimulated GSIS in dispersed rat pancreatic islets even at high concentration (10 μM) in the presence of 10 nM GLP1(9–36)NH<sub>2</sub> to an extent, which is comparable to the positive control (10 nM GLP-1 (7–36)NH<sub>2</sub>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c). Moreover, when tested alone, it did not show any inhibitory effect. It is important to note that the insulinotropic response in this assay was absent at low glucose concentrations (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a> for details).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Glucose-stimulated insulin secretion (GSIS) from dispersed rat islets for PAM-compounds <b>14</b> (a, b) and <b>19</b> (c). Dispersed islets were incubated with high (15 mM) glucose in the presence of vehicle control (DMSO) ± respective compound (1 μM) or GLP-1 ligand (1/10/100 nM) ± respective compound (1 μM). Diluent for GLP-1 ligand was DMSO. <i>N</i> ≥ 9/condition. **<i>p</i> ≤ 0.001 vs respective control; ****<i>p</i> ≤ 0.00001 vs respective control. For (b) and (c), incubation was done ± respective compound (10 μM) or GLP-1 ligand (10 nM) ± respective compound (10 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether the inhibitory effect on the glucose-stimulated insulin secretion observed with compound <b>14</b> at high concentration is an effect, which is not mediated by GLP-1R, we tested <b>14</b> in mouse islets derived from GLP-1R(−/−) mice (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In this model, neither GLP-1(7–36)NH<sub>2</sub> nor GLP1(9–36)NH<sub>2</sub> induced the insulinotropic response at either low or high glucose. Compound <b>14</b> still displayed an inhibitory effect on the insulin secretion when tested in the presence or in the absence of GLP1(9–36)NH<sub>2</sub> in a magnitude comparable to the one observed in the rat islets. This finding suggests that the inhibitory mechanism for compound <b>14</b> is likely linked to an off-target effect.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect on GSIS on islets of GLP-1(−/−) CD-1 mice. Dispersed mouse islets were incubated at low (3 mM) and high (15 mM) glucose with 100 nM GLP-1(7–36)NH<sub>2</sub>, 100 nM GLP1(9–36)NH<sub>2</sub>, 10 μM compound <b>14</b>, and 100 nM GLP1(9–36)NH<sub>2</sub> + 10 μM compound <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As further selectivity testing of compound <b>14</b> did not reveal a single receptor or ion channel responsible for this inhibitory effect, we hypothesized that it was possibly due to a polypharmacology effect causing a counter-regulatory response in the insulin secretion pathway. Indeed, when testing the influence of compound <b>14</b> alone in a Ca<sup>2+</sup> mobilization assay in the mouse pancreatic β-cell line Min6-c4, it blocked glucose-mediated Ca<sup>2+</sup> influx in a similar manner as the known K<sub>ATP</sub> opener diazoxide, suggesting a detrimental influence on metabolism-secretion coupling upstream of insulin granule exocytosis and independent of the GLP-1 pathway. This phenotypic high-throughput assay allowed us then to efficiently exclude other compounds from further profiling that abrogated glucose-stimulated Ca<sup>2+</sup> influx like compound <b>14</b>.</div><div class="NLM_p">Indeed, as shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, compound <b>19</b> tested under similar conditions did not inhibit Ca<sup>2+</sup> mobilization even at the highest concentration, prompting us to evaluate its potential in subsequent in vivo studies.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds <b>19</b> (left) and <b>14</b> (right) on Ca<sup>2+</sup> mobilization. LG: low glucose (2.5 mM). HG: high glucose (15 mM). DIA: K<sub>ATP</sub> opener diazoxide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Ligand Binding Mode Hypothesis in GLP-1R</h3><div class="NLM_p">The X-ray structure of the full-length GLP-1R with a peptidic agonist (peptide 5 with modified GLP-1 residues 8–17, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2">5NX2</a>, resolution 3.7 Å)<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> in the active conformation<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was used to derive a binding hypothesis for the 3,4,5,6-tetrahydro-1<i>H</i>-1,5-epiminoazocino[4,5-<i>b</i>]indole scaffold. However, due to the lack of a cocrystal structure and dedicated GLP-1R mutants, this is only a hypothesis to illustrate our reasoning for ligand optimization, while other potential binding modes for this series cannot be excluded.</div><div class="NLM_p">The following arguments suggest that our series binds to a region overlapping with the orthosteric pocket: (1) The ligands exhibit a positive allosteric effect with addition of the truncated peptide GLP1(9–36)NH<sub>2</sub> but not in the presence of the full GLP-1(7–36)NH<sub>2</sub> with amino acids His7-Ala8 close to the orthosteric site, thereby blocking the entrance into this area; (2) activation of GLP-1R is only possible by contacting both the ECD with the truncated GLP-1 peptide derivative and the 7TM domain; (3) the binding site hypothesis allows us to sterically accommodate our ligand series.</div><div class="NLM_p">For compound <b>9</b>, induced fit docking (IFD)<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> produced a hypothesis consistent with SAR (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The Boc tertiary-butyl group is possibly located next to Leu388 (helix 7). The exocyclic ligand amide oxygen possibly interacts with Arg190 (helix 2) critical for GLP-1 binding affinity.<a onclick="showRef(event, 'ref43 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref43 ref47 ref48">(43,47,48)</a> The difluorocyclohexyl group might be located in a hydrophobic pocket at the bottom near Tyr241 (helix 3). The piperazinone amide might interact with Gln234 (helix 3) and Met233 (helix 3), an important residue for peptide binding.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> The indole is possibly located in the upper pocket area close to Trp306 (helix 5) and Arg380 (helix7). The postulated binding modes for compounds <b>9</b>, <b>14</b>, and <b>19</b> are similar, with the carboxylic acid in compound <b>19</b> possibly contacting the Lys197 (helix 2) side chain.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Postulated binding model for <b>9</b> (green carbon atoms) from induced fit docking into the GLP-1R X-ray structure from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2">5NX2</a> (resolution 3.7 Å). Potential hydrogen bonds are indicated by dotted yellow lines, π–π interactions as dotted cyan lines, and cation−π interactions as dotted green lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">This model agrees with the GLP-1R active conformation with the indole oriented toward the outward-shifted helix 6. It is also consistent with the cryoelectron microscopy (Cryo-EM) structure of activated GLP-1R with GLP-1 and G<sub>s</sub> (5VAI, 4.1 Å).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Removing the first residues of GLP-1 (His7-Ala8) in the Cryo-EM structure would allow accommodating the ligands.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro ADME and in Vivo Pharmacokinetic Profiling of Compound <b>19</b></h3><div class="NLM_p">On the basis of encouraging in vitro pharmacological data of compound <b>19</b> in primary tissue, we evaluated its ADME profile to assess its potential for in vivo studies as tool compound toward a proof-of-concept (PoC). Relevant in vitro data for this compound are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. Compound <b>19</b> is metabolically stable in human and mouse liver microsomes and exhibits high cell permeability in Caco-2 TC7 cell transwell experiments (<i>P</i><sub>app</sub> = 32 × 10<sup>–7</sup> cm/s with a threshold of 20 × 10<sup>–7</sup> cm/s for highly permeable compounds) under standard test conditions (pH 6.5 and 0.5% BSA apical and pH 7.4 and 5% BSA basolateral). Furthermore, this compound did not inhibit CYP3A4, displays good aqueous solubility, and is chemically stable under different conditions including GSH and mouse plasma. In mouse hepatocytes, compound <b>19</b> displays an intermediary clearance (0.145 (mL/h)/10<sup>6</sup> cells), which corresponds to 20% of hepatic blood flow.</div><div class="NLM_p">However, after oral administration, the obtained mouse in vivo pharmacokinetic (PK) data revealed extensive clearance (6.52 L h<sup>–1</sup> kg<sup>–1</sup>) with associated low oral bioavailability (<i>F</i> = 7.2%) and a moderate volume of distribution (<i>V</i><sub>diss</sub>). Relevant data for mouse and rat PK studies after oral and iv administration are also summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The half-life in mouse plasma was low (0.29 h) and high concentrations of metabolically unchanged compound <b>19</b> were recovered in bile (rat fistula study, 74% of iv dose recovered in bile), suggesting that biliary excretion plays an important role in the clearance process for this compound.</div><div class="NLM_p">In order to understand the mechanism for biliary clearance of this compound, we performed transporter studies employing HEK293 cells overexpressing the human organic anion transporters hOATP1B1 (organic anion transporting polypeptide 1B1, SLCO1B1) and hOATP1B3 (organic anion transporting polypeptide 1B3, SLCO1B3).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> In particular OATP1B1 is one of the most highly expressed uptake transporters in human liver, and there are numerous reports regarding OATP1B1-mediated clinical drug–drug interactions.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The structure of <b>19</b>, containing an alkyl carboxylic acid moiety and relatively high molecular weight, suggested that this compound could potentially be a substrate for these liver transporters.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a> Therefore, we applied our internal in silico transporter profile, a collection of 2D-QSAR models built from internal compounds and data, to this structure.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> As expected, compound <b>19</b> was predicted to interact with OATP1B1 and OATP1B2 plus also classified as substrate for P-gp.</div><div class="NLM_p">Subsequently compound <b>19</b> was experimentally identified as a substrate of hOATP1B1 and hOATP1B3 hepatic uptake transporter by a time-dependent increase of uptake in the overexpressing cell lines compared to the control HEK293 wild type cells (background) and with uptake ratios ranging from 6- to 22-fold, as obvious from inspection of <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>19</b> was identified as substrate of hOATP1B1 and hOATP1B3 transporter by a time-dependent incubation of 1 μM compound <b>19</b> with HEK cells overexpressing hOATP1B1 (left) and hOATP1B3 (right) or HEK293 wild type cells (control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additionally, we examined the efflux behavior of compound <b>19</b> in the presence and absence of efflux transporter inhibitors. Studies with Caco-2 TC7 cells revealed that under isocratic conditions (pH 7.4 and 0.5% BSA in apical and basolateral compartment), compound <b>19</b> shows a much lower permeability (0.18 × 10<sup>–7</sup> cm/s) and a high efflux ratio (ER = 247).</div><div class="NLM_p">In the presence of the efflux-transport-inhibitor cyclosporine A, the efflux could be inhibited (ER = 2). This finding shows that compound <b>19</b> is indeed a substrate for efflux transporters, most likely P-glycoprotein (P-gp) or MRP2 (multidrug resistance protein 1, MDR1, multidrug resistance-associated protein 2, ABCC2),<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> two important proteins in the cell membrane acting as ATP-dependent efflux pump with broad substrate specificity. Additionally, this result highly suggests an involvement of P-gp and MRP2 for active elimination of compound <b>19</b> in hepatocytes, as both transporters are expressed in the canalicular membrane.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">Although we could then identify the structural motif leading to a lowering of liver transporter recognition, the resulting compounds significantly lost their GLP-1R PAM activity (data not shown). Since a direct use of compound <b>19</b> for in vivo proof-of-concept studies was precluded due to its poor pharmacokinetic profile, we then envisioned a study design that would still allow the evaluation of this compound in vivo. Since the exposure of compound <b>19</b> was restricted by interactions with transporters in the small intestine, but especially in the liver, we hypothesized that its coadministration with the known OATP/MRP2 inhibitor rifampicin would have a beneficial effect on plasma exposure of compound <b>19</b>.<a onclick="showRef(event, 'ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref58 ref59 ref60 ref61">(58−61)</a> Indeed, the mean exposure of compound <b>19</b> could be increased by a factor of 6 after iv administration and a factor of 85 after po administration, when dosed to rats which had been pretreated with rifampicin. This observation clearly supports our hypothesis that the above-mentioned transporters are responsible for restricted absorption and high hepatic clearance of compound <b>19</b>. Under these modified conditions, the plasma exposure of compound <b>19</b> was found sufficient to allow for an in vivo proof-of-concept study (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p last">The rat PK study in the presence and absence of rifampicin was performed to confirm our in vitro data from overexpressing cell lines, showing that the clearance of compound <b>19</b> is mainly driven by transporters especially of the OATP family in rodents. As this was clearly proven in a rat model, we selected an equal dose of 60 mg/kg po in the pharmacological mice species. Moreover, the PK of rifampicin in mice is described in the literature.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Here even at a lower dose of 10 mg/kg, <i>C</i><sub>max</sub> is reached after 1.5 h with a total concentration of 13 μM. This value is well above the IC<sub>50</sub> values described for OATPs. The higher dose was used in our study to inhibit the efflux transporters in the intestine in parallel, which cannot easily be predicted, as the intestinal concentration is not known.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Pharmacology for Compound <b>19</b></h3><div class="NLM_p">As described above, compound <b>19</b> was applied in the presence of rifampicin for a proof-of-concept study in ob/ob mice, which is a well-accepted disease model for T2DM (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Rifampicin was orally dosed 2.5 h prior to the oral glucose-tolerance test (oGTT) to establish appropriate blood plasma concentration (data not shown). Subsequently, 1 h prior to the oGTT, compound <b>19</b> was orally administered and, when indicated, GLP1(9–36)NH<sub>2</sub> was intraperitoneally coadministered 15 min prior to the oGTT. For the oGTT, mice were fasted overnight and 2 g/kg glucose challenge was used.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Proof-of-concept study for compound <b>19</b> in 11-week-old ob/ob mice (<i>n</i> = 7), an animal model of T2DM. Compound <b>19</b> required the presence of rifampicin and GLP1(9–36)NH<sub>2</sub>. GLP1(9–36)NH<sub>2</sub> was given intraperitoneally. In the presence of both GLP1(9–36)NH<sub>2</sub> and compound <b>19</b>, a significant reduction in blood glucose concentration was observed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In all models used, compound <b>19</b> alone did not show any effect on blood glucose concentration in the absence of rifampicin and/or GLP1(9–36)NH<sub>2</sub>. Rifampicin at 60 mg/kg alone or in combination with compound <b>19</b> at 30 mg/kg orally dosed to ob/ob mice (<i>n</i> = 7) had no effect on the blood glucose concentration in the oGTT. However, the intraperitoneal administration of GLP1(9–36)NH<sub>2</sub> to the combination of rifampicin and compound <b>19</b> evoked a significant reduction in blood glucose concentration, as shown in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. In contrast, the peptide GLP1(9–36)NH<sub>2</sub> alone at a concentration of 4.5 mg/kg had no effect with or without addition of rifampicin on blood glucose concentration (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>). Furthermore, a dose–response relationship for the peptide GLP1(9–36)NH<sub>2</sub> and compound <b>19</b> was established in normoglycemic C57Bl/6 mice (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). At all doses tested for the peptide GLP1(9–36)NH<sub>2</sub>, compound <b>19</b> evoked a significant dose-dependent reduction of the blood glucose concentration during the oGTT.</div><figure id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Dose–response relationship for compound <b>19</b> and the less active peptide GLP1(9–36)NH<sub>2</sub> in 11-week-old normoglycemic C57Bl/6 mice (<i>n</i> = 6). Compound <b>19</b> required the presence of rifampicin and GLP1(9–36)NH<sub>2</sub> for a biological effect. GLP1(9–36)NH<sub>2</sub> has been given intraperitoneally at 0.3, 1, 3, and 4.5 mg/kg. Compound <b>19</b> evoked at all inactive GLP-1 doses a significant reduction in blood glucose concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To finally demonstrate that the in vivo effects of compound <b>19</b> strongly depends on the GLP-1 receptor, an oGTT in the GLP-1R<sup>–/–</sup> mouse was performed, as shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>. To explore the effect of compound <b>19</b> in GLP-1R<sup>–/–</sup> mice, the compound was tested in the presence of rifampicin at 60 mg/kg and in the absence or in combination of intraperitoneally applied GLP1(9–36)NH<sub>2</sub> (4.5 mg/kg). Rifampicin and compound <b>19</b> were both applied orally in this setting.</div><figure id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0012.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Demonstration of the GLP-1R dependent effect of compound <b>19</b> in 10-week-old GLP-1R<sup>–/–</sup> mice (<i>n</i> = 6). Compound <b>19</b> does not induce a significant blood glucose reduction in GLP1R<sup>–/–</sup> mice in the presence of rifampicin and GLP1(9–36)NH<sub>2</sub> at the highest dose tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Under all the conditions tested in GLP-1R<sup>–/–</sup> mice, compound <b>19</b> did not show any effect on blood glucose concentration, strongly supporting our hypothesis that the interesting pharmacological effect of this positive allosteric modulator <b>19</b> is directly mediated by its interaction with the GLP-1 receptor (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The glucagon-like peptide 1 (GLP-1) hormone is secreted from intestinal L-cells after food intake and plays a crucial role for blood glucose regulation and control of appetite and body weight. Its activation of GLP-1R triggers glucose-dependent insulin secretion and leads to suppression of glucagon secretion in the pancreas. For treatment of T2DM, several approaches, like GLP-1 mimetics and DPP-IV inhibitors, are directed to enhance activation of GLP-1R. In this contribution we report a new compound as positive allosteric modulator (PAM) for this important GPCR, namely, compound <b>19</b> as potent, noncovalent, and selective PAM based on a 3,4,5,6-tetrahydro-1<i>H</i>-1,5-epiminoazocino[4,5-<i>b</i>]indole scaffold. This PAM is able to turn the significantly less active metabolite GLP1(9–36)NH<sub>2</sub> into a potent ligand able to activate GLP-1R in a similar manner as the active GLP-1 peptide itself does.</div><div class="NLM_p">Our best compound <b>19</b> demonstrates high activity and selectivity in various functional assays. Due to its favorable in vitro ADME and ex vivo profile, it was further evaluated in vivo. We could explain the observed high biliary clearance in animal PK studies and attributed this to interaction of compound <b>19</b> with human organic anion transporters hOATP1B1 and hOATP1B3. This finding required coadministration of the transporter inhibitor rifampicin for a successful in vivo proof-of-concept study of compound <b>19</b> as tool for our proposed mode of action.</div><div class="NLM_p">Unfortunately, the need of exogenous addition of GLP1(9–36)NH<sub>2</sub> to elicit a significant response on glucose homeostasis experiments in vivo clearly shows that the PAM ability of our best compound <b>19</b> is not yet sufficient to induce a significant response under physiological conditions without addition of this exogenous peptide. The requirement of exogenous GLP1(9–36)NH<sub>2</sub> for a successful in vivo effect might not be so surprising, since the EC<sub>50</sub> shift observed for GLP1(9–36)NH<sub>2</sub> in the presence of 10 μM of our best PAM <b>19</b> in pancreatic 1.1B4 cells was not sufficient to match the EC<sub>50</sub> value of GLP1(7–36)NH<sub>2</sub>. GLP1(7–36)NH<sub>2</sub> is approximately 10 000 more potent than its less active counterpart GLP1(9–36)NH<sub>2.</sub> Taking into account the higher concentration of the less active metabolite in vivo, a potentiation by a factor of ∼2500 is anticipated to be required at an in vivo relevant compound concentration to achieve full therapeutic utility.</div><div class="NLM_p last">Therefore, even if compound <b>19</b> has proven to be a valuable tool to proof the feasibility of GLP1(9–36)NH<sub>2</sub> potentiation in vivo, the validity of this approach under physiological conditions remains an open question. The data presented herein suggest that a significant amount of optimization would still be needed to arrive at a successful clinical candidate. In our opinion, it is questionable whether the challenging goal of identifying a noncovalent, orally available GLP1(9–36)NH<sub>2</sub> potentiator that works under physiological conditions can be reached at all.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Biological Assays. Min6 Ca<sup>2+</sup> Mobilization Assay</h3><div class="NLM_p last">MIN6-c4 cells (Osaka University)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> were plated at a density of 5 × 10<sup>4</sup> cells per well into black 96-well plates and cultured for 20–24 h at 37 °C and 5% CO<sub>2</sub>. For cell loading, culture supernatants were aspirated and 100 μL of assay buffer (Krebs–Ringer buffer, 10 mM HEPES, 0.1% BSA, 2.5 mM glucose) and an equal volume of calcium 6 dye (FLIPR calcium 6 assay kit, Molecular Devices, R8191) dissolved in the same buffer according to instructions of the manufacturer were added to each well. Cells were incubated for 70 min at 37 °C/5% CO<sub>2</sub> and equilibrated for an additional 10 min at room temperature in the dark. To assess the effect of test compounds on glucose-mediated increase in intracellular Ca<sup>2+</sup>, a volume of 50 μL assay buffer containing 75 mM glucose (resulting in a final concentration of 15 mM glucose) and test compounds or DMSO was added per well during detection on a FLIPR Tetra instrument (molecular devices). For low glucose controls, 50 μL of starvation buffer without additional glucose was added to keep the final glucose concentration at 2.5 mM. Calcium flux was quantified by calculating the area under the curve of fluorescence readings from 3 s to 372 s.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> cAMP Stimulation Assay in PSC-HEK293 Cell Line Stably Expressing Human GLP-1R</h3><div class="NLM_p">In vitro cellular assays for GLP-1R agonists and positive allosteric modulators were conducted in 1536-well plates using thaw-and-use frozen cells. Prior to use, frozen cells were thawed quickly at 37 °C and washed (5 min at 900 rpm) with 20 mL of cell buffer (1× HBSS; 20 mM HEPES, 0.1% BSA). Cells were resuspended in assay buffer (cell buffer plus 2 mM IBMX) and adjusted to a cell density of 1 million cells/mL. To a 1536-well microtiter plate, an amount of 2 μL of cells is added (final 2000 cells/well) and 2 μL compound for an agonist assay. For a PAM assay, two assay formats were applied, namely, (a) an enhancer assay with 1 μL of different doses of the compound and 1 μL of a fixed concentration (EC<sub>20</sub>) of GLP1(9–36)NH<sub>2</sub> and (b) a shift assay with 1 μL of different doses of GLP1(9–36)NH<sub>2</sub> and 1 μL of 10 μM and 3 μM compound. The mixtures containing 2 μL of each cells and compounds were incubated for 30 min at room temperature.</div><div class="NLM_p last">The cAMP content of cells was determined using a kit from Cisbio Corp. (catalog no. 62AM4PEC) based on HTRF (homogeneous time resolved fluorescence). After addition of HTRF reagents diluted in lysis buffer (kit components), plates were incubated for 1 h, followed by measurement of the fluorescence ratio at 665/620 nm. Dose–response results were calculated with the internal software <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ecae85839f98ac98c1bf9c898988">[email protected]</a> version 2.0 HTS using a four-parameter logistic model.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> cAMP Stimulation Assay in the Human Pancreatic β-Cell Line 1.1B4</h3><div class="NLM_p last">In vitro cellular assays of GLP-1(7–36)NH<sub>2</sub>, GLP1(9–36)NH<sub>2</sub>, and test compounds were conducted using the human pancreatic β-cell line 1.1B4. Upon GLP-1R activation, the 1.1B4 cells accumulate intracellular cyclic adenosine monophosphate (cAMP). Cyclic AMP formation was measured using a commercial immunoassay technology with HTRF readout. In these experiments, all reagents necessary for quantification of cAMP were supplied in a kit (catalog no. 62AM4PEC from Cisbio Corp., France) and applied according to protocols supplied by the vendor. Two assay formats were applied, namely, (a) an enhancer assay with a compound concentration–response curve and a fixed concentration of 10 nM GLP1(9–36)NH<sub>2</sub> and (b) a shift assay with a GLP1(9–36)NH<sub>2</sub> concentration–response curve and a fixed concentration of 1 μM compound. 20 000 cells were seeded into a 96-well microtiter plate. Following overnight culturing, cells were washed twice, and serial dilutions of GLP-1R ligand or test compound with or without the respective fixed concentration of either test compound or GLP1(9–36)NH<sub>2</sub> were transferred to the cells. After incubation for 30 min with the test agents, the cells were lysed and prepared for cAMP determination according to the manufacturer’s description. Data points were obtained by fluorescence measurement at 665 and 620 nm, calculation of 665/620 nm ratio, and expression in percentage of effect relative to negative (0%) and positive (100%) controls. The negative control was assay buffer (1× HBSS, 0.1% BSA, 1 mM IBMX), and the positive control was GLP-1(7–36)NH<sub>2</sub>. Concentration–response results were calculated with internal software <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="46042f29353206326b1536232322">[email protected]</a> version 2.0 LTS using a four-parameter logistic model. The adjustment was obtained by nonlinear regression using the Marquardt algorithm in SAS version 9.1.3.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Rat Pancreatic Islet Isolation and Islet Dispersion</h3><div class="NLM_p last">For islet isolation, a collagenase enzyme solution was injected into the common bile duct of the euthanized male animal (Sprague Dawley, 225 g). The pancreas was excised and further digested at 37 °C for 15 min. The obtained tissue suspension was washed three times with cell culture medium 199 containing 10% newborn fetal calf serum, followed by repeated filtration through a 600 μm screen. In a further purification step, gradient separation of islets from pancreatic acinar tissue using Histopaque was applied. Finally, islets were handpicked under a dissecting microscope and cultured overnight in an incubator under 95% O<sub>2</sub>/5% CO<sub>2</sub> at 37 °C. To disperse islet cells into cell suspensions, islets were digested with Accutase solution, seeded into a 96-well cell culture dish, and cultured for up to 4 days at 37 °C in a humidified CO<sub>2</sub> incubator under 95% O<sub>2</sub>/5% CO<sub>2</sub> prior to glucose-stimulated insulin secretion assays.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Functional Activity in Glucose-Stimulated Insulin Secretion Assay and Insulin Measurement</h3><div class="NLM_p last">All determinations of insulin secretion were performed in dispersed pancreatic islets under static incubation. Briefly, dispersed islets seeded into 96-well plates were preincubated for 1 h at 37 °C in Krebs–Ringer (KR) buffer containing 120 mM NaCl, 4 mM KCl, 2 mM MgCl<sub>2</sub>·6H<sub>2</sub>O, 2 mM CaCl<sub>2</sub>·2H<sub>2</sub>O, 1.19 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 20 mM NaHCO<sub>3</sub>, 10 mM HEPES equilibrated to pH 7.4, 0.05% bovine serum albumin, 5.6 mM glucose. The preincubation medium was then replaced with KR buffer supplemented with different glucose concentrations (basal, 3 mM; stimulatory, 15 mM) as well as other test agents. After incubation for 2 h at 37 °C, the supernatant was collected and stored at −80 °C for later analysis of insulin content. KR buffer supplemented with 1.25% Triton X100 was added to the remaining cells for lysis. The cell lysate was stored as well at −80 °C for later analysis of insulin content. Insulin was measured by ELISA (Cisbio Corp., France) using a Tecan Envision plate reader. Two measurements of fluorescence upon excitation at 320 nm are carried out at 620 nm for the cryptate emission and at 665 nm for the specific signal emitted by the acceptor. Results are calculated from the 665 nm/620 nm ratio in percentage of insulin secreted relative to total insulin and expressed as <i>n</i>-fold insulin secretion versus respective controls.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> ADME Assays</h3><div class="NLM_p">Permeability assays were performed with Caco-2/TC7 cells.<a onclick="showRef(event, 'ref65 ref66 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67 ref68">(65−68)</a> Conditions for the apical compartment were pH 6.5; 0.5% bovine serum albumin (BSA); compound concentration 20 μM; basolateral compartment pH 7.4; 5% BSA; 2 h incubation time. Efflux was determined under isocratic conditions with pH 7.4 and 0.5% BSA in both compartments and compound concentration of 2 μM. All analyses were performed with LC–MS/MS.</div><div class="NLM_p">CYP inhibition assays<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> were performed with pooled and phenotyped human hepatic microsomes (0.1 mg/mL for CYP3A4). As cofactors, 6 mM MgCl<sub>2</sub>, 0.5 mM EDTA, 1 mg/mL BSA, 1 mM NADPH were used; compound concentration tested was in the range of 0.001–200 μM (in duplicate). Results were expressed as % inhibition or IC<sub>50</sub>. As substrates, midazolam and testosterone were used for CYP3A4.<a onclick="showRef(event, 'ref70 ref71 ref72 ref73 ref74 ref75 ref76 ref77 ref78 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72 ref73 ref74 ref75 ref76 ref77 ref78 ref79 ref80">(70−80)</a></div><div class="NLM_p last">Lability assays were performed with pooled and phenotyped human liver microsomes taking samples at time 0 and time 20 min for LC–MS/MS analysis.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Clearance in vitro was determined using primary human hepatocytes at 1.4 × 10<sup>–6</sup> cells/mL or mouse hepatocytes.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Individual compound concentration varied from 0.5 μM to 5 μM. CYP contribution was determined by addition of either quinidine for CYP2D6 inhibition or ketoconazole for CYP3A4 inhibition to the assay plate. All bioanalytical analyses were performed by LC–MS/MS.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Transporter Assays with Recombinant Cell Lines for OATP1B1 and OATP1B3</h3><div class="NLM_p last">HEK<sup>TR</sup>, HEK<sup>TR</sup>-hOATP1B1, and HEK<sup>TR</sup>-hOATP1B3 cell lines were seeded at 1 × 10<sup>5</sup> (cells/well)/100 μL onto poly-<span class="smallcaps smallerCapital">d</span>-lysine coated 96-well plates (BD BioCoat) in culture medium, and experiments were conducted 1 day after cell seeding. All inhibition experiments were performed with HBSS assay buffer in 96-well plates in quadruplet at 37 °C. The buffer volume was 50 μL in each well. Overexpressing cells and control cells were always treated in parallel. Cells were washed with 200 μL of HBSS assay buffer (37 °C) and then incubated in the presence of the substrate. Uptake was stopped by adding 150 μL/well ice-cold HBSS assay buffer. Solution was removed, and cells were washed two times with 200 μL/well ice-cold HBSS assay buffer. After the complete removal of the washing solution cells were lysed and uptake was quantified by LSC or LC–MS/MS techniques. Functionality of the assay (not shown) was proven with probe substrates for OATP1B1 and OATP1B3 (1 μM <sup>3</sup>H-E17βG (10 min) and 0.5 μM <sup>3</sup>H-CCK8 (5 min)) in the absence and the presence of the probe inhibitor rifampicin (10 μM) for both transporters.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Animal Studies</h3><div class="NLM_p last">All studies with animals were conducted in accordance with German laws for protection of animals. Furthermore, the investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of health.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Pharmacokinetic Parameters in Rats and Mice</h3><div class="NLM_p last">The plasma concentrations and pharmacokinetic parameters of compound <b>19</b> were determined after single intravenous administration of 3 mg/kg body weight in solution (75% purified water/25% (75% Glycoferol/25% Cremophor)) and single oral administration of 10 mg/kg bodyweight in wet milled suspension (0.6% methylcellulose/0.5% Tween 80 in purified water) to male Wistar rats (<i>n</i> = 3 per route) and to female C57Bl6 mice (<i>n</i> = 24 per route). Additionally rifampicin (40 mg/kg bodyweight solved in 0.6% methylcellulose, 0.5% Tween 80 in purified water) was orally coadministered 2 h before iv or po dosing of compound <b>19</b>. Sampling time points were 0.083, 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after intravenous route and 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after oral route for both species. Analysis was performed with ESI-LC/MS–MS assay of compound <b>19</b> in heparinized plasma after protein precipitation with acetonitrile, with a limit of quantitation (LOQ) of 1 ng/mL in rat and of 5 ng/mL in mice.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> The pharmacokinetic parameters were calculated by the program WinNonlin 6.4 using a noncompartmental model and linear trapezoidal interpolation calculation.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> In Vivo Pharmacology Studies</h3><div class="NLM_p last">Adult male ob/ob, C57Bl/6J, and GLP-1R knockout (GLP-1R<sup>–/–</sup>) mice were obtained from Charles River (Sulzfeld, Germany). Animals at 10–11 weeks of age were used. Mice were housed in environmentally controlled conditions with a 12 h light/dark cycle and had free access to water and standard rodent pellet food. Prior to the test procedures blood glucose concentration (BG) of the ob/ob mice was determined to randomize the animals for the study. Animals were fasted overnight. On the day of the test, fasted animals were treated 2.5 h prior to the oGTT orally with rifampicin at 60 mg/kg, 1 h prior to the oGTT orally with compound <b>19</b>, and 15 min prior to the oGTT intraperitoneally with inactive GLP1(9–36)NH<sub>2</sub> (Bachem, Germany) at the doses indicated. The oGTT has been performed with an oral administration of glucose at 2 g/kg bodyweight. Blood glucose levels were determined in blood samples from the tail vein at 0 (prior to glucose administration) and 15, 30, 60, and 90 min after glucose administration using standard glucometers: Accu-chek (Roche) or Star Strip Xpress (DSI) where appropriate.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Computational Methods</h3><div class="NLM_p">Calculations were performed using the Schrödinger Molecular Modeling Suite.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Protein structures from the Protein Data Bank (PDB)<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> were prepared using the Protein Preparation Wizard.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Ligand structures were prepared with LigPrep and minimized using OPLS3.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a> Molecules were treated in ionized form at neutral pH. Hydrogen bond networks of X-ray structures were optimized using the Protein Preparation Wizard. Final models were minimized by a staged protocol in Prime using OPLS3.</div><div class="NLM_p">Ligands were docked into the GLP-1R model and the X-ray structure from PDB file <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2">5NX2</a> using Glide XP<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> with weak core constraints to the indole toward a reasonable alignment. Final poses were optimized using Prime with side chains in a 3 Å sphere around ligands flexible. Induced fit docking (IFD)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was applied for consistent poses of the reference ligand <b>9</b>. Subsequently for other ligands, the docked pose of the reference served for weak core constraints using the indole substructure of the tetracyclic core.</div><div class="NLM_p">In silico ADME models were generated using data from multiple internal series.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Model building for end points like human microsomal lability and PXR activation is described elsewhere.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87,88)</a> Pretreatment included removal of counterions and smaller fragments, neutralization plus canonization of structures. Canonical 3D geometries including hydrogen positions were generated using Corina.<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89,90)</a> The 2D-QSAR models were based on MOE,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> CATS,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> and Ghose–Crippen atom type<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> descriptors (internal implementations for both latter sets). For quantitative models the program Cubist<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> constructing a rule-based decision tree as consensus of five individual trees is applied, while classification models are developed using the program C5.0.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> A GA-based approach<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a> for variable selection maximizes the sum of regression coefficients or minimizes classification errors for training and test sets.</div><div class="NLM_p last">For OATP1B1 interaction, a model was obtained with a cross-validated <i>r</i><sup>2</sup> value of 0.436 and an <i>r</i><sup>2</sup> value of 0.757. Prediction using a test set of 258 compounds resulted in an <i>r</i><sup>2</sup> value of 0.593. For OATP1B3, a model was obtained with a cross-validated <i>r</i><sup>2</sup> value of 0.423 and an <i>r</i><sup>2</sup> value of 0.828, while prediction using 259 compounds led to an <i>r</i><sup>2</sup> value of 0.548. Both models can be applied qualitatively only. For classification of P-gp substrates, an internal C5 decision tree classification based on a data set from Wang et al.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> was derived. This classifier is based on a training set of 249 and a test set of 82 compounds with prediction quality of >96% for both sets.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Chemistry</h3><div class="NLM_p last">Solvents and other reagents were used as received without further purification. Normal phase column chromatography was carried out on Merck silica gel 60 (230–400 mesh). Reversed phase high pressure chromatography was conducted on an Agilent 1100 instrument using an Agilent Prep C18 column (10 μm, 30 mm × 250 mm). Varying ratios of acetonitrile and 0.1% trifluoroacetic acid in water were used as solvent systems. Thin-layer chromatography was carried out on TLC aluminum sheets with silica gel 60 F254 from Merck. NMR spectra were recorded in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> on either a Bruker ARX 500 or a Bruker DRX 400. Chemical shifts are reported as δ values from an internal tetramethylsilane standard. Purity and characterization of compounds were established by a combination of analytical UPLC–MS and NMR analytical techniques. All tested compounds were found to be >95% pure by analytical UPLC–MS analysis unless otherwise stated. UPLC–MS analyses were performed with a Waters ACQUITY UPLC system, column C18 1.7 μm, 2.1 mm × 50 mm; gradient (H<sub>2</sub>O + 0.05% TFA)/(MeCN + 0.035% TFA) 95:5 (0 min) to 5:95 (2 min) to 5:95 (2.6 min) to 95:5 (2.7 min) to 95:5 (3 min), flow rate 0.9 mL/min, temperature 55 °C; mass detector Waters SQD single quadrupole, ESI+ mode.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Synthetic Procedures</h3><div class="NLM_p last">Synthetic procedures are illustrated by the synthesis of compound <b>19</b>. For synthesis of other compounds, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_1_13_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl 3-((<i>S</i>)-2-((((9<i>H</i>-Fluoren-9-yl)methoxy)carbonyl)amino)-3-((2<i>S</i>,4<i>R</i>)-2-(hydroxymethyl)-4-(2-methoxy-2-oxoethyl)pyrrolidin-1-yl)-3-oxopropyl)-1<i>H</i>-indole-1-carboxylate (<b>16</b>)</h3><div class="NLM_p last">A mixture of <b>9b</b> (5.0 g, 9.5 mmol), methyl 2-((3<i>R</i>,5<i>S</i>)-5-(hydroxymethyl)pyrrolidin-3-yl)acetate <b>15</b> (1.73 g, 9.97 mmol), HATU (4.33 g, 11.39 mmol) and DIPEA (3.3 mL, 18.9 mmol) in THF (30 mL) was stirred at rt overnight. The reaction mixture was evaporated and purified by column chromatography on silica gel (eluent hexanes/EtOAc 1:1 to 100% EtOAc) to give the desired product <b>16</b> as a white foam (2.45 g, 37%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.94–8.07 (m, 1H), 7.70–7.90 (m, 2H), 7.48–7.74 (m, 4H), 7.17–7.44 (m, 4H), 4.64–4.75 (m, 1H), 4.38–4.59 (m, 1H), 4.12–4.26 (m, 1H), 3.45–3.61 (m, 1H), 3.57 (s, 3H), 3.15–3.29 (m, 1H), 2.91–3.14 (m, 1H), 2.80 (br t, <i>J</i> = 9.11 Hz, 1H), 2.22–2.43 (m, 1H), 2.07–2.22 (m, 1H), 1.74 (br s, 1H), 1.50–1.63 (m, 1H), 1.35–1.47 (m, 1H), 0.83–0.89 (m, 9H), 0.66–0.74 (m, 1H). LCMS: 1.56 min, <i>m</i>/<i>z</i> 586.2 [M + H]+.</div></div><div id="sec4_1_13_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 14-((9<i>H</i>-Fluoren-9-yl)methyl) 12-(<i>tert</i>-Butyl) (2<i>R</i>,6<i>S</i>,13<i>S</i>,13a<i>S</i>)-2-(2-Methoxy-2-oxoethyl)-5-oxo-1,2,3,5,6,7,13,13a-octahydro-12<i>H</i>-6,13-epiminopyrrolo[1′,2′:1,2]azocino[4,5-<i>b</i>]indole-12,14-dicarboxylate (<b>17</b>)</h3><div class="NLM_p last">To a solution of <b>16</b> (2.45 g, 3.59 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (60 mL), Dess–Martin periodinane was added (3.0 g, 7.2 mmol) and the mixture stirred at rt overnight. Then the mixture was quenched with saturated NaHCO<sub>3</sub> and then with NaHSO<sub>3</sub>. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was taken up in HCO<sub>2</sub>H (45 mL) and stirred at rt for 1 h. LC/MS analysis showed a 1:1 mixture of desired product <b>17</b> and Boc-deprotected derivative. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and H<sub>2</sub>O and extracted. The water phase was then extracted once more with CH<sub>2</sub>Cl<sub>2</sub> and purified by column chromatography using EtOAc/heptane/MeOH gradient to give the desired product as a white solid (939 mg, 40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) <sup>1</sup>H NMR (400.23 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.02 (br t, <i>J</i> = 8.56, 8.56 Hz, 1 H),7.91 (br d, <i>J</i> = 7.70 Hz, 1 H), 7.76 (br dd, <i>J</i> = 18.65, 7.40 Hz, 1 H), 7.65 (br d, <i>J</i> = 7.82 Hz, 1 H), 7.56 (m, 3 H), 7.40 (m, 5 H), 7.24 (m, 4 H), 6.17 (m, 1H isomer 1), 6.10 (m, 1H, isomer 2), 4.71 (br s, 1 H), 4.58 (m, 3 H), 4.31 (m, 2 H), 4.23 (br d, <i>J</i> = 5.13 Hz, 1H), 4.04 (ddd, <i>J</i> = 14.12, 6.97, 6.79 Hz, 1 H), 3.88 (br d, <i>J</i> = 11.49 Hz, 1 H), 3.60 (m, 1 H), 3.53 (br d, <i>J</i> = 12.84 Hz, 4 H), 3.43 (u), 2.94 (br s, 1 H), 2.75 (m, 2 H), 2.50 (u), 2.38 (m, 3 H), 2.26 (m, 2 H), 2.17 (m 2H), 1.56 (m, 1H), 0.52 (m, 1H). LCMS: 2.08 min, <i>m</i>/<i>z</i> 662.28 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (2<i>R</i>,6<i>S</i>,13<i>S</i>,13a<i>S</i>)-2-(2-Methoxy-2-oxoethyl)-5-oxo-1,2,3,5,6,7,13,13a-octahydro-12<i>H</i>-6,13-epiminopyrrolo[1′,2′:1,2]azocino[4,5-<i>b</i>]indole-12-carboxylate (<b>18</b>)</h3><div class="NLM_p last">A solution of <b>17</b> (670 mg, 1.10 mmol) in a mixture of THF/dimethylamine (2:1, 30 mL) was stirred at rt overnight. The solvent was evaporated and the residue purified by column chromatography on silica gel (gradient EtOAc/MeOH 100:0 to 4:1) to give the desired product singel diastereomer <b>18</b> as a white solid (323 mg, 72%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.10 (d, <i>J</i> = 8.53 Hz, conformer 1, 1H), 8.01 (d, <i>J</i> = 8.34 Hz, conformer 2, 1H), 7.46–7.48 (m, 1H), 7.25–7.39 (m, 2H), 7.00 (d, <i>J</i> = 4.58 Hz, conformer 1, 1H), 6.36 (d, <i>J</i> = 4.20 Hz, conformer 2, 1H), 5.54 (br d, <i>J</i> = 2.82 Hz, conformer 2, 1H), 4.83 (br d, <i>J</i> = 5.96 Hz, conformer 1, 1H), 4.23 (m, conformer 2, 1H), 4.17 (m, conformer 1, 1H), 3.68 (m, 1H), 3.65 (s, 3H), 3.31 (d, <i>J</i> = 16.44 Hz, conformer 1, 1H), 2.99–3.20 (m, 3H), 2.60 (m, 1H), 2.48 (m, 1H), 2.40–2.20 (m, 4H), 2.07–1.92 (m, 3H), 1.72–1.83 (m, 2H), 1.73 (s, 9H), 1.32 (m, 2H), 0.97 (m, 1H). LC–MS method A: 1.44 min, <i>m</i>/<i>z</i> 440.21 [M + H]<sup>+</sup>. The relative configuration was unambiguously determined by 2D NMR. See <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a> for details.</div></div><div id="sec4_1_13_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-((2<i>R</i>,6<i>S</i>,13<i>S</i>,13a<i>S</i>)-12-(<i>tert</i>-Butoxycarbonyl)-14-(2-(4,4-difluorocyclohexyl)acetyl)-5-oxo-2,3,5,6,7,12,13,13a-octahydro-1<i>H</i>-6,13-epiminopyrrolo[1′,2′:1,2]azocino[4,5-<i>b</i>]indol-2-yl)acetic acid (<b>19</b>)</h3><div class="NLM_p"><i>Step 1:</i> A mixture of 2-(4,4-difluorocyclohexyl)acetic acid (34 mg, 0.189 mmol), <b>18</b> (50 mg, 0.09 mmol), HATU (42 mg, 0.11 mmol), and DIPEA (47 μL, 0.27 mmol) in THF (4 mL) was stirred at rt overnight. The mixture was diluted with dichloromethane and washed with saturated NaHCO<sub>3</sub>. The organic layer was washed with 10% aq citric acid, dried and evaporated, and used in the next step without further purification.</div><div class="NLM_p last"><i>Step 2:</i> To a solution of the above crude (64 mg, 85.4 mmol) in THF/H<sub>2</sub>O 1:1 (8 mL) at 0 °C, LiOH (21 mg, 854 mmol) was added. The mixture was stirred for 20 min at 0 °C and then carefully taken to pH 6 with slow addition of citric acid (10% solution in water). The mixture was then extracted with dichloromethane and the organic layer washed with water. The water layer, which still contained some product, was extracted with EtOAc (3 times), and the organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was dissolved in DMF and purified by HPLC to give the desired product <b>19</b> as a white solid (17 mg, 38%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>-<i>d</i>) δ 8.07 (d, <i>J</i> = 8.53 Hz, conformer 1, 1H), 7.99 (d, <i>J</i> = 8.34 Hz, conformer 2, 1H), 7.39–7.48 (m, 1H), 7.27–7.37 (m, 2H), 7.00 (d, <i>J</i> = 4.58 Hz, conformer 1, 1H), 6.34 (d, <i>J</i> = 4.20 Hz, conformer 2, 1H), 5.55 (br d, <i>J</i> = 2.82 Hz, conformer 2, 1H), 4.91 (br d, <i>J</i> = 5.96 Hz, conformer 1, 1H), 4.22 (m, conformer 2, 1H), 4.17 (m, conformer 1, 1H), 3.72 (m, 1H), 3.28 (d, <i>J</i> = 16.44 Hz, conformer 1, 1H), 2.94–3.19 (m, 2H), 2.59 (m, 1H), 2.48 (m, 1H), 2.38–2.20 (m, 4H), 1.91–2.12 (m, 3H), 1.72–1.83 (m, 2H), 1.70 (s, 9H), 1.29 (m, 2H), 0.97 (m, 1H). LCMS method A: <i>t</i><sub>R</sub> = 1.82 min, <i>m</i>/<i>z</i> 586.2 [M + H]+. HRMS <i>m</i>/<i>z</i> calculated for C<sub>31</sub>H<sub>37</sub>F<sub>2</sub>N<sub>3</sub>O<sub>6</sub>: 585.2650. Found: 585.2652. Chiral HPLC method A: 6.89 min.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01071" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01071" class="ext-link">10.1021/acs.jmedchem.9b01071</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Chemistry methods and general procedures; synthesis schemes and procedures for <b>9</b> and <b>14</b>; structure elucidation of <b>18</b>; results for selectivity testing for <b>9</b>, <b>14</b>. and <b>19</b>; pharmacokinetic data for <b>19</b>; in vitro data for literature reference compounds and/or close analogues; effect of ip administration of GLP1(9–36)NH<sub>2</sub> (9 mg/kg) on glucose excursion in C57BL/6 mice; in vivo effect of GLP1(9–36)NH<sub>2</sub> of <b>9</b> and BETP in combination with GLP1(9–36)NH<sub>2</sub>; effect of glucose concentration on insulin secretion in pancreatic rat islets (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of all compounds and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf">jm9b01071_si_001.pdf (1.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_002.csv">jm9b01071_si_002.csv (0.43 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01071" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Méndez</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6832-2714" title="Orcid link">http://orcid.org/0000-0002-6832-2714</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#377a56455e56197a525953524d675245524d7744565958515e1954585a"><span class="__cf_email__" data-cfemail="95d8f4e7fcf4bbd8f0fbf1f0efc5f0e7f0efd5e6f4fbfaf3fcbbf6faf8">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hans Matter</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aee6cfc0dd80e3cfdadacbdceeddcfc0c1c8c780cdc1c3"><span class="__cf_email__" data-cfemail="db93bab5a8f596baafafbea99ba8bab5b4bdb2f5b8b4b6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth Defossa</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Kurz</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvain Lebreton</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span>; 
    <span>Present Address:
                        S.L. and P.S.: Icagen, 2090 E. Innovation Park Drive, Oro Valley, AZ 85755, U.S</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ziyu Li</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Lohmann</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Löhn</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hartmut Mors</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Podeschwa</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nils Rackelmann</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jens Riedel</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pavel Safar</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span>; 
    <span>Present Address:
                        S.L. and P.S.: Icagen, 2090 E. Innovation Park Drive, Oro Valley, AZ 85755, U.S</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Thorpe</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span>; 
    <span>Present Address:
                        D.T.: Clinical Sciences & Translational Medicine Division of Cardiology, Department of Medicine, Sarver Heart Center, University of Arizona,, 1501 N Campbell Avenue, Tucson, AZ 85724, U.S</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Schäfer</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dietmar Weitz</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Breitschopf</span> - <span class="hlFld-Affiliation affiliation">Sanofi-Aventis Deutschland
GmbH, Industriepark Höchst, 65926 Frankfurt, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3047-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our colleagues O. Eckhardt, I. Burmann, A. Sihorsch, and A. Struppmann for synthesis and U. Messinger, T. Klöckener, R. Noll, and S. Stengelin for technical support. We also gratefully acknowledge interesting discussions with W. Czechtizky, M. Dreyer, A. Evers, G. Hessler, A.A. Konkar, A. Plowright, and P. Larsen.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, excretion, metabolism</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last">butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CRF1-R</td><td class="NLM_def"><p class="first last">corticotropin-releasing hormone receptor 1</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Eagle’s minimal essential medium</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">ECD</td><td class="NLM_def"><p class="first last">extracellular domain</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">fluorenylmethyloxycarbonyl</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">gastric inhibitory polypeptide</p></td></tr><tr><td class="NLM_term">GIPR</td><td class="NLM_def"><p class="first last">gastric inhibitory polypeptide receptor</p></td></tr><tr><td class="NLM_term">GCGR</td><td class="NLM_def"><p class="first last">glucagon receptor</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">GLP-1R</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1-receptor</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GSIS</td><td class="NLM_def"><p class="first last">glucose-stimulated insulin secretion</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank’s balanced salt solution</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human embryonic kidney cells 293</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">hOATP1B1</td><td class="NLM_def"><p class="first last">human organic anion transporting polypeptide 1B1</p></td></tr><tr><td class="NLM_term">hOATP1B3</td><td class="NLM_def"><p class="first last">human organic anion transporting polypeptide 1B3</p></td></tr><tr><td class="NLM_term">IFD</td><td class="NLM_def"><p class="first last">induced fit docking</p></td></tr><tr><td class="NLM_term">KR</td><td class="NLM_def"><p class="first last">Krebs–Ringer</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MeMgBr</td><td class="NLM_def"><p class="first last">methylmagnesium bromide</p></td></tr><tr><td class="NLM_term">MRP2</td><td class="NLM_def"><p class="first last">multidrug-resistance-associated protein 2</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">OATP</td><td class="NLM_def"><p class="first last">organic anion transporting polypeptide</p></td></tr><tr><td class="NLM_term">OATP1B1</td><td class="NLM_def"><p class="first last">organic anion transporting polypeptide 1B1</p></td></tr><tr><td class="NLM_term">OATP1B3</td><td class="NLM_def"><p class="first last">organic anion transporting polypeptide 1B3</p></td></tr><tr><td class="NLM_term">oGTT</td><td class="NLM_def"><p class="first last">oral glucose-tolerance test</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PoC</td><td class="NLM_def"><p class="first last">proof-of-concept</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">T2DM</td><td class="NLM_def"><p class="first last">type 2 diabetes mellitus</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane domain</p></td></tr><tr><td class="NLM_term">VIPR2</td><td class="NLM_def"><p class="first last">vasoactive intestinal peptide 2 receptor</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>diss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">Z</td><td class="NLM_def"><p class="first last">benzyloxycarbonyl</p></td></tr><tr><td class="NLM_term">7TM</td><td class="NLM_def"><p class="first last">seven-transmembrane-helix domain</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 97 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Glucagon-like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1124/pr.115.011395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fpr.115.011395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=27630114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVyjtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=954-1013&author=C.+De%0AGraafauthor=D.+Donnellyauthor=D.+Woottenauthor=J.+Lauauthor=P.+M.+Sextonauthor=L.+Millerauthor=J.-M.+Ahnauthor=J.+Liaoauthor=M.+M.+Fletcherauthor=D.+Yangauthor=A.+J.+H.+Brownauthor=C.+Zhouauthor=J.+Dengauthor=M.-W.+Wang&title=Glucagon-like+Peptide-1+and+Its+Class+B+G+Protein-Coupled+Receptors%3A+A+Long+March+to+Therapeutic+Successes&doi=10.1124%2Fpr.115.011395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes</span></div><div class="casAuthors">de Graaf, Chris; Donnelly, Dan; Wootten, Denise; Lau, Jesper; Sexton, Patrick M.; Miller, Laurence J.; Ahn, Jung-Mo; Liao, Jiayu; Fletcher, Madeleine M.; Yang, Dehua; Brown, Alastair J. H.; Zhou, Caihong; Deng, Jiejie; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">954-1013</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The glucagon-likepeptide (GLP)-1 receptor (GLP-1R) is a class B G protein-coupled receptor (GPCR) that mediates the action of GLP-1, a peptide hormone secretedfromthreemajor tissues inhumans,enteroendocrine L cells in the distal intestine, a cells in the pancreas, and the central nervous system, which exerts important actions useful in the management of type 2 diabetes mellitus and obesity, including glucose homeostasis and regulation of gastric motility and food intake.  Peptidic analogs of GLP-1 have been successfully developed with enhanced bioavailability and pharmacol. activity.  Physiol. and biochem. studies with truncated, chimeric, and mutated peptides and GLP-1R variants, together with ligand-bound crystal structures of the extracellular domain and the first three-dimensional structures of the 7-helical transmembrane domain of class B GPCRs, have provided the basis for a two domain-binding mechanism of GLP-1 with its cognate receptor.  Although efforts in discovering therapeutically viable nonpeptidic GLP-1R agonists have been hampered, small-moleculemodulators offer complementary chem. tools to peptide analogs to investigate ligand-directed biased cellular signaling of GLP-1R.  The integrated pharmacol. and structural information of different GLP-1 analogs and homologous receptors give new insights into the mol. determinants of GLP-1R ligand selectivity and functional activity, thereby providing novel opportunities in the design and development of more efficacious agents to treat metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCtj0RWeAUbVg90H21EOLACvtfcHk0lgw_-7hrD0iUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVyjtb%252FJ&md5=3ef82a52b0d8f678840a9faa344624a3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011395%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26aulast%3DDonnelly%26aufirst%3DD.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.-M.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DFletcher%26aufirst%3DM.%2BM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DGlucagon-like%2520Peptide-1%2520and%2520Its%2520Class%2520B%2520G%2520Protein-Coupled%2520Receptors%253A%2520A%2520Long%2520March%2520to%2520Therapeutic%2520Successes%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D954%26epage%3D1013%26doi%3D10.1124%2Fpr.115.011395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Recent Progress and Future Options in the Development of GLP-1 Receptor Agonists for the Treatment of Diabesity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.bmcl.2013.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23743288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4011-4018&author=M.+Lorenzauthor=A.+Eversauthor=M.+Wagner&title=Recent+Progress+and+Future+Options+in+the+Development+of+GLP-1+Receptor+Agonists+for+the+Treatment+of+Diabesity&doi=10.1016%2Fj.bmcl.2013.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity</span></div><div class="casAuthors">Lorenz, Martin; Evers, Andreas; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4018</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dramatic rise of the twin epidemics, type 2 diabetes and obesity is assocd. with increased mortality and morbidity worldwide.  Based on this global development there is clin. need for anti-diabetic therapies with accompanied wt. redn.  From the approved therapies, the injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are the only class of agents which are assocd. with a modest wt. redn.  Physiol. effects of the gastro-intestinal hormone GLP-1 are improvement of glycemic control as well as a redn. in appetite and food intake.  Different approaches are currently under clin. evaluation to optimize the therapeutic potential of GLP-1 RAs directed to once-weekly up to once-monthly administration.  The next generation of peptidic co-agonists comprises the activity of GLP-1 plus addnl. gastro-intestinal hormones with the potential for increased therapeutic benefits compared to GLP-1 RAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre3s3NEw8b_7Vg90H21EOLACvtfcHk0lgz6wwvhXk6Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVamu7o%253D&md5=f9c6df0f924fb6cbd804c86fb764d875</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DRecent%2520Progress%2520and%2520Future%2520Options%2520in%2520the%2520Development%2520of%2520GLP-1%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Diabesity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4011%26epage%3D4018%26doi%3D10.1016%2Fj.bmcl.2013.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turton, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beak, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatei, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span> <span> </span><span class="NLM_article-title">A Role for Glucagon-like Peptide-1 in the Central Regulation of Feeding</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1038/379069a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2F379069a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=8538742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK28XivVKgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=69-72&author=M.+D.+Turtonauthor=D.+O%E2%80%99Sheaauthor=I.+Gunnauthor=S.+A.+Beakauthor=C.+M.+Edwardsauthor=K.+Meeranauthor=S.+J.+Choiauthor=G.+M.+Taylorauthor=M.+M.+Heathauthor=P.+D.+Lambertauthor=J.+P.+Wildingauthor=D.+M.+Smithauthor=M.+A.+Ghateiauthor=J.+Herbertauthor=S.+R.+Bloom&title=A+Role+for+Glucagon-like+Peptide-1+in+the+Central+Regulation+of+Feeding&doi=10.1038%2F379069a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A role for glucagon-like peptide-1 in the central regulation of feeding</span></div><div class="casAuthors">Turton, M. D.; O'Shea, D.; Gunn, I.; Beak, S. A.; Edwards, C. M. B.; Meeran, K.; Choi, S. J.; Taylor, G. M.; Heath, M. M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6560</span>),
    <span class="NLM_cas:pages">69-72</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The sequence of glucagon-like peptide-1 (7-36) amide (GLP-1) is completely conserved in all mammalian species studied, implying that it plays a crit. physiol. role.  The authors have shown that GLP-1 and its specific receptors are present in the hypothalamus.  No physiol. role for central GLP-1 has been established.  The authors report here that intracerebroventricular (ICV) GLP-1 powerfully inhibits feeding in fasted rats.  ICV injection of the specific GLP-1-receptor antagonist, exendin (9-39), blocked the inhibitory effect of GLP-1 on food intake.  Exendin (9-39) alone had no influence on fast-induced feeding but more than doubled food intake in satiated rats, and augmented the feeding response to the appetite stimulant, neuropeptide Y.  Induction of c-fos is a marker of neuronal activation.  Following ICV GLP-1 injection, c-fos appeared exclusively in the paraventricular nucleus of the hypothalamus and central nucleus of the amygdala, and this was inhibited by prior administration of exendin (9-39).  Both of these regions of the brain are of primary importance in the regulation of feeding.  These findings suggest that central GLP-1 is a new physiol. mediator of satiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPdbQku_Y0rVg90H21EOLACvtfcHk0lgz6wwvhXk6Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVKgsA%253D%253D&md5=b299a5b0e9b9dec7bf2814b10611f241</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F379069a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379069a0%26sid%3Dliteratum%253Aachs%26aulast%3DTurton%26aufirst%3DM.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%26aulast%3DGunn%26aufirst%3DI.%26aulast%3DBeak%26aufirst%3DS.%2BA.%26aulast%3DEdwards%26aufirst%3DC.%2BM.%26aulast%3DMeeran%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DTaylor%26aufirst%3DG.%2BM.%26aulast%3DHeath%26aufirst%3DM.%2BM.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26aulast%3DWilding%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DGhatei%26aufirst%3DM.%2BA.%26aulast%3DHerbert%26aufirst%3DJ.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DA%2520Role%2520for%2520Glucagon-like%2520Peptide-1%2520in%2520the%2520Central%2520Regulation%2520of%2520Feeding%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D69%26epage%3D72%26doi%3D10.1038%2F379069a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad-Reddy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, D.</span></span> <span> </span><span class="NLM_article-title">A Clinical Review of GLP-1 Receptor Agonists: Efficacy and Safety in Diabetes and Beyond</span>. <i>Drugs Context</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">212283</span>, <span class="refDoi"> DOI: 10.7573/dic.212283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.7573%2Fdic.212283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26213556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FntV2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=212283&author=L.+Prasad-Reddyauthor=D.+Isaacs&title=A+Clinical+Review+of+GLP-1+Receptor+Agonists%3A+Efficacy+and+Safety+in+Diabetes+and+Beyond&doi=10.7573%2Fdic.212283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond</span></div><div class="casAuthors">Prasad-Reddy Lalita; Isaacs Diana</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in context</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212283</span>
        ISSN:<span class="NLM_cas:issn">1745-1981</span>.
    </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing at an astounding rate.  Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain.  Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with benefits extending outside glucose control, including positive effects on weight, blood pressure, cholesterol levels, and beta-cell function.  They mimic the effects of the incretin hormone GLP-1, which is released from the intestine in response to food intake.  Their effects include increasing insulin secretion, decreasing glucagon release, increasing satiety, and slowing gastric emptying.  There are currently four approved GLP-1 receptor agonists in the United States: exenatide, liraglutide, albiglutide, and dulaglutide.  A fifth agent, lixisenatide, is available in Europe.  There are important pharmacodynamic, pharmacokinetic, and clinical differences of each agent.  The most common adverse effects seen with GLP-1 therapy include nausea, vomiting, and injection-site reactions.  Other warnings and precautions include pancreatitis and thyroid cell carcinomas.  GLP-1 receptor agonists are an innovative and effective option to improve blood glucose control, with other potential benefits of preserving beta-cell function, weight loss, and increasing insulin sensitivity.  Once-weekly formulations may also improve patient adherence.  Overall, these are effective agents for patients with type 2 diabetes, who are either uncontrolled on metformin or intolerant to metformin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvs0wxfJtjQ5PlX7E30qdzfW6udTcc2eYsTxxoGNZZTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FntV2gtw%253D%253D&md5=9adaf3d9ffbd6cdb7a81d72abb1dc719</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7573%2Fdic.212283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7573%252Fdic.212283%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad-Reddy%26aufirst%3DL.%26aulast%3DIsaacs%26aufirst%3DD.%26atitle%3DA%2520Clinical%2520Review%2520of%2520GLP-1%2520Receptor%2520Agonists%253A%2520Efficacy%2520and%2520Safety%2520in%2520Diabetes%2520and%2520Beyond%26jtitle%3DDrugs%2520Context%26date%3D2015%26volume%3D4%26spage%3D212283%26doi%3D10.7573%2Fdic.212283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manandhar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-M.</span></span> <span> </span><span class="NLM_article-title">Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.1021/jm500810s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500810s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVegu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1020-1037&author=B.+Manandharauthor=J.-M.+Ahn&title=Glucagon-like+Peptide-1+%28GLP-1%29+Analogs%3A+Recent+Advances%2C+New+Possibilities%2C+and+Therapeutic+Implications&doi=10.1021%2Fjm500810s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications</span></div><div class="casAuthors">Manandhar, Bikash; Ahn, Jung-Mo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1020-1037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is an incretin that plays important physiol. roles in glucose homeostasis.  Produced from intestine upon food intake, it stimulates insulin secretion and keeps pancreatic β-cells healthy and proliferating.  Because of these beneficial effects, it has attracted a great deal of attention in the past decade, and an entirely new line of diabetic therapeutics has emerged based on the peptide.  In addn. to the therapeutic applications, GLP-1 analogs have demonstrated a potential in mol. imaging of pancreatic β-cells; this may be useful in early detection of the disease and evaluation of therapeutic interventions, including islet transplantation.  In this Perspective, we focus on GLP-1 analogs for their studies on improvement of biol. activities, enhancement of metabolic stability, investigation of receptor interaction, and visualization of the pancreatic islets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMy2rBwK-zv7Vg90H21EOLACvtfcHk0liskxdiRvScVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVegu7vK&md5=5a934017b4f5f1df251a435e871b1c66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm500810s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500810s%26sid%3Dliteratum%253Aachs%26aulast%3DManandhar%26aufirst%3DB.%26aulast%3DAhn%26aufirst%3DJ.-M.%26atitle%3DGlucagon-like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogs%253A%2520Recent%2520Advances%252C%2520New%2520Possibilities%252C%2520and%2520Therapeutic%2520Implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1020%26epage%3D1037%26doi%3D10.1021%2Fjm500810s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, P. R.</span></span> <span> </span><span class="NLM_article-title">New Perspectives on Exploitation of Incretin Peptides for the Treatment of Diabetes and Related Disorders</span>. <i>World J. Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.4239/wjd.v6.i15.1285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.4239%2Fwjd.v6.i15.1285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26557956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC28vhtVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1285-1295&author=N.+Irwinauthor=P.+R.+Flatt&title=New+Perspectives+on+Exploitation+of+Incretin+Peptides+for+the+Treatment+of+Diabetes+and+Related+Disorders&doi=10.4239%2Fwjd.v6.i15.1285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders</span></div><div class="casAuthors">Irwin Nigel; Flatt Peter R</div><div class="citationInfo"><span class="NLM_cas:title">World journal of diabetes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1285-95</span>
        ISSN:<span class="NLM_cas:issn">1948-9358</span>.
    </div><div class="casAbstract">The applicability of stable gut hormones for the treatment of obesity-related diabetes is now undisputable.  This is based predominantly on prominent and sustained glucose-lowering actions, plus evidence that these peptides can augment insulin secretion and pancreatic islet function over time.  This review highlights the therapeutic potential of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), oxyntomodulin (OXM) and cholecystokinin (CCK) for obesity-related diabetes.  Stable GLP-1 mimetics have already been successfully adopted into the diabetic clinic, whereas GIP, CCK and OXM molecules offer promise as potential new classes of antidiabetic drugs.  Moreover, recent studies have shown improved therapeutic effects following simultaneous modulation of multiple receptor signalling pathways by combination therapy or use of dual/triple agonist peptides.  However, timing and composition of injections may be important to permit interludes of beta-cell rest.  The review also addresses the possible perils of incretin based drugs for treatment of prediabetes.  Finally, the unanticipated utility of stable gut peptides as effective treatments for complications of diabetes, bone disorders, cognitive impairment and cardiovascular dysfunction is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp6Vp3EMYdeo2y4bB4mnvYfW6udTcc2eb_9t6t0bmzhbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhtVyktA%253D%253D&md5=f9a9c32462e4b174cf1f52b5c958d8df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4239%2Fwjd.v6.i15.1285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4239%252Fwjd.v6.i15.1285%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DN.%26aulast%3DFlatt%26aufirst%3DP.%2BR.%26atitle%3DNew%2520Perspectives%2520on%2520Exploitation%2520of%2520Incretin%2520Peptides%2520for%2520the%2520Treatment%2520of%2520Diabetes%2520and%2520Related%2520Disorders%26jtitle%3DWorld%2520J.%2520Diabetes%26date%3D2015%26volume%3D6%26spage%3D1285%26epage%3D1295%26doi%3D10.4239%2Fwjd.v6.i15.1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span> <span> </span><span class="NLM_article-title">Oral GLP-1 Modulators for the Treatment of Diabetes</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-417150-3.00009-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FB978-0-12-417150-3.00009-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=119-130&author=D.+J.+Edmondsauthor=D.+A.+Price&title=Oral+GLP-1+Modulators+for+the+Treatment+of+Diabetes&doi=10.1016%2FB978-0-12-417150-3.00009-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GLP-1 modulators for the treatment of diabetes</span></div><div class="casAuthors">Edmonds, David J.; Price, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Incretin hormones were postulated following the observation that oral administration of glucose leads to higher and more sustained insulin levels than an equiv. glucose infusion.  Two such hormones were subsequently discovered, named glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (also sometimes referred to as glucose-dependent insulinotropic peptide), and found to stimulate insulin release from pancreatic beta cells.  In this review, the authors discuss the next evolution of the GLP-1 field, which is the invention of GLP -1 receptor modulators that have the convenience of oral administration and the efficacy profile of the injectable peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGnDqcjyXdfLVg90H21EOLACvtfcHk0lhpSxFU-zlzdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu77I&md5=3fb3cee115bc0088384a76e520cd0035</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00009-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00009-0%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DOral%2520GLP-1%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D119%26epage%3D130%26doi%3D10.1016%2FB978-0-12-417150-3.00009-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Discovery at the Glucagon-like Peptide Receptor</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">709893</span>, <span class="refDoi"> DOI: 10.1155/2012/709893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1155%2F2012%2F709893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22611375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC38nksVCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=709893&author=F.+S.+Willardauthor=A.+B.+Buenoauthor=K.+W.+Sloop&title=Small+Molecule+Discovery+at+the+Glucagon-like+Peptide+Receptor&doi=10.1155%2F2012%2F709893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule drug discovery at the glucagon-like peptide-1 receptor</span></div><div class="casAuthors">Willard Francis S; Bueno Ana B; Sloop Kyle W</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">709893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small molecule GLP-1 receptor agonists.  Although the GLP-1 receptor is a member of the structurally complex class B1 family of GPCRs, in recent years, a diverse array of orthosteric and allosteric nonpeptide ligands has been reported.  These compounds include antagonists, agonists, and positive allosteric modulators with intrinsic efficacy.  In this paper, a comprehensive review of currently disclosed small molecule GLP-1 receptor ligands is presented.  In addition, examples of "ligand bias" and "probe dependency" for the GLP-1 receptor are discussed; these emerging concepts may influence further optimization of known molecules or persuade designs of expanded screening strategies to identify novel chemical starting points for GLP-1 receptor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQid3Y_NVG497mQt-ICR3qNfW6udTcc2eawtoTWlUpbDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nksVCitQ%253D%253D&md5=bdde1079f0c47549e4b6636ac1c9e89b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1155%2F2012%2F709893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F709893%26sid%3Dliteratum%253Aachs%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26atitle%3DSmall%2520Molecule%2520Discovery%2520at%2520the%2520Glucagon-like%2520Peptide%2520Receptor%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D709893%26doi%3D10.1155%2F2012%2F709893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofoed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, L.B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensgaard, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thygesen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedtz-Runge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7370</span>– <span class="NLM_lpage">7380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7370-7380&author=J.+Lauauthor=P.+Blochauthor=L.+Schafferauthor=I.+Petterssonauthor=J.+Spetzlerauthor=J.+Kofoedauthor=K.+Madsenauthor=L.B.+Knudsenauthor=J.+McGuireauthor=D.+B.+Steensgaardauthor=H.+M.+Straussauthor=D.+X.+Gramauthor=S.+M.+Knudsenauthor=F.+S.+Nielsenauthor=P.+Thygesenauthor=S.+Reedtz-Rungeauthor=T.+Kruse&title=Discovery+of+the+Once-Weekly+Glucagon-Like+Peptide-1+%28GLP-1%29+Analogue+Semaglutide&doi=10.1021%2Facs.jmedchem.5b00726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span></div><div class="casAuthors">Lau, Jesper; Bloch, Paw; Schaffer, Lauge; Pettersson, Ingrid; Spetzler, Jane; Kofoed, Jacob; Madsen, Kjeld; Knudsen, Lotte Bjerre; McGuire, James; Steensgaard, Dorte Bjerre; Strauss, Holger Martin; Gram, Dorte X.; Knudsen, Sanne Moeller; Nielsen, Flemming Seier; Thygesen, Peter; Reedtz-Runge, Steffen; Kruse, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7370-7380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity.  The aim of the present studies was to design a once weekly GLP-1 analog by increasing albumin affinity and secure full stability against metabolic degrdn.  The fatty acid moiety and the linking chem. to GLP-1 were the key features to secure high albumin affinity and GLP-1 receptor (GLP-1R) potency and in obtaining a prolonged exposure and action of the GLP-1 analog.  Semaglutide was selected as the optimal once weekly candidate.  Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.  The GLP-1R affinity of semaglutide (0.38 ± 0.06 nM) was three-fold decreased compared to liraglutide, whereas the albumin affinity was increased.  The plasma half-life was 46.1 h in mini-pigs following i.v. administration, and semaglutide has an MRT of 63.6 h after s.c. dosing to mini-pigs.  Semaglutide is currently in phase 3 clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tFc0FzEro7Vg90H21EOLACvtfcHk0lhpSxFU-zlzdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM&md5=0478fe17f9f4dcc0cb58919b1c55869a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00726%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DBloch%26aufirst%3DP.%26aulast%3DSchaffer%26aufirst%3DL.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DSpetzler%26aufirst%3DJ.%26aulast%3DKofoed%26aufirst%3DJ.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.B.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DStrauss%26aufirst%3DH.%2BM.%26aulast%3DGram%26aufirst%3DD.%2BX.%26aulast%3DKnudsen%26aufirst%3DS.%2BM.%26aulast%3DNielsen%26aufirst%3DF.%2BS.%26aulast%3DThygesen%26aufirst%3DP.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26aulast%3DKruse%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520the%2520Once-Weekly%2520Glucagon-Like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogue%2520Semaglutide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7370%26epage%3D7380%26doi%3D10.1021%2Facs.jmedchem.5b00726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadereit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4293</span>– <span class="NLM_lpage">4303</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4293-4303&author=A.+Eversauthor=T.+Haackauthor=M.+Lorenzauthor=M.+Bossartauthor=R.+Elvertauthor=B.+Henkelauthor=S.+Stengelinauthor=M.+Kurzauthor=M.+Glienauthor=A.+Duddaauthor=K.+Lorenzauthor=D.+Kadereitauthor=M.+Wagner&title=Design+of+Novel+Exendin-Based+Dual+Glucagon-like+Peptide+1+%28GLP-1%29%2FGlucagon+Receptor+Agonists&doi=10.1021%2Facs.jmedchem.7b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists</span></div><div class="casAuthors">Evers, Andreas; Haack, Torsten; Lorenz, Martin; Bossart, Martin; Elvert, Ralf; Henkel, Bernd; Stengelin, Siegfried; Kurz, Michael; Glien, Maike; Dudda, Angela; Lorenz, Katrin; Kadereit, Dieter; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4293-4303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual activation of the glucagon-like peptide 1 (GLP-1) and glucagon receptor has the potential to lead to a novel therapy principle for the treatment of diabesity.  Here, we report a series of novel peptides with dual activity on these receptors that were discovered by rational design.  On the basis of sequence anal. and structure-based design, structural elements of glucagon were engineered into the selective GLP-1 receptor agonist exendin-4, resulting in hybrid peptides with potent dual GLP-1/glucagon receptor activity.  Detailed structure-activity relationship data are shown.  Further modifications with unnatural and modified amino acids resulted in novel metabolically stable peptides that demonstrated a significant dose-dependent decrease in blood glucose in chronic studies in diabetic db/db mice and reduced body wt. in diet-induced obese (DIO) mice.  Structural anal. by NMR spectroscopy confirmed that the peptides maintain an exendin-4-like structure with its characteristic tryptophan-cage fold motif that is responsible for favorable chem. and phys. stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrewDgurwTT4LVg90H21EOLACvtfcHk0li1jS6BkjsNXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslKrsr8%253D&md5=b59a7a25cdd56516b78c988860b39211</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00174%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DBossart%26aufirst%3DM.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DHenkel%26aufirst%3DB.%26aulast%3DStengelin%26aufirst%3DS.%26aulast%3DKurz%26aufirst%3DM.%26aulast%3DGlien%26aufirst%3DM.%26aulast%3DDudda%26aufirst%3DA.%26aulast%3DLorenz%26aufirst%3DK.%26aulast%3DKadereit%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DDesign%2520of%2520Novel%2520Exendin-Based%2520Dual%2520Glucagon-like%2520Peptide%25201%2520%2528GLP-1%2529%252FGlucagon%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4293%26epage%3D4303%26doi%3D10.1021%2Facs.jmedchem.7b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer-Marek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukasczyk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfenninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadereit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5580</span>– <span class="NLM_lpage">5593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2isLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5580-5593&author=A.+Eversauthor=M.+Bossartauthor=S.+Pfeiffer-Marekauthor=R.+Elvertauthor=H.+Schreuderauthor=M.+Kurzauthor=S.+Stengelinauthor=M.+Lorenzauthor=A.+Herlingauthor=A.+Konkarauthor=U.+Lukasczykauthor=A.+Pfenningerauthor=K.+Lorenzauthor=T.+Haackauthor=D.+Kadereitauthor=M.+Wagner&title=Dual+Glucagon-like+Peptide+1+%28GLP-1%29%2FGlucagon+Receptor+Agonists+Specifically+Optimized+for+Multidose+Formulations&doi=10.1021%2Facs.jmedchem.8b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations</span></div><div class="casAuthors">Evers, Andreas; Bossart, Martin; Pfeiffer-Marek, Stefania; Elvert, Ralf; Schreuder, Herman; Kurz, Michael; Stengelin, Siegfried; Lorenz, Martin; Herling, Andreas; Konkar, Anish; Lukasczyk, Ulrike; Pfenninger, Anja; Lorenz, Katrin; Haack, Torsten; Kadereit, Dieter; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5580-5593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel peptidic dual agonists of the glucagon-like peptide 1 (GLP-1) and glucagon receptor are reported to have enhanced efficacy over pure GLP-1 receptor agonists with regard to treatment of obesity and diabetes.  We describe novel exendin-4 based dual agonists designed with an activity ratio favoring the GLP-1 vs. the glucagon receptor.  As result of an iterative optimization procedure that included mol. modeling, structural biol. studies (X-ray, NMR), peptide design and synthesis, exptl. activity, and soly. profiling, a candidate mol. was identified.  Novel SAR points are reported that allowed us to fine-tune the desired receptor activity ratio and increased soly. in the presence of antimicrobial preservatives, findings that can be of general applicability for any peptide discovery project.  The peptide was evaluated in chronic in vivo studies in obese diabetic monkeys as translational model for the human situation and demonstrated favorable blood glucose and body wt. lowering effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6Q6G9iY2lrVg90H21EOLACvtfcHk0li1jS6BkjsNXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2isLrL&md5=cba1860c3a7b83427ee1cc0336b0e52c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00292%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DBossart%26aufirst%3DM.%26aulast%3DPfeiffer-Marek%26aufirst%3DS.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DKurz%26aufirst%3DM.%26aulast%3DStengelin%26aufirst%3DS.%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DHerling%26aufirst%3DA.%26aulast%3DKonkar%26aufirst%3DA.%26aulast%3DLukasczyk%26aufirst%3DU.%26aulast%3DPfenninger%26aufirst%3DA.%26aulast%3DLorenz%26aufirst%3DK.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DKadereit%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DDual%2520Glucagon-like%2520Peptide%25201%2520%2528GLP-1%2529%252FGlucagon%2520Receptor%2520Agonists%2520Specifically%2520Optimized%2520for%2520Multidose%2520Formulations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5580%26epage%3D5593%26doi%3D10.1021%2Facs.jmedchem.8b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Extending the Structural View of Class B GPCRs</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.tibs.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=29132948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSktb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=946-960&author=C.+De%0AGraafauthor=G.+Songauthor=C.+Caoauthor=Q.+Zhaoauthor=M.-W.+Wangauthor=B.+Wuauthor=R.+C.+Stevens&title=Extending+the+Structural+View+of+Class+B+GPCRs&doi=10.1016%2Fj.tibs.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the Structural View of Class B GPCRs</span></div><div class="casAuthors">de Graaf, Chris; Song, Gaojie; Cao, Can; Zhao, Qiang; Wang, Ming-Wei; Wu, Beili; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">946-960</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The secretin-like class B family of G protein-coupled receptors (GPCRs) are key players in hormonal homeostasis.  Recent structures of various receptors in complex with a variety of orthosteric and allosteric ligands provide fundamental new insights into the function and mechanism of class B GPCRs, including: (i) ligand-induced changes in the relative orientation of the extracellular and transmembrane receptor domains; (ii) intramol. interaction networks that stabilize conformational changes to accommodate intracellular G protein binding; and (iii) allosteric modulation of receptor activation.  This review provides a comprehensive anal. of the structural, biochem., and pharmacol. data on class B GPCRs for understanding ligand-receptor interaction and modulation mechanisms and assessing the potential implications for drug discovery for the secretin-like GPCR family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB3zzE8S9kfrVg90H21EOLACvtfcHk0li1jS6BkjsNXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSktb7E&md5=3e0c0b52f9078a329d3eb80290a44c97</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DM.-W.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DExtending%2520the%2520Structural%2520View%2520of%2520Class%2520B%2520GPCRs%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2017%26volume%3D42%26spage%3D946%26epage%3D960%26doi%3D10.1016%2Fj.tibs.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Emerging Paradigms in GPCR allostery: Implications for Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/nrd4052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnrd4052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23903222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=630-644&author=D.+Woottenauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Emerging+Paradigms+in+GPCR+allostery%3A+Implications+for+Drug+Discovery&doi=10.1038%2Fnrd4052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging paradigms in GPCR allostery: implications for drug discovery</span></div><div class="casAuthors">Wootten, Denise; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">630-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Allosteric ligands bind to G protein-coupled receptors (GPCRs; also known as seven-transmembrane receptors) at sites that are distinct from the sites to which endogenous ligands bind.  The existence of allosteric ligands has enriched the ways in which the functions of GPCRs can be manipulated for potential therapeutic benefit, yet the complexity of their actions provides both challenges and opportunities for drug screening and development.  Converging avenues of research in areas such as biased signalling by allosteric ligands and the mechanisms by which allosteric ligands modulate the effects of diverse endogenous ligands have provided new insights into how interactions between allosteric ligands and GPCRs could be exploited for drug discovery.  These new findings have the potential to alter how screening for allosteric drugs is performed and may increase the chances of success in the development of allosteric modulators as clin. lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRlmQUCUlsLVg90H21EOLACvtfcHk0lgZDno52wxPTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SjtbvO&md5=59b74e5fbd5eeb832785dd879daa7c77</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4052%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DEmerging%2520Paradigms%2520in%2520GPCR%2520allostery%253A%2520Implications%2520for%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D630%26epage%3D644%26doi%3D10.1038%2Fnrd4052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1124/mol.112.079319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fmol.112.079319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22576254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=281-290&author=D.+Woottenauthor=E.+E.+Savageauthor=C.+Valantauthor=L.+T.+Mayauthor=K.+W.+Sloopauthor=J.+Ficorilliauthor=A.+D.+Showalterauthor=F.+S.+Willardauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Allosteric+Modulation+of+Endogenous+Metabolites+as+an+Avenue+for+Drug+Discovery&doi=10.1124%2Fmol.112.079319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of endogenous metabolites as an avenue for drug discovery</span></div><div class="casAuthors">Wootten, Denise; Savage, Emilia E.; Valant, Celine; May, Lauren T.; Sloop, Kyle W.; Ficorilli, James; Showalter, Aaron D.; Willard, Francis S.; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors and a key drug target class.  Recently, allosteric drugs that can cobind with and modulate the activity of the endogenous ligand(s) for the receptor have become a major focus of the pharmaceutical and biotechnol. industry for the development of novel GPCR therapeutic agents.  This class of drugs has distinct properties compared with drugs targeting the endogenous (orthosteric) ligand-binding site that include the ability to sculpt cellular signaling and to respond differently in the presence of discrete orthosteric ligands, a behavior termed "probe dependence.".  Here, using cell signaling assays combined with ex vivo and in vivo studies of insulin secretion, we demonstrate that allosteric ligands can cause marked potentiation of previously "inert" metabolic products of neurotransmitters and peptide hormones, a novel consequence of the phenomenon of probe dependence.  Indeed, at the muscarinic M2 receptor and glucagon-like peptide 1 (GLP-1) receptor, allosteric potentiation of the metabolites, choline and GLP-1(9-36)NH2, resp., was ∼100-fold and up to 200-fold greater than that seen with the physiol. signaling mols. acetylcholine and GLP-1(7-36)NH2.  Modulation of GLP-1(9-36)NH2 was also demonstrated in ex vivo and in vivo assays of insulin secretion.  This work opens up new avenues for allosteric drug discovery by directly targeting modulation of metabolites, but it also identifies a behavior that could contribute to unexpected clin. outcomes if interaction of allosteric drugs with metabolites is not part of their preclin. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAjsIIKnjaMLVg90H21EOLACvtfcHk0lgZDno52wxPTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrurvO&md5=fa4b734eb8c2f533cea5ca0cf4ab06e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.079319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.079319%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSavage%26aufirst%3DE.%2BE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26aulast%3DFicorilli%26aufirst%3DJ.%26aulast%3DShowalter%26aufirst%3DA.%2BD.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DAllosteric%2520Modulation%2520of%2520Endogenous%2520Metabolites%2520as%2520an%2520Avenue%2520for%2520Drug%2520Discovery%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D281%26epage%3D290%26doi%3D10.1124%2Fmol.112.079319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span>; <span class="NLM_string-name">Hong, Y.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Von Geldern, T. W.</span>; <span class="NLM_string-name">Zhang, K. E.</span></span> <span> </span><span class="NLM_article-title">Phenylalanine Derivatives and Their Use as Non-Peptide GLP-1 Receptor Modulators</span>. <span class="NLM_patent">WO 2011/094890</span> and <span class="NLM_patent">WO 2011/097300</span>, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liao%2C+J.%3B+Hong%2C+Y.%3B+Wang%2C+Y.%3B+Von+Geldern%2C+T.+W.%3B+Zhang%2C+K.+E.+Phenylalanine+Derivatives+and+Their+Use+as+Non-Peptide+GLP-1+Receptor+Modulators.+WO+2011%2F094890+and+WO+2011%2F097300%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26atitle%3DPhenylalanine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Non-Peptide%2520GLP-1%2520Receptor%2520Modulators" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e2892</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0002892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1371%2Fjournal.pone.0002892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18682834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD1crgtVGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2892&author=H.+Suauthor=M.+Heauthor=H.+Liauthor=Q.+Liuauthor=J.+Wangauthor=Y.+Wangauthor=W.+Gaoauthor=L.+Zhouauthor=J.+Liaoauthor=A.+A.+Youngauthor=M.-W.+Wang&title=Boc5%2C+a+Non-Peptidic+Glucagon-Like+Peptide-1+Receptor+Agonist%2C+Invokes+Sustained+Glycemic+Control+and+Weight+Loss+in+Diabetic+Mice&doi=10.1371%2Fjournal.pone.0002892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice</span></div><div class="casAuthors">Su Haoran; He Min; Li Hongmei; Liu Qing; Wang Jia; Wang Yiqian; Gao Weiwei; Zhou Ling; Liao Jiayu; Young Andrew A; Wang Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e2892</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our recent discovery of the substituted cyclobutane Boc5, one of the first non-peptidic agonists at glucagon-like peptide-1 receptors, offers the potential of combining oral availability with full agonism capable of eliciting antidiabetic and antiobesity effects.  The present study was aimed at determining the in vivo pharmacologic properties of Boc5 in both normal and diabetic mice following chronic administration, with emphasis on glycemic control and weight loss.  METHODOLOGY/PRINCIPAL FINDINGS:  C57BL/6J and db/db mice were treated daily with Boc5 for 4 weeks and a range of pharmacologic parameters, including hemoglobin A1c, intraperitoneal glucose tolerance, insulin tolerance, fasting insulin and leptin levels, food intake, body weight and fat mass, were assessed before and after the treatment.  Effects on food intake, gastric emptying, and insulinogenic index were also investigated in animals acutely administered with Boc5.  Boc5 (3 mg) was able to induce a durable restoration of glycemic control (normalization of both hemoglobin A1c and intraperitoneal glucose tolerance) in db/db mice, following 4 weeks of daily administration.  As with peptidic glucagon-like peptide-1 receptor agonists, its glycemic benefit and weight (fat) loss were associated with dose-dependent effects that included reduction in food intake, slowing of gastric emptying (both of which reduce nutrient-drive at beta-cells), stimulation of insulin secretion (which was glucose-dependent), and elevation in insulin sensitivity.  There was little effect on normal mice treated in the same manner.  CONCLUSIONS/SIGNIFICANCE:  Our findings suggest that Boc5 is the only non-peptidic molecule reported thus far to simultaneously activate this spectrum of antidiabetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0xID2dFlutresJRIHUP1ofW6udTcc2eYhjKawEQN907ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crgtVGqtA%253D%253D&md5=14f710abf52ecef18f3df53a65f91f26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002892%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DA.%2BA.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DBoc5%252C%2520a%2520Non-Peptidic%2520Glucagon-Like%2520Peptide-1%2520Receptor%2520Agonist%252C%2520Invokes%2520Sustained%2520Glycemic%2520Control%2520and%2520Weight%2520Loss%2520in%2520Diabetic%2520Mice%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2892%26doi%3D10.1371%2Fjournal.pone.0002892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesing, E. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Cyclobutane Derivatives as Novel Non-Peptidic Small Molecule Agonists of Glucagon-like Peptide-1 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1021/jm201150j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201150j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2ktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=250-267&author=Q.+Liuauthor=N.+Liauthor=Y.+Yuanauthor=H.+Luauthor=X.+Wuauthor=C.+Zhouauthor=M.+Heauthor=H.+Suauthor=M.+Zhangauthor=J.+Wangauthor=B.+Wangauthor=Y.+Wangauthor=D.+Maauthor=Y.+Yeauthor=H.-C.+Weissauthor=E.+R.+F.+Gesingauthor=J.+Liaoauthor=M.-W.+Wang&title=Cyclobutane+Derivatives+as+Novel+Non-Peptidic+Small+Molecule+Agonists+of+Glucagon-like+Peptide-1+Receptor&doi=10.1021%2Fjm201150j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutane Derivatives As Novel Nonpeptidic Small Molecule Agonists of Glucagon-Like Peptide-1 Receptor</span></div><div class="casAuthors">Liu, Qing; Li, Na; Yuan, Yunyun; Lu, Huilu; Wu, Xiaoyan; Zhou, Caihong; He, Min; Su, Haoran; Zhang, Meng; Wang, Jia; Wang, Bao; Wang, You; Na, Dawei; Ye, Yang; Weiss, Hans-Christoph; Gesing, Ernst R. F.; Liao, Jiayu; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">250-267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel cyclobutane class of nonpeptidic glucagon-like peptide-1 (GLP-1) receptor agonists, exemplified by 3, was identified using receptor binding and multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assays.  The structures of 3 and its three isomers were elucidated by NMR, HRESIMS, and X-ray crystallog.  A series of structural modifications were also made based on the core structure of 3 with different substitution groups at the west and east ends.  Among these analogs, compd. 16 was found to be 4- to 5-fold more potent than 3 both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XNB9-G7vYrVg90H21EOLACvtfcHk0ljTSa_mlbGZHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2ktrjJ&md5=ea10cfadd0acfc6f8ecb5cd86fe7837e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm201150j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201150j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DH.-C.%26aulast%3DGesing%26aufirst%3DE.%2BR.%2BF.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DCyclobutane%2520Derivatives%2520as%2520Novel%2520Non-Peptidic%2520Small%2520Molecule%2520Agonists%2520of%2520Glucagon-like%2520Peptide-1%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D250%26epage%3D267%26doi%3D10.1021%2Fjm201150j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>See company
Web site: <a href="http://vtvtherapeutics.com/pipeline/ttp273" class="extLink">http://vtvtherapeutics.com/pipeline/ttp273</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+company%0AWeb+site%3A+http%3A%2F%2Fvtvtherapeutics.com%2Fpipeline%2Fttp273+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mjalli, A. M. M.</span>; <span class="NLM_string-name">Behme, C.</span>; <span class="NLM_string-name">Christen, D. P.</span>; <span class="NLM_string-name">Polisetti, D. R.</span>; <span class="NLM_string-name">Quada, J.</span>; <span class="NLM_string-name">Santhosh, K.</span>; <span class="NLM_string-name">Bondlela, M.</span>; <span class="NLM_string-name">Guzel, M.</span>; <span class="NLM_string-name">Yarragunta, R. R.</span>; <span class="NLM_string-name">Gohimukkula, D. R.</span>; <span class="NLM_string-name">Andrews, R. C.</span>; <span class="NLM_string-name">Davis, S. T.</span>; <span class="NLM_string-name">Yokum, T. S.</span>; <span class="NLM_string-name">Freeman, J. L. R.</span></span> <span> </span><span class="NLM_article-title">Substituted azoantracene derivatives, pharmaceutical compositions, and methods of use thereof</span>. <span class="NLM_patent">WO 2010/114824</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+M.+M.+Mjalli&author=C.+Behme&author=D.+P.+Christen&author=D.+R.+Polisetti&author=J.+Quada&author=K.+Santhosh&author=M.+Bondlela&author=M.+Guzel&author=R.+R.+Yarragunta&author=D.+R.+Gohimukkula&author=R.+C.+Andrews&author=S.+T.+Davis&author=T.+S.+Yokum&author=J.+L.+R.+Freeman&title=Substituted+azoantracene+derivatives%2C+pharmaceutical+compositions%2C+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMjalli%26aufirst%3DA.%2BM.%2BM.%26atitle%3DSubstituted%2520azoantracene%2520derivatives%252C%2520pharmaceutical%2520compositions%252C%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almariego, D.</span>; <span class="NLM_string-name">Polisetti, D. R.</span>; <span class="NLM_string-name">Benjamin, E.</span>; <span class="NLM_string-name">El Abdellaoui, H.</span>; <span class="NLM_string-name">Sahoo, S. P.</span></span> <span> </span><span class="NLM_article-title">Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof</span>. <span class="NLM_patent">WO 2013/142569</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Almariego&author=D.+R.+Polisetti&author=E.+Benjamin&author=H.+El+Abdellaoui&author=S.+P.+Sahoo&title=Tris%28hydroxymethyl%29aminomethane+salts+of+a+small-molecule+GLP1R+agonist+and+pharmaceutical+compositions+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmariego%26aufirst%3DD.%26atitle%3DTris%2528hydroxymethyl%2529aminomethane%2520salts%2520of%2520a%2520small-molecule%2520GLP1R%2520agonist%2520and%2520pharmaceutical%2520compositions%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>LOGRA:
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in
Subjects With Type 2 Diabetes, NCT02653599. <a href="https://clinicaltrials.gov/ct2/show/NCT02653599" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02653599</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LOGRA%3A%0AA+Study+to+Evaluate+Safety+and+Efficacy+of+TTP273+for+12+Weeks+in%0ASubjects+With+Type+2+Diabetes%2C+NCT02653599.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02653599+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>Pfizer
company pipeline. <a href="https://www.pfizer.com/science/drug-product-pipeline" class="extLink">https://www.pfizer.com/science/drug-product-pipeline</a> (consulted on Sep 3, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pfizer%0Acompany+pipeline.+https%3A%2F%2Fwww.pfizer.com%2Fscience%2Fdrug-product-pipeline+%28consulted+on+Sep+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span>Company
pipeline. <a href="https://www.lilly.com/discovery/pipeline" class="extLink">https://www.lilly.com/discovery/pipeline</a> (consulted on Sep 3, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Company%0Apipeline.+https%3A%2F%2Fwww.lilly.com%2Fdiscovery%2Fpipeline+%28consulted+on+Sep+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span>; <span class="NLM_string-name">Tanino, F.</span>; <span class="NLM_string-name">Fukazawa, M.</span>; <span class="NLM_string-name">Ogawa, K.</span>; <span class="NLM_string-name">Nagao, S.</span>; <span class="NLM_string-name">Yoshino, H.</span>; <span class="NLM_string-name">Komatsu, S.-I.</span>; <span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Kawabe, Y.</span></span> <span> </span><span class="NLM_article-title">OWL833, an Orally Active Nonpeptide GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion and Reduces Food Intake of Cynomolgus Monkeys</span>. Presented at the American Diabetes Association, 78th Scientific Sessions, Orlando, FL, <span class="NLM_year">2018</span>; Poster 1118.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=T.+Kawai&author=F.+Tanino&author=M.+Fukazawa&author=K.+Ogawa&author=S.+Nagao&author=H.+Yoshino&author=S.-I.+Komatsu&author=Y.+Suzuki&author=Y.+Kawabe&title=OWL833%2C+an+Orally+Active+Nonpeptide+GLP-1+Receptor+Agonist%2C+Improves+Glucose+Tolerance+by+Increasing+Insulin+Secretion+and+Reduces+Food+Intake+of+Cynomolgus+Monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DT.%26atitle%3DOWL833%252C%2520an%2520Orally%2520Active%2520Nonpeptide%2520GLP-1%2520Receptor%2520Agonist%252C%2520Improves%2520Glucose%2520Tolerance%2520by%2520Increasing%2520Insulin%2520Secretion%2520and%2520Reduces%2520Food%2520Intake%2520of%2520Cynomolgus%2520Monkeys%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span>; <span class="NLM_string-name">Bagley, S. W.</span>; <span class="NLM_string-name">Curto, J. M.</span>; <span class="NLM_string-name">Doivling, M. S.</span>; <span class="NLM_string-name">Edmonds, D.</span>; <span class="NLM_string-name">Flanagan, M. E.</span>; <span class="NLM_string-name">Futatsugi, K.</span>; <span class="NLM_string-name">Griffith, D. A.</span>; <span class="NLM_string-name">Huard, K.</span>; <span class="NLM_string-name">Ingle, G.</span>; <span class="NLM_string-name">Jiao, W.</span>; <span class="NLM_string-name">Limberskis, C.</span>; <span class="NLM_string-name">Ylathiowctz, A. M.</span>; <span class="NLM_string-name">Piotrowski, D. W.</span>; <span class="NLM_string-name">Ruggeri, R. B.</span></span> <span> </span><span class="NLM_article-title">GLP1 Agonists and Uses Thereof</span>. <span class="NLM_patent">US 20180170908</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+E.+Aspnes&author=S.+W.+Bagley&author=J.+M.+Curto&author=M.+S.+Doivling&author=D.+Edmonds&author=M.+E.+Flanagan&author=K.+Futatsugi&author=D.+A.+Griffith&author=K.+Huard&author=G.+Ingle&author=W.+Jiao&author=C.+Limberskis&author=A.+M.+Ylathiowctz&author=D.+W.+Piotrowski&author=R.+B.+Ruggeri&title=GLP1+Agonists+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26atitle%3DGLP1%2520Agonists%2520and%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshino, H.</span>; <span class="NLM_string-name">Tsuchiya, S.</span>; <span class="NLM_string-name">Matsuo, A.</span>; <span class="NLM_string-name">Sato, T.</span>; <span class="NLM_string-name">Nishimoto, M.</span>; <span class="NLM_string-name">Oguri, K.</span>; <span class="NLM_string-name">Ogawa, H.</span>; <span class="NLM_string-name">Nishimura, Y.</span>; <span class="NLM_string-name">Furuta, Y.</span>; <span class="NLM_string-name">Kashiwagi, H.</span>; <span class="NLM_string-name">Hori, N.</span>; <span class="NLM_string-name">Kamon, T.</span>; <span class="NLM_string-name">Shiraishi, T.</span>; <span class="NLM_string-name">Yoshida, S.</span>; <span class="NLM_string-name">Kawai, T.</span>; <span class="NLM_string-name">Tanida, S.</span>; <span class="NLM_string-name">Aoki, M.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyridine Derivative having GLP-1 Receptor Agonist Effect</span>. <span class="NLM_patent">WO 2018/056453</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=H.+Yoshino&author=S.+Tsuchiya&author=A.+Matsuo&author=T.+Sato&author=M.+Nishimoto&author=K.+Oguri&author=H.+Ogawa&author=Y.+Nishimura&author=Y.+Furuta&author=H.+Kashiwagi&author=N.+Hori&author=T.+Kamon&author=T.+Shiraishi&author=S.+Yoshida&author=T.+Kawai&author=S.+Tanida&author=M.+Aoki&title=Pyrazolopyridine+Derivative+having+GLP-1+Receptor+Agonist+Effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYoshino%26aufirst%3DH.%26atitle%3DPyrazolopyridine%2520Derivative%2520having%2520GLP-1%2520Receptor%2520Agonist%2520Effect%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainscott, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutsman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span> <span> </span><span class="NLM_article-title">Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10715</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.696039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1074%2Fjbc.M115.696039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26975372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVamt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10700-10715&author=A.+B.+Buenoauthor=A.+D.+Showalterauthor=D.+B.+Wainscottauthor=C.+Stutsmanauthor=A.+Mar%C3%ADnauthor=J.+Ficorilliauthor=O.+Cabreraauthor=F.+S.+Willardauthor=K.+W.+Sloop&title=Positive+Allosteric+Modulation+of+the+Glucagon-like+Peptide-1+Receptor+by+Diverse+Electrophiles&doi=10.1074%2Fjbc.M115.696039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles</span></div><div class="casAuthors">Bueno, Ana B.; Showalter, Aaron D.; Wainscott, David B.; Stutsman, Cynthia; Marin, Aranzazu; Ficorilli, James; Cabrera, Over; Willard, Francis S.; Sloop, Kyle W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10700-10715</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Therapeutic intervention to activate the glucagon-like peptide-1 receptor (GLP-1R) enhances glucose-dependent insulin secretion and improves energy balance in patients with type 2 diabetes mellitus.  Studies investigating mechanisms whereby peptide ligands activate GLP-1R have utilized mutagenesis, receptor chimeras, photo-affinity labeling, hydrogen-deuterium exchange, and crystallog. of the ligand-binding ectodomain to establish receptor homol. models.  However, this has not enabled the design or discovery of drug-like non-peptide GLP-1R activators.  Recently, studies investigating 4-(3-benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), a GLP-1R-pos. allosteric modulator, detd. that Cys 347 in the GLP-1R is required for pos. allosteric modulator activity via covalent modification.  To advance small mol. activation of the GLP-1R, the authors characterized the insulinotropic mechanism of BETP.  In guanosine 5'-3-O-(thio)triphosphate binding and INS1 832-3 insulinoma cell cAMP assays, BETP enhanced GLP-1(9-36)-NH2-stimulated cAMP signaling.  Using isolated pancreatic islets, BETP potentiated insulin secretion in a glucose-dependent manner that requires both the peptide ligand and GLP-1R.  In studies of the covalent mechanism, PAGE fluorog. showed labeling of GLP-1R in immunopptn. expts. from GLP-1R-expressing cells incubated with [3H]BETP.  Furthermore, the authors investigated whether other reported GLP-1R activators and compds. identified from screening campaigns modulate GLP-1R by covalent modification.  Similar to BETP, several mols. were found to enhance GLP-1R signaling in a Cys 347-dependent manner.  These chemotypes are electrophiles that react with GSH, and LC/MS detd. the cysteine adducts formed upon conjugation.  Together, the authors' results suggest covalent modification may be used to stabilize the GLP-1R in an active conformation.  Moreover, the findings provide pharmacol. guidance for the discovery and characterization of small mol. GLP-1R ligands as possible therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg9lAp7MV5N7Vg90H21EOLACvtfcHk0liMFCIQhcJdow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVamt7w%253D&md5=5b003ca0630b264ebd333a374dc3fabf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.696039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.696039%26sid%3Dliteratum%253Aachs%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DShowalter%26aufirst%3DA.%2BD.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DStutsman%26aufirst%3DC.%26aulast%3DMar%25C3%25ADn%26aufirst%3DA.%26aulast%3DFicorilli%26aufirst%3DJ.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26atitle%3DPositive%2520Allosteric%2520Modulation%2520of%2520the%2520Glucagon-like%2520Peptide-1%2520Receptor%2520by%2520Diverse%2520Electrophiles%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D10700%26epage%3D10715%26doi%3D10.1074%2Fjbc.M115.696039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span> <span> </span><span class="NLM_article-title">A Potentiator of Orthosteric Ligand Activity at GLP-1R acts via Covalent Modification</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnchembio.1581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=24997604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=629-631&author=W.+M.+Nolteauthor=J.+P.+Fortinauthor=B.+D.+Stevensauthor=G.+E.+Aspnesauthor=D.+A.+Griffithauthor=L.+R.+Hothauthor=R.+B.+Ruggeriauthor=A.+M.+Mathiowetzauthor=C.+Limberakisauthor=D.+Hepworthauthor=P.+A.+Carpino&title=A+Potentiator+of+Orthosteric+Ligand+Activity+at+GLP-1R+acts+via+Covalent+Modification&doi=10.1038%2Fnchembio.1581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification</span></div><div class="casAuthors">Nolte, Whitney M.; Fortin, Jean-Philippe; Stevens, Benjamin D.; Aspnes, Gary E.; Griffith, David A.; Hoth, Lise R.; Ruggeri, Roger B.; Mathiowetz, Alan M.; Limberakis, Chris; Hepworth, David; Carpino, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">629-631</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report that 4-(3-(benzyloxy)phenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), which behaves as a pos. allosteric modulator at the glucagon-like peptide-1 receptor (GLP-1R), covalently modifies cysteines 347 and 438 in GLP-1R.  C347, located in intracellular loop 3 of GLP-1R, is crit. to the activity of BETP and a structurally distinct GLP-1R ago-allosteric modulator, N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine.  We further show that substitution of cysteine for phenylalanine 345 in the glucagon receptor is sufficient to confer sensitivity to BETP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRJ3ys4ywhgLVg90H21EOLACvtfcHk0liMFCIQhcJdow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrO&md5=9b0d431ea2c96e8889f774c50fdf9452</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1581%26sid%3Dliteratum%253Aachs%26aulast%3DNolte%26aufirst%3DW.%2BM.%26aulast%3DFortin%26aufirst%3DJ.%2BP.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DGriffith%26aufirst%3DD.%2BA.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26atitle%3DA%2520Potentiator%2520of%2520Orthosteric%2520Ligand%2520Activity%2520at%2520GLP-1R%2520acts%2520via%2520Covalent%2520Modification%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D629%26epage%3D631%26doi%3D10.1038%2Fnchembio.1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Corresponding in vitro data are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Moorjani, M.</span>; <span class="NLM_string-name">Tamiya, J.</span>; <span class="NLM_string-name">Huang, L.</span>; <span class="NLM_string-name">Yeager, A. R.</span>; <span class="NLM_string-name">Brahmachary, E.</span>; <span class="NLM_string-name">Fowler, T.</span>; <span class="NLM_string-name">Novak, A.</span>; <span class="NLM_string-name">Meghani, P.</span>, <span class="NLM_string-name">Knaags, M.</span></span> <span> </span><span class="NLM_article-title">Novel GLP-1 Receptor Modulators</span>. <span class="NLM_patent">WO 2016/015014</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Boehm&author=E.+Martinborough&author=M.+Moorjani&author=J.+Tamiya&author=L.+Huang&author=A.+R.+Yeager&author=E.+Brahmachary&author=T.+Fowler&author=A.+Novak&author=P.+Meghani&author=M.+Knaags&title=Novel+GLP-1+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%26atitle%3DNovel%2520GLP-1%2520Receptor%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nance, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Days, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locuson, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10192</span>– <span class="NLM_lpage">10197</span>, <span class="refDoi"> DOI: 10.1021/jm501375c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501375c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10192-10197&author=L.+C.+Morrisauthor=K.+D.+Nanceauthor=P.+R.+Gentryauthor=E.+L.+Daysauthor=C.+D.+Weaverauthor=C.+M.+Niswenderauthor=A.+D.+Thompsonauthor=C.+K.+Jonesauthor=C.+W.+Locusonauthor=R.+D.+Morrisonauthor=J.+S.+Danielsauthor=K.+D.+Niswenderauthor=C.+W.+Lindsley&title=Discovery+of+%28S%29-2-Cyclopentyl-N-%28%281-isopropylpyrrolidin2-yl%29-9-methyl-1-oxo-2%2C9-dihydro-1H-pyrrido%5B3%2C4-b%5Dindole-4-carboxamide+%28VU0453379%29%3A+A+Novel%2C+CNS+Penetrant+Glucagon-like+Peptide+1+Receptor+%28GLP-1R%29+Positive+Allosteric+Modulator+%28PAM%29&doi=10.1021%2Fjm501375c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin-2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)</span></div><div class="casAuthors">Morris, Lindsey C.; Nance, Kellie D.; Gentry, Patrick R.; Days, Emily L.; Weaver, C. David; Niswender, Colleen M.; Thompson, Analisa D.; Jones, Carrie K.; Locuson, Chuck W.; Morrison, Ryan D.; Daniels, J. Scott; Niswender, Kevin D.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10192-10197</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A duplexed, functional multiaddn. high throughput screening and subsequent iterative parallel synthesis effort identified the first highly selective and CNS penetrant glucagon-like peptide-1R (GLP-1R) pos. allosteric modulator (PAM).  PAM 1H-pyrido[3,4-b]indole-4-carboxamide deriv. I potentiated low-dose exenatide to augment insulin secretion in primary mouse pancreatic islets, and it alone was effective in potentiating endogenous GLP-1R to reverse haloperidol-induced catalepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHpe3U-qyvtbVg90H21EOLACvtfcHk0ljX-0jbNyAu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrbE&md5=e2b51406183729a3429e9d666df12e7b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm501375c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501375c%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DL.%2BC.%26aulast%3DNance%26aufirst%3DK.%2BD.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DDays%26aufirst%3DE.%2BL.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLocuson%26aufirst%3DC.%2BW.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DK.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-2-Cyclopentyl-N-%2528%25281-isopropylpyrrolidin2-yl%2529-9-methyl-1-oxo-2%252C9-dihydro-1H-pyrrido%255B3%252C4-b%255Dindole-4-carboxamide%2520%2528VU0453379%2529%253A%2520A%2520Novel%252C%2520CNS%2520Penetrant%2520Glucagon-like%2520Peptide%25201%2520Receptor%2520%2528GLP-1R%2529%2520Positive%2520Allosteric%2520Modulator%2520%2528PAM%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10192%26epage%3D10197%26doi%3D10.1021%2Fjm501375c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G.</span>; <span class="NLM_string-name">Clemons, B.</span>; <span class="NLM_string-name">Desale, H.</span>; <span class="NLM_string-name">Dvorak, L.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Peach, R. J.</span>; <span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">RPC8844 Is a Small Molecule GLP-1R Positive Allosteric Modulator for GLP-1(7-36), GLP-1(9-36) and Oxyntomodulin, and Enhances Glucose-Stimulated Insulin Secretion from Human Pancreatic Islets</span>. Presented at the American Diabetes Association, 76th Scientific Sessions, New Orleans, LA, <span class="NLM_year">2016</span>; Poster 1080.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Reinhart&author=B.+Clemons&author=H.+Desale&author=L.+Dvorak&author=E.+Martinborough&author=M.+Boehm&author=R.+J.+Peach&author=F.+L.+Scott&title=RPC8844+Is+a+Small+Molecule+GLP-1R+Positive+Allosteric+Modulator+for+GLP-1%287-36%29%2C+GLP-1%289-36%29+and+Oxyntomodulin%2C+and+Enhances+Glucose-Stimulated+Insulin+Secretion+from+Human+Pancreatic+Islets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReinhart%26aufirst%3DG.%26atitle%3DRPC8844%2520Is%2520a%2520Small%2520Molecule%2520GLP-1R%2520Positive%2520Allosteric%2520Modulator%2520for%2520GLP-1%25287-36%2529%252C%2520GLP-1%25289-36%2529%2520and%2520Oxyntomodulin%252C%2520and%2520Enhances%2520Glucose-Stimulated%2520Insulin%2520Secretion%2520from%2520Human%2520Pancreatic%2520Islets%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G.</span>; <span class="NLM_string-name">Clemons, B.</span>; <span class="NLM_string-name">Desale, H.</span>; <span class="NLM_string-name">Dvorak, L.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Peach, R. J.</span>; <span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">RPC8844 Is a Small Molecule GLP-1R Positive Allosteric Modulator that Significantly Improves Hyperglycemia and Induces Weight Loss in Type 2 Diabetes Disease Models after Daily Oral Administration</span>. Presented at the American Diabetes Association, 76th Scientific Sessions, New Orleans, LA, <span class="NLM_year">2016</span>; Poster 1107.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Reinhart&author=B.+Clemons&author=H.+Desale&author=L.+Dvorak&author=E.+Martinborough&author=M.+Boehm&author=R.+J.+Peach&author=F.+L.+Scott&title=RPC8844+Is+a+Small+Molecule+GLP-1R+Positive+Allosteric+Modulator+that+Significantly+Improves+Hyperglycemia+and+Induces+Weight+Loss+in+Type+2+Diabetes+Disease+Models+after+Daily+Oral+Administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReinhart%26aufirst%3DG.%26atitle%3DRPC8844%2520Is%2520a%2520Small%2520Molecule%2520GLP-1R%2520Positive%2520Allosteric%2520Modulator%2520that%2520Significantly%2520Improves%2520Hyperglycemia%2520and%2520Induces%2520Weight%2520Loss%2520in%2520Type%25202%2520Diabetes%2520Disease%2520Models%2520after%2520Daily%2520Oral%2520Administration%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rijkelijkhuizen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuarrie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girman, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijpels, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, J.-M.</span></span> <span> </span><span class="NLM_article-title">Effects of Meal Size and Composition on Incretin, α-Cell, and β-Cell Responses</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2009.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.metabol.2009.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19846181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=502-511&author=J.+M.+Rijkelijkhuizenauthor=K.+McQuarrieauthor=C.+J.+Girmanauthor=P.+P.+Steinauthor=A.+Mariauthor=J.+J.+Holstauthor=G.+Nijpelsauthor=J.-M.+Dekker&title=Effects+of+Meal+Size+and+Composition+on+Incretin%2C+%CE%B1-Cell%2C+and+%CE%B2-Cell+Responses&doi=10.1016%2Fj.metabol.2009.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of meal size and composition on incretin, α-cell, and β-cell responses</span></div><div class="casAuthors">Rijkelijkhuizen, Josina M.; McQuarrie, Kelly; Girman, Cynthia J.; Stein, Peter P.; Mari, Andrea; Holst, Jens J.; Nijpels, Giel; Dekker, Jacqueline M.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">502-511</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate postprandial insulin release from the β-cells.  We investigated the effects of 3 standardized meals with different caloric and nutritional content in terms of postprandial glucose, insulin, glucagon, and incretin responses.  In a randomized crossover study, 18 subjects with type 2 diabetes mellitus and 6 healthy volunteers underwent three 4-h meal tolerance tests (small carbohydrate [CH]-rich meal, large CH-rich meal, and fat-rich meal).  Non-model-based and model-based ests. of β-cell function and incremental areas under the curve of glucose, insulin, C-peptide, glucagon, GLP-1, and GIP were calcd.  Mixed models and Friedman tests were used to test for differences in meal responses.  The large CH-rich meal and fat-rich meal resulted in a slightly larger insulin response as compared with the small CH-rich meal and led to a slightly shorter period of hyperglycemia, but only in healthy subjects.  Model-based insulin secretion ests. did not show pronounced differences between meals.  Both in healthy individuals and in those with diabetes, more CH resulted in higher GLP-1 release.  In contrast with the other meals, GIP release was still rising 2 h after the fat-rich meal.  The initial glucagon response was stimulated by the large CH-rich meal, whereas the fat-rich meal induced a late glucagon response.  Fat preferentially stimulates GIP secretion, whereas CH stimulates GLP-1 secretion.  Differences in meal size and compn. led to differences in insulin and incretin responses but not to differences in postprandial glucose levels of the well-controlled patients with diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHXyrJtxaXLVg90H21EOLACvtfcHk0ljX-0jbNyAu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSrsrw%253D&md5=908e5073675fb9488311b9897ab9048f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2009.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2009.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DRijkelijkhuizen%26aufirst%3DJ.%2BM.%26aulast%3DMcQuarrie%26aufirst%3DK.%26aulast%3DGirman%26aufirst%3DC.%2BJ.%26aulast%3DStein%26aufirst%3DP.%2BP.%26aulast%3DMari%26aufirst%3DA.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DNijpels%26aufirst%3DG.%26aulast%3DDekker%26aufirst%3DJ.-M.%26atitle%3DEffects%2520of%2520Meal%2520Size%2520and%2520Composition%2520on%2520Incretin%252C%2520%25CE%25B1-Cell%252C%2520and%2520%25CE%25B2-Cell%2520Responses%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2010%26volume%3D59%26spage%3D502%26epage%3D511%26doi%3D10.1016%2Fj.metabol.2009.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">Solid-Phase Parallel Synthesis of Natural Product-like Diaza-bridged Heterocycles through Pictet-Spengler Intramolecular Cyclization</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1021/cc0501054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc0501054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=50-57&author=S.-C+Leeauthor=S.+B.+Park&title=Solid-Phase+Parallel+Synthesis+of+Natural+Product-like+Diaza-bridged+Heterocycles+through+Pictet-Spengler+Intramolecular+Cyclization&doi=10.1021%2Fcc0501054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Parallel Synthesis of Natural Product-Like Diaza-Bridged Heterocycles through Pictet-Spengler Intramolecular Cyclization</span></div><div class="casAuthors">Lee, Sung-Chan; Park, Seung Bum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multistep, practical solid-phase strategy for the synthesis of natural product-like diaza-bridged heterocycles was developed.  A key step in the library synthesis is tandem acidolytic cleavage with subsequent in situ iminium formation followed by the Pictet-Spengler intramol. cyclization.  The Pictet-Spengler-type intramol. cyclization step was regioselective and diastereoselective to give final products as single diastereomers in exceptional yields and purities, which was confirmed by NMR structural study and LC/MS anal.  This approach is exemplified by the prepn. of a 384-member library of 3,9-diazabicyclo[3.3.1]non-6-en-2-one skeletons, fused with indole and dihydroxybenzene and diversified at two bridging nitrogen atoms, using the solid-phase parallel synthetic methodol. without further purifn.  In this pilot library, two diastereomerically enriched diaza-bridged core skeletons were modified by amide and urea bond formation on bridging nitrogen atoms, and this scheme exhibits the potential for expansion to obtain further diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvLQVyw2DQ8bVg90H21EOLACvtfcHk0lgorXKZuLYVsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyqsbzI&md5=533526608c1ca9a6d5e24f66111e1515</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcc0501054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0501054%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-C%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DSolid-Phase%2520Parallel%2520Synthesis%2520of%2520Natural%2520Product-like%2520Diaza-bridged%2520Heterocycles%2520through%2520Pictet-Spengler%2520Intramolecular%2520Cyclization%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2006%26volume%3D8%26spage%3D50%26epage%3D57%26doi%3D10.1021%2Fcc0501054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H. A.</span></span> <span> </span><span class="NLM_article-title">’Rule of Three’ for Fragment-Based Lead Discovery?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+A.+Jhoti&title=%E2%80%99Rule+of+Three%E2%80%99+for+Fragment-Based+Lead+Discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eZXA59G4YPDMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%2BA.%26atitle%3D%25E2%2580%2599Rule%2520of%2520Three%25E2%2580%2599%2520for%2520Fragment-Based%2520Lead%2520Discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">For preparation of amine <b>15</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span>Eurofins
CEREP SA, Le bois l’Evêque, 86600 Celle-Lévescault,
France. <a href="http://www.eurofins.com" class="extLink">http://www.eurofins.com</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eurofins%0ACEREP+SA%2C+Le+bois+l%E2%80%99Ev%C3%AAque%2C+86600+Celle-L%C3%A9vescault%2C%0AFrance.+http%3A%2F%2Fwww.eurofins.com+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">Full selectivity data given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="note"><p class="first last">In our internal assay systems, reference compounds <b>5</b> and <b>6</b> proved to be inferior in shifting the EC<sub>50</sub> value for GLP1(9–36)NH<sub>2</sub>. See <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a> for corresponding data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="note"><p class="first last">Compound <b>19</b> showed no effect on the agonistic activity of glucagon on the cAMP accumulation assay on HEK2 cells overexpressing the GLP1-R.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">This inhibitory effect had also been observed with other isomerically pure compounds from this series, and therefore it was considered unprobable that it arised from one of the diasteroisomers only.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">Unfortunately, we did not have access to islets of GLP1R(−/−) rats, while in vitro data showed that efficacy of these compounds in recombinant mouse and rat orthologues assays is comparable to the human assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazayeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teobald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dore, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the GLP-1 Receptor Bound to a Peptide Agonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1038/nature22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnature22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=28562585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=254-258&author=A.+Jazayeriauthor=M.+Rappasauthor=A.+J.+H.+Brownauthor=J.+Keanauthor=J.+C.+Erreyauthor=N.+J.+Robertsonauthor=C.+Fiez-Vandalauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=A.+Bortolatoauthor=J.+S.+Masonauthor=A.+H.+Baigauthor=I.+Teobaldauthor=A.+S.+Doreauthor=M.+Weirauthor=R.+M.+Cookeauthor=F.+H.+Marshall&title=Crystal+Structure+of+the+GLP-1+Receptor+Bound+to+a+Peptide+Agonist&doi=10.1038%2Fnature22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span></div><div class="casAuthors">Jazayeri, Ali; Rappas, Mathieu; Brown, Alastair J. H.; Kean, James; Errey, James C.; Robertson, Nathan J.; Fiez-Vandal, Cedric; Andrews, Stephen P.; Congreve, Miles; Bortolato, Andrea; Mason, Jonathan S.; Baig, Asma H.; Teobald, Iryna; Dore, Andrew S.; Weir, Malcolm; Cooke, Robert M.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">254-258</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas.  GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes.  To gain insight into the mol. mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist.  The peptide agonist retains an α-helical conformation as it sits deep within the receptor-binding pocket.  The arrangement of the transmembrane helixes reveals hallmarks of an active conformation similar to that obsd. in class A receptors.  Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ibc110QxrVg90H21EOLACvtfcHk0lgorXKZuLYVsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D&md5=0a5c99161af8bae506a184e0ab6306c1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22800%26sid%3Dliteratum%253Aachs%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKean%26aufirst%3DJ.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%2BJ.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DBaig%26aufirst%3DA.%2BH.%26aulast%3DTeobald%26aufirst%3DI.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520GLP-1%2520Receptor%2520Bound%2520to%2520a%2520Peptide%2520Agonist%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D254%26epage%3D258%26doi%3D10.1038%2Fnature22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Vega, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span> <span> </span><span class="NLM_article-title">Conformational Thermostabilization of the Beta1-Adrenergic Receptor in a Detergent-Resistant Form</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1073/pnas.0711253105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1073%2Fpnas.0711253105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18192400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1eqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=877-882&author=M.+J.+Serrano-Vegaauthor=F.+Magnaniauthor=Y.+Shibataauthor=C.+G.+Tate&title=Conformational+Thermostabilization+of+the+Beta1-Adrenergic+Receptor+in+a+Detergent-Resistant+Form&doi=10.1073%2Fpnas.0711253105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form</span></div><div class="casAuthors">Serrano-Vega, Maria J.; Magnani, Francesca; Shibata, Yoko; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">There are ≈ 350 non-odorant G protein-coupled receptors (GPCRs) encoded by the human genome, many of which are predicted to be potential therapeutic targets, but there are only two structures available to represent the whole of the family.  The authors hypothesized that improving the detergent stability of these receptors and simultaneously locking them into one preferred conformation will greatly improve the chances of crystn.  The authors developed a generic strategy for the isolation of detergent-solubilized thermostable mutants of a GPCR, the β1-adrenergic receptor.  The most stable mutant receptor, βAR-m23, contained six point mutations that led to an apparent Tm 21°C higher than the native protein, and, in the presence of bound antagonist, βAR-m23 was as stable as bovine rhodopsin.  In addn., βAR-m23 was significantly more stable in a wide range of detergents ideal for crystn. and was preferentially in an antagonist conformation in the absence of ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIc_m__7gNUrVg90H21EOLACvtfcHk0lgUK19ZUht36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1eqtLs%253D&md5=19c8e268961afb861cd123a1934ae162</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711253105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711253105%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Vega%26aufirst%3DM.%2BJ.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DConformational%2520Thermostabilization%2520of%2520the%2520Beta1-Adrenergic%2520Receptor%2520in%2520a%2520Detergent-Resistant%2520Form%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D877%26epage%3D882%26doi%3D10.1073%2Fpnas.0711253105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+Procedure+for+Modeling+Ligand%2FReceptor+Induced+Fit+Effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0lgUK19ZUht36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520Procedure%2520for%2520Modeling%2520Ligand%252FReceptor%2520Induced%2520Fit%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Polar Transmembrane Interactions Drive Formation of Ligand-Specific and Signal Pathway-biased Family B G Protein-Coupled Receptor Conformation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5211</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1073/pnas.1221585110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1073%2Fpnas.1221585110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23479653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVelt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5211-5216&author=D.+Woottenauthor=J.+Simmsauthor=L.+J.+Millerauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Polar+Transmembrane+Interactions+Drive+Formation+of+Ligand-Specific+and+Signal+Pathway-biased+Family+B+G+Protein-Coupled+Receptor+Conformation&doi=10.1073%2Fpnas.1221585110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations</span></div><div class="casAuthors">Wootten, Denise; Simms, John; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5211-5216, S5211/1-S5211/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Recently, the concept of ligand-directed signaling - the ability of different ligands of an individual receptor to promote distinct patterns of cellular response - has gained much traction in the field of drug discovery, with the potential to sculpt biol. response to favor therapeutically beneficial signaling pathways over those leading to harmful effects.  However, there is limited understanding of the mechanistic basis underlying biased signaling.  The glucagon-like peptide-1 receptor is a major target for treatment of type-2 diabetes and is subject to ligand-directed signaling.  Importance of polar transmembrane residues conserved within family B G protein-coupled receptors, not only for protein folding and expression, but also in controlling activation transition, ligand-biased, and pathway-biased signaling.  Distinct clusters of polar residues were important for receptor activation and signal preference, globally changing the profile of receptor response to distinct peptide ligands, including endogenous ligands glucagon-like peptide-1, oxyntomodulin, and the clin. used mimetic exendin-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYFX8fAi9607Vg90H21EOLACvtfcHk0lgUK19ZUht36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVelt7o%253D&md5=c37b65fb9e9fded3208f392ec0ab71f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221585110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221585110%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DPolar%2520Transmembrane%2520Interactions%2520Drive%2520Formation%2520of%2520Ligand-Specific%2520and%2520Signal%2520Pathway-biased%2520Family%2520B%2520G%2520Protein-Coupled%2520Receptor%2520Conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5211%26epage%3D5216%26doi%3D10.1073%2Fpnas.1221585110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coopman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willars, G. B.</span></span> <span> </span><span class="NLM_article-title">Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1804</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1210/me.2011-1160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1210%2Fme.2011-1160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=21868452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOkurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1804-1818&author=K.+Coopmanauthor=R.+Wallisauthor=G.+Robbauthor=A.+J.+H.+Brownauthor=G.+F.+Wilkinsonauthor=D.+Timmsauthor=G.+B.+Willars&title=Residues+within+the+Transmembrane+Domain+of+the+Glucagon-Like+Peptide-1+Receptor+Involved+in+Ligand+Binding+and+Receptor+Activation%3A+Modelling+the+Ligand-Bound+Receptor&doi=10.1210%2Fme.2011-1160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor</span></div><div class="casAuthors">Coopman, K.; Wallis, R.; Robb, G.; Brown, A. J. H.; Wilkinson, G. F.; Timms, D.; Willars, G. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1804-1818</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The C-terminal regions of glucagon-like peptide-1 (GLP-1) bind to the N terminus of the GLP-1 receptor (GLP-1R), facilitating interaction of the ligand N terminus with the receptor transmembrane domain.  In contrast, the agonist exendin-4 relies less on the transmembrane domain, and truncated antagonist analogs (e.g. exendin 9-39) may interact solely with the receptor N terminus.  Here we used mutagenesis to explore the role of residues highly conserved in the predicted transmembrane helixes of mammalian GLP-1Rs and conserved in family B G protein coupled receptors in ligand binding and GLP-1R activation.  By iteration using information from the mutagenesis, along with the available crystal structure of the receptor N terminus and a model of the active opsin transmembrane domain, we developed a structural receptor model with GLP-1 bound and used this to better understand consequences of mutations.  Mutation at Y152 [transmembrane helix (TM) 1], R190 (TM2), Y235 (TM3), H363 (TM6), and E364 (TM6) produced similar redns. in affinity for GLP-1 and exendin 9-39.  In contrast, other mutations either preferentially [K197 (TM2), Q234 (TM3), and W284 (extracellular loop 2)] or solely [D198 (TM2) and R310 (TM5)] reduced GLP-1 affinity.  Reduced agonist affinity was always assocd. with reduced potency.  However, redns. in potency exceeded redns. in agonist affinity for K197A, W284A, and R310A, while H363A was uncoupled from cAMP generation, highlighting crit. roles of these residues in translating binding to activation.  Data show important roles in ligand binding and receptor activation of conserved residues within the transmembrane domain of the GLP-1R.  The receptor structural model provides insight into the roles of these residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25eaT7V1l2LVg90H21EOLACvtfcHk0lhlzAw4xfRMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOkurjK&md5=616cc74cd7fa6cdfc44bedca8420f527</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1210%2Fme.2011-1160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2011-1160%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DK.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DWilkinson%26aufirst%3DG.%2BF.%26aulast%3DTimms%26aufirst%3DD.%26aulast%3DWillars%26aufirst%3DG.%2BB.%26atitle%3DResidues%2520within%2520the%2520Transmembrane%2520Domain%2520of%2520the%2520Glucagon-Like%2520Peptide-1%2520Receptor%2520Involved%2520in%2520Ligand%2520Binding%2520and%2520Receptor%2520Activation%253A%2520Modelling%2520the%2520Ligand-Bound%2520Receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D1804%26epage%3D1818%26doi%3D10.1210%2Fme.2011-1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrasch, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM Structure of the Activated GLP-1 Receptor in Complex with a G Protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature22394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnature22394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=28538729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=248-253&author=Y.+Zhangauthor=B.+Sunauthor=D.+Fengauthor=H.+Huauthor=M.+Chuauthor=Q.+Quauthor=J.+T.+Tarraschauthor=S.+Liauthor=T.+S.+Kobilkaauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Cryo-EM+Structure+of+the+Activated+GLP-1+Receptor+in+Complex+with+a+G+Protein&doi=10.1038%2Fnature22394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span></div><div class="casAuthors">Zhang, Yan; Sun, Bingfa; Feng, Dan; Hu, Hongli; Chu, Matthew; Qu, Qianhui; Tarrasch, Jeffrey T.; Li, Shane; Sun Kobilka, Tong; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) is a hormone with essential roles in regulating insulin secretion, carbohydrate metab. and appetite.  GLP-1 effects are mediated through binding to the GLP-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) that signals primarily through the stimulatory G protein Gs.  Class B GPCRs are important therapeutic targets; however, our understanding of their mechanism of action is limited by the lack of structural information on activated and full-length receptors.  Here we report the cryo-electron microscopy structure of the peptide-activated GLP-1R-Gs complex at near at. resoln.  The peptide is clasped between the N-terminal domain and the transmembrane core of the receptor, and further stabilized by extracellular loops.  Conformational changes in the transmembrane domain result in a sharp kink in the middle of transmembrane helix 6, which pivots its intracellular half outward to accommodate the α5-helix of the Ras-like domain of Gs.  These results provide a structural framework for understanding class B GPCR activation through hormone binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRFGRwMs1bVg90H21EOLACvtfcHk0lhlzAw4xfRMJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D&md5=5e7ebd94012ba47ecc299ad0502975de</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnature22394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22394%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DTarrasch%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DCryo-EM%2520Structure%2520of%2520the%2520Activated%2520GLP-1%2520Receptor%2520in%2520Complex%2520with%2520a%2520G%2520Protein%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature22394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giacomini, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgren, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamek-Gliszczynski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Membrane Transporters in Drug Development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nrd3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.+M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+Transporters+in+Drug+Development&doi=10.1038%2Fnrd3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0ljnpZchXPCFmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520Transporters%2520in%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236%26doi%3D10.1038%2Fnrd3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalliokoski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemi, M.</span></span> <span> </span><span class="NLM_article-title">Impact of OATP Transporters on Pharmacokinetics</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00430.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1111%2Fj.1476-5381.2009.00430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19785645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=693-705&author=A.+Kalliokoskiauthor=M.+Niemi&title=Impact+of+OATP+Transporters+on+Pharmacokinetics&doi=10.1111%2Fj.1476-5381.2009.00430.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of OATP transporters on pharmacokinetics</span></div><div class="casAuthors">Kalliokoski, A.; Niemi, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Membrane transporters are now recognized as important determinants of the transmembrane passage of drugs.  Org. anion transporting polypeptides (OATP) form a family of influx transporters expressed in various tissues important for pharmacokinetics.  Of the 11 human OATP transporters, OATP1B1, OATP1B3 and OATP2B1 are expressed on the sinusoidal membrane of hepatocytes and can facilitate the liver uptake of their substrate drugs.  OATP1A2 is expressed on the luminal membrane of small intestinal enterocytes and at the blood-brain barrier, potentially mediating drug transport at these sites.  Several clin. used drugs have been identified as substrates of OATP transporters (e.g. many statins are substrates of OATP1B1).  Some drugs may inhibit OATP transporters (e.g. cyclosporine) causing pharmacokinetic drug-drug interactions.  Moreover, genetic variability in genes encoding OATP transporters can result in marked inter-individual differences in pharmacokinetics.  For example, a single nucleotide polymorphism (c.521T > C, p.Val174Ala) in the SLCO1B1 gene encoding OATP1B1 decreases the ability of OATP1B1 to transport active simvastatin acid from portal circulation into the liver, resulting in markedly increased plasma concns. of simvastatin acid and an enhanced risk of simvastatin-induced myopathy.  SLCO1B1 polymorphism also affects the pharmacokinetics of many other, but not all (fluvastatin), statins and that of the antidiabetic drug repaglinide, the antihistamine fexofenadine and the endothelin A receptor antagonist atrasentan.  This review compiles the current knowledge about the expression and function of human OATP transporters, their substrate and inhibitor specificities, as well as pharmacogenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTPf2q4a0OLVg90H21EOLACvtfcHk0ljnpZchXPCFmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7rE&md5=0a07b22ca5cd25c31eebb7a557bca183</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00430.x%26sid%3Dliteratum%253Aachs%26aulast%3DKalliokoski%26aufirst%3DA.%26aulast%3DNiemi%26aufirst%3DM.%26atitle%3DImpact%2520of%2520OATP%2520Transporters%2520on%2520Pharmacokinetics%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D693%26epage%3D705%26doi%3D10.1111%2Fj.1476-5381.2009.00430.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vildhede, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norinder, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haglund, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4740</span>– <span class="NLM_lpage">4763</span>, <span class="refDoi"> DOI: 10.1021/jm300212s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300212s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4740-4763&author=M.+Karlgrenauthor=A.+Vildhedeauthor=U.+Norinderauthor=J.+R.+Wisniewskiauthor=E.+Kimotoauthor=Y.+Laiauthor=U.+Haglundauthor=P.+Artursson&title=Classification+of+Inhibitors+of+Hepatic+Organic+Anion+Transporting+Polypeptides+%28OATPs%29%3A+Influence+of+Protein+Expression+on+Drug%E2%80%93Drug+Interactions&doi=10.1021%2Fjm300212s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug-Drug Interactions</span></div><div class="casAuthors">Karlgren, Maria; Vildhede, Anna; Norinder, Ulf; Wisniewski, Jacek R.; Kimoto, Emi; Lai, Yurong; Haglund, Ulf; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4740-4763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatic org. anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clin. drug-drug interactions.  Predicting potential interactions with OATPs is, therefore, of value.  Here, we developed in vitro and in silico models for identification and prediction of specific and general inhibitors of OATP1B1, OATP1B3, and OATP2B1.  The maximal transport activity (MTA) of each OATP in human liver was predicted from transport kinetics and protein quantification.  We then used MTA to predict the effects of a subset of inhibitors on atorvastatin uptake in vivo.  Using a data set of 225 drug-like compds., 91 OATP inhibitors were identified.  In silico models indicated that lipophilicity and polar surface area are key mol. features of OATP inhibition.  MTA predictions identified OATP1B1 and OATP1B3 as major determinants of atorvastatin uptake in vivo.  The relative contributions to overall hepatic uptake varied with isoform specificities of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTZXuqAFWG7Vg90H21EOLACvtfcHk0ljnpZchXPCFmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqur0%253D&md5=460b8f4ca6a399a16881f5fafd7f3b1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300212s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300212s%26sid%3Dliteratum%253Aachs%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DVildhede%26aufirst%3DA.%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DWisniewski%26aufirst%3DJ.%2BR.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DHaglund%26aufirst%3DU.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DClassification%2520of%2520Inhibitors%2520of%2520Hepatic%2520Organic%2520Anion%2520Transporting%2520Polypeptides%2520%2528OATPs%2529%253A%2520Influence%2520of%2520Protein%2520Expression%2520on%2520Drug%25E2%2580%2593Drug%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4740%26epage%3D4763%26doi%3D10.1021%2Fjm300212s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotsampasakou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Inhibitors of Arganic Anion Transporting Polypeptides 1B1 and 1B3 (PATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4395</span>– <span class="NLM_lpage">4404</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00583</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00583" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Gks77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4395-4404&author=E.+Kotsampasakouauthor=S.+Brennerauthor=S.+J%C3%A4gerauthor=G.+F.+Ecker&title=Identification+of+Novel+Inhibitors+of+Arganic+Anion+Transporting+Polypeptides+1B1+and+1B3+%28PATP1B1+and+OATP1B3%29+Using+a+Consensus+Vote+of+Six+Classification+Models&doi=10.1021%2Facs.molpharmaceut.5b00583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models</span></div><div class="casAuthors">Kotsampasakou, Eleni; Brenner, Stefan; Jaeger, Walter; Ecker, Gerhard F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4395-4404</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Org. anion transporting polypeptides 1B1 and 1B3 are transporters selectively expressed on the basolateral membrane of the hepatocyte.  Several studies reveal that they are involved in drug-drug interactions, cancer, and hyperbilirubinemia.  In this study, we developed a set of classification models for OATP1B1 and 1B3 inhibition based on more than 1700 carefully curated compds. from literature, which were validated via cross-validation and by use of an external test set.  After combining several sets of descriptors and classifiers, the 6 best models were selected according to their statistical performance and were used for virtual screening of DrugBank.  Consensus scoring of the screened compds. resulted in the selection and purchase of nine compds. as potential dual inhibitors and of one compd. as potential selective OATP1B3 inhibitor.  Biol. testing of the compds. confirmed the validity of the models, yielding an accuracy of 90% for OATP1B1 and 80% for OATP1B3, resp.  Moreover, at least half of the new identified inhibitors are assocd. with hyperbilirubinemia or hepatotoxicity, implying a relationship between OATP inhibition and these severe side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQ9NCKeW4y7Vg90H21EOLACvtfcHk0lj8W7AytW2OQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Gks77E&md5=5809374e111405f7fbc161e45d77b800</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00583%26sid%3Dliteratum%253Aachs%26aulast%3DKotsampasakou%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DS.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26atitle%3DIdentification%2520of%2520Novel%2520Inhibitors%2520of%2520Arganic%2520Anion%2520Transporting%2520Polypeptides%25201B1%2520and%25201B3%2520%2528PATP1B1%2520and%2520OATP1B3%2529%2520Using%2520a%2520Consensus%2520Vote%2520of%2520Six%2520Classification%2520Models%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4395%26epage%3D4404%26doi%3D10.1021%2Facs.molpharmaceut.5b00583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matter, H.</span>; <span class="NLM_string-name">Buning, C.</span>; <span class="NLM_string-name">Giegerich, C.</span></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Matter%2C+H.%3B+Buning%2C+C.%3B+Giegerich%2C+C.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharom, F. J.</span></span> <span> </span><span class="NLM_article-title">ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.2217/14622416.9.1.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.2217%2F14622416.9.1.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18154452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=105-127&author=F.+J.+Sharom&title=ABC+Multidrug+Transporters%3A+Structure%2C+Function+and+Role+in+Chemoresistance&doi=10.2217%2F14622416.9.1.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">ABC multidrug transporters: structure, function and role in chemoresistance</span></div><div class="casAuthors">Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">PARMFL</span>;
        ISSN:<span class="NLM_cas:issn">1462-2416</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Three ATP-binding cassette (ABC)-superfamily multidrug efflux pumps are known to be responsible for chemoresistance; P-glycoprotein (ABCB1), MRP1 (ABCC1) and ABCG2 (BCRP).  These transporters play an important role in normal physiol. by protecting tissues from toxic xenobiotics and endogenous metabolites.  Hydrophobic amphipathic compds., including many clin. used drugs, interact with the substrate-binding pocket of these proteins via flexible hydrophobic and H-bonding interactions.  These efflux pumps are expressed in many human tumors, where they likely contribute to resistance to chemotherapy treatment.  However, the use of efflux-pump modulators in clin. cancer treatment has proved disappointing.  Single nucleotide polymorphisms in ABC drug-efflux pumps may play a role in responses to drug therapy and disease susceptibility.  The effect of various genotypes and haplotypes on the expression and function of these proteins is not yet clear, and their true impact remains controversial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodtANKweyrPrVg90H21EOLACvtfcHk0lj8W7AytW2OQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOjsg%253D%253D&md5=7594f33bc3a524c65d3622b00750dbe6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2217%2F14622416.9.1.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14622416.9.1.105%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520Multidrug%2520Transporters%253A%2520Structure%252C%2520Function%2520and%2520Role%2520in%2520Chemoresistance%26jtitle%3DPharmacogenomics%26date%3D2008%26volume%3D9%26spage%3D105%26epage%3D127%26doi%3D10.2217%2F14622416.9.1.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aller, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittaboina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbatsch, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span> <span> </span><span class="NLM_article-title">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">1718</span>– <span class="NLM_lpage">1722</span>, <span class="refDoi"> DOI: 10.1126/science.1168750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-Glycoprotein+Reveals+a+Molecular+Basis+for+Poly-Specific+Drug+Binding&doi=10.1126%2Fscience.1168750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0lj8W7AytW2OQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-Glycoprotein%2520Reveals%2520a%2520Molecular%2520Basis%2520for%2520Poly-Specific%2520Drug%2520Binding%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722%26doi%3D10.1126%2Fscience.1168750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nies, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span> <span> </span><span class="NLM_article-title">Interplay of Conjugating Enzymes with OATP Uptake Transporters and ABCC/MRP Efflux Pumps in the Elimination of Drugs</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1517/17425255.4.5.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1517%2F17425255.4.5.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18484914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=545-568&author=A.+T.+Niesauthor=M.+Schwabauthor=D.+Keppler&title=Interplay+of+Conjugating+Enzymes+with+OATP+Uptake+Transporters+and+ABCC%2FMRP+Efflux+Pumps+in+the+Elimination+of+Drugs&doi=10.1517%2F17425255.4.5.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs</span></div><div class="casAuthors">Nies, Anne T.; Schwab, Matthias; Keppler, Dietrich</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-568</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Biliary excretion is a major elimination route of many drugs and their metabolites.  Hepatobiliary elimination is a vectorial process involving uptake transporters in the basolateral hepatocyte membrane, possibly Phase I and Phase II metabolizing enzymes, and ATP-dependent efflux pumps in the apical hepatocyte membrane.  Because many drugs and their metabolites are anions, this review focuses on transporters involved in their hepatocellular uptake (members of the org. anion transporting polypeptide (OATP) family) and biliary elimination (apical conjugate efflux pump ABCC2/MRP2).  The mol. and functional characteristics of the human OATP and ABCC/MRP transporters are presented, including a detailed overview of endogenous and drug substrates.  Examples illustrate the interplay of transporters with Phase II conjugating enzymes.  Model systems to study the vectorial transport of org. anions are also discussed.  OATP uptake transporters, conjugating enzymes, and ABCC2/MRP2 work in concert to enable the hepatobiliary elimination of anionic drugs and their metabolites.  It is increasingly important to understand how genetic variants of these transporters and enzymes influence the interindividual variability of drug elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQlXbU-NQPbVg90H21EOLACvtfcHk0lj8W7AytW2OQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWrtrg%253D&md5=b7bf0bd75a0b09427bf5d8ac58fc5e53</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.5.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.5.545%26sid%3Dliteratum%253Aachs%26aulast%3DNies%26aufirst%3DA.%2BT.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DKeppler%26aufirst%3DD.%26atitle%3DInterplay%2520of%2520Conjugating%2520Enzymes%2520with%2520OATP%2520Uptake%2520Transporters%2520and%2520ABCC%252FMRP%2520Efflux%2520Pumps%2520in%2520the%2520Elimination%2520of%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D545%26epage%3D568%26doi%3D10.1517%2F17425255.4.5.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkaichi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirouchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, T.</span></span> <span> </span><span class="NLM_article-title">Integrated Approach of in Vivo and in Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats using Rifampicin as an Inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1442</span>– <span class="NLM_lpage">1449</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.051052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.113.051052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23640987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1442-1449&author=T.+Imaokaauthor=T.+Mikkaichiauthor=K.+Abeauthor=M.+Hirouchiauthor=N.+Okudairaauthor=T.+Izumi&title=Integrated+Approach+of+in+Vivo+and+in+Vitro+Evaluation+of+the+Involvement+of+Hepatic+Uptake+Organic+Anion+Transporters+in+the+Drug+Disposition+in+Rats+using+Rifampicin+as+an+Inhibitor&doi=10.1124%2Fdmd.113.051052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor</span></div><div class="casAuthors">Imaoka, Tomoki; Mikkaichi, Tsuyoshi; Abe, Koji; Hirouchi, Masakazu; Okudaira, Noriko; Izumi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1442-1449</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cumulative studies describe the importance of drug transporters as one of the key determinants of pharmacokinetics that necessitate investigation and assessment of the involvement of drug transporters in drug discovery and development.  The present study investigated an integrated in vivo and in vitro approach to det. the involvement of org. anion transporting polypeptides (Oatps) in the disposition of drugs in rats using rifampicin as an inhibitor.  When bromosulfophthalein (BSP) and HMG-CoA reductase inhibitors (statins), which were used as model substrates for Oatps, were administered i.v. (3 and 1 mg/kg, resp.) to rats pretreated with rifampicin orally (30 mg/kg), the total plasma clearance of BSP and statins was attenuated compared with that in control rats, suggesting the involvement of Oatps in the disposition of these drugs in vivo.  On the other hand, the pharmacokinetics of midazolam, used as a model substrate of cytochrome P 450 3a (Cyp3a), was unchanged between control rats and rifampicin-pretreated rats.  The involvement of Oatps in the disposition of statins obsd. in vivo was further clarified by employing an in vitro hepatic uptake study and media-loss assay in the presence or absence of 100 μM rifampicin.  Hepatic intrinsic clearance was reduced in the presence of rifampicin in both the media-loss assay and hepatocyte uptake study.  The present study suggests in vivo investigations in rats using rifampicin together with in vitro investigations with a media-loss assay and/or uptake assay using rat hepatocytes can help det. whether a clin. drug-drug interaction study is necessary in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3jdG9AtaNLVg90H21EOLACvtfcHk0lgzbjPALgZlzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtr7N&md5=7144466f633a54164000d0f5fdbfb6e1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.051052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.051052%26sid%3Dliteratum%253Aachs%26aulast%3DImaoka%26aufirst%3DT.%26aulast%3DMikkaichi%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DN.%26aulast%3DIzumi%26aufirst%3DT.%26atitle%3DIntegrated%2520Approach%2520of%2520in%2520Vivo%2520and%2520in%2520Vitro%2520Evaluation%2520of%2520the%2520Involvement%2520of%2520Hepatic%2520Uptake%2520Organic%2520Anion%2520Transporters%2520in%2520the%2520Drug%2520Disposition%2520in%2520Rats%2520using%2520Rifampicin%2520as%2520an%2520Inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1442%26epage%3D1449%26doi%3D10.1124%2Fdmd.113.051052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shingaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijuin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashinaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Oatp and Mrp2 Activities in Hepatobiliary Excretion Using Newly Developed Positron Emission Tomography Tracer [<sup>11</sup>C]Dehydropravastatin in Rats</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.206425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fjpet.113.206425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23926287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=193-202&author=T.+Shingakiauthor=T.+Takashimaauthor=R.+Ijuinauthor=X.+Zhangauthor=T.+Onoueauthor=Y.+Katayamaauthor=T.+Okauchiauthor=E.+Hayashinakaauthor=Y.+Cuiauthor=Y.+Wadaauthor=M.+Suzukiauthor=K.+Maedaauthor=H.+Kusuharaauthor=Y.+Sugiyamaauthor=Y.+Watanabe&title=Evaluation+of+Oatp+and+Mrp2+Activities+in+Hepatobiliary+Excretion+Using+Newly+Developed+Positron+Emission+Tomography+Tracer+%5B11C%5DDehydropravastatin+in+Rats&doi=10.1124%2Fjpet.113.206425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats</span></div><div class="casAuthors">Shingaki, Tomotaka; Takashima, Tadayuki; Ijuin, Ryosuke; Zhang, Xuan; Onoue, Tomohiro; Katayama, Yumiko; Okauchi, Takashi; Hayashinaka, Emi; Cui, Yilong; Wada, Yasuhiro; Suzuki, Masaaki; Maeda, Kazuya; Kusuhara, Hiroyuki; Sugiyama, Yuichi; Watanabe, Yasuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-202</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We developed a pravastatin deriv., sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S)-6-hydroxy-2-methyl-8-((1-[11C]-(E)-2-methyl-but-2-enoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate ([11C]DPV), as a positron emission tomog. (PET) probe for noninvasive measurement of hepatobiliary transport, and conducted pharmacokinetic anal. in rats as a feasibility study for future clin. study.  Transport activities of DPV in freshly isolated rat hepatocytes and rodent multidrug resistance-assocd. protein 2 (rMrp2; human, MRP2)-expressing membrane vesicles were similar to those of pravastatin.  Rifampicin diminished the uptake of DPV and pravastatin by the hepatocytes, with similar inhibition potency.  [11C]DPV underwent biotransformation to produce at least two metabolites in rat, but metab. of [11C]DPV occurred negligibly in human hepatocytes during a 90-min incubation.  After i.v. injection, [11C]DPV was mainly distributed to the liver and kidneys, where the tissue uptake clearances (CLuptake,liver and CLuptake,kidney) were blood-flow-limited (73.6 ± 4.8 and 24.6 ± 0.6 mL/min per kg, resp.).  Systemic elimination of [11C]DPV was delayed in rifampicin-treated rat and an Mrp2-deficient mutant rat, Eisai hyperbilirubinemic mutant rat (EHBR).  Rifampicin treatment decreased both CLuptake,liver and CLuptake,kidney of [11C]DPV by 30% (P < 0.05), whereas these parameters were unchanged in EHBR.  Meanwhile, the canalicular efflux clearance (CLint,bile) of [11C]DPV, which was 12.2 ± 1.5 mL/min per kg in the control rat, decreased by 60% and 89% in rifampicin-treated rat and EHBR (P < 0.05), resp.  These results indicate that [11C]DPV is taken up into the liver by org. anion-transporting polypeptides (rodent, Oatps; human, OATP) and excreted into bile by Mrp2 in rat, and that rifampicin may inhibit Mrp2 as well as Oatps, and consequently increase systemic exposure of [11C]DPV.  PET using [11C]DPV is feasible for studies prior to the future clin. investigation of OATP and MRP2 functionality, esp. for personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouxK1RXE4HfbVg90H21EOLACvtfcHk0lgzbjPALgZlzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jP&md5=3cfb24088a48bed605bb0155271d8c27</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.206425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.206425%26sid%3Dliteratum%253Aachs%26aulast%3DShingaki%26aufirst%3DT.%26aulast%3DTakashima%26aufirst%3DT.%26aulast%3DIjuin%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOnoue%26aufirst%3DT.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DHayashinaka%26aufirst%3DE.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26atitle%3DEvaluation%2520of%2520Oatp%2520and%2520Mrp2%2520Activities%2520in%2520Hepatobiliary%2520Excretion%2520Using%2520Newly%2520Developed%2520Positron%2520Emission%2520Tomography%2520Tracer%2520%255B11C%255DDehydropravastatin%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D193%26epage%3D202%26doi%3D10.1124%2Fjpet.113.206425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span> <span> </span><span class="NLM_article-title">Liver Uptake of Cefditoren is Mediated by OATP1B1 and OATP2B1 in Humans and Oatp1a1, Oatp1a4, and Oatp1b2 in Rats</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">30038</span>– <span class="NLM_lpage">30048</span>, <span class="refDoi"> DOI: 10.1039/C7RA03537C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1039%2FC7RA03537C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1GktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=30038-30048&author=H.+Wangauthor=P.+Sunauthor=C.+Wangauthor=Q.+Mengauthor=Z.+Liuauthor=X.+Huoauthor=H.+Sunauthor=X.+Maauthor=J.+Pengauthor=K.+Liu&title=Liver+Uptake+of+Cefditoren+is+Mediated+by+OATP1B1+and+OATP2B1+in+Humans+and+Oatp1a1%2C+Oatp1a4%2C+and+Oatp1b2+in+Rats&doi=10.1039%2FC7RA03537C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats</span></div><div class="casAuthors">Wang, Hepeng; Sun, Pengyuan; Wang, Changyuan; Meng, Qiang; Liu, Zhihao; Huo, Xiaokui; Sun, Huijun; Ma, Xiaodong; Peng, Jinyong; Liu, Kexin</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">30038-30048</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cefditoren, a β-lactam antibiotic, is widely used in respiratory tract and skin infections in the clinic.  This study was aimed at investigating the mechanism underlying hepatic uptake of cefditoren in rats and humans.  Cmax of cefditoren plasma exposure was increased (0.80 ± 0.06 to 1.02 ± 0.16 μg mL-1) when co-administrated with rifampicin.  Extn. ratio of cefditoren was decreased (34.70% ± 4.61% to 18.30% ± 2.89%) by combining with rifampicin in perfused rat livers in situ.  Uptake of cefditoren by rat liver slices was temp.-dependent and significantly inhibited by Oatp modulators, such as ibuprofen, digoxin, cyclosporin A and glycyrrhizic acid, but not by tetraethylammonium or p-aminohippurate.  Uptake of cefditoren in hOATP1B1- and hOATP2B1-human embryonic kidney (HEK) 293 cells indicated a saturable process with a Km of 189.7 ± 60.4 μmol L-1 and 122.7 ± 37.37 μmol L-1, resp.  Sartans inhibited the transport of cefditoren in hOATP1B1- and hOATP2B1-HEK293 cells.  Moreover, cefditoren could increase the gene and protein expression levels of Oatp1a1 in rat liver, while Oatp1a4 and Oatp1b2 were unchanged.  These results indicated that OATP1B1 and OATP2B1 are involved in hepatic uptake of cefditoren in humans, and multiple Oatps (Oatp1a1, Oatp1a4 and Oatp1b2) might participate in this process in rats.  In addn., cefditoren could prompt the up-regulation of Oatp1a1 expression.  In the clinic, addnl. attention should be paid to the alternative exposure of cefditoren when co-administrated with sartans or other drugs that are substrates or inhibitors of OATP1B1 and/or OATP2B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQwcE7J7T07Vg90H21EOLACvtfcHk0lh6c5nrsOKpjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1GktL0%253D&md5=d4d9bbd28db205fc21326ccab9514123</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC7RA03537C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA03537C%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHuo%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26atitle%3DLiver%2520Uptake%2520of%2520Cefditoren%2520is%2520Mediated%2520by%2520OATP1B1%2520and%2520OATP2B1%2520in%2520Humans%2520and%2520Oatp1a1%252C%2520Oatp1a4%252C%2520and%2520Oatp1b2%2520in%2520Rats%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D30038%26epage%3D30048%26doi%3D10.1039%2FC7RA03537C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-HJ.</span></span> <span> </span><span class="NLM_article-title">Influence of Rifampicin on the Pharmacokinetics of Salvianolic Acid B May Involve Inhibition of Organic Anion Transporting Polypeptide (Oatp) Mediated Influx</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1002/ptr.3522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fptr.3522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=21567510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjsl2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=118-121&author=D.+Zhaoauthor=Z.-D.+Gaoauthor=D.+Hanauthor=N.+Liauthor=Y.-J.+Zhangauthor=Y.+Luauthor=T.-T+Liauthor=X.-HJ.+Chen&title=Influence+of+Rifampicin+on+the+Pharmacokinetics+of+Salvianolic+Acid+B+May+Involve+Inhibition+of+Organic+Anion+Transporting+Polypeptide+%28Oatp%29+Mediated+Influx&doi=10.1002%2Fptr.3522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Rifampicin on the Pharmacokinetics of Salvianolic Acid B May Involve Inhibition of Organic Anion Transporting Polypeptide (Oatp) Mediated Influx</span></div><div class="casAuthors">Zhao, Di; Gao, Zi-dong; Han, De-en; Li, Ning; Zhang, Yong-jie; Lu, Yang; Li, Ting-ting; Chen, Xi-jing</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-121</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This article studied the possible effect of rifampicin (RIF), an inhibitor of org. anion transporting polypeptide (Oatp), on the pharmacokinetics of salvianolic acid B (SAB) in rats.  Rifampicin was administered i.v. 15 min prior to SAB (5 mg/kg) in rats at doses of 0, 5.0, 10.0 and 20.0 mg/kg, resp.  The concns. of SAB in plasma and bile were detd. using a Shimadzu HPLC system coupled to a LC-MS-2010EV mass spectrometer.  Compared with the control group, the AUC0-t and Cmax values of SAB were increased significantly, while the CLtotal and CLbile were decreased significantly.  These results suggested that pretreatment with rifampicin prior to SAB administration could decrease significantly the total and bile elimination of SAB and alter its pharmacokinetic profiles.  The influence of rifampicin on the pharmacokinetics of SAB may be attributed to the inhibition of Oatp-mediated influx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNlpCXeTDtX7Vg90H21EOLACvtfcHk0lh6c5nrsOKpjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjsl2rsw%253D%253D&md5=775a32600bfeb7ce71feb1154a965264</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fptr.3522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.3522%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DGao%26aufirst%3DZ.-D.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.-J.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DT.-T%26aulast%3DChen%26aufirst%3DX.-HJ.%26atitle%3DInfluence%2520of%2520Rifampicin%2520on%2520the%2520Pharmacokinetics%2520of%2520Salvianolic%2520Acid%2520B%2520May%2520Involve%2520Inhibition%2520of%2520Organic%2520Anion%2520Transporting%2520Polypeptide%2520%2528Oatp%2529%2520Mediated%2520Influx%26jtitle%3DPhytother.%2520Res.%26date%3D2012%26volume%3D26%26spage%3D118%26epage%3D121%26doi%3D10.1002%2Fptr.3522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J.</span></span> <span> </span><span class="NLM_article-title">A Physiologically Based Pharmacokinetic Model of Rifampin in Mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">1771</span>, <span class="refDoi"> DOI: 10.1128/AAC.01567-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1128%2FAAC.01567-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23357766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1763-1771&author=M.+A.+Lyonsauthor=B.+Reisfeldauthor=R.+S.+H.+Yangauthor=A.+J.+Lenaerts&title=A+Physiologically+Based+Pharmacokinetic+Model+of+Rifampin+in+Mice&doi=10.1128%2FAAC.01567-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A physiologically based pharmacokinetic model of rifampin in mice</span></div><div class="casAuthors">Lyons, Michael A.; Reisfeld, Brad; Yang, Raymond S. H.; Lenaerts, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1763-1771</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">One problem assocd. with regimen-based development of antituberculosis (anti-TB) drugs is the difficulty of a systematic and thorough in vivo evaluation of the large no. of possible regimens that arise from consideration of multiple drugs tested together.  A math. model capable of simulating the pharmacokinetics and pharmacodynamics of exptl. combination chemotherapy of TB offers a way to mitigate this problem by extending the use of available data to investigate regimens that are not initially tested.  In order to increase the available math. tools needed to support such a model for preclin. anti-TB drug development, we constructed a preliminary whole-body physiol. based pharmacokinetic (PBPK) model of rifampin in mice, using data from the literature.  Interindividual variability was approximated using Monte Carlo (MC) simulation with assigned probability distributions for the model parameters.  An MC sensitivity anal. was also performed to det. correlations between model parameters and plasma concn. to inform future model development.  Model predictions for rifampin concns. in plasma, liver, kidneys, and lungs, following oral administration, were generally in agreement with published exptl. data from multiple studies.  Sensitive model parameters included those descriptive of oral absorption, total clearance, and partitioning of rifampin between blood and muscle.  This PBPK model can serve as a starting point for the integration of rifampin pharmacokinetics in mice into a larger math. framework, including the immune response to Mycobacterium tuberculosis infection, and pharmacokinetic models for other anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGwB4sBkKejrVg90H21EOLACvtfcHk0lh6c5nrsOKpjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKrsLw%253D&md5=f96b54a6378bf80f2f77aa347601784e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2FAAC.01567-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01567-12%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DM.%2BA.%26aulast%3DReisfeld%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DR.%2BS.%2BH.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26atitle%3DA%2520Physiologically%2520Based%2520Pharmacokinetic%2520Model%2520of%2520Rifampin%2520in%2520Mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1763%26epage%3D1771%26doi%3D10.1128%2FAAC.01567-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Harte, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gault, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriott, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, P. R.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Anti-Diabetic Effects of GIP- and GLP1-Receptor Activation in Obese Diabetic (ob/ob) Mice: Studies with DPP IV resistant N-AcGIP and exendin(1- 39)amide</span>. <i>Diabetes/Metab. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1002/dmrr.729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fdmrr.729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=17315241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=572-579&author=N.+Irwinauthor=P.+L.+McCleanauthor=R.+S.+Cassidyauthor=F.+P.+O%E2%80%99Harteauthor=B.+D.+Greenauthor=V.+A.+Gaultauthor=P.+Harriottauthor=P.+R.+Flatt&title=Comparison+of+the+Anti-Diabetic+Effects+of+GIP-+and+GLP1-Receptor+Activation+in+Obese+Diabetic+%28ob%2Fob%29+Mice%3A+Studies+with+DPP+IV+resistant+N-AcGIP+and+exendin%281-+39%29amide&doi=10.1002%2Fdmrr.729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide</span></div><div class="casAuthors">Irwin, Nigel; McClean, Paula L.; Cassidy, Roslyn S.; O'Harte, Finbarr P. M.; Green, Brian D.; Gault, Victor A.; Harriott, Patrick; Flatt, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Background: The two major incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are being actively explored as anti-diabetic agents because they lower blood glucose through multiple mechanisms.  The rapid inactivation of GIP and GLP-1 by the ubiquitous enzyme, dipeptidyl peptidase IV (DPP IV) makes their biol. actions short-lived, but stable agonists such as N-acetylated GIP (N-AcGIP) and exendin(1-39)amide have been advocated as stable and specific GIP and GLP-1 analogs.  Methods: The present study examd. the sub-chronic (14 days) anti-diabetic actions of single daily doses of N-AcGIP and exendin(1-39)amide given alone or in combination to obese diabetic (ob/ob) mice over a 14-day period.  Results: Initial expts. confirmed the potent anti-hyperglycemic and insulinotropic properties of N-AcGIP and exendin(1-39)amide.  Sub-chronic administration of N-AcGIP alone or in combination with exendin(1-39)amide significantly decreased non-fasting plasma glucose and improved glucose tolerance compared to control ob/ob mice.  This was assocd. with a significant enhancement of the insulin response to glucose and a notable improvement of insulin sensitivity.  Combined treatment with N-AcGIP and exendin(1-39)amide also significantly decreased glycated Hb.  Exendin(1-39)amide alone had no significant effect on any of the metabolic parameters monitored.  In addn., no significant effects were obsd. on body wt. and food intake in any of the treatment groups.  Conclusions: The results illustrate significant anti-diabetic potential of N-AcGIP alone and in combination with exendin(1-39)amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoglOsyAPPrY7Vg90H21EOLACvtfcHk0lh6c5nrsOKpjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqs7nL&md5=4b1c5e2aa07e5268ee137264a04dfa61</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.729%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DN.%26aulast%3DMcClean%26aufirst%3DP.%2BL.%26aulast%3DCassidy%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Harte%26aufirst%3DF.%2BP.%26aulast%3DGreen%26aufirst%3DB.%2BD.%26aulast%3DGault%26aufirst%3DV.%2BA.%26aulast%3DHarriott%26aufirst%3DP.%26aulast%3DFlatt%26aufirst%3DP.%2BR.%26atitle%3DComparison%2520of%2520the%2520Anti-Diabetic%2520Effects%2520of%2520GIP-%2520and%2520GLP1-Receptor%2520Activation%2520in%2520Obese%2520Diabetic%2520%2528ob%252Fob%2529%2520Mice%253A%2520Studies%2520with%2520DPP%2520IV%2520resistant%2520N-AcGIP%2520and%2520exendin%25281-%252039%2529amide%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2007%26volume%3D23%26spage%3D572%26epage%3D579%26doi%3D10.1002%2Fdmrr.729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, K.</span></span> <span> </span><span class="NLM_article-title">Establishment of a Pancreatic Beta Cell Line that Retains Glucose Inducible Insulin Secretion: Special Reference to Expression of Glucose Transporter Isoforms</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1210/endo-127-1-126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1210%2Fendo-127-1-126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=2163307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3cXltV2lsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1990&pages=126-132&author=J.+Miyazakiauthor=K.+Arakiauthor=E.+Yamatoauthor=H.+Ikegamiauthor=T.+Asanoauthor=Y.+Shibasakiauthor=Y.+Okaauthor=K.+Yamamura&title=Establishment+of+a+Pancreatic+Beta+Cell+Line+that+Retains+Glucose+Inducible+Insulin+Secretion%3A+Special+Reference+to+Expression+of+Glucose+Transporter+Isoforms&doi=10.1210%2Fendo-127-1-126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion:  special reference to expression of glucose transporter isoforms</span></div><div class="casAuthors">Miyazaki, Junichi; Araki, Kimi; Yamato, Eiji; Ikegami, Hiroshi; Asano, Tomoichiro; Shibasaki, Yoshikazu; Oka, Yoshitomo; Yamamura, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-32</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    </div><div class="casAbstract">Two cell lines have been established from insulinomas obtained by targeted expression of the simian virus 40 T antigen gene in transgenic mice.  These cell lines, designated MIN6 and MIN7, produce insulin and T antigen and have morphol. characteristics of pancreatic β cells.  MIN6 cells exhibit glucose-inducible insulin secretion comparable with cultured normal mouse islet cells, whereas MIN7 cells do not.  Both cell lines produce liver-type glucose transporter (GT) mRNA at high level.  Brain-type GT mRNA is also present at considerable level in MIN7 cells, but is barely detectable in MIN6 cells, suggesting that exclusive expression of the liver-type GT is related to glucose-inducible insulin secretion.  MIN6 cells do not express either major histocompatibility (MHC) class I or class II antigens on the cell surface.  However, treatment with interferon-γ induces high levels of MHC class I antigens, and a combination of interferon-γ and tumor necrosis factor-α induces a MHC class II antigen on the cell surface.  Apparently, the MIN6 cell line retains physiol. characteristics of normal β cells.  The MIN6 cell line will be esp. useful to analyze the mol. mechanisms by which β cells regulate insulin secretion in response to extracellular glucose concns.  A possible role of GT isoforms in glucose sensing by β cells is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzD14EusM_NLVg90H21EOLACvtfcHk0liHF7ATDQnJSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltV2lsbo%253D&md5=520dbbae9a050f75fa1d8fc7ada0198f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1210%2Fendo-127-1-126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-127-1-126%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DYamato%26aufirst%3DE.%26aulast%3DIkegami%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DY.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DK.%26atitle%3DEstablishment%2520of%2520a%2520Pancreatic%2520Beta%2520Cell%2520Line%2520that%2520Retains%2520Glucose%2520Inducible%2520Insulin%2520Secretion%253A%2520Special%2520Reference%2520to%2520Expression%2520of%2520Glucose%2520Transporter%2520Isoforms%26jtitle%3DEndocrinology%26date%3D1990%26volume%3D127%26spage%3D126%26epage%3D132%26doi%3D10.1210%2Fendo-127-1-126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span> <span> </span><span class="NLM_article-title">Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(91)91647-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+Oral+Drug+Absorption+in+Humans+and+Apparent+Drug+Permeability+Coefficients+in+Human+Intestinal+Epithelial+%28Caco-2%29+Cells&doi=10.1016%2F0006-291X%2891%2991647-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 × 10-8 to 5 × 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 × 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 × 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of ≤1 × 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0liHF7ATDQnJSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520Oral%2520Drug%2520Absorption%2520in%2520Humans%2520and%2520Apparent%2520Drug%2520Permeability%2520Coefficients%2520in%2520Human%2520Intestinal%2520Epithelial%2520%2528Caco-2%2529%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885%26doi%3D10.1016%2F0006-291X%2891%2991647-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span>; <span class="NLM_string-name">Freidinger, R. M.</span>; <span class="NLM_string-name">Sawyer, T. K.</span></span> <i>Integration of Pharmaceutical Discovery and Development</i>; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2Fb114429" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=R.+T.+Borchardt&author=R.+M.+Freidinger&author=T.+K.+Sawyer&title=Integration+of+Pharmaceutical+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fb114429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fb114429%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26btitle%3DIntegration%2520of%2520Pharmaceutical%2520Discovery%2520and%2520Development%26pub%3DPlenum%2520Press%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Human Colon Carcinoma Cell line (Caco-2) as a Model System for Intestinal Epithelial Permeability</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(89)90897-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS0016-5085%2889%2980072-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=2914637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADyaL1M7itFeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1989&pages=736-749&author=I.+J.+Hidalgoauthor=T.+J.+Raubauthor=R.+T.+Borchardt&title=Characterization+of+the+Human+Colon+Carcinoma+Cell+line+%28Caco-2%29+as+a+Model+System+for+Intestinal+Epithelial+Permeability&doi=10.1016%2F0016-5085%2889%2990897-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability</span></div><div class="casAuthors">Hidalgo I J; Raub T J; Borchardt R T</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">736-49</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">Caco-2 cells develop morphologic characteristics of normal enterocytes when grown on plastic dishes or nitrocellulose filters.  The purpose of this study was to determine whether Caco-2 cells undergo similar differentiation when grown on Transwell polycarbonate membranes, and to study the suitability of Caco-2 monolayers as an intestinal epithelial transport model system.  Transepithelial electrical resistance values after confluence were 173.5 omega.cm2 and remained unchanged through day 17.  Permeabilities to the water-soluble fluid-phase markers that do not permeate the membrane, Lucifer yellow CH, [14C]inulin, [14C]polyethylene glycol, and [3H] dextran were less than 0.25% of the administered amount per hour after day 10.  Qualitative evaluation of uptake and permeability to horseradish peroxidase confirmed the similarity in uptake and barrier properties between this cell system and the small intestinal epithelial layer.  We conclude that Caco-2 cells grown on collagen-coated polycarbonate membranes should represent a valuable transport model system for the small intestinal epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOn97989rzEIqdXsLcGTEUfW6udTcc2eaF9HR3gmIBj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7itFeqsg%253D%253D&md5=59ffccc1dd4dccb01400c05df95ac1ff</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2889%2980072-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252889%252980072-1%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520Human%2520Colon%2520Carcinoma%2520Cell%2520line%2520%2528Caco-2%2529%2520as%2520a%2520Model%2520System%2520for%2520Intestinal%2520Epithelial%2520Permeability%26jtitle%3DGastroenterology%26date%3D1989%26volume%3D96%26spage%3D736%26epage%3D749%26doi%3D10.1016%2F0016-5085%2889%2990897-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Epithelial Transport of Drug in Cell Culture. I: a Model for Studying the Passive Diffusion of Drugs over Intestinal Absorptive (Caco-2) cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">476</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1002/jps.2600790604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fjps.2600790604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1975619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1990&pages=476-82&author=P.+Artursson&title=Epithelial+Transport+of+Drug+in+Cell+Culture.+I%3A+a+Model+for+Studying+the+Passive+Diffusion+of+Drugs+over+Intestinal+Absorptive+%28Caco-2%29+cells&doi=10.1002%2Fjps.2600790604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial transport of drugs in cell culture.  I:  a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells</span></div><div class="casAuthors">Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">476-82</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A human intestinal cell line, Caco-2, was used as a model to study the passive diffusion of drugs across intestinal epithelium.  The cells formed continuous monolayers when grown on permeable filters of polycarbonate.  After 10 days in culture, the monolayers had a transmembrane resistance of ∼260 Ω.cm2 and a cell d. of 0.9 × 106 cells/cm2.  At this time the cells were impermeable to [14C]polyethyleneglycol (MW 4000).  These characteristics remained const. for 20 days (i.e., from day 10 to day 30).  Six β-blocking agents with a 2000-fold range of lipophilicity were studied for their transepithelial transport properties.  The transport parameters were independent of drug concn. and transport direction.  The apparent permeability coeffs. ranged from 41.91 × 10-6 cm/s for the most lipophilic drug, propranolol, to 0.203 × 10-6 cm/s for the most hydrophilic drug, atenolol.  The transport parameters were compared with those published for rat ileum.  The transport rates were similar for four out of five drugs.  Atenolol was transported at a slower rate in the Caco-2 model, which may be explained by the fact that the Caco-2 cells form a tighter epithelium than the rat ileal enterocytes.  Thus, Caco-2 cells may be used to model the intestinal absorption of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RIMzEBiAqrVg90H21EOLACvtfcHk0lgWEgdXVEG-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D&md5=68642fc4f08aaaa5a343822bea9ee95f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600790604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600790604%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEpithelial%2520Transport%2520of%2520Drug%2520in%2520Cell%2520Culture.%2520I%253A%2520a%2520Model%2520for%2520Studying%2520the%2520Passive%2520Diffusion%2520of%2520Drugs%2520over%2520Intestinal%2520Absorptive%2520%2528Caco-2%2529%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1990%26volume%3D79%26spage%3D476%26epage%3D82%26doi%3D10.1002%2Fjps.2600790604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dudda, A.</span>; <span class="NLM_string-name">Kürzel, G. U.</span></span> <span> </span><span class="NLM_article-title">Metabolism Studies in vitro and in vivo</span>. In  <i>Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, H. G.</span>, <span class="NLM_string-name">Hock, F. J.</span>, <span class="NLM_string-name">Maas, J.</span>, <span class="NLM_string-name">Mayer, D.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">520</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2F3-540-29804-5_25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=493-520&author=A.+Dudda&author=G.+U.+K%C3%BCrzelauthor=H.+G.+Vogel&author=F.+J.+Hock&author=J.+Maas&author=D.+Mayer&title=Drug+Discovery+and+Evaluation%3A+Safety+and+Pharmacokinetic+Assays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2F3-540-29804-5_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F3-540-29804-5_25%26sid%3Dliteratum%253Aachs%26aulast%3DDudda%26aufirst%3DA.%26atitle%3DMetabolism%2520Studies%2520in%2520vitro%2520and%2520in%2520vivo%26btitle%3DDrug%2520Discovery%2520and%2520Evaluation%253A%2520Safety%2520and%2520Pharmacokinetic%2520Assays%26aulast%3DVogel%26aufirst%3DH.%2BG.%26pub%3DSpringer%26date%3D2006%26spage%3D493%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span> <i>Guidance for industry:
Drug Interaction Studies—Study Design,
Data Analysis and Implications for Dosing and Labeling Recommendations,
Draft Guidance</i>; <span class="NLM_publisher-name">U.S. Department of Health
and Human Services, Food and Drug Administration, and Center for Drug
Evaluation and Research</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Guidance+for+industry%3A%0ADrug+Interaction+Studies%E2%80%94Study+Design%2C%0AData+Analysis+and+Implications+for+Dosing+and+Labeling+Recommendations%2C%0ADraft+Guidance%3B+U.S.+Department+of+Health%0Aand+Human+Services%2C+Food+and+Drug+Administration%2C+and+Center+for+Drug%0AEvaluation+and+Research%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuidance%2520for%2520industry%253A%250ADrug%2520Interaction%2520Studies%25E2%2580%2594Study%2520Design%252C%250AData%2520Analysis%2520and%2520Implications%2520for%2520Dosing%2520and%2520Labeling%2520Recommendations%252C%250ADraft%2520Guidance%26pub%3DU.S.%2520Department%2520of%2520Health%250Aand%2520Human%2520Services%252C%2520Food%2520and%2520Drug%2520Administration%252C%2520and%2520Center%2520for%2520Drug%250AEvaluation%2520and%2520Research%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>EMA,
Guideline
on the Investigation of Drug Interactions, Draft Guideline <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EMA%2C%0AGuideline%0Aon+the+Investigation+of+Drug+Interactions%2C+Draft+Guideline+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span> <i>Guideline on the Investigation of Drug Interactions</i>; <span class="NLM_publisher-name">European Medicines Agency</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Guideline+on+the+Investigation+of+Drug+Interactions%3B+European+Medicines+Agency%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuideline%2520on%2520the%2520Investigation%2520of%2520Drug%2520Interactions%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochrome p450 and Chemical Toxicology</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1021/tx700079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=70-83&author=F.+P.+Guengerich&title=Cytochrome+p450+and+Chemical+Toxicology&doi=10.1021%2Ftx700079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 and Chemical Toxicology</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of cytochrome P 450 (P 450) research has developed considerably over the past 20 years, and many important papers on the roles of P450s in chem. toxicol. have appeared in Chem. Research in Toxicol.  Today, our basic understanding of many of the human P450s is relatively well-established, in terms of the details of the individual genes, sequences, and basic catalytic mechanisms.  Crystal structures of several of the major human P450s are now in hand.  The animal P450s are still important in the context of metab. and safety testing.  Many well-defined examples exist for roles of P450s in decreasing the adverse effects of drugs through biotransformation, and an equally interesting field of investigation is the bioactivation of chems., including drugs.  Unresolved problems include the characterization of the minor "orphan" P450s, ligand cooperativity and kinetic complexity of several P450s, the prediction of metab., the overall contribution of bioactivation to drug idiosyncratic problems, the extrapolation of animal test results to humans in drug development, and the contribution of genetic variation in human P450s to cancer incidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnvzpBM_I4LVg90H21EOLACvtfcHk0lgWEgdXVEG-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF&md5=444b8d63bf07dc2449af6413fa7fff00</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Ftx700079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700079z%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochrome%2520p450%2520and%2520Chemical%2520Toxicology%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D70%26epage%3D83%26doi%3D10.1021%2Ftx700079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.093229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fjpet.105.093229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=16192315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslCisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=336-348&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnanauthor=E.+A.+Gamanauthor=J.+B.+Houstonauthor=L.+M.+Tremaine&title=The+Utility+of+in+Vitro+Cytochrome+P450+Inhibition+Data+in+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fjpet.105.093229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik; Gaman, Emily A.; Houston, J. Brian; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">336-348</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The accuracy of in vitro inhibition parameters in scaling to in vivo drug-drug interactions (DDI) was examd. for over 40 drugs using seven human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, and fraction of the probe drug cleared by the inhibited enzyme) to predict increases in exposure to probe drugs, and the predictions were compared with in vivo DDI gathered from clin. studies reported in the scientific literature.  For drugs that had been tested as precipitants of drug interactions for more than one P 450 in vivo, the order of inhibitory potencies in vitro generally aligned with the magnitude of the in vivo interactions.  With the exception of many drugs known to be mechanism-based inactivators, the use of in vitro IC50, the fraction of the affected drug metabolized by the target enzyme [fm(CYP)] and an est. of free hepatic inlet Cmax, was generally successful in identifying those drugs that cause at least a 2-fold increase in the exposure to P 450 marker substrate drugs.  For CYP3A, incorporation of inhibition of both hepatic and intestinal metab. was needed for the prediction of DDI.  Many CYP3A inhibitors showed a different inhibitory potency for three different CYP3A marker activities; however, these differences generally did not alter the conclusions regarding whether a drug would cause a CYP3A DDI in vivo.  Overall, these findings support the conclusion that P 450 in vitro inhibition data are valuable in designing clin. DDI study strategies and can be used to predict the magnitudes of DDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUhOqooYvvbVg90H21EOLACvtfcHk0ljH8VWeJf97mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslCisg%253D%253D&md5=988174eb3bb0d41655508395b1f982dd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093229%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DGaman%26aufirst%3DE.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DThe%2520Utility%2520of%2520in%2520Vitro%2520Cytochrome%2520P450%2520Inhibition%2520Data%2520in%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D336%26epage%3D348%26doi%3D10.1124%2Fjpet.105.093229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.106.012633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=17093004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=246-255&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnan&title=Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+Enzymes+and+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.106.012633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to use vitro inactivation kinetic parameters in scaling to in vivo drug-drug interactions (DDIs) for mechanism-based inactivators of human cytochrome P 450 (P 450) enzymes was examd. using eight human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, in vivo P 450 enzyme degrdn. rate consts. estd. from clin. pharmacokinetic data, and fraction of the affected drug cleared by the inhibited enzyme) to predict increases in exposure to drugs, and the predictions were compared with in vivo DDIs gathered from clin. studies reported in the scientific literature.  In general, the use of unbound systemic Cmax as the inactivator concn. in vivo yielded the most accurate predictions of DDI with a mean -fold error of 1.64.  Abbreviated in vitro approaches to identifying mechanism-based inactivators were developed.  Testing potential inactivators at a single concn. (IC25) in a 30-min preincubation with human liver microsomes in the absence and presence of NADPH followed by assessment of P 450 marker activities readily identified those compds. known to be mechanism-based inactivators and represents an approach that can be used with greater throughput.  Measurement of decreases in IC50 occurring with a 30-min preincubation with liver microsomes and NADPH was also useful in identifying mechanism-based inactivators, and the IC50 measured after such a preincubation was highly correlated with the kinact/K1 ratio measured after a full characterization of inactivation.  Overall, these findings support the conclusion that P 450 in vitro inactivation data are valuable in predicting clin. DDIs that can occur via this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPRf5ZGrW6LVg90H21EOLACvtfcHk0ljH8VWeJf97mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D&md5=71733cfafba3b2c9cc6b47a46e7b3f40</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012633%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26atitle%3DMechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520and%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D246%26epage%3D255%26doi%3D10.1124%2Fdmd.106.012633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M.</span></span> <span> </span><span class="NLM_article-title">Predicting Drug–Drug Interactions: An FDA Perspective</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9106-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1208%2Fs12248-009-9106-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19418230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=300-306&author=L.+Zhangauthor=Y.+D.+Zhangauthor=P.+Zhaoauthor=S.-M.+Huang&title=Predicting+Drug%E2%80%93Drug+Interactions%3A+An+FDA+Perspective&doi=10.1208%2Fs12248-009-9106-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting drug-drug interactions: an FDA perspective</span></div><div class="casAuthors">Zhang, Lei; Zhang, Yuanchao; Zhao, Ping; Huang, Shiew-Mei</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetic drug interactions can lead to serious adverse events, and the evaluation of a new mol. entity's drug-drug interaction potential is an integral part of drug development and regulatory review prior to its market approval.  Alteration of enzyme and/or transporter activities involved in the absorption, distribution, metab., or excretion of a new mol. entity by other concomitant drugs may lead to a change in exposure leading to altered response (safety or efficacy).  Over the years, various in vitro methodologies have been developed to predict drug interaction potential in vivo.  In vitro study has become a crit. first step in the assessment of drug interactions.  Well-executed in vitro studies can be used as a screening tool for the need for further in vivo assessment and can provide the basis for the design of subsequent in vivo drug interaction studies.  Besides in vitro expts., in silico modeling and simulation may also assist in the prediction of drug interactions.  The recent FDA draft drug interaction guidance highlighted the in vitro models and criteria that may be used to guide further in vivo drug interaction studies and to construct informative labeling.  This report summarizes crit. elements in the in vitro evaluation of drug interaction potential during drug development and uses a case study to highlight the impact of in vitro information on drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6hVDt5xvRrVg90H21EOLACvtfcHk0ljH8VWeJf97mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rL&md5=92e7b8a8607de8f39254ccd142d73a32</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9106-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9106-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%2BD.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DS.-M.%26atitle%3DPredicting%2520Drug%25E2%2580%2593Drug%2520Interactions%253A%2520An%2520FDA%2520Perspective%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D300%26epage%3D306%26doi%3D10.1208%2Fs12248-009-9106-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einolf, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skordos, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonn, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Horn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">The Conduct of in Vitro Studies to Address Time-Dpendent Inhibition of Drug Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.026716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.109.026716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19359406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFenu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1355-1370&author=S.+W.+Grimmauthor=H.+J.+Einolfauthor=S.+D.+Hallauthor=K.+Heauthor=H.+K.+Limauthor=K.-H.+Lingauthor=C.+Luauthor=A.+A.+Nomeirauthor=E.+Seibertauthor=K.+W.+Skordosauthor=G.+R.+Tonnauthor=R.+Van+Hornauthor=R.+W.+Wangauthor=Y.+N.+Wongauthor=T.+J.+Yangauthor=R.+S.+Obach&title=The+Conduct+of+in+Vitro+Studies+to+Address+Time-Dpendent+Inhibition+of+Drug+Metabolizing+Enzymes%3A+A+Perspective+of+the+Pharmaceutical+Research+and+Manufacturers+of+America&doi=10.1124%2Fdmd.109.026716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the Pharmaceutical Research and Manufacturers of America</span></div><div class="casAuthors">Grimm, Scott W.; Einolf, Heidi J.; Hall, Steven D.; He, Kan; Lim, Heng-Keang; Ling, Kah-Hiing John; Lu, Chuang; Nomeir, Amin A.; Seibert, Eleanore; Skordos, Konstantine W.; Tonn, George R.; Van Horn, Robert; Wang, Regina W.; Wong, Y. Nancy; Yang, Tian J.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1355-1370</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of cytochrome P 450 enzymes caused by new mol. entities (NMEs) is of concern because such compds. can be responsible for clin. relevant drug-drug interactions (DDI).  Although the biochem. underlying mechanism-based inactivation (MBI) of P 450 enzymes has been generally understood for several years, significant advances have been made only in the past few years regarding how in vitro time-dependent inhibition data can be used to understand and predict clin. DDI.  In this article, a team of scientists from 16 pharmaceutical research organizations that are member companies of the Pharmaceutical Research and Manufacturers of America offer a discussion of the phenomenon of TDI with emphasis on the lab. methods used in its measurement.  Results of an anonymous survey regarding pharmaceutical industry practices and strategies around TDI are reported.  Specific topics that still possess a high degree of uncertainty are raised, such as parameter ests. needed to make predictions of DDI magnitude from in vitro inactivation parameters.  A description of follow-up mechanistic expts. that can be done to characterize TDI are described.  A consensus recommendation regarding common practices to address TDI is included, the salient points of which include the use of a tiered approach wherein abbreviated assays are first used to det. whether NMEs demonstrate TDI or not, followed by more thorough inactivation studies for those that do to define the parameters needed for prediction of DDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc57kHA3HAP7Vg90H21EOLACvtfcHk0ljH8VWeJf97mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFenu7o%253D&md5=7f74567b5c9298806f8a5cc58355b867</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.026716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.026716%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DS.%2BW.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DHall%26aufirst%3DS.%2BD.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DLing%26aufirst%3DK.-H.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSeibert%26aufirst%3DE.%26aulast%3DSkordos%26aufirst%3DK.%2BW.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DVan%2BHorn%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%2BW.%26aulast%3DWong%26aufirst%3DY.%2BN.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520Conduct%2520of%2520in%2520Vitro%2520Studies%2520to%2520Address%2520Time-Dpendent%2520Inhibition%2520of%2520Drug%2520Metabolizing%2520Enzymes%253A%2520A%2520Perspective%2520of%2520the%2520Pharmaceutical%2520Research%2520and%2520Manufacturers%2520of%2520America%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1355%26epage%3D1370%26doi%3D10.1124%2Fdmd.109.026716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Cytochrome P450 Enzymes: an Evaluation of Early Decision Making <i>in vitro</i> Approaches and Drug–Drug Interaction Prediction Methods</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.ejps.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19013237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=175-191&author=K.+H.+Grimeauthor=J.+Birdauthor=D.+Fergusonauthor=R.+J.+Riley&title=Mechanism-Based+Inhibition+of+Cytochrome+P450+Enzymes%3A+an+Evaluation+of+Early+Decision+Making+in+vitro+Approaches+and+Drug%E2%80%93Drug+Interaction+Prediction+Methods&doi=10.1016%2Fj.ejps.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods</span></div><div class="casAuthors">Grime, Kenneth H.; Bird, James; Ferguson, Douglas; Riley, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">175-191</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability to use in vitro human cytochrome P 450 (CYP) time-dependent inhibition (TDI) data for in vivo drug-drug interaction (DDI) predictions should be viewed as a prerequisite to generating the data.  Important terms in making such predictions are kinact and KI but first-line screening assays typically involve characterization of an IC50 value or a time dependent shift in IC50.  In the work presented here, two key screening methods from the scientific literature were appraised both in terms of practicality and quality of kinact/KI estn.  The utility of TDI screening data in DDI predictions was investigated and particular ref. given to a simple DDI simulation model based on a spreadsheet that calcs. the systemic exposure of unbound inhibitor drug following the input of human pharmacokinetic parameters.  Using several clin. mechanism-based CYP DDI examples, the effectiveness of the approach was assessed and compared to other widely available approaches (a simple algorithm that employs a single in vivo unbound inhibitor concn., a seven-compartment physiol. based pharmacokinetic (PBPK) model that defines the extent of interaction as a result of hepatic inhibitor concns. and the com. available software SimCYP).  All the methods gave predictions that compared favorably with the obsd. DDIs, but various advantages and disadvantages of each were also given full consideration.  The new model facilitates rapid sensitivity anal. (parameters can be easily input and altered to give a visual representation of the impact on the active enzyme concn.) and it was therefore used to derive "rules of thumb" demonstrating the relationship between extent of DDI, time-dependent IC50 and dose for typical acidic and basic drugs.  Addnl., a TDI decision tree linking into reactive metabolite investigations is proposed for use in a Drug Discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM7p75JgXkwLVg90H21EOLACvtfcHk0ljR_F_YaZQtLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWhtQ%253D%253D&md5=1621091a7cf8f8909e2e8d0c802fdfd0</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DGrime%26aufirst%3DK.%2BH.%26aulast%3DBird%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Cytochrome%2520P450%2520Enzymes%253A%2520an%2520Evaluation%2520of%2520Early%2520Decision%2520Making%2520in%2520vitro%2520Approaches%2520and%2520Drug%25E2%2580%2593Drug%2520Interaction%2520Prediction%2520Methods%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D36%26spage%3D175%26epage%3D191%26doi%3D10.1016%2Fj.ejps.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delarosa, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Time-Dependent Cytochrome P450 Inhibition in a High-Throughput, Automated Assay: Introducing a Novel Area Under the Curve Shift Approach</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.2174/187231212800229309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.2174%2F187231212800229309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22372554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2gsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=43-53&author=S.+Mukadamauthor=S.+Tayauthor=D.+Tranauthor=L.+Wangauthor=E.+M.+Delarosaauthor=S.+C.+Khojastehauthor=J.+S.+Halladayauthor=J.+R.+Kenny&title=Evaluation+of+Time-Dependent+Cytochrome+P450+Inhibition+in+a+High-Throughput%2C+Automated+Assay%3A+Introducing+a+Novel+Area+Under+the+Curve+Shift+Approach&doi=10.2174%2F187231212800229309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of time-dependent cytochrome P450 inhibition in a high-throughput, automated assay: introducing a novel area under the curve shift approach</span></div><div class="casAuthors">Mukadam, Sophie; Tay, Suzanne; Tran, Daniel; Wang, Leslie; Delarosa, Erlie M.; Khojasteh, S. Cyrus; Halladay, Jason S.; Kenny, Jane R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Early in the drug discovery process, the identification of cytochrome P 450 (CYP) time-dependent inhibition (TDI) is an important step for compd. optimization.  Here we describe a high-throughput, automated method for the evaluation of TDI utilizing human liver microsomes and conventional CYP-specific mass spectrometer-based probes in a 384-well format.  One of the key differences from other published TDI assays is the use of a shift in area the under curve of the percent activity remaining vs. inhibitor concn. plot (AUC shift) rather than the traditional fold-shift in IC50, to det. the magnitude of TDI.  An AUC shift of <15% suggests neg. TDI and >15% suggests potential TDI.  This AUC shift was used to achieve quant. data reporting, even in the case of weak inhibitors for which IC50 values cannot be quantified.  An Agilent Technologies BioCel 1200 System was programmed such that the TDI liability of up to 77 test compds., incubated at four test concns., with and without NADPH in the pre-incubation, can be analyzed in a single run.  The detailed automated methodol., assay validation, data reporting and the novel TDI AUC shift approach to describe magnitude of TDI are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMWd8ERjyqLVg90H21EOLACvtfcHk0ljR_F_YaZQtLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2gsb0%253D&md5=fa66fc58babb575bcc03957ed430e6e9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.2174%2F187231212800229309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231212800229309%26sid%3Dliteratum%253Aachs%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520Time-Dependent%2520Cytochrome%2520P450%2520Inhibition%2520in%2520a%2520High-Throughput%252C%2520Automated%2520Assay%253A%2520Introducing%2520a%2520Novel%2520Area%2520Under%2520the%2520Curve%2520Shift%2520Approach%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2012%26volume%3D6%26spage%3D43%26epage%3D53%26doi%3D10.2174%2F187231212800229309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, B. W.</span>; <span class="NLM_string-name">Usuki, E.</span>; <span class="NLM_string-name">Yerino, P.</span>; <span class="NLM_string-name">Parkinson, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro Approaches for Studying the Inhibition of Drug-Metabolizing Enzymes Responsible for the Metabolism of Drugs (Reaction Phenotyping) with Emphasis on Eytochrome P450</span>. In  <i>Drug-Drug Interactions</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>, Ed.; Drugs and the Pharmaceutical Sciences, Vol. 179; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">358</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=231-358&author=B.+W.+Ogilvie&author=E.+Usuki&author=P.+Yerino&author=A.+Parkinsonauthor=A.+D.+Rodrigues&title=Drug-Drug+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOgilvie%26aufirst%3DB.%2BW.%26atitle%3DIn%2520Vitro%2520Approaches%2520for%2520Studying%2520the%2520Inhibition%2520of%2520Drug-Metabolizing%2520Enzymes%2520Responsible%2520for%2520the%2520Metabolism%2520of%2520Drugs%2520%2528Reaction%2520Phenotyping%2529%2520with%2520Emphasis%2520on%2520Eytochrome%2520P450%26btitle%3DDrug-Drug%2520Interactions%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26pub%3DInforma%2520Healthcare%26date%3D2011%26spage%3D231%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Urso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, G.</span></span> <span> </span><span class="NLM_article-title">A short introduction to pharmacokinetics</span>. <i>Eur. Rev. Med. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=12708608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ovFeitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=33-44&author=R.+Ursoauthor=P.+Blardiauthor=G.+Giorgi&title=A+short+introduction+to+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">A short introduction to pharmacokinetics</span></div><div class="casAuthors">Urso R; Blardi P; Giorgi G</div><div class="citationInfo"><span class="NLM_cas:title">European review for medical and pharmacological sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">33-44</span>
        ISSN:<span class="NLM_cas:issn">1128-3602</span>.
    </div><div class="casAbstract">Phamacokinetics is proposed to study the absorption, the distribution, the biotransformations and the elimination of drugs in man and animals.  A single kinetic profile may be well summarized by Cmax, Tmax, t 1/2 and AUC and, having more than one profile, 8 parameters at least, the mean and standard deviation of these parameters, may well summarize the drug kinetics in the whole population.  A more carefull description of the data can be obtained interpolating and extrapolating the drug concentrations with some mathematical functions.  These functions may be used to reduce all the data in a small set of parameters, or to verify if the hypotheses incorporated in the functions are confirmed by the observations.  In the first case, we can say that the task is to get a simulation of the data, in the second to get a model.  The functions used to interpolate and reduce the pharmacokinetic data are the multiexponential functions and the reference models are the compartmental models whose solutions are just the multiexponential functions.  Using models, new meaningfull pharmacokinetic parameters may be defined which can be used to find relationships between the drug kinetic profile and the physiological process which drive the drug absorption, distribution and elimination.  For example, compartmental models allow to define easily the clearance which is dependent on the drug elimination process, or the volume of distribution which depends on the drug distribution in the tissues.  Models provide also an easy way to get an estimate of drug absorption after extravasculare drug administration (bioavailability).  Model building is a complex multistep process where, experiment by experiment and simulation by simulation, new hypothesis are proven and disproven through a continuous interaction between the experimenter and the computer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPFsEkk26QzUEksK8CslK8fW6udTcc2eZUAPpWPxyV6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ovFeitg%253D%253D&md5=8c55add9ed575fc0e79b4a2068e1175c</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrso%26aufirst%3DR.%26aulast%3DBlardi%26aufirst%3DP.%26aulast%3DGiorgi%26aufirst%3DG.%26atitle%3DA%2520short%2520introduction%2520to%2520pharmacokinetics%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D6%26spage%3D33%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritschel, W. A.</span>; <span class="NLM_string-name">Kearns, G. L.</span></span> <i>Handbook of Basic Pharmacokinetics</i>, <span class="NLM_edition">6</span>th ed.; <span class="NLM_publisher-name">APhA</span>: <span class="NLM_publisher-loc">Washington, DC, U.S.</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+A.+Ritschel&author=G.+L.+Kearns&title=Handbook+of+Basic+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRitschel%26aufirst%3DW.%2BA.%26btitle%3DHandbook%2520of%2520Basic%2520Pharmacokinetics%26pub%3DAPhA%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit81c"><span><span class="NLM_label">(c) </span> Food and Drug
Administration. Additional Studies Part B. Metabolism and Pharmacokinetic
Studies, 1993 Draft “Redbook II”. Guidance for Industry
and Other Stakeholders Toxicological Principles for the Safety Assessment
of Food Ingredients. Redbook 2000 (Revised 2007). <a href="http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM078741.pdf" class="extLink">http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM078741.pdf</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Food+and+Drug%0AAdministration.+Additional+Studies+Part+B.+Metabolism+and+Pharmacokinetic%0AStudies%2C+1993+Draft+%E2%80%9CRedbook+II%E2%80%9D.+Guidance+for+Industry%0Aand+Other+Stakeholders+Toxicological+Principles+for+the+Safety+Assessment%0Aof+Food+Ingredients.+Redbook+2000+%28Revised+2007%29.+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FFood%2FGuidanceRegulation%2FUCM078741.pdf+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span> <i>Schrödinger
Molecular Modeling Suite</i>, release <span class="NLM_edition">2018-1</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0AMolecular+Modeling+Suite%2C+release+2018-1%3B+Schr%C3%B6dinger+LLC%3A+New+York%2C+NY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250AMolecular%2520Modeling%2520Suite%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83a1"><span>PDB
files from RCSB Protein Database. <a href="http://www.rcsb.org/pdb" class="extLink">http://www.rcsb.org/pdb</a> (accessed Feb 22, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PDB%0Afiles+from+RCSB+Protein+Database.+http%3A%2F%2Fwww.rcsb.org%2Fpdb+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit83a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koetzle, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanouchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasumi, M.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank: a Computer-Based Archival File for Macromolecular Structures</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(77)80200-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS0022-2836%2877%2980200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=875032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaE2sXkvVert7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1977&pages=535-542&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=G.+J.+B.+Williamsauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+Protein+Data+Bank%3A+a+Computer-Based+Archival+File+for+Macromolecular+Structures&doi=10.1016%2FS0022-2836%2877%2980200-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83aR"><div class="casContent"><span class="casTitleNuber">83a</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank:  a computer-based archival file for macromolecular structures</span></div><div class="casAuthors">Bernstein, Frances C.; Koetzle, Thomas F.; Williams, Graheme J. B.; Meyer, Edgar F., Jr.; Brice, Michael D.; Rodgers, John R.; Kennard, Olga; Shimanouchi, Takehiko; Tasumi, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-42</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The Protein Data Bank is a computer-based archival file for macromol. structures.  The Bank stores in a uniform format at. coordinates and partial bond connectivities, as derived from crystallog. studies.  Text included in each data entry gives pertinent information for the structure at hand (e.g., species from which the mol. was obtained, resoln. of diffraction data, literature citations, and specifications of secondary structure).  In addn., the Protein Data Bank stores structure factors and phases.  Input of data and general maintenance functions are at Brookhaven National Lab.  All data are available on magnetic tape for public distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tv93dkDhxrVg90H21EOLACvtfcHk0lj13svyGu3ujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXkvVert7o%253D&md5=07736506e495f157c600cf51a253a0a0</span></div><a href="/servlet/linkout?suffix=cit83a&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2877%2980200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252877%252980200-3%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%2BB.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520Protein%2520Data%2520Bank%253A%2520a%2520Computer-Based%2520Archival%2520File%2520for%2520Macromolecular%2520Structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1977%26volume%3D112%26spage%3D535%26epage%3D542%26doi%3D10.1016%2FS0022-2836%2877%2980200-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit83b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=J.+W.+Bermanauthor=F.+Zukangauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83bR"><div class="casContent"><span class="casTitleNuber">83b</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lj13svyGu3ujw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit83b&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DJ.%2BW.%26aulast%3DZukang%26aufirst%3DF.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eahcNfh5vquPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">2558</span>, <span class="refDoi"> DOI: 10.1021/ct300203w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300203w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2553-2558&author=D.+Shivakumarauthor=E.+Harderauthor=W.+Dammauthor=R.+A.+Friesnerauthor=W.+Sherman&title=Improving+the+Prediction+of+Absolute+Solvation+Free+Energies+Using+the+Next+Generation+OPLS+Force+Field&doi=10.1021%2Fct300203w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Harder, Edward; Damm, Wolfgang; Friesner, Richard A.; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Explicit solvent mol. dynamics free energy perturbation simulations were performed to predict abs. solvation free energies of 239 diverse small mols.  We use OPLS2.0, the next generation OPLS force field, and compare the results with popular small mol. force fields-OPLS_2005, GAFF, and CHARMm-MSI.  OPLS2.0 produces the best correlation with exptl. data (R2 = 0.95, slope = 0.96) and the lowest av. unsigned errors (0.7 kcal/mol).  Important classes of compds. that performed suboptimally with OPLS_2005 show significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEngE5xV9Ev7Vg90H21EOLACvtfcHk0liD2nMf5f2Ezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D&md5=eceb7dab3a8d0c6ac586c620848412d1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fct300203w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300203w%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DImproving%2520the%2520Prediction%2520of%2520Absolute%2520Solvation%2520Free%2520Energies%2520Using%2520the%2520Next%2520Generation%2520OPLS%2520Force%2520Field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D2553%26epage%3D2558%26doi%3D10.1021%2Fct300203w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS33: A Force Field Providing Broad Coverage of Drug-Like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS33%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-Like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0liD2nMf5f2Ezg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS33%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-Like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K.-H.</span>; <span class="NLM_string-name">Hessler, G.</span>; <span class="NLM_string-name">Matter, H.</span>; <span class="NLM_string-name">Schmidt, F.</span></span> <span> </span><span class="NLM_article-title">Development and Applications of Global ADMET Models: In Silico Prediction of Human Microsomal Lability</span>. In  <i>Chemoinformatics for Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">265</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=245-265&author=K.-H.+Baringhaus&author=G.+Hessler&author=H.+Matter&author=F.+Schmidtauthor=J.+Bajorath&title=Chemoinformatics+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBaringhaus%26aufirst%3DK.-H.%26atitle%3DDevelopment%2520and%2520Applications%2520of%2520Global%2520ADMET%2520Models%253A%2520In%2520Silico%2520Prediction%2520of%2520Human%2520Microsomal%2520Lability%26btitle%3DChemoinformatics%2520for%2520Drug%2520Discovery%26aulast%3DBajorath%26aufirst%3DJ.%26pub%3DWiley%26date%3D2014%26spage%3D245%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anger, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giegerich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K.-H.</span></span> <span> </span><span class="NLM_article-title">Development of in Silico Filters to Predict Activation of the Pregnane X Receptor (PXR) by Structurally Diverse Drug-Like Molecules</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5352</span>– <span class="NLM_lpage">5365</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.bmc.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22560839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms12rsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5352-5365&author=H.+Matterauthor=L.+T.+Angerauthor=C.+Giegerichauthor=S.+G%C3%BCssregenauthor=G.+Hesslerauthor=K.-H.+Baringhaus&title=Development+of+in+Silico+Filters+to+Predict+Activation+of+the+Pregnane+X+Receptor+%28PXR%29+by+Structurally+Diverse+Drug-Like+Molecules&doi=10.1016%2Fj.bmc.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules</span></div><div class="casAuthors">Matter, Hans; Anger, Lennart T.; Giegerich, Clemens; Guessregen, Stefan; Hessler, Gerhard; Baringhaus, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5352-5365</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pregnane X receptor (PXR), a member of the nuclear hormone superfamily, regulates the expression of several enzymes and transporters involved in metabolically relevant processes.  The significant induction of CYP450 enzymes by PXR, in particular CYP3A4, might significantly alter the metab. of prescribed drugs.  In order to early identify mols. in drug discovery with a potential to activate PXR as antitarget, we developed fast and reliable in silico filters by ligand-based QSAR techniques.  Two classification models were established on a diverse dataset of 434 drug-like mols.  A second augmented set allowed focusing on interesting regions in chem. space.  These classifiers are based on decision trees combined with a genetic algorithm based variable selection to arrive at predictive models.  The classifier for the first dataset on 29 descriptors showed good performance on a test set with a correct classification of both 100% for PXR activators and non-activators plus 87% for activators and 83% for non-activators in an external dataset.  The second classifier then correctly predicts 97% activators and 91% non-activators in a test set and 94% for activators and 64% non-activators in an external set of 50 mols., which still qualifies for application as a filter focusing on PXR activators.  Finally a quant. model for PXR activation for a subset of these mols. was derived using a regression-tree approach combined with GA variable selection.  This final model shows a predictive r2 of 0.774 for the test set and 0.452 for an external set of 33 mols.  Thus, the combination of these filters consistently provide guidelines for lowering PXR activation in novel candidate mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIMqHB3fyKbVg90H21EOLACvtfcHk0lgXesdSvvWIKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms12rsr4%253D&md5=9f2ce599c60a3290670ce53eedab0ed7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DAnger%26aufirst%3DL.%2BT.%26aulast%3DGiegerich%26aufirst%3DC.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DHessler%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.-H.%26atitle%3DDevelopment%2520of%2520in%2520Silico%2520Filters%2520to%2520Predict%2520Activation%2520of%2520the%2520Pregnane%2520X%2520Receptor%2520%2528PXR%2529%2520by%2520Structurally%2520Diverse%2520Drug-Like%2520Molecules%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5352%26epage%3D5365%26doi%3D10.1016%2Fj.bmc.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span> <span> </span><span class="NLM_article-title">The Generation of 3D-Models of Host-Guest Complexes</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/0003-2670(92)85029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2F0003-2670%2892%2985029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK38XlslSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1992&pages=233-241&author=J.+Sadowskiauthor=C.+Rudolphauthor=J.+Gasteiger&title=The+Generation+of+3D-Models+of+Host-Guest+Complexes&doi=10.1016%2F0003-2670%2892%2985029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The generation of 3D models of host-guest complexes</span></div><div class="casAuthors">Sadowski, Jens; Rudolph, Christine; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-41</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    </div><div class="casAbstract">A program has been developed for the completely automatic generation of 3D at. coordinates of org. mols.  This system has been extended also to process polymacrocyclic structures, allowing complex host mols. to be modelled.  A three-step approach has been developed for modeling the geometry and energies of host-guest complexes which avoids the problem of being trapped in local min.  Two examples are given that illustrate that fine exptl. details can be derived from this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquF_ZvHvLOXrVg90H21EOLACvtfcHk0lgXesdSvvWIKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlslSmsb0%253D&md5=8290558c7bc3ba649d41718a2c6c975b</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0003-2670%2892%2985029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2670%252892%252985029-6%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DThe%2520Generation%2520of%25203D-Models%2520of%2520Host-Guest%2520Complexes%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D1992%26volume%3D265%26spage%3D233%26epage%3D241%26doi%3D10.1016%2F0003-2670%2892%2985029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span> <i>Corina</i>, version <span class="NLM_edition">3.491</span>; <span class="NLM_publisher-name">Molecular Networks
Inc.</span>: <span class="NLM_publisher-loc">Erlangen,
Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Corina%2C+version+3.491%3B+Molecular+Networks%0AInc.%3A+Erlangen%2C%0AGermany."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span> <i>MOE</i>,
version <span class="NLM_edition">2011</span>; <span class="NLM_publisher-name">Chemical Computing
Group (CCG)</span>: <span class="NLM_publisher-loc">Montreal,
Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%2C%0Aversion+2011%3B+Chemical+Computing%0AGroup+%28CCG%29%3A+Montreal%2C%0ACanada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%26pub%3DChemical%2520Computing%250AGroup%2520%2528CCG%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, G.</span></span> <span> </span><span class="NLM_article-title">“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2894</span>– <span class="NLM_lpage">2896</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK1MXmslKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2894-2896&author=G.+Schneiderauthor=W.+Neidhartauthor=T.+Gillerauthor=G.+Schmid&title=%E2%80%9CScaffold-Hopping%E2%80%9D+by+Topological+Pharmacophore+Search%3A+A+Contribution+to+Virtual+Screening&doi=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">"Scaffold-Hopping" by topological pharmacophore search: a contribution to virtual screening</span></div><div class="casAuthors">Schneider, Gisbert; Neidhart, Werner; Giller, Thomas; Schmid, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2894-2896</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">We present the successful application of a novel straightforward technique to "scaffold-hopping", i.e., identification of isofunctional mol. structures with significantly different mol. backbones.  The technique was applied to the prediction of novel cardiac T-type Ca2+ channel blocking agents using mibefradil as the seed structure.  The 12 highest-ranking mols. were tested using a cell culture assay for their ability to inhibit cellular Ca2+ influx.  One compd. (clopimozide) had an IC50 < 1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgaa9cDF2whrVg90H21EOLACvtfcHk0ljA4YMwkE_fFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslKht78%253D&md5=460b2116abc32e54ba9eb3b712333eb9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991004%252938%253A19%253C2894%253A%253AAID-ANIE2894%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DG.%26atitle%3D%25E2%2580%259CScaffold-Hopping%25E2%2580%259D%2520by%2520Topological%2520Pharmacophore%2520Search%253A%2520A%2520Contribution%2520to%2520Virtual%2520Screening%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2894%26epage%3D2896%26doi%3D10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crippen, G. M.</span></span> <span> </span><span class="NLM_article-title">Atomic Physicochemical Parameters for Three-Dimensional-Structure-Directed Quantitative Structure-Activity Relationships. 2. Modeling Dispersive and Hydrophobic Interactions</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1021/ci00053a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00053a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1987&pages=21-35&author=A.+K.+Ghoseauthor=G.+M.+Crippen&title=Atomic+Physicochemical+Parameters+for+Three-Dimensional-Structure-Directed+Quantitative+Structure-Activity+Relationships.+2.+Modeling+Dispersive+and+Hydrophobic+Interactions&doi=10.1021%2Fci00053a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fci00053a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00053a005%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DCrippen%26aufirst%3DG.%2BM.%26atitle%3DAtomic%2520Physicochemical%2520Parameters%2520for%2520Three-Dimensional-Structure-Directed%2520Quantitative%2520Structure-Activity%2520Relationships.%25202.%2520Modeling%2520Dispersive%2520and%2520Hydrophobic%2520Interactions%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1987%26volume%3D27%26spage%3D21%26epage%3D35%26doi%3D10.1021%2Fci00053a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Improved Estimates for the Accuracy of Small Disjuncts</span>. <i>Machine Learn.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/BF00153762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2FBF00153762" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=93-98&author=J.+R.+Quinlan&title=Improved+Estimates+for+the+Accuracy+of+Small+Disjuncts&doi=10.1007%2FBF00153762"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2FBF00153762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00153762%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DImproved%2520Estimates%2520for%2520the%2520Accuracy%2520of%2520Small%2520Disjuncts%26jtitle%3DMachine%2520Learn.%26date%3D1991%26volume%3D6%26spage%3D93%26epage%3D98%26doi%3D10.1007%2FBF00153762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Learning with Continuous Classes</span>.  <i>AI ’92: Proceedings of the 5th Australian Joint Conference on Artificial Intelligence</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, A.</span>, <span class="NLM_string-name">Sterling, L.</span></span>, Eds.; <span class="NLM_publisher-name">World Scientific</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">1992</span>; pp  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">348</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=343-348&author=J.+R.+Quinlanauthor=A.+Adams&author=L.+Sterling&title=AI+%E2%80%9992%3A+Proceedings+of+the+5th+Australian+Joint+Conference+on+Artificial+Intelligence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DLearning%2520with%2520Continuous%2520Classes%26btitle%3DAI%2520%25E2%2580%259992%253A%2520Proceedings%2520of%2520the%25205th%2520Australian%2520Joint%2520Conference%2520on%2520Artificial%2520Intelligence%26aulast%3DAdams%26aufirst%3DA.%26pub%3DWorld%2520Scientific%26date%3D1992%26spage%3D343%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Combining Instance-Based and Model-Based Learning</span>.  <i>Machine Learning Proceedings 1993</i>, Proceedings of the Tenth International Conference; <span class="NLM_contrib-group"><span class="NLM_string-name">Utgoff, P. E.</span></span>, Ed.; <span class="NLM_publisher-name">Morgan Kaufmann</span>: <span class="NLM_publisher-loc">Los Altos, CA</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FB978-1-55860-307-3.50037-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=J.+R.+Quinlanauthor=P.+E.+Utgoff&title=Machine+Learning+Proceedings+1993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FB978-1-55860-307-3.50037-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-55860-307-3.50037-X%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DCombining%2520Instance-Based%2520and%2520Model-Based%2520Learning%26btitle%3DMachine%2520Learning%2520Proceedings%25201993%26aulast%3DUtgoff%26aufirst%3DP.%2BE.%26pub%3DMorgan%2520Kaufmann%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, A.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein Substrate Models using Support Vector Machines Based on a Comprehensive data set</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/ci2001583</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci2001583" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1447-1456&author=Z.+Wangauthor=Y.+Chenauthor=H.+Liangauthor=A.+Benderauthor=R.+C.+Glenauthor=A.+Yan&title=P-glycoprotein+Substrate+Models+using+Support+Vector+Machines+Based+on+a+Comprehensive+data+set&doi=10.1021%2Fci2001583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set</span></div><div class="casAuthors">Wang, Zhi; Chen, Yuanying; Liang, Hu; Bender, Andreas; Glen, Robert C.; Yan, Aixia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1447-1456</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is one of the major ABC transporters and involved in many essential processes such as lipid and steroid transport across cell membranes but also in the uptake of drugs such as HIV protease and reverse transcriptase inhibitors.  Despite its importance, reliable models predicting substrates of P-gp are scarce.  In this study, the authors have built several computational models to predict whether or not a compd. is a P-gp substrate, based on the largest data set yet published, employing 332 distinct structures.  Each mol. is represented by ADRIANA.Code, MOE, and ECFP_4 fingerprint descriptors.  The models are computed using a support vector machine based on a training set which includes 131 substrates and 81 nonsubstrates that were evaluated by 5-, 10-fold, and leave-one-out (LOO) cross-validation.  The best model gives a Matthews Correlation Coeff. of 0.73 and a prediction accuracy of 0.88 on the test set.  Examn. of the model based on ECFP_4 fingerprints revealed several substructures which could have significance in sepg. substrates and nonsubstrates of P-gp, such as the nitrile and sulfoxide functional groups which have a higher frequency in nonsubstrates than in substrates.  In addn. structural isomerism in sugars was found to result in remarkable differences regarding the likelihood of a compd. to be a substrate for P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTOVOdq4wKrVg90H21EOLACvtfcHk0lgyhqxXI2Lj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFSlur0%253D&md5=2cbbf22dfc3a7bd511e92c68c5a73f14</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fci2001583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci2001583%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DYan%26aufirst%3DA.%26atitle%3DP-glycoprotein%2520Substrate%2520Models%2520using%2520Support%2520Vector%2520Machines%2520Based%2520on%2520a%2520Comprehensive%2520data%2520set%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1447%26epage%3D1456%26doi%3D10.1021%2Fci2001583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':[],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':['cit38'],'ref39':[],'ref40':[],'ref41':[],'ref42':[],'ref43':[],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81a','cit81b','cit81c'],'ref82':['cit82'],'ref83':['cit83a1','cit83a','cit83b'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Francis S. Willard, David B. Wainscott, Aaron D. Showalter, Cynthia Stutsman, Wenzhen Ma, Guemalli R. Cardona, Richard W. Zink, Christopher M. Corkins, Qi Chen, Nathan Yumibe, Javier Agejas, Graham R. Cumming, José Miguel Minguez, Alma Jiménez, Ana I. Mateo, Ana M. Castaño, Daniel A. Briere, Kyle W. Sloop, <span class="NLM_string-name hlFld-ContribAuthor">Ana B. Bueno</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3439-3448. <a href="https://doi.org/10.1021/acs.jmedchem.1c00029" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BOrally%252BEfficacious%252BPositive%252BAllosteric%252BModulator%252Bof%252Bthe%252BGlucagon-like%252BPeptide-1%252BReceptor%26aulast%3DWillard%26aufirst%3DFrancis%2BS.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D15032021%26volume%3D64%26issue%3D6%26spage%3D3439%26epage%3D3448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lin Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jin He</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-Catalyzed Michael/Alkylation Cascade Reactions Involving α-Substituted Ammonium Ylides for the Construction of Spirocyclopropyl Oxindoles: Access to the Powerful Chemical Leads against HIV-1. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (8)
                                     , 5203-5219. <a href="https://doi.org/10.1021/acs.joc.9b03164" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03164%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDABCO-Catalyzed%252BMichael%25252FAlkylation%252BCascade%252BReactions%252BInvolving%252B%2525CE%2525B1-Substituted%252BAmmonium%252BYlides%252Bfor%252Bthe%252BConstruction%252Bof%252BSpirocyclopropyl%252BOxindoles%25253A%252BAccess%252Bto%252Bthe%252BPowerful%252BChemical%252BLeads%252Bagainst%252BHIV-1%26aulast%3DChen%26aufirst%3DLin%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D03122019%26date%3D03042020%26date%3D23032020%26volume%3D85%26issue%3D8%26spage%3D5203%26epage%3D5219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A  Nauck</span>, <span class="hlFld-ContribAuthor ">Jakob  Wefers</span>, <span class="hlFld-ContribAuthor ">Juris J  Meier</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. </span><span class="cited-content_cbyCitation_journal-name">The Lancet Diabetes & Endocrinology</span><span> <strong>2021,</strong> <em>9 </em>
                                    (8)
                                     , 525-544. <a href="https://doi.org/10.1016/S2213-8587(21)00113-3" title="DOI URL">https://doi.org/10.1016/S2213-8587(21)00113-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S2213-8587(21)00113-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS2213-8587%2821%2900113-3%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Lancet%2520Diabetes%2520%2526%2520Endocrinology%26atitle%3DTreatment%252Bof%252Btype%252B2%252Bdiabetes%25253A%252Bchallenges%25252C%252Bhopes%25252C%252Band%252Banticipated%252Bsuccesses%26aulast%3DNauck%26aufirst%3DMichael%2BA%26date%3D2021%26volume%3D9%26issue%3D8%26spage%3D525%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng-Kun  Kuang</span>, <span class="hlFld-ContribAuthor ">Xi-Yao  Cheng</span>, <span class="hlFld-ContribAuthor ">Zi-Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Yu-Xi  Guo</span>, <span class="hlFld-ContribAuthor ">Yong-Qi  Huang</span>, <span class="hlFld-ContribAuthor ">Zheng-Ding  Su</span>. </span><span class="cited-content_cbyCitation_article-title">In silico prediction of GLP-1R agonists using machine learning approach. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2021,</strong> <em>75 </em>
                                    (7)
                                     , 3587-3598. <a href="https://doi.org/10.1007/s11696-021-01600-3" title="DOI URL">https://doi.org/10.1007/s11696-021-01600-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-021-01600-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-021-01600-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DIn%252Bsilico%252Bprediction%252Bof%252BGLP-1R%252Bagonists%252Busing%252Bmachine%252Blearning%252Bapproach%26aulast%3DKuang%26aufirst%3DZheng-Kun%26date%3D2021%26date%3D2021%26volume%3D75%26issue%3D7%26spage%3D3587%26epage%3D3598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingtong  Zhou</span>, <span class="hlFld-ContribAuthor ">Wanjing  Guo</span>, <span class="hlFld-ContribAuthor ">Antao  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Cai</span>, <span class="hlFld-ContribAuthor ">Márton  Vass</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Wenqing  Shui</span>, <span class="hlFld-ContribAuthor ">Suwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Dehua  Yang</span>, <span class="hlFld-ContribAuthor ">Ming-Wei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 929. <a href="https://doi.org/10.3390/biom11070929" title="DOI URL">https://doi.org/10.3390/biom11070929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11070929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11070929%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DDiscovery%252Bof%252BNovel%252BAllosteric%252BModulators%252BTargeting%252Ban%252BExtra-Helical%252BBinding%252BSite%252Bof%252BGLP-1R%252BUsing%252BStructure-%252Band%252BLigand-Based%252BVirtual%252BScreening%26aulast%3DZhou%26aufirst%3DQingtong%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prateek  Sharma</span>, <span class="hlFld-ContribAuthor ">Sukhbir  Singh</span>, <span class="hlFld-ContribAuthor ">Vinay  Thakur</span>, <span class="hlFld-ContribAuthor ">Neelam  Sharma</span>, <span class="hlFld-ContribAuthor ">Ajmer Singh  Grewal</span>. </span><span class="cited-content_cbyCitation_article-title">Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name">Obesity Medicine</span><span> <strong>2021,</strong> <em>23 </em>, 100329. <a href="https://doi.org/10.1016/j.obmed.2021.100329" title="DOI URL">https://doi.org/10.1016/j.obmed.2021.100329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.obmed.2021.100329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.obmed.2021.100329%26sid%3Dliteratum%253Aachs%26jtitle%3DObesity%2520Medicine%26atitle%3DNovel%252Band%252Bemerging%252Btherapeutic%252Bdrug%252Btargets%252Bfor%252Bmanagement%252Bof%252Btype%252B2%252BDiabetes%252BMellitus%26aulast%3DSharma%26aufirst%3DPrateek%26date%3D2021%26volume%3D23%26spage%3D100329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faisal  Malik</span>, <span class="hlFld-ContribAuthor ">Zhijun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>176 </em><a href="https://doi.org/10.1111/bph.15446" title="DOI URL">https://doi.org/10.1111/bph.15446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15446%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNon%2525E2%252580%252590peptide%252Bagonists%252Band%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bglucagon%2525E2%252580%252590like%252Bpeptide%2525E2%252580%2525901%252Breceptors%25253A%252BAlternative%252Bapproaches%252Bfor%252Btreatment%252Bof%252BType%252B2%252Bdiabetes%26aulast%3DMalik%26aufirst%3DFaisal%26date%3D2021%26date%3D2021%26volume%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Small molecule GLP-1R agonists and allosteric modulators in the literature.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of HTS hit (<b>8</b>) and advanced hit (<b>9</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response curves from functional in vitro assay data for cAMP response of GLP-1(7–36)NH<sub>2</sub> and GLP1(9–36)NH<sub>2</sub> with or without test compounds in PSC-HEK293 cells overexpressing GLP-1R using the shift assay format. Left: 10 μM compound concentration. Right: 3 μM compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b> and <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EDC, oxyma, DMAP, <i>N</i>-methylmorpholine, DMF, rt, 74%; then DMAP, Boc<sub>2</sub>O, MeCN, 45%; (b) HCO<sub>2</sub>H, rt, 80%; (c) Boc<sub>2</sub>O, CH<sub>3</sub>CN, DMAP, rt; (d) HCO<sub>2</sub>H, rt; (e) H<sub>2</sub>, Pd/C, MeOH, rt, 90%; (f) R<sub>2</sub>CO<sub>2</sub>H, EDC, oxyma, DMAP, <i>N</i>-methylmorpholine, DMF, rt, 75%; (g) acrolein, NaOH, THF; (h) MeMgBr, THF, 27% over two steps, dr 1:1.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HATU, DIPEA, THF, rt, 37%; (b) Dess–Martin, CH<sub>2</sub>Cl<sub>2</sub>, rt, 40%; (c) H<sub>2</sub>CO<sub>2</sub>H, rt, 45%; (d) Me<sub>2</sub>NH, THF, rt, 72%; (e) 2-(4,4-difluorocyclohexyl)acetic acid, HATU, DIPEA, THF, rt; (f) LiOH, MeOH/H<sub>2</sub>O, rt (38% over two steps).</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose–response curves from functional in vitro assay for cAMP response of GLP-1(7–36)NH<sub>2</sub> and GLP1(9–36)NH<sub>2</sub> with or without test compounds in human pancreatic 1.1B4 cells using the shift assay format.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Glucose-stimulated insulin secretion (GSIS) from dispersed rat islets for PAM-compounds <b>14</b> (a, b) and <b>19</b> (c). Dispersed islets were incubated with high (15 mM) glucose in the presence of vehicle control (DMSO) ± respective compound (1 μM) or GLP-1 ligand (1/10/100 nM) ± respective compound (1 μM). Diluent for GLP-1 ligand was DMSO. <i>N</i> ≥ 9/condition. **<i>p</i> ≤ 0.001 vs respective control; ****<i>p</i> ≤ 0.00001 vs respective control. For (b) and (c), incubation was done ± respective compound (10 μM) or GLP-1 ligand (10 nM) ± respective compound (10 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect on GSIS on islets of GLP-1(−/−) CD-1 mice. Dispersed mouse islets were incubated at low (3 mM) and high (15 mM) glucose with 100 nM GLP-1(7–36)NH<sub>2</sub>, 100 nM GLP1(9–36)NH<sub>2</sub>, 10 μM compound <b>14</b>, and 100 nM GLP1(9–36)NH<sub>2</sub> + 10 μM compound <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of compounds <b>19</b> (left) and <b>14</b> (right) on Ca<sup>2+</sup> mobilization. LG: low glucose (2.5 mM). HG: high glucose (15 mM). DIA: K<sub>ATP</sub> opener diazoxide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Postulated binding model for <b>9</b> (green carbon atoms) from induced fit docking into the GLP-1R X-ray structure from <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2">5NX2</a> (resolution 3.7 Å). Potential hydrogen bonds are indicated by dotted yellow lines, π–π interactions as dotted cyan lines, and cation−π interactions as dotted green lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Compound <b>19</b> was identified as substrate of hOATP1B1 and hOATP1B3 transporter by a time-dependent incubation of 1 μM compound <b>19</b> with HEK cells overexpressing hOATP1B1 (left) and hOATP1B3 (right) or HEK293 wild type cells (control).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Proof-of-concept study for compound <b>19</b> in 11-week-old ob/ob mice (<i>n</i> = 7), an animal model of T2DM. Compound <b>19</b> required the presence of rifampicin and GLP1(9–36)NH<sub>2</sub>. GLP1(9–36)NH<sub>2</sub> was given intraperitoneally. In the presence of both GLP1(9–36)NH<sub>2</sub> and compound <b>19</b>, a significant reduction in blood glucose concentration was observed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Dose–response relationship for compound <b>19</b> and the less active peptide GLP1(9–36)NH<sub>2</sub> in 11-week-old normoglycemic C57Bl/6 mice (<i>n</i> = 6). Compound <b>19</b> required the presence of rifampicin and GLP1(9–36)NH<sub>2</sub> for a biological effect. GLP1(9–36)NH<sub>2</sub> has been given intraperitoneally at 0.3, 1, 3, and 4.5 mg/kg. Compound <b>19</b> evoked at all inactive GLP-1 doses a significant reduction in blood glucose concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/medium/jm9b01071_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0012.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Demonstration of the GLP-1R dependent effect of compound <b>19</b> in 10-week-old GLP-1R<sup>–/–</sup> mice (<i>n</i> = 6). Compound <b>19</b> does not induce a significant blood glucose reduction in GLP1R<sup>–/–</sup> mice in the presence of rifampicin and GLP1(9–36)NH<sub>2</sub> at the highest dose tested.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01071/20200306/images/large/jm9b01071_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01071&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 97 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Glucagon-like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1124/pr.115.011395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fpr.115.011395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=27630114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVyjtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=954-1013&author=C.+De%0AGraafauthor=D.+Donnellyauthor=D.+Woottenauthor=J.+Lauauthor=P.+M.+Sextonauthor=L.+Millerauthor=J.-M.+Ahnauthor=J.+Liaoauthor=M.+M.+Fletcherauthor=D.+Yangauthor=A.+J.+H.+Brownauthor=C.+Zhouauthor=J.+Dengauthor=M.-W.+Wang&title=Glucagon-like+Peptide-1+and+Its+Class+B+G+Protein-Coupled+Receptors%3A+A+Long+March+to+Therapeutic+Successes&doi=10.1124%2Fpr.115.011395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes</span></div><div class="casAuthors">de Graaf, Chris; Donnelly, Dan; Wootten, Denise; Lau, Jesper; Sexton, Patrick M.; Miller, Laurence J.; Ahn, Jung-Mo; Liao, Jiayu; Fletcher, Madeleine M.; Yang, Dehua; Brown, Alastair J. H.; Zhou, Caihong; Deng, Jiejie; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">954-1013</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The glucagon-likepeptide (GLP)-1 receptor (GLP-1R) is a class B G protein-coupled receptor (GPCR) that mediates the action of GLP-1, a peptide hormone secretedfromthreemajor tissues inhumans,enteroendocrine L cells in the distal intestine, a cells in the pancreas, and the central nervous system, which exerts important actions useful in the management of type 2 diabetes mellitus and obesity, including glucose homeostasis and regulation of gastric motility and food intake.  Peptidic analogs of GLP-1 have been successfully developed with enhanced bioavailability and pharmacol. activity.  Physiol. and biochem. studies with truncated, chimeric, and mutated peptides and GLP-1R variants, together with ligand-bound crystal structures of the extracellular domain and the first three-dimensional structures of the 7-helical transmembrane domain of class B GPCRs, have provided the basis for a two domain-binding mechanism of GLP-1 with its cognate receptor.  Although efforts in discovering therapeutically viable nonpeptidic GLP-1R agonists have been hampered, small-moleculemodulators offer complementary chem. tools to peptide analogs to investigate ligand-directed biased cellular signaling of GLP-1R.  The integrated pharmacol. and structural information of different GLP-1 analogs and homologous receptors give new insights into the mol. determinants of GLP-1R ligand selectivity and functional activity, thereby providing novel opportunities in the design and development of more efficacious agents to treat metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCtj0RWeAUbVg90H21EOLACvtfcHk0liDyr7nRxBbvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVyjtb%252FJ&md5=3ef82a52b0d8f678840a9faa344624a3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011395%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26aulast%3DDonnelly%26aufirst%3DD.%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DMiller%26aufirst%3DL.%26aulast%3DAhn%26aufirst%3DJ.-M.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DFletcher%26aufirst%3DM.%2BM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DGlucagon-like%2520Peptide-1%2520and%2520Its%2520Class%2520B%2520G%2520Protein-Coupled%2520Receptors%253A%2520A%2520Long%2520March%2520to%2520Therapeutic%2520Successes%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D954%26epage%3D1013%26doi%3D10.1124%2Fpr.115.011395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Recent Progress and Future Options in the Development of GLP-1 Receptor Agonists for the Treatment of Diabesity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4011</span>– <span class="NLM_lpage">4018</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.bmcl.2013.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23743288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVamu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4011-4018&author=M.+Lorenzauthor=A.+Eversauthor=M.+Wagner&title=Recent+Progress+and+Future+Options+in+the+Development+of+GLP-1+Receptor+Agonists+for+the+Treatment+of+Diabesity&doi=10.1016%2Fj.bmcl.2013.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity</span></div><div class="casAuthors">Lorenz, Martin; Evers, Andreas; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4011-4018</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The dramatic rise of the twin epidemics, type 2 diabetes and obesity is assocd. with increased mortality and morbidity worldwide.  Based on this global development there is clin. need for anti-diabetic therapies with accompanied wt. redn.  From the approved therapies, the injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are the only class of agents which are assocd. with a modest wt. redn.  Physiol. effects of the gastro-intestinal hormone GLP-1 are improvement of glycemic control as well as a redn. in appetite and food intake.  Different approaches are currently under clin. evaluation to optimize the therapeutic potential of GLP-1 RAs directed to once-weekly up to once-monthly administration.  The next generation of peptidic co-agonists comprises the activity of GLP-1 plus addnl. gastro-intestinal hormones with the potential for increased therapeutic benefits compared to GLP-1 RAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre3s3NEw8b_7Vg90H21EOLACvtfcHk0li3AmNKhz_jwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVamu7o%253D&md5=f9c6df0f924fb6cbd804c86fb764d875</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DRecent%2520Progress%2520and%2520Future%2520Options%2520in%2520the%2520Development%2520of%2520GLP-1%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520Diabesity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4011%26epage%3D4018%26doi%3D10.1016%2Fj.bmcl.2013.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turton, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beak, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heath, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghatei, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloom, S. R.</span></span> <span> </span><span class="NLM_article-title">A Role for Glucagon-like Peptide-1 in the Central Regulation of Feeding</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1038/379069a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2F379069a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=8538742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK28XivVKgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=69-72&author=M.+D.+Turtonauthor=D.+O%E2%80%99Sheaauthor=I.+Gunnauthor=S.+A.+Beakauthor=C.+M.+Edwardsauthor=K.+Meeranauthor=S.+J.+Choiauthor=G.+M.+Taylorauthor=M.+M.+Heathauthor=P.+D.+Lambertauthor=J.+P.+Wildingauthor=D.+M.+Smithauthor=M.+A.+Ghateiauthor=J.+Herbertauthor=S.+R.+Bloom&title=A+Role+for+Glucagon-like+Peptide-1+in+the+Central+Regulation+of+Feeding&doi=10.1038%2F379069a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A role for glucagon-like peptide-1 in the central regulation of feeding</span></div><div class="casAuthors">Turton, M. D.; O'Shea, D.; Gunn, I.; Beak, S. A.; Edwards, C. M. B.; Meeran, K.; Choi, S. J.; Taylor, G. M.; Heath, M. M.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6560</span>),
    <span class="NLM_cas:pages">69-72</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The sequence of glucagon-like peptide-1 (7-36) amide (GLP-1) is completely conserved in all mammalian species studied, implying that it plays a crit. physiol. role.  The authors have shown that GLP-1 and its specific receptors are present in the hypothalamus.  No physiol. role for central GLP-1 has been established.  The authors report here that intracerebroventricular (ICV) GLP-1 powerfully inhibits feeding in fasted rats.  ICV injection of the specific GLP-1-receptor antagonist, exendin (9-39), blocked the inhibitory effect of GLP-1 on food intake.  Exendin (9-39) alone had no influence on fast-induced feeding but more than doubled food intake in satiated rats, and augmented the feeding response to the appetite stimulant, neuropeptide Y.  Induction of c-fos is a marker of neuronal activation.  Following ICV GLP-1 injection, c-fos appeared exclusively in the paraventricular nucleus of the hypothalamus and central nucleus of the amygdala, and this was inhibited by prior administration of exendin (9-39).  Both of these regions of the brain are of primary importance in the regulation of feeding.  These findings suggest that central GLP-1 is a new physiol. mediator of satiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPdbQku_Y0rVg90H21EOLACvtfcHk0li3AmNKhz_jwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivVKgsA%253D%253D&md5=b299a5b0e9b9dec7bf2814b10611f241</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F379069a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379069a0%26sid%3Dliteratum%253Aachs%26aulast%3DTurton%26aufirst%3DM.%2BD.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%26aulast%3DGunn%26aufirst%3DI.%26aulast%3DBeak%26aufirst%3DS.%2BA.%26aulast%3DEdwards%26aufirst%3DC.%2BM.%26aulast%3DMeeran%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DTaylor%26aufirst%3DG.%2BM.%26aulast%3DHeath%26aufirst%3DM.%2BM.%26aulast%3DLambert%26aufirst%3DP.%2BD.%26aulast%3DWilding%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BM.%26aulast%3DGhatei%26aufirst%3DM.%2BA.%26aulast%3DHerbert%26aufirst%3DJ.%26aulast%3DBloom%26aufirst%3DS.%2BR.%26atitle%3DA%2520Role%2520for%2520Glucagon-like%2520Peptide-1%2520in%2520the%2520Central%2520Regulation%2520of%2520Feeding%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D69%26epage%3D72%26doi%3D10.1038%2F379069a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasad-Reddy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, D.</span></span> <span> </span><span class="NLM_article-title">A Clinical Review of GLP-1 Receptor Agonists: Efficacy and Safety in Diabetes and Beyond</span>. <i>Drugs Context</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">212283</span>, <span class="refDoi"> DOI: 10.7573/dic.212283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.7573%2Fdic.212283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26213556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FntV2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=212283&author=L.+Prasad-Reddyauthor=D.+Isaacs&title=A+Clinical+Review+of+GLP-1+Receptor+Agonists%3A+Efficacy+and+Safety+in+Diabetes+and+Beyond&doi=10.7573%2Fdic.212283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond</span></div><div class="casAuthors">Prasad-Reddy Lalita; Isaacs Diana</div><div class="citationInfo"><span class="NLM_cas:title">Drugs in context</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">212283</span>
        ISSN:<span class="NLM_cas:issn">1745-1981</span>.
    </div><div class="casAbstract">The prevalence of type 2 diabetes is increasing at an astounding rate.  Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain.  Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with benefits extending outside glucose control, including positive effects on weight, blood pressure, cholesterol levels, and beta-cell function.  They mimic the effects of the incretin hormone GLP-1, which is released from the intestine in response to food intake.  Their effects include increasing insulin secretion, decreasing glucagon release, increasing satiety, and slowing gastric emptying.  There are currently four approved GLP-1 receptor agonists in the United States: exenatide, liraglutide, albiglutide, and dulaglutide.  A fifth agent, lixisenatide, is available in Europe.  There are important pharmacodynamic, pharmacokinetic, and clinical differences of each agent.  The most common adverse effects seen with GLP-1 therapy include nausea, vomiting, and injection-site reactions.  Other warnings and precautions include pancreatitis and thyroid cell carcinomas.  GLP-1 receptor agonists are an innovative and effective option to improve blood glucose control, with other potential benefits of preserving beta-cell function, weight loss, and increasing insulin sensitivity.  Once-weekly formulations may also improve patient adherence.  Overall, these are effective agents for patients with type 2 diabetes, who are either uncontrolled on metformin or intolerant to metformin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvs0wxfJtjQ5PlX7E30qdzfW6udTcc2eagYy65s2DjR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FntV2gtw%253D%253D&md5=9adaf3d9ffbd6cdb7a81d72abb1dc719</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7573%2Fdic.212283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7573%252Fdic.212283%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad-Reddy%26aufirst%3DL.%26aulast%3DIsaacs%26aufirst%3DD.%26atitle%3DA%2520Clinical%2520Review%2520of%2520GLP-1%2520Receptor%2520Agonists%253A%2520Efficacy%2520and%2520Safety%2520in%2520Diabetes%2520and%2520Beyond%26jtitle%3DDrugs%2520Context%26date%3D2015%26volume%3D4%26spage%3D212283%26doi%3D10.7573%2Fdic.212283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manandhar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.-M.</span></span> <span> </span><span class="NLM_article-title">Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1037</span>, <span class="refDoi"> DOI: 10.1021/jm500810s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500810s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVegu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1020-1037&author=B.+Manandharauthor=J.-M.+Ahn&title=Glucagon-like+Peptide-1+%28GLP-1%29+Analogs%3A+Recent+Advances%2C+New+Possibilities%2C+and+Therapeutic+Implications&doi=10.1021%2Fjm500810s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications</span></div><div class="casAuthors">Manandhar, Bikash; Ahn, Jung-Mo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1020-1037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glucagon-like peptide-1 (GLP-1) is an incretin that plays important physiol. roles in glucose homeostasis.  Produced from intestine upon food intake, it stimulates insulin secretion and keeps pancreatic β-cells healthy and proliferating.  Because of these beneficial effects, it has attracted a great deal of attention in the past decade, and an entirely new line of diabetic therapeutics has emerged based on the peptide.  In addn. to the therapeutic applications, GLP-1 analogs have demonstrated a potential in mol. imaging of pancreatic β-cells; this may be useful in early detection of the disease and evaluation of therapeutic interventions, including islet transplantation.  In this Perspective, we focus on GLP-1 analogs for their studies on improvement of biol. activities, enhancement of metabolic stability, investigation of receptor interaction, and visualization of the pancreatic islets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMy2rBwK-zv7Vg90H21EOLACvtfcHk0liVd6FtHESxFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVegu7vK&md5=5a934017b4f5f1df251a435e871b1c66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm500810s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500810s%26sid%3Dliteratum%253Aachs%26aulast%3DManandhar%26aufirst%3DB.%26aulast%3DAhn%26aufirst%3DJ.-M.%26atitle%3DGlucagon-like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogs%253A%2520Recent%2520Advances%252C%2520New%2520Possibilities%252C%2520and%2520Therapeutic%2520Implications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1020%26epage%3D1037%26doi%3D10.1021%2Fjm500810s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, P. R.</span></span> <span> </span><span class="NLM_article-title">New Perspectives on Exploitation of Incretin Peptides for the Treatment of Diabetes and Related Disorders</span>. <i>World J. Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.4239/wjd.v6.i15.1285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.4239%2Fwjd.v6.i15.1285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26557956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC28vhtVyktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1285-1295&author=N.+Irwinauthor=P.+R.+Flatt&title=New+Perspectives+on+Exploitation+of+Incretin+Peptides+for+the+Treatment+of+Diabetes+and+Related+Disorders&doi=10.4239%2Fwjd.v6.i15.1285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on exploitation of incretin peptides for the treatment of diabetes and related disorders</span></div><div class="casAuthors">Irwin Nigel; Flatt Peter R</div><div class="citationInfo"><span class="NLM_cas:title">World journal of diabetes</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1285-95</span>
        ISSN:<span class="NLM_cas:issn">1948-9358</span>.
    </div><div class="casAbstract">The applicability of stable gut hormones for the treatment of obesity-related diabetes is now undisputable.  This is based predominantly on prominent and sustained glucose-lowering actions, plus evidence that these peptides can augment insulin secretion and pancreatic islet function over time.  This review highlights the therapeutic potential of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), oxyntomodulin (OXM) and cholecystokinin (CCK) for obesity-related diabetes.  Stable GLP-1 mimetics have already been successfully adopted into the diabetic clinic, whereas GIP, CCK and OXM molecules offer promise as potential new classes of antidiabetic drugs.  Moreover, recent studies have shown improved therapeutic effects following simultaneous modulation of multiple receptor signalling pathways by combination therapy or use of dual/triple agonist peptides.  However, timing and composition of injections may be important to permit interludes of beta-cell rest.  The review also addresses the possible perils of incretin based drugs for treatment of prediabetes.  Finally, the unanticipated utility of stable gut peptides as effective treatments for complications of diabetes, bone disorders, cognitive impairment and cardiovascular dysfunction is considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRp6Vp3EMYdeo2y4bB4mnvYfW6udTcc2eagYy65s2DjR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vhtVyktA%253D%253D&md5=f9a9c32462e4b174cf1f52b5c958d8df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.4239%2Fwjd.v6.i15.1285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4239%252Fwjd.v6.i15.1285%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DN.%26aulast%3DFlatt%26aufirst%3DP.%2BR.%26atitle%3DNew%2520Perspectives%2520on%2520Exploitation%2520of%2520Incretin%2520Peptides%2520for%2520the%2520Treatment%2520of%2520Diabetes%2520and%2520Related%2520Disorders%26jtitle%3DWorld%2520J.%2520Diabetes%26date%3D2015%26volume%3D6%26spage%3D1285%26epage%3D1295%26doi%3D10.4239%2Fwjd.v6.i15.1285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span> <span> </span><span class="NLM_article-title">Oral GLP-1 Modulators for the Treatment of Diabetes</span>. <i>Annu. Rep. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">130</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-417150-3.00009-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FB978-0-12-417150-3.00009-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2013&pages=119-130&author=D.+J.+Edmondsauthor=D.+A.+Price&title=Oral+GLP-1+Modulators+for+the+Treatment+of+Diabetes&doi=10.1016%2FB978-0-12-417150-3.00009-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Oral GLP-1 modulators for the treatment of diabetes</span></div><div class="casAuthors">Edmonds, David J.; Price, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-130</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Incretin hormones were postulated following the observation that oral administration of glucose leads to higher and more sustained insulin levels than an equiv. glucose infusion.  Two such hormones were subsequently discovered, named glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (also sometimes referred to as glucose-dependent insulinotropic peptide), and found to stimulate insulin release from pancreatic beta cells.  In this review, the authors discuss the next evolution of the GLP-1 field, which is the invention of GLP -1 receptor modulators that have the convenience of oral administration and the efficacy profile of the injectable peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGnDqcjyXdfLVg90H21EOLACvtfcHk0liVd6FtHESxFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGqu77I&md5=3fb3cee115bc0088384a76e520cd0035</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-417150-3.00009-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-417150-3.00009-0%26sid%3Dliteratum%253Aachs%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26atitle%3DOral%2520GLP-1%2520Modulators%2520for%2520the%2520Treatment%2520of%2520Diabetes%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2013%26volume%3D48%26spage%3D119%26epage%3D130%26doi%3D10.1016%2FB978-0-12-417150-3.00009-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Discovery at the Glucagon-like Peptide Receptor</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">709893</span>, <span class="refDoi"> DOI: 10.1155/2012/709893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1155%2F2012%2F709893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22611375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC38nksVCitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=709893&author=F.+S.+Willardauthor=A.+B.+Buenoauthor=K.+W.+Sloop&title=Small+Molecule+Discovery+at+the+Glucagon-like+Peptide+Receptor&doi=10.1155%2F2012%2F709893"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule drug discovery at the glucagon-like peptide-1 receptor</span></div><div class="casAuthors">Willard Francis S; Bueno Ana B; Sloop Kyle W</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">709893</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The therapeutic success of peptide glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of type 2 diabetes mellitus has inspired discovery efforts aimed at developing orally available small molecule GLP-1 receptor agonists.  Although the GLP-1 receptor is a member of the structurally complex class B1 family of GPCRs, in recent years, a diverse array of orthosteric and allosteric nonpeptide ligands has been reported.  These compounds include antagonists, agonists, and positive allosteric modulators with intrinsic efficacy.  In this paper, a comprehensive review of currently disclosed small molecule GLP-1 receptor ligands is presented.  In addition, examples of "ligand bias" and "probe dependency" for the GLP-1 receptor are discussed; these emerging concepts may influence further optimization of known molecules or persuade designs of expanded screening strategies to identify novel chemical starting points for GLP-1 receptor drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQid3Y_NVG497mQt-ICR3qNfW6udTcc2eYwGYGCmnL4brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38nksVCitQ%253D%253D&md5=bdde1079f0c47549e4b6636ac1c9e89b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1155%2F2012%2F709893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F709893%26sid%3Dliteratum%253Aachs%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26atitle%3DSmall%2520Molecule%2520Discovery%2520at%2520the%2520Glucagon-like%2520Peptide%2520Receptor%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D709893%26doi%3D10.1155%2F2012%2F709893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spetzler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kofoed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, L.B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuire, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensgaard, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gram, D. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thygesen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reedtz-Runge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruse, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7370</span>– <span class="NLM_lpage">7380</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00726</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00726" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7370-7380&author=J.+Lauauthor=P.+Blochauthor=L.+Schafferauthor=I.+Petterssonauthor=J.+Spetzlerauthor=J.+Kofoedauthor=K.+Madsenauthor=L.B.+Knudsenauthor=J.+McGuireauthor=D.+B.+Steensgaardauthor=H.+M.+Straussauthor=D.+X.+Gramauthor=S.+M.+Knudsenauthor=F.+S.+Nielsenauthor=P.+Thygesenauthor=S.+Reedtz-Rungeauthor=T.+Kruse&title=Discovery+of+the+Once-Weekly+Glucagon-Like+Peptide-1+%28GLP-1%29+Analogue+Semaglutide&doi=10.1021%2Facs.jmedchem.5b00726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide</span></div><div class="casAuthors">Lau, Jesper; Bloch, Paw; Schaffer, Lauge; Pettersson, Ingrid; Spetzler, Jane; Kofoed, Jacob; Madsen, Kjeld; Knudsen, Lotte Bjerre; McGuire, James; Steensgaard, Dorte Bjerre; Strauss, Holger Martin; Gram, Dorte X.; Knudsen, Sanne Moeller; Nielsen, Flemming Seier; Thygesen, Peter; Reedtz-Runge, Steffen; Kruse, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7370-7380</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Liraglutide is an acylated glucagon-like peptide-1 (GLP-1) analog that binds to serum albumin in vivo and is approved for once-daily treatment of diabetes as well as obesity.  The aim of the present studies was to design a once weekly GLP-1 analog by increasing albumin affinity and secure full stability against metabolic degrdn.  The fatty acid moiety and the linking chem. to GLP-1 were the key features to secure high albumin affinity and GLP-1 receptor (GLP-1R) potency and in obtaining a prolonged exposure and action of the GLP-1 analog.  Semaglutide was selected as the optimal once weekly candidate.  Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.  The GLP-1R affinity of semaglutide (0.38 ± 0.06 nM) was three-fold decreased compared to liraglutide, whereas the albumin affinity was increased.  The plasma half-life was 46.1 h in mini-pigs following i.v. administration, and semaglutide has an MRT of 63.6 h after s.c. dosing to mini-pigs.  Semaglutide is currently in phase 3 clin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tFc0FzEro7Vg90H21EOLACvtfcHk0ljsktLzOPhOvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtl2qu7%252FM&md5=0478fe17f9f4dcc0cb58919b1c55869a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00726%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DJ.%26aulast%3DBloch%26aufirst%3DP.%26aulast%3DSchaffer%26aufirst%3DL.%26aulast%3DPettersson%26aufirst%3DI.%26aulast%3DSpetzler%26aufirst%3DJ.%26aulast%3DKofoed%26aufirst%3DJ.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DKnudsen%26aufirst%3DL.B.%26aulast%3DMcGuire%26aufirst%3DJ.%26aulast%3DSteensgaard%26aufirst%3DD.%2BB.%26aulast%3DStrauss%26aufirst%3DH.%2BM.%26aulast%3DGram%26aufirst%3DD.%2BX.%26aulast%3DKnudsen%26aufirst%3DS.%2BM.%26aulast%3DNielsen%26aufirst%3DF.%2BS.%26aulast%3DThygesen%26aufirst%3DP.%26aulast%3DReedtz-Runge%26aufirst%3DS.%26aulast%3DKruse%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520the%2520Once-Weekly%2520Glucagon-Like%2520Peptide-1%2520%2528GLP-1%2529%2520Analogue%2520Semaglutide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7370%26epage%3D7380%26doi%3D10.1021%2Facs.jmedchem.5b00726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadereit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4293</span>– <span class="NLM_lpage">4303</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4293-4303&author=A.+Eversauthor=T.+Haackauthor=M.+Lorenzauthor=M.+Bossartauthor=R.+Elvertauthor=B.+Henkelauthor=S.+Stengelinauthor=M.+Kurzauthor=M.+Glienauthor=A.+Duddaauthor=K.+Lorenzauthor=D.+Kadereitauthor=M.+Wagner&title=Design+of+Novel+Exendin-Based+Dual+Glucagon-like+Peptide+1+%28GLP-1%29%2FGlucagon+Receptor+Agonists&doi=10.1021%2Facs.jmedchem.7b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists</span></div><div class="casAuthors">Evers, Andreas; Haack, Torsten; Lorenz, Martin; Bossart, Martin; Elvert, Ralf; Henkel, Bernd; Stengelin, Siegfried; Kurz, Michael; Glien, Maike; Dudda, Angela; Lorenz, Katrin; Kadereit, Dieter; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4293-4303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dual activation of the glucagon-like peptide 1 (GLP-1) and glucagon receptor has the potential to lead to a novel therapy principle for the treatment of diabesity.  Here, we report a series of novel peptides with dual activity on these receptors that were discovered by rational design.  On the basis of sequence anal. and structure-based design, structural elements of glucagon were engineered into the selective GLP-1 receptor agonist exendin-4, resulting in hybrid peptides with potent dual GLP-1/glucagon receptor activity.  Detailed structure-activity relationship data are shown.  Further modifications with unnatural and modified amino acids resulted in novel metabolically stable peptides that demonstrated a significant dose-dependent decrease in blood glucose in chronic studies in diabetic db/db mice and reduced body wt. in diet-induced obese (DIO) mice.  Structural anal. by NMR spectroscopy confirmed that the peptides maintain an exendin-4-like structure with its characteristic tryptophan-cage fold motif that is responsible for favorable chem. and phys. stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrewDgurwTT4LVg90H21EOLACvtfcHk0ljsktLzOPhOvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslKrsr8%253D&md5=b59a7a25cdd56516b78c988860b39211</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00174%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DBossart%26aufirst%3DM.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DHenkel%26aufirst%3DB.%26aulast%3DStengelin%26aufirst%3DS.%26aulast%3DKurz%26aufirst%3DM.%26aulast%3DGlien%26aufirst%3DM.%26aulast%3DDudda%26aufirst%3DA.%26aulast%3DLorenz%26aufirst%3DK.%26aulast%3DKadereit%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DDesign%2520of%2520Novel%2520Exendin-Based%2520Dual%2520Glucagon-like%2520Peptide%25201%2520%2528GLP-1%2529%252FGlucagon%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4293%26epage%3D4303%26doi%3D10.1021%2Facs.jmedchem.7b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossart, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeiffer-Marek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreuder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengelin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herling, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukasczyk, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfenninger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haack, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadereit, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, M.</span></span> <span> </span><span class="NLM_article-title">Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5580</span>– <span class="NLM_lpage">5593</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2isLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5580-5593&author=A.+Eversauthor=M.+Bossartauthor=S.+Pfeiffer-Marekauthor=R.+Elvertauthor=H.+Schreuderauthor=M.+Kurzauthor=S.+Stengelinauthor=M.+Lorenzauthor=A.+Herlingauthor=A.+Konkarauthor=U.+Lukasczykauthor=A.+Pfenningerauthor=K.+Lorenzauthor=T.+Haackauthor=D.+Kadereitauthor=M.+Wagner&title=Dual+Glucagon-like+Peptide+1+%28GLP-1%29%2FGlucagon+Receptor+Agonists+Specifically+Optimized+for+Multidose+Formulations&doi=10.1021%2Facs.jmedchem.8b00292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations</span></div><div class="casAuthors">Evers, Andreas; Bossart, Martin; Pfeiffer-Marek, Stefania; Elvert, Ralf; Schreuder, Herman; Kurz, Michael; Stengelin, Siegfried; Lorenz, Martin; Herling, Andreas; Konkar, Anish; Lukasczyk, Ulrike; Pfenninger, Anja; Lorenz, Katrin; Haack, Torsten; Kadereit, Dieter; Wagner, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5580-5593</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel peptidic dual agonists of the glucagon-like peptide 1 (GLP-1) and glucagon receptor are reported to have enhanced efficacy over pure GLP-1 receptor agonists with regard to treatment of obesity and diabetes.  We describe novel exendin-4 based dual agonists designed with an activity ratio favoring the GLP-1 vs. the glucagon receptor.  As result of an iterative optimization procedure that included mol. modeling, structural biol. studies (X-ray, NMR), peptide design and synthesis, exptl. activity, and soly. profiling, a candidate mol. was identified.  Novel SAR points are reported that allowed us to fine-tune the desired receptor activity ratio and increased soly. in the presence of antimicrobial preservatives, findings that can be of general applicability for any peptide discovery project.  The peptide was evaluated in chronic in vivo studies in obese diabetic monkeys as translational model for the human situation and demonstrated favorable blood glucose and body wt. lowering effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj6Q6G9iY2lrVg90H21EOLACvtfcHk0lhH8_XOqbrAEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2isLrL&md5=cba1860c3a7b83427ee1cc0336b0e52c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00292%26sid%3Dliteratum%253Aachs%26aulast%3DEvers%26aufirst%3DA.%26aulast%3DBossart%26aufirst%3DM.%26aulast%3DPfeiffer-Marek%26aufirst%3DS.%26aulast%3DElvert%26aufirst%3DR.%26aulast%3DSchreuder%26aufirst%3DH.%26aulast%3DKurz%26aufirst%3DM.%26aulast%3DStengelin%26aufirst%3DS.%26aulast%3DLorenz%26aufirst%3DM.%26aulast%3DHerling%26aufirst%3DA.%26aulast%3DKonkar%26aufirst%3DA.%26aulast%3DLukasczyk%26aufirst%3DU.%26aulast%3DPfenninger%26aufirst%3DA.%26aulast%3DLorenz%26aufirst%3DK.%26aulast%3DHaack%26aufirst%3DT.%26aulast%3DKadereit%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DM.%26atitle%3DDual%2520Glucagon-like%2520Peptide%25201%2520%2528GLP-1%2529%252FGlucagon%2520Receptor%2520Agonists%2520Specifically%2520Optimized%2520for%2520Multidose%2520Formulations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5580%26epage%3D5593%26doi%3D10.1021%2Facs.jmedchem.8b00292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Graaf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Extending the Structural View of Class B GPCRs</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1016/j.tibs.2017.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.tibs.2017.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=29132948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSktb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=946-960&author=C.+De%0AGraafauthor=G.+Songauthor=C.+Caoauthor=Q.+Zhaoauthor=M.-W.+Wangauthor=B.+Wuauthor=R.+C.+Stevens&title=Extending+the+Structural+View+of+Class+B+GPCRs&doi=10.1016%2Fj.tibs.2017.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the Structural View of Class B GPCRs</span></div><div class="casAuthors">de Graaf, Chris; Song, Gaojie; Cao, Can; Zhao, Qiang; Wang, Ming-Wei; Wu, Beili; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">946-960</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The secretin-like class B family of G protein-coupled receptors (GPCRs) are key players in hormonal homeostasis.  Recent structures of various receptors in complex with a variety of orthosteric and allosteric ligands provide fundamental new insights into the function and mechanism of class B GPCRs, including: (i) ligand-induced changes in the relative orientation of the extracellular and transmembrane receptor domains; (ii) intramol. interaction networks that stabilize conformational changes to accommodate intracellular G protein binding; and (iii) allosteric modulation of receptor activation.  This review provides a comprehensive anal. of the structural, biochem., and pharmacol. data on class B GPCRs for understanding ligand-receptor interaction and modulation mechanisms and assessing the potential implications for drug discovery for the secretin-like GPCR family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB3zzE8S9kfrVg90H21EOLACvtfcHk0lhH8_XOqbrAEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSktb7E&md5=3e0c0b52f9078a329d3eb80290a44c97</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2017.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGraaf%26aufirst%3DC.%26aulast%3DSong%26aufirst%3DG.%26aulast%3DCao%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DM.-W.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DExtending%2520the%2520Structural%2520View%2520of%2520Class%2520B%2520GPCRs%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2017%26volume%3D42%26spage%3D946%26epage%3D960%26doi%3D10.1016%2Fj.tibs.2017.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Emerging Paradigms in GPCR allostery: Implications for Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">630</span>– <span class="NLM_lpage">644</span>, <span class="refDoi"> DOI: 10.1038/nrd4052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnrd4052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23903222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1SjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=630-644&author=D.+Woottenauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Emerging+Paradigms+in+GPCR+allostery%3A+Implications+for+Drug+Discovery&doi=10.1038%2Fnrd4052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging paradigms in GPCR allostery: implications for drug discovery</span></div><div class="casAuthors">Wootten, Denise; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">630-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Allosteric ligands bind to G protein-coupled receptors (GPCRs; also known as seven-transmembrane receptors) at sites that are distinct from the sites to which endogenous ligands bind.  The existence of allosteric ligands has enriched the ways in which the functions of GPCRs can be manipulated for potential therapeutic benefit, yet the complexity of their actions provides both challenges and opportunities for drug screening and development.  Converging avenues of research in areas such as biased signalling by allosteric ligands and the mechanisms by which allosteric ligands modulate the effects of diverse endogenous ligands have provided new insights into how interactions between allosteric ligands and GPCRs could be exploited for drug discovery.  These new findings have the potential to alter how screening for allosteric drugs is performed and may increase the chances of success in the development of allosteric modulators as clin. lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxRlmQUCUlsLVg90H21EOLACvtfcHk0lhH8_XOqbrAEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1SjtbvO&md5=59b74e5fbd5eeb832785dd879daa7c77</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4052%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DEmerging%2520Paradigms%2520in%2520GPCR%2520allostery%253A%2520Implications%2520for%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D630%26epage%3D644%26doi%3D10.1038%2Fnrd4052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1124/mol.112.079319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fmol.112.079319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22576254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOrurvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2012&pages=281-290&author=D.+Woottenauthor=E.+E.+Savageauthor=C.+Valantauthor=L.+T.+Mayauthor=K.+W.+Sloopauthor=J.+Ficorilliauthor=A.+D.+Showalterauthor=F.+S.+Willardauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Allosteric+Modulation+of+Endogenous+Metabolites+as+an+Avenue+for+Drug+Discovery&doi=10.1124%2Fmol.112.079319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of endogenous metabolites as an avenue for drug discovery</span></div><div class="casAuthors">Wootten, Denise; Savage, Emilia E.; Valant, Celine; May, Lauren T.; Sloop, Kyle W.; Ficorilli, James; Showalter, Aaron D.; Willard, Francis S.; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors and a key drug target class.  Recently, allosteric drugs that can cobind with and modulate the activity of the endogenous ligand(s) for the receptor have become a major focus of the pharmaceutical and biotechnol. industry for the development of novel GPCR therapeutic agents.  This class of drugs has distinct properties compared with drugs targeting the endogenous (orthosteric) ligand-binding site that include the ability to sculpt cellular signaling and to respond differently in the presence of discrete orthosteric ligands, a behavior termed "probe dependence.".  Here, using cell signaling assays combined with ex vivo and in vivo studies of insulin secretion, we demonstrate that allosteric ligands can cause marked potentiation of previously "inert" metabolic products of neurotransmitters and peptide hormones, a novel consequence of the phenomenon of probe dependence.  Indeed, at the muscarinic M2 receptor and glucagon-like peptide 1 (GLP-1) receptor, allosteric potentiation of the metabolites, choline and GLP-1(9-36)NH2, resp., was ∼100-fold and up to 200-fold greater than that seen with the physiol. signaling mols. acetylcholine and GLP-1(7-36)NH2.  Modulation of GLP-1(9-36)NH2 was also demonstrated in ex vivo and in vivo assays of insulin secretion.  This work opens up new avenues for allosteric drug discovery by directly targeting modulation of metabolites, but it also identifies a behavior that could contribute to unexpected clin. outcomes if interaction of allosteric drugs with metabolites is not part of their preclin. assessment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAjsIIKnjaMLVg90H21EOLACvtfcHk0lgXDmmZKAHEoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOrurvO&md5=fa4b734eb8c2f533cea5ca0cf4ab06e2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.079319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.079319%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSavage%26aufirst%3DE.%2BE.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26aulast%3DFicorilli%26aufirst%3DJ.%26aulast%3DShowalter%26aufirst%3DA.%2BD.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DAllosteric%2520Modulation%2520of%2520Endogenous%2520Metabolites%2520as%2520an%2520Avenue%2520for%2520Drug%2520Discovery%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D82%26spage%3D281%26epage%3D290%26doi%3D10.1124%2Fmol.112.079319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span>; <span class="NLM_string-name">Hong, Y.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Von Geldern, T. W.</span>; <span class="NLM_string-name">Zhang, K. E.</span></span> <span> </span><span class="NLM_article-title">Phenylalanine Derivatives and Their Use as Non-Peptide GLP-1 Receptor Modulators</span>. <span class="NLM_patent">WO 2011/094890</span> and <span class="NLM_patent">WO 2011/097300</span>, 2011.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Liao%2C+J.%3B+Hong%2C+Y.%3B+Wang%2C+Y.%3B+Von+Geldern%2C+T.+W.%3B+Zhang%2C+K.+E.+Phenylalanine+Derivatives+and+Their+Use+as+Non-Peptide+GLP-1+Receptor+Modulators.+WO+2011%2F094890+and+WO+2011%2F097300%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%26atitle%3DPhenylalanine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Non-Peptide%2520GLP-1%2520Receptor%2520Modulators" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e2892</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0002892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1371%2Fjournal.pone.0002892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18682834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD1crgtVGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2892&author=H.+Suauthor=M.+Heauthor=H.+Liauthor=Q.+Liuauthor=J.+Wangauthor=Y.+Wangauthor=W.+Gaoauthor=L.+Zhouauthor=J.+Liaoauthor=A.+A.+Youngauthor=M.-W.+Wang&title=Boc5%2C+a+Non-Peptidic+Glucagon-Like+Peptide-1+Receptor+Agonist%2C+Invokes+Sustained+Glycemic+Control+and+Weight+Loss+in+Diabetic+Mice&doi=10.1371%2Fjournal.pone.0002892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice</span></div><div class="casAuthors">Su Haoran; He Min; Li Hongmei; Liu Qing; Wang Jia; Wang Yiqian; Gao Weiwei; Zhou Ling; Liao Jiayu; Young Andrew A; Wang Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e2892</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Our recent discovery of the substituted cyclobutane Boc5, one of the first non-peptidic agonists at glucagon-like peptide-1 receptors, offers the potential of combining oral availability with full agonism capable of eliciting antidiabetic and antiobesity effects.  The present study was aimed at determining the in vivo pharmacologic properties of Boc5 in both normal and diabetic mice following chronic administration, with emphasis on glycemic control and weight loss.  METHODOLOGY/PRINCIPAL FINDINGS:  C57BL/6J and db/db mice were treated daily with Boc5 for 4 weeks and a range of pharmacologic parameters, including hemoglobin A1c, intraperitoneal glucose tolerance, insulin tolerance, fasting insulin and leptin levels, food intake, body weight and fat mass, were assessed before and after the treatment.  Effects on food intake, gastric emptying, and insulinogenic index were also investigated in animals acutely administered with Boc5.  Boc5 (3 mg) was able to induce a durable restoration of glycemic control (normalization of both hemoglobin A1c and intraperitoneal glucose tolerance) in db/db mice, following 4 weeks of daily administration.  As with peptidic glucagon-like peptide-1 receptor agonists, its glycemic benefit and weight (fat) loss were associated with dose-dependent effects that included reduction in food intake, slowing of gastric emptying (both of which reduce nutrient-drive at beta-cells), stimulation of insulin secretion (which was glucose-dependent), and elevation in insulin sensitivity.  There was little effect on normal mice treated in the same manner.  CONCLUSIONS/SIGNIFICANCE:  Our findings suggest that Boc5 is the only non-peptidic molecule reported thus far to simultaneously activate this spectrum of antidiabetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0xID2dFlutresJRIHUP1ofW6udTcc2eYS0pRAK_-1urntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crgtVGqtA%253D%253D&md5=14f710abf52ecef18f3df53a65f91f26</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002892%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DH.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DA.%2BA.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DBoc5%252C%2520a%2520Non-Peptidic%2520Glucagon-Like%2520Peptide-1%2520Receptor%2520Agonist%252C%2520Invokes%2520Sustained%2520Glycemic%2520Control%2520and%2520Weight%2520Loss%2520in%2520Diabetic%2520Mice%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2892%26doi%3D10.1371%2Fjournal.pone.0002892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesing, E. R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">Cyclobutane Derivatives as Novel Non-Peptidic Small Molecule Agonists of Glucagon-like Peptide-1 Receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">250</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1021/jm201150j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201150j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2ktrjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=250-267&author=Q.+Liuauthor=N.+Liauthor=Y.+Yuanauthor=H.+Luauthor=X.+Wuauthor=C.+Zhouauthor=M.+Heauthor=H.+Suauthor=M.+Zhangauthor=J.+Wangauthor=B.+Wangauthor=Y.+Wangauthor=D.+Maauthor=Y.+Yeauthor=H.-C.+Weissauthor=E.+R.+F.+Gesingauthor=J.+Liaoauthor=M.-W.+Wang&title=Cyclobutane+Derivatives+as+Novel+Non-Peptidic+Small+Molecule+Agonists+of+Glucagon-like+Peptide-1+Receptor&doi=10.1021%2Fjm201150j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclobutane Derivatives As Novel Nonpeptidic Small Molecule Agonists of Glucagon-Like Peptide-1 Receptor</span></div><div class="casAuthors">Liu, Qing; Li, Na; Yuan, Yunyun; Lu, Huilu; Wu, Xiaoyan; Zhou, Caihong; He, Min; Su, Haoran; Zhang, Meng; Wang, Jia; Wang, Bao; Wang, You; Na, Dawei; Ye, Yang; Weiss, Hans-Christoph; Gesing, Ernst R. F.; Liao, Jiayu; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">250-267</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel cyclobutane class of nonpeptidic glucagon-like peptide-1 (GLP-1) receptor agonists, exemplified by 3, was identified using receptor binding and multiple response element/cAMP response element (MRE/CRE)-driven reporter gene assays.  The structures of 3 and its three isomers were elucidated by NMR, HRESIMS, and X-ray crystallog.  A series of structural modifications were also made based on the core structure of 3 with different substitution groups at the west and east ends.  Among these analogs, compd. 16 was found to be 4- to 5-fold more potent than 3 both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0XNB9-G7vYrVg90H21EOLACvtfcHk0lgTC5BmBpGKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2ktrjJ&md5=ea10cfadd0acfc6f8ecb5cd86fe7837e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm201150j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201150j%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DC.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DWeiss%26aufirst%3DH.-C.%26aulast%3DGesing%26aufirst%3DE.%2BR.%2BF.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DCyclobutane%2520Derivatives%2520as%2520Novel%2520Non-Peptidic%2520Small%2520Molecule%2520Agonists%2520of%2520Glucagon-like%2520Peptide-1%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D250%26epage%3D267%26doi%3D10.1021%2Fjm201150j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>See company
Web site: <a href="http://vtvtherapeutics.com/pipeline/ttp273" class="extLink">http://vtvtherapeutics.com/pipeline/ttp273</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+company%0AWeb+site%3A+http%3A%2F%2Fvtvtherapeutics.com%2Fpipeline%2Fttp273+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mjalli, A. M. M.</span>; <span class="NLM_string-name">Behme, C.</span>; <span class="NLM_string-name">Christen, D. P.</span>; <span class="NLM_string-name">Polisetti, D. R.</span>; <span class="NLM_string-name">Quada, J.</span>; <span class="NLM_string-name">Santhosh, K.</span>; <span class="NLM_string-name">Bondlela, M.</span>; <span class="NLM_string-name">Guzel, M.</span>; <span class="NLM_string-name">Yarragunta, R. R.</span>; <span class="NLM_string-name">Gohimukkula, D. R.</span>; <span class="NLM_string-name">Andrews, R. C.</span>; <span class="NLM_string-name">Davis, S. T.</span>; <span class="NLM_string-name">Yokum, T. S.</span>; <span class="NLM_string-name">Freeman, J. L. R.</span></span> <span> </span><span class="NLM_article-title">Substituted azoantracene derivatives, pharmaceutical compositions, and methods of use thereof</span>. <span class="NLM_patent">WO 2010/114824</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+M.+M.+Mjalli&author=C.+Behme&author=D.+P.+Christen&author=D.+R.+Polisetti&author=J.+Quada&author=K.+Santhosh&author=M.+Bondlela&author=M.+Guzel&author=R.+R.+Yarragunta&author=D.+R.+Gohimukkula&author=R.+C.+Andrews&author=S.+T.+Davis&author=T.+S.+Yokum&author=J.+L.+R.+Freeman&title=Substituted+azoantracene+derivatives%2C+pharmaceutical+compositions%2C+and+methods+of+use+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMjalli%26aufirst%3DA.%2BM.%2BM.%26atitle%3DSubstituted%2520azoantracene%2520derivatives%252C%2520pharmaceutical%2520compositions%252C%2520and%2520methods%2520of%2520use%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almariego, D.</span>; <span class="NLM_string-name">Polisetti, D. R.</span>; <span class="NLM_string-name">Benjamin, E.</span>; <span class="NLM_string-name">El Abdellaoui, H.</span>; <span class="NLM_string-name">Sahoo, S. P.</span></span> <span> </span><span class="NLM_article-title">Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof</span>. <span class="NLM_patent">WO 2013/142569</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=D.+Almariego&author=D.+R.+Polisetti&author=E.+Benjamin&author=H.+El+Abdellaoui&author=S.+P.+Sahoo&title=Tris%28hydroxymethyl%29aminomethane+salts+of+a+small-molecule+GLP1R+agonist+and+pharmaceutical+compositions+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlmariego%26aufirst%3DD.%26atitle%3DTris%2528hydroxymethyl%2529aminomethane%2520salts%2520of%2520a%2520small-molecule%2520GLP1R%2520agonist%2520and%2520pharmaceutical%2520compositions%2520and%2520uses%2520thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>LOGRA:
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in
Subjects With Type 2 Diabetes, NCT02653599. <a href="https://clinicaltrials.gov/ct2/show/NCT02653599" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02653599</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=LOGRA%3A%0AA+Study+to+Evaluate+Safety+and+Efficacy+of+TTP273+for+12+Weeks+in%0ASubjects+With+Type+2+Diabetes%2C+NCT02653599.+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02653599+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>Pfizer
company pipeline. <a href="https://www.pfizer.com/science/drug-product-pipeline" class="extLink">https://www.pfizer.com/science/drug-product-pipeline</a> (consulted on Sep 3, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pfizer%0Acompany+pipeline.+https%3A%2F%2Fwww.pfizer.com%2Fscience%2Fdrug-product-pipeline+%28consulted+on+Sep+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span>Company
pipeline. <a href="https://www.lilly.com/discovery/pipeline" class="extLink">https://www.lilly.com/discovery/pipeline</a> (consulted on Sep 3, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Company%0Apipeline.+https%3A%2F%2Fwww.lilly.com%2Fdiscovery%2Fpipeline+%28consulted+on+Sep+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, T.</span>; <span class="NLM_string-name">Tanino, F.</span>; <span class="NLM_string-name">Fukazawa, M.</span>; <span class="NLM_string-name">Ogawa, K.</span>; <span class="NLM_string-name">Nagao, S.</span>; <span class="NLM_string-name">Yoshino, H.</span>; <span class="NLM_string-name">Komatsu, S.-I.</span>; <span class="NLM_string-name">Suzuki, Y.</span>; <span class="NLM_string-name">Kawabe, Y.</span></span> <span> </span><span class="NLM_article-title">OWL833, an Orally Active Nonpeptide GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion and Reduces Food Intake of Cynomolgus Monkeys</span>. Presented at the American Diabetes Association, 78th Scientific Sessions, Orlando, FL, <span class="NLM_year">2018</span>; Poster 1118.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=T.+Kawai&author=F.+Tanino&author=M.+Fukazawa&author=K.+Ogawa&author=S.+Nagao&author=H.+Yoshino&author=S.-I.+Komatsu&author=Y.+Suzuki&author=Y.+Kawabe&title=OWL833%2C+an+Orally+Active+Nonpeptide+GLP-1+Receptor+Agonist%2C+Improves+Glucose+Tolerance+by+Increasing+Insulin+Secretion+and+Reduces+Food+Intake+of+Cynomolgus+Monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DT.%26atitle%3DOWL833%252C%2520an%2520Orally%2520Active%2520Nonpeptide%2520GLP-1%2520Receptor%2520Agonist%252C%2520Improves%2520Glucose%2520Tolerance%2520by%2520Increasing%2520Insulin%2520Secretion%2520and%2520Reduces%2520Food%2520Intake%2520of%2520Cynomolgus%2520Monkeys%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span>; <span class="NLM_string-name">Bagley, S. W.</span>; <span class="NLM_string-name">Curto, J. M.</span>; <span class="NLM_string-name">Doivling, M. S.</span>; <span class="NLM_string-name">Edmonds, D.</span>; <span class="NLM_string-name">Flanagan, M. E.</span>; <span class="NLM_string-name">Futatsugi, K.</span>; <span class="NLM_string-name">Griffith, D. A.</span>; <span class="NLM_string-name">Huard, K.</span>; <span class="NLM_string-name">Ingle, G.</span>; <span class="NLM_string-name">Jiao, W.</span>; <span class="NLM_string-name">Limberskis, C.</span>; <span class="NLM_string-name">Ylathiowctz, A. M.</span>; <span class="NLM_string-name">Piotrowski, D. W.</span>; <span class="NLM_string-name">Ruggeri, R. B.</span></span> <span> </span><span class="NLM_article-title">GLP1 Agonists and Uses Thereof</span>. <span class="NLM_patent">US 20180170908</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=G.+E.+Aspnes&author=S.+W.+Bagley&author=J.+M.+Curto&author=M.+S.+Doivling&author=D.+Edmonds&author=M.+E.+Flanagan&author=K.+Futatsugi&author=D.+A.+Griffith&author=K.+Huard&author=G.+Ingle&author=W.+Jiao&author=C.+Limberskis&author=A.+M.+Ylathiowctz&author=D.+W.+Piotrowski&author=R.+B.+Ruggeri&title=GLP1+Agonists+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26atitle%3DGLP1%2520Agonists%2520and%2520Uses%2520Thereof%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshino, H.</span>; <span class="NLM_string-name">Tsuchiya, S.</span>; <span class="NLM_string-name">Matsuo, A.</span>; <span class="NLM_string-name">Sato, T.</span>; <span class="NLM_string-name">Nishimoto, M.</span>; <span class="NLM_string-name">Oguri, K.</span>; <span class="NLM_string-name">Ogawa, H.</span>; <span class="NLM_string-name">Nishimura, Y.</span>; <span class="NLM_string-name">Furuta, Y.</span>; <span class="NLM_string-name">Kashiwagi, H.</span>; <span class="NLM_string-name">Hori, N.</span>; <span class="NLM_string-name">Kamon, T.</span>; <span class="NLM_string-name">Shiraishi, T.</span>; <span class="NLM_string-name">Yoshida, S.</span>; <span class="NLM_string-name">Kawai, T.</span>; <span class="NLM_string-name">Tanida, S.</span>; <span class="NLM_string-name">Aoki, M.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyridine Derivative having GLP-1 Receptor Agonist Effect</span>. <span class="NLM_patent">WO 2018/056453</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=H.+Yoshino&author=S.+Tsuchiya&author=A.+Matsuo&author=T.+Sato&author=M.+Nishimoto&author=K.+Oguri&author=H.+Ogawa&author=Y.+Nishimura&author=Y.+Furuta&author=H.+Kashiwagi&author=N.+Hori&author=T.+Kamon&author=T.+Shiraishi&author=S.+Yoshida&author=T.+Kawai&author=S.+Tanida&author=M.+Aoki&title=Pyrazolopyridine+Derivative+having+GLP-1+Receptor+Agonist+Effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYoshino%26aufirst%3DH.%26atitle%3DPyrazolopyridine%2520Derivative%2520having%2520GLP-1%2520Receptor%2520Agonist%2520Effect%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainscott, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutsman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marín, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sloop, K. W.</span></span> <span> </span><span class="NLM_article-title">Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">10700</span>– <span class="NLM_lpage">10715</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.696039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1074%2Fjbc.M115.696039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=26975372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC28XnvVamt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=10700-10715&author=A.+B.+Buenoauthor=A.+D.+Showalterauthor=D.+B.+Wainscottauthor=C.+Stutsmanauthor=A.+Mar%C3%ADnauthor=J.+Ficorilliauthor=O.+Cabreraauthor=F.+S.+Willardauthor=K.+W.+Sloop&title=Positive+Allosteric+Modulation+of+the+Glucagon-like+Peptide-1+Receptor+by+Diverse+Electrophiles&doi=10.1074%2Fjbc.M115.696039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles</span></div><div class="casAuthors">Bueno, Ana B.; Showalter, Aaron D.; Wainscott, David B.; Stutsman, Cynthia; Marin, Aranzazu; Ficorilli, James; Cabrera, Over; Willard, Francis S.; Sloop, Kyle W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">10700-10715</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Therapeutic intervention to activate the glucagon-like peptide-1 receptor (GLP-1R) enhances glucose-dependent insulin secretion and improves energy balance in patients with type 2 diabetes mellitus.  Studies investigating mechanisms whereby peptide ligands activate GLP-1R have utilized mutagenesis, receptor chimeras, photo-affinity labeling, hydrogen-deuterium exchange, and crystallog. of the ligand-binding ectodomain to establish receptor homol. models.  However, this has not enabled the design or discovery of drug-like non-peptide GLP-1R activators.  Recently, studies investigating 4-(3-benzyloxyphenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), a GLP-1R-pos. allosteric modulator, detd. that Cys 347 in the GLP-1R is required for pos. allosteric modulator activity via covalent modification.  To advance small mol. activation of the GLP-1R, the authors characterized the insulinotropic mechanism of BETP.  In guanosine 5'-3-O-(thio)triphosphate binding and INS1 832-3 insulinoma cell cAMP assays, BETP enhanced GLP-1(9-36)-NH2-stimulated cAMP signaling.  Using isolated pancreatic islets, BETP potentiated insulin secretion in a glucose-dependent manner that requires both the peptide ligand and GLP-1R.  In studies of the covalent mechanism, PAGE fluorog. showed labeling of GLP-1R in immunopptn. expts. from GLP-1R-expressing cells incubated with [3H]BETP.  Furthermore, the authors investigated whether other reported GLP-1R activators and compds. identified from screening campaigns modulate GLP-1R by covalent modification.  Similar to BETP, several mols. were found to enhance GLP-1R signaling in a Cys 347-dependent manner.  These chemotypes are electrophiles that react with GSH, and LC/MS detd. the cysteine adducts formed upon conjugation.  Together, the authors' results suggest covalent modification may be used to stabilize the GLP-1R in an active conformation.  Moreover, the findings provide pharmacol. guidance for the discovery and characterization of small mol. GLP-1R ligands as possible therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg9lAp7MV5N7Vg90H21EOLACvtfcHk0lgTC5BmBpGKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnvVamt7w%253D&md5=5b003ca0630b264ebd333a374dc3fabf</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.696039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.696039%26sid%3Dliteratum%253Aachs%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DShowalter%26aufirst%3DA.%2BD.%26aulast%3DWainscott%26aufirst%3DD.%2BB.%26aulast%3DStutsman%26aufirst%3DC.%26aulast%3DMar%25C3%25ADn%26aufirst%3DA.%26aulast%3DFicorilli%26aufirst%3DJ.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DWillard%26aufirst%3DF.%2BS.%26aulast%3DSloop%26aufirst%3DK.%2BW.%26atitle%3DPositive%2520Allosteric%2520Modulation%2520of%2520the%2520Glucagon-like%2520Peptide-1%2520Receptor%2520by%2520Diverse%2520Electrophiles%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D10700%26epage%3D10715%26doi%3D10.1074%2Fjbc.M115.696039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoth, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberakis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span> <span> </span><span class="NLM_article-title">A Potentiator of Orthosteric Ligand Activity at GLP-1R acts via Covalent Modification</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnchembio.1581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=24997604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=629-631&author=W.+M.+Nolteauthor=J.+P.+Fortinauthor=B.+D.+Stevensauthor=G.+E.+Aspnesauthor=D.+A.+Griffithauthor=L.+R.+Hothauthor=R.+B.+Ruggeriauthor=A.+M.+Mathiowetzauthor=C.+Limberakisauthor=D.+Hepworthauthor=P.+A.+Carpino&title=A+Potentiator+of+Orthosteric+Ligand+Activity+at+GLP-1R+acts+via+Covalent+Modification&doi=10.1038%2Fnchembio.1581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification</span></div><div class="casAuthors">Nolte, Whitney M.; Fortin, Jean-Philippe; Stevens, Benjamin D.; Aspnes, Gary E.; Griffith, David A.; Hoth, Lise R.; Ruggeri, Roger B.; Mathiowetz, Alan M.; Limberakis, Chris; Hepworth, David; Carpino, Philip A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">629-631</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report that 4-(3-(benzyloxy)phenyl)-2-ethylsulfinyl-6-(trifluoromethyl)pyrimidine (BETP), which behaves as a pos. allosteric modulator at the glucagon-like peptide-1 receptor (GLP-1R), covalently modifies cysteines 347 and 438 in GLP-1R.  C347, located in intracellular loop 3 of GLP-1R, is crit. to the activity of BETP and a structurally distinct GLP-1R ago-allosteric modulator, N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine.  We further show that substitution of cysteine for phenylalanine 345 in the glucagon receptor is sufficient to confer sensitivity to BETP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRJ3ys4ywhgLVg90H21EOLACvtfcHk0li4u8pQFQz6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFSlsLrO&md5=9b0d431ea2c96e8889f774c50fdf9452</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1581%26sid%3Dliteratum%253Aachs%26aulast%3DNolte%26aufirst%3DW.%2BM.%26aulast%3DFortin%26aufirst%3DJ.%2BP.%26aulast%3DStevens%26aufirst%3DB.%2BD.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DGriffith%26aufirst%3DD.%2BA.%26aulast%3DHoth%26aufirst%3DL.%2BR.%26aulast%3DRuggeri%26aufirst%3DR.%2BB.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26atitle%3DA%2520Potentiator%2520of%2520Orthosteric%2520Ligand%2520Activity%2520at%2520GLP-1R%2520acts%2520via%2520Covalent%2520Modification%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D629%26epage%3D631%26doi%3D10.1038%2Fnchembio.1581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Corresponding in vitro data are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Moorjani, M.</span>; <span class="NLM_string-name">Tamiya, J.</span>; <span class="NLM_string-name">Huang, L.</span>; <span class="NLM_string-name">Yeager, A. R.</span>; <span class="NLM_string-name">Brahmachary, E.</span>; <span class="NLM_string-name">Fowler, T.</span>; <span class="NLM_string-name">Novak, A.</span>; <span class="NLM_string-name">Meghani, P.</span>, <span class="NLM_string-name">Knaags, M.</span></span> <span> </span><span class="NLM_article-title">Novel GLP-1 Receptor Modulators</span>. <span class="NLM_patent">WO 2016/015014</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+Boehm&author=E.+Martinborough&author=M.+Moorjani&author=J.+Tamiya&author=L.+Huang&author=A.+R.+Yeager&author=E.+Brahmachary&author=T.+Fowler&author=A.+Novak&author=P.+Meghani&author=M.+Knaags&title=Novel+GLP-1+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoehm%26aufirst%3DM.%26atitle%3DNovel%2520GLP-1%2520Receptor%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nance, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Days, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locuson, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10192</span>– <span class="NLM_lpage">10197</span>, <span class="refDoi"> DOI: 10.1021/jm501375c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501375c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10192-10197&author=L.+C.+Morrisauthor=K.+D.+Nanceauthor=P.+R.+Gentryauthor=E.+L.+Daysauthor=C.+D.+Weaverauthor=C.+M.+Niswenderauthor=A.+D.+Thompsonauthor=C.+K.+Jonesauthor=C.+W.+Locusonauthor=R.+D.+Morrisonauthor=J.+S.+Danielsauthor=K.+D.+Niswenderauthor=C.+W.+Lindsley&title=Discovery+of+%28S%29-2-Cyclopentyl-N-%28%281-isopropylpyrrolidin2-yl%29-9-methyl-1-oxo-2%2C9-dihydro-1H-pyrrido%5B3%2C4-b%5Dindole-4-carboxamide+%28VU0453379%29%3A+A+Novel%2C+CNS+Penetrant+Glucagon-like+Peptide+1+Receptor+%28GLP-1R%29+Positive+Allosteric+Modulator+%28PAM%29&doi=10.1021%2Fjm501375c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-2-Cyclopentyl-N-((1-isopropylpyrrolidin-2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrido[3,4-b]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM)</span></div><div class="casAuthors">Morris, Lindsey C.; Nance, Kellie D.; Gentry, Patrick R.; Days, Emily L.; Weaver, C. David; Niswender, Colleen M.; Thompson, Analisa D.; Jones, Carrie K.; Locuson, Chuck W.; Morrison, Ryan D.; Daniels, J. Scott; Niswender, Kevin D.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10192-10197</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A duplexed, functional multiaddn. high throughput screening and subsequent iterative parallel synthesis effort identified the first highly selective and CNS penetrant glucagon-like peptide-1R (GLP-1R) pos. allosteric modulator (PAM).  PAM 1H-pyrido[3,4-b]indole-4-carboxamide deriv. I potentiated low-dose exenatide to augment insulin secretion in primary mouse pancreatic islets, and it alone was effective in potentiating endogenous GLP-1R to reverse haloperidol-induced catalepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHpe3U-qyvtbVg90H21EOLACvtfcHk0li4u8pQFQz6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFOhtrbE&md5=e2b51406183729a3429e9d666df12e7b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm501375c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501375c%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DL.%2BC.%26aulast%3DNance%26aufirst%3DK.%2BD.%26aulast%3DGentry%26aufirst%3DP.%2BR.%26aulast%3DDays%26aufirst%3DE.%2BL.%26aulast%3DWeaver%26aufirst%3DC.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DThompson%26aufirst%3DA.%2BD.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLocuson%26aufirst%3DC.%2BW.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DK.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520%2528S%2529-2-Cyclopentyl-N-%2528%25281-isopropylpyrrolidin2-yl%2529-9-methyl-1-oxo-2%252C9-dihydro-1H-pyrrido%255B3%252C4-b%255Dindole-4-carboxamide%2520%2528VU0453379%2529%253A%2520A%2520Novel%252C%2520CNS%2520Penetrant%2520Glucagon-like%2520Peptide%25201%2520Receptor%2520%2528GLP-1R%2529%2520Positive%2520Allosteric%2520Modulator%2520%2528PAM%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10192%26epage%3D10197%26doi%3D10.1021%2Fjm501375c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G.</span>; <span class="NLM_string-name">Clemons, B.</span>; <span class="NLM_string-name">Desale, H.</span>; <span class="NLM_string-name">Dvorak, L.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Peach, R. J.</span>; <span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">RPC8844 Is a Small Molecule GLP-1R Positive Allosteric Modulator for GLP-1(7-36), GLP-1(9-36) and Oxyntomodulin, and Enhances Glucose-Stimulated Insulin Secretion from Human Pancreatic Islets</span>. Presented at the American Diabetes Association, 76th Scientific Sessions, New Orleans, LA, <span class="NLM_year">2016</span>; Poster 1080.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Reinhart&author=B.+Clemons&author=H.+Desale&author=L.+Dvorak&author=E.+Martinborough&author=M.+Boehm&author=R.+J.+Peach&author=F.+L.+Scott&title=RPC8844+Is+a+Small+Molecule+GLP-1R+Positive+Allosteric+Modulator+for+GLP-1%287-36%29%2C+GLP-1%289-36%29+and+Oxyntomodulin%2C+and+Enhances+Glucose-Stimulated+Insulin+Secretion+from+Human+Pancreatic+Islets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReinhart%26aufirst%3DG.%26atitle%3DRPC8844%2520Is%2520a%2520Small%2520Molecule%2520GLP-1R%2520Positive%2520Allosteric%2520Modulator%2520for%2520GLP-1%25287-36%2529%252C%2520GLP-1%25289-36%2529%2520and%2520Oxyntomodulin%252C%2520and%2520Enhances%2520Glucose-Stimulated%2520Insulin%2520Secretion%2520from%2520Human%2520Pancreatic%2520Islets%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G.</span>; <span class="NLM_string-name">Clemons, B.</span>; <span class="NLM_string-name">Desale, H.</span>; <span class="NLM_string-name">Dvorak, L.</span>; <span class="NLM_string-name">Martinborough, E.</span>; <span class="NLM_string-name">Boehm, M.</span>; <span class="NLM_string-name">Peach, R. J.</span>; <span class="NLM_string-name">Scott, F. L.</span></span> <span> </span><span class="NLM_article-title">RPC8844 Is a Small Molecule GLP-1R Positive Allosteric Modulator that Significantly Improves Hyperglycemia and Induces Weight Loss in Type 2 Diabetes Disease Models after Daily Oral Administration</span>. Presented at the American Diabetes Association, 76th Scientific Sessions, New Orleans, LA, <span class="NLM_year">2016</span>; Poster 1107.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Reinhart&author=B.+Clemons&author=H.+Desale&author=L.+Dvorak&author=E.+Martinborough&author=M.+Boehm&author=R.+J.+Peach&author=F.+L.+Scott&title=RPC8844+Is+a+Small+Molecule+GLP-1R+Positive+Allosteric+Modulator+that+Significantly+Improves+Hyperglycemia+and+Induces+Weight+Loss+in+Type+2+Diabetes+Disease+Models+after+Daily+Oral+Administration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DReinhart%26aufirst%3DG.%26atitle%3DRPC8844%2520Is%2520a%2520Small%2520Molecule%2520GLP-1R%2520Positive%2520Allosteric%2520Modulator%2520that%2520Significantly%2520Improves%2520Hyperglycemia%2520and%2520Induces%2520Weight%2520Loss%2520in%2520Type%25202%2520Diabetes%2520Disease%2520Models%2520after%2520Daily%2520Oral%2520Administration%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rijkelijkhuizen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQuarrie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girman, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijpels, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, J.-M.</span></span> <span> </span><span class="NLM_article-title">Effects of Meal Size and Composition on Incretin, α-Cell, and β-Cell Responses</span>. <i>Metab., Clin. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1016/j.metabol.2009.07.039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.metabol.2009.07.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19846181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=502-511&author=J.+M.+Rijkelijkhuizenauthor=K.+McQuarrieauthor=C.+J.+Girmanauthor=P.+P.+Steinauthor=A.+Mariauthor=J.+J.+Holstauthor=G.+Nijpelsauthor=J.-M.+Dekker&title=Effects+of+Meal+Size+and+Composition+on+Incretin%2C+%CE%B1-Cell%2C+and+%CE%B2-Cell+Responses&doi=10.1016%2Fj.metabol.2009.07.039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of meal size and composition on incretin, α-cell, and β-cell responses</span></div><div class="casAuthors">Rijkelijkhuizen, Josina M.; McQuarrie, Kelly; Girman, Cynthia J.; Stein, Peter P.; Mari, Andrea; Holst, Jens J.; Nijpels, Giel; Dekker, Jacqueline M.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">502-511</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The incretins glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) regulate postprandial insulin release from the β-cells.  We investigated the effects of 3 standardized meals with different caloric and nutritional content in terms of postprandial glucose, insulin, glucagon, and incretin responses.  In a randomized crossover study, 18 subjects with type 2 diabetes mellitus and 6 healthy volunteers underwent three 4-h meal tolerance tests (small carbohydrate [CH]-rich meal, large CH-rich meal, and fat-rich meal).  Non-model-based and model-based ests. of β-cell function and incremental areas under the curve of glucose, insulin, C-peptide, glucagon, GLP-1, and GIP were calcd.  Mixed models and Friedman tests were used to test for differences in meal responses.  The large CH-rich meal and fat-rich meal resulted in a slightly larger insulin response as compared with the small CH-rich meal and led to a slightly shorter period of hyperglycemia, but only in healthy subjects.  Model-based insulin secretion ests. did not show pronounced differences between meals.  Both in healthy individuals and in those with diabetes, more CH resulted in higher GLP-1 release.  In contrast with the other meals, GIP release was still rising 2 h after the fat-rich meal.  The initial glucagon response was stimulated by the large CH-rich meal, whereas the fat-rich meal induced a late glucagon response.  Fat preferentially stimulates GIP secretion, whereas CH stimulates GLP-1 secretion.  Differences in meal size and compn. led to differences in insulin and incretin responses but not to differences in postprandial glucose levels of the well-controlled patients with diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsHXyrJtxaXLVg90H21EOLACvtfcHk0ljtGCwyEkSQvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSrsrw%253D&md5=908e5073675fb9488311b9897ab9048f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.metabol.2009.07.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.metabol.2009.07.039%26sid%3Dliteratum%253Aachs%26aulast%3DRijkelijkhuizen%26aufirst%3DJ.%2BM.%26aulast%3DMcQuarrie%26aufirst%3DK.%26aulast%3DGirman%26aufirst%3DC.%2BJ.%26aulast%3DStein%26aufirst%3DP.%2BP.%26aulast%3DMari%26aufirst%3DA.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DNijpels%26aufirst%3DG.%26aulast%3DDekker%26aufirst%3DJ.-M.%26atitle%3DEffects%2520of%2520Meal%2520Size%2520and%2520Composition%2520on%2520Incretin%252C%2520%25CE%25B1-Cell%252C%2520and%2520%25CE%25B2-Cell%2520Responses%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D2010%26volume%3D59%26spage%3D502%26epage%3D511%26doi%3D10.1016%2Fj.metabol.2009.07.039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. B.</span></span> <span> </span><span class="NLM_article-title">Solid-Phase Parallel Synthesis of Natural Product-like Diaza-bridged Heterocycles through Pictet-Spengler Intramolecular Cyclization</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1021/cc0501054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc0501054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=50-57&author=S.-C+Leeauthor=S.+B.+Park&title=Solid-Phase+Parallel+Synthesis+of+Natural+Product-like+Diaza-bridged+Heterocycles+through+Pictet-Spengler+Intramolecular+Cyclization&doi=10.1021%2Fcc0501054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Solid-Phase Parallel Synthesis of Natural Product-Like Diaza-Bridged Heterocycles through Pictet-Spengler Intramolecular Cyclization</span></div><div class="casAuthors">Lee, Sung-Chan; Park, Seung Bum</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-57</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A multistep, practical solid-phase strategy for the synthesis of natural product-like diaza-bridged heterocycles was developed.  A key step in the library synthesis is tandem acidolytic cleavage with subsequent in situ iminium formation followed by the Pictet-Spengler intramol. cyclization.  The Pictet-Spengler-type intramol. cyclization step was regioselective and diastereoselective to give final products as single diastereomers in exceptional yields and purities, which was confirmed by NMR structural study and LC/MS anal.  This approach is exemplified by the prepn. of a 384-member library of 3,9-diazabicyclo[3.3.1]non-6-en-2-one skeletons, fused with indole and dihydroxybenzene and diversified at two bridging nitrogen atoms, using the solid-phase parallel synthetic methodol. without further purifn.  In this pilot library, two diastereomerically enriched diaza-bridged core skeletons were modified by amide and urea bond formation on bridging nitrogen atoms, and this scheme exhibits the potential for expansion to obtain further diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvLQVyw2DQ8bVg90H21EOLACvtfcHk0ljtGCwyEkSQvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyqsbzI&md5=533526608c1ca9a6d5e24f66111e1515</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fcc0501054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc0501054%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DS.-C%26aulast%3DPark%26aufirst%3DS.%2BB.%26atitle%3DSolid-Phase%2520Parallel%2520Synthesis%2520of%2520Natural%2520Product-like%2520Diaza-bridged%2520Heterocycles%2520through%2520Pictet-Spengler%2520Intramolecular%2520Cyclization%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2006%26volume%3D8%26spage%3D50%26epage%3D57%26doi%3D10.1021%2Fcc0501054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H. A.</span></span> <span> </span><span class="NLM_article-title">’Rule of Three’ for Fragment-Based Lead Discovery?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(03)02831-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS1359-6446%2803%2902831-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=14554012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+A.+Jhoti&title=%E2%80%99Rule+of+Three%E2%80%99+for+Fragment-Based+Lead+Discovery%3F&doi=10.1016%2FS1359-6446%2803%2902831-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">A 'rule of three' for fragment-based lead discovery?</span></div><div class="casAuthors">Congreve Miles; Carr Robin; Murray Chris; Jhoti Harren</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">876-7</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfFswFSn5vb43yKPtYViAGfW6udTcc2eY4XYjiMr2k8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svns1Cnsw%253D%253D&md5=137886dbb2062f7a3ad39277dd888df3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902831-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902831-9%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%2BA.%26atitle%3D%25E2%2580%2599Rule%2520of%2520Three%25E2%2580%2599%2520for%2520Fragment-Based%2520Lead%2520Discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877%26doi%3D10.1016%2FS1359-6446%2803%2902831-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">For preparation of amine <b>15</b>, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span>Eurofins
CEREP SA, Le bois l’Evêque, 86600 Celle-Lévescault,
France. <a href="http://www.eurofins.com" class="extLink">http://www.eurofins.com</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eurofins%0ACEREP+SA%2C+Le+bois+l%E2%80%99Ev%C3%AAque%2C+86600+Celle-L%C3%A9vescault%2C%0AFrance.+http%3A%2F%2Fwww.eurofins.com+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">Full selectivity data given in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="note"><p class="first last">In our internal assay systems, reference compounds <b>5</b> and <b>6</b> proved to be inferior in shifting the EC<sub>50</sub> value for GLP1(9–36)NH<sub>2</sub>. See <a href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf" class="ext-link">Supporting Information</a> for corresponding data.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="note"><p class="first last">Compound <b>19</b> showed no effect on the agonistic activity of glucagon on the cAMP accumulation assay on HEK2 cells overexpressing the GLP1-R.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">This inhibitory effect had also been observed with other isomerically pure compounds from this series, and therefore it was considered unprobable that it arised from one of the diasteroisomers only.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">Unfortunately, we did not have access to islets of GLP1R(−/−) rats, while in vitro data showed that efficacy of these compounds in recombinant mouse and rat orthologues assays is comparable to the human assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jazayeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kean, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Errey, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baig, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teobald, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dore, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the GLP-1 Receptor Bound to a Peptide Agonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1038/nature22800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnature22800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=28562585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=254-258&author=A.+Jazayeriauthor=M.+Rappasauthor=A.+J.+H.+Brownauthor=J.+Keanauthor=J.+C.+Erreyauthor=N.+J.+Robertsonauthor=C.+Fiez-Vandalauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=A.+Bortolatoauthor=J.+S.+Masonauthor=A.+H.+Baigauthor=I.+Teobaldauthor=A.+S.+Doreauthor=M.+Weirauthor=R.+M.+Cookeauthor=F.+H.+Marshall&title=Crystal+Structure+of+the+GLP-1+Receptor+Bound+to+a+Peptide+Agonist&doi=10.1038%2Fnature22800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the GLP-1 receptor bound to a peptide agonist</span></div><div class="casAuthors">Jazayeri, Ali; Rappas, Mathieu; Brown, Alastair J. H.; Kean, James; Errey, James C.; Robertson, Nathan J.; Fiez-Vandal, Cedric; Andrews, Stephen P.; Congreve, Miles; Bortolato, Andrea; Mason, Jonathan S.; Baig, Asma H.; Teobald, Iryna; Dore, Andrew S.; Weir, Malcolm; Cooke, Robert M.; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">254-258</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas.  GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes.  To gain insight into the mol. mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist.  The peptide agonist retains an α-helical conformation as it sits deep within the receptor-binding pocket.  The arrangement of the transmembrane helixes reveals hallmarks of an active conformation similar to that obsd. in class A receptors.  Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX6Ibc110QxrVg90H21EOLACvtfcHk0ljKhdT62xRbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCrs70%253D&md5=0a5c99161af8bae506a184e0ab6306c1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fnature22800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22800%26sid%3Dliteratum%253Aachs%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKean%26aufirst%3DJ.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%2BJ.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DBortolato%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DBaig%26aufirst%3DA.%2BH.%26aulast%3DTeobald%26aufirst%3DI.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DR.%2BM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520GLP-1%2520Receptor%2520Bound%2520to%2520a%2520Peptide%2520Agonist%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D254%26epage%3D258%26doi%3D10.1038%2Fnature22800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Vega, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span> <span> </span><span class="NLM_article-title">Conformational Thermostabilization of the Beta1-Adrenergic Receptor in a Detergent-Resistant Form</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">877</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.1073/pnas.0711253105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1073%2Fpnas.0711253105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18192400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1eqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=877-882&author=M.+J.+Serrano-Vegaauthor=F.+Magnaniauthor=Y.+Shibataauthor=C.+G.+Tate&title=Conformational+Thermostabilization+of+the+Beta1-Adrenergic+Receptor+in+a+Detergent-Resistant+Form&doi=10.1073%2Fpnas.0711253105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form</span></div><div class="casAuthors">Serrano-Vega, Maria J.; Magnani, Francesca; Shibata, Yoko; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">877-882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">There are ≈ 350 non-odorant G protein-coupled receptors (GPCRs) encoded by the human genome, many of which are predicted to be potential therapeutic targets, but there are only two structures available to represent the whole of the family.  The authors hypothesized that improving the detergent stability of these receptors and simultaneously locking them into one preferred conformation will greatly improve the chances of crystn.  The authors developed a generic strategy for the isolation of detergent-solubilized thermostable mutants of a GPCR, the β1-adrenergic receptor.  The most stable mutant receptor, βAR-m23, contained six point mutations that led to an apparent Tm 21°C higher than the native protein, and, in the presence of bound antagonist, βAR-m23 was as stable as bovine rhodopsin.  In addn., βAR-m23 was significantly more stable in a wide range of detergents ideal for crystn. and was preferentially in an antagonist conformation in the absence of ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIc_m__7gNUrVg90H21EOLACvtfcHk0ljKhdT62xRbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1eqtLs%253D&md5=19c8e268961afb861cd123a1934ae162</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0711253105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0711253105%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Vega%26aufirst%3DM.%2BJ.%26aulast%3DMagnani%26aufirst%3DF.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DConformational%2520Thermostabilization%2520of%2520the%2520Beta1-Adrenergic%2520Receptor%2520in%2520a%2520Detergent-Resistant%2520Form%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D877%26epage%3D882%26doi%3D10.1073%2Fpnas.0711253105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farid, R.</span></span> <span> </span><span class="NLM_article-title">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">534</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1021/jm050540c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050540c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=534-553&author=W.+Shermanauthor=T.+Dayauthor=M.+P.+Jacobsonauthor=R.+A.+Friesnerauthor=R.+Farid&title=Novel+Procedure+for+Modeling+Ligand%2FReceptor+Induced+Fit+Effects&doi=10.1021%2Fjm050540c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects</span></div><div class="casAuthors">Sherman, Woody; Day, Tyler; Jacobson, Matthew P.; Friesner, Richard A.; Farid, Ramy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">534-553</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present a novel protein-ligand docking method that accurately accounts for both ligand and receptor flexibility by iteratively combining rigid receptor docking (Glide) with protein structure prediction (Prime) techniques.  While traditional rigid-receptor docking methods are useful when the receptor structure does not change substantially upon ligand binding, success is limited when the protein must be "induced" into the correct binding conformation for a given ligand.  We provide an in-depth description of our novel methodol. and present results for 21 pharmaceutically relevant examples.  Traditional rigid-receptor docking for these 21 cases yields an av. RMSD of 5.5 Å.  The av. ligand RMSD for docking to a flexible receptor for the 21 pairs is 1.4 Å; the RMSD is ≤1.8 Å for 18 of the cases.  For the three cases with RMSDs greater than 1.8 Å, the core of the ligand is properly docked and all key protein/ligand interactions are captured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm3E6ctnPGSrVg90H21EOLACvtfcHk0ljKhdT62xRbkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlCgsr7I&md5=388811ead5cee1fd460951263de486cb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm050540c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050540c%26sid%3Dliteratum%253Aachs%26aulast%3DSherman%26aufirst%3DW.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DFarid%26aufirst%3DR.%26atitle%3DNovel%2520Procedure%2520for%2520Modeling%2520Ligand%252FReceptor%2520Induced%2520Fit%2520Effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D534%26epage%3D553%26doi%3D10.1021%2Fjm050540c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wootten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span> <span> </span><span class="NLM_article-title">Polar Transmembrane Interactions Drive Formation of Ligand-Specific and Signal Pathway-biased Family B G Protein-Coupled Receptor Conformation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5211</span>– <span class="NLM_lpage">5216</span>, <span class="refDoi"> DOI: 10.1073/pnas.1221585110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1073%2Fpnas.1221585110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23479653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVelt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5211-5216&author=D.+Woottenauthor=J.+Simmsauthor=L.+J.+Millerauthor=A.+Christopoulosauthor=P.+M.+Sexton&title=Polar+Transmembrane+Interactions+Drive+Formation+of+Ligand-Specific+and+Signal+Pathway-biased+Family+B+G+Protein-Coupled+Receptor+Conformation&doi=10.1073%2Fpnas.1221585110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations</span></div><div class="casAuthors">Wootten, Denise; Simms, John; Miller, Laurence J.; Christopoulos, Arthur; Sexton, Patrick M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5211-5216, S5211/1-S5211/13</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Recently, the concept of ligand-directed signaling - the ability of different ligands of an individual receptor to promote distinct patterns of cellular response - has gained much traction in the field of drug discovery, with the potential to sculpt biol. response to favor therapeutically beneficial signaling pathways over those leading to harmful effects.  However, there is limited understanding of the mechanistic basis underlying biased signaling.  The glucagon-like peptide-1 receptor is a major target for treatment of type-2 diabetes and is subject to ligand-directed signaling.  Importance of polar transmembrane residues conserved within family B G protein-coupled receptors, not only for protein folding and expression, but also in controlling activation transition, ligand-biased, and pathway-biased signaling.  Distinct clusters of polar residues were important for receptor activation and signal preference, globally changing the profile of receptor response to distinct peptide ligands, including endogenous ligands glucagon-like peptide-1, oxyntomodulin, and the clin. used mimetic exendin-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYFX8fAi9607Vg90H21EOLACvtfcHk0lhCFUfDDDE34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVelt7o%253D&md5=c37b65fb9e9fded3208f392ec0ab71f7</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1221585110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1221585110%26sid%3Dliteratum%253Aachs%26aulast%3DWootten%26aufirst%3DD.%26aulast%3DSimms%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DL.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26atitle%3DPolar%2520Transmembrane%2520Interactions%2520Drive%2520Formation%2520of%2520Ligand-Specific%2520and%2520Signal%2520Pathway-biased%2520Family%2520B%2520G%2520Protein-Coupled%2520Receptor%2520Conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D5211%26epage%3D5216%26doi%3D10.1073%2Fpnas.1221585110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coopman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timms, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willars, G. B.</span></span> <span> </span><span class="NLM_article-title">Residues within the Transmembrane Domain of the Glucagon-Like Peptide-1 Receptor Involved in Ligand Binding and Receptor Activation: Modelling the Ligand-Bound Receptor</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1804</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1210/me.2011-1160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1210%2Fme.2011-1160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=21868452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOkurjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=1804-1818&author=K.+Coopmanauthor=R.+Wallisauthor=G.+Robbauthor=A.+J.+H.+Brownauthor=G.+F.+Wilkinsonauthor=D.+Timmsauthor=G.+B.+Willars&title=Residues+within+the+Transmembrane+Domain+of+the+Glucagon-Like+Peptide-1+Receptor+Involved+in+Ligand+Binding+and+Receptor+Activation%3A+Modelling+the+Ligand-Bound+Receptor&doi=10.1210%2Fme.2011-1160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor</span></div><div class="casAuthors">Coopman, K.; Wallis, R.; Robb, G.; Brown, A. J. H.; Wilkinson, G. F.; Timms, D.; Willars, G. B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1804-1818</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The C-terminal regions of glucagon-like peptide-1 (GLP-1) bind to the N terminus of the GLP-1 receptor (GLP-1R), facilitating interaction of the ligand N terminus with the receptor transmembrane domain.  In contrast, the agonist exendin-4 relies less on the transmembrane domain, and truncated antagonist analogs (e.g. exendin 9-39) may interact solely with the receptor N terminus.  Here we used mutagenesis to explore the role of residues highly conserved in the predicted transmembrane helixes of mammalian GLP-1Rs and conserved in family B G protein coupled receptors in ligand binding and GLP-1R activation.  By iteration using information from the mutagenesis, along with the available crystal structure of the receptor N terminus and a model of the active opsin transmembrane domain, we developed a structural receptor model with GLP-1 bound and used this to better understand consequences of mutations.  Mutation at Y152 [transmembrane helix (TM) 1], R190 (TM2), Y235 (TM3), H363 (TM6), and E364 (TM6) produced similar redns. in affinity for GLP-1 and exendin 9-39.  In contrast, other mutations either preferentially [K197 (TM2), Q234 (TM3), and W284 (extracellular loop 2)] or solely [D198 (TM2) and R310 (TM5)] reduced GLP-1 affinity.  Reduced agonist affinity was always assocd. with reduced potency.  However, redns. in potency exceeded redns. in agonist affinity for K197A, W284A, and R310A, while H363A was uncoupled from cAMP generation, highlighting crit. roles of these residues in translating binding to activation.  Data show important roles in ligand binding and receptor activation of conserved residues within the transmembrane domain of the GLP-1R.  The receptor structural model provides insight into the roles of these residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25eaT7V1l2LVg90H21EOLACvtfcHk0lhCFUfDDDE34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOkurjK&md5=616cc74cd7fa6cdfc44bedca8420f527</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1210%2Fme.2011-1160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2011-1160%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DK.%26aulast%3DWallis%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DG.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DWilkinson%26aufirst%3DG.%2BF.%26aulast%3DTimms%26aufirst%3DD.%26aulast%3DWillars%26aufirst%3DG.%2BB.%26atitle%3DResidues%2520within%2520the%2520Transmembrane%2520Domain%2520of%2520the%2520Glucagon-Like%2520Peptide-1%2520Receptor%2520Involved%2520in%2520Ligand%2520Binding%2520and%2520Receptor%2520Activation%253A%2520Modelling%2520the%2520Ligand-Bound%2520Receptor%26jtitle%3DMol.%2520Endocrinol.%26date%3D2011%26volume%3D25%26spage%3D1804%26epage%3D1818%26doi%3D10.1210%2Fme.2011-1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarrasch, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiniotis, G.</span></span> <span> </span><span class="NLM_article-title">Cryo-EM Structure of the Activated GLP-1 Receptor in Complex with a G Protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>546</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1038/nature22394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnature22394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=28538729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2017&pages=248-253&author=Y.+Zhangauthor=B.+Sunauthor=D.+Fengauthor=H.+Huauthor=M.+Chuauthor=Q.+Quauthor=J.+T.+Tarraschauthor=S.+Liauthor=T.+S.+Kobilkaauthor=B.+K.+Kobilkaauthor=G.+Skiniotis&title=Cryo-EM+Structure+of+the+Activated+GLP-1+Receptor+in+Complex+with+a+G+Protein&doi=10.1038%2Fnature22394"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein</span></div><div class="casAuthors">Zhang, Yan; Sun, Bingfa; Feng, Dan; Hu, Hongli; Chu, Matthew; Qu, Qianhui; Tarrasch, Jeffrey T.; Li, Shane; Sun Kobilka, Tong; Kobilka, Brian K.; Skiniotis, Georgios</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">7657</span>),
    <span class="NLM_cas:pages">248-253</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glucagon-like peptide 1 (GLP-1) is a hormone with essential roles in regulating insulin secretion, carbohydrate metab. and appetite.  GLP-1 effects are mediated through binding to the GLP-1 receptor (GLP-1R), a class B G-protein-coupled receptor (GPCR) that signals primarily through the stimulatory G protein Gs.  Class B GPCRs are important therapeutic targets; however, our understanding of their mechanism of action is limited by the lack of structural information on activated and full-length receptors.  Here we report the cryo-electron microscopy structure of the peptide-activated GLP-1R-Gs complex at near at. resoln.  The peptide is clasped between the N-terminal domain and the transmembrane core of the receptor, and further stabilized by extracellular loops.  Conformational changes in the transmembrane domain result in a sharp kink in the middle of transmembrane helix 6, which pivots its intracellular half outward to accommodate the α5-helix of the Ras-like domain of Gs.  These results provide a structural framework for understanding class B GPCR activation through hormone binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmDRFGRwMs1bVg90H21EOLACvtfcHk0lhCFUfDDDE34w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVagtLo%253D&md5=5e7ebd94012ba47ecc299ad0502975de</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnature22394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22394%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DB.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DQ.%26aulast%3DTarrasch%26aufirst%3DJ.%2BT.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DKobilka%26aufirst%3DT.%2BS.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DSkiniotis%26aufirst%3DG.%26atitle%3DCryo-EM%2520Structure%2520of%2520the%2520Activated%2520GLP-1%2520Receptor%2520in%2520Complex%2520with%2520a%2520G%2520Protein%26jtitle%3DNature%26date%3D2017%26volume%3D546%26spage%3D248%26epage%3D253%26doi%3D10.1038%2Fnature22394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giacomini, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedie, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benet, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouwer, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillgren, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmaster, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaan, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ware, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamek-Gliszczynski, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Membrane Transporters in Drug Development</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1038/nrd3028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1038%2Fnrd3028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=20190787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=215-236&author=K.+M.+Giacominiauthor=S.+M.+Huangauthor=D.+J.+Tweedieauthor=L.+Z.+Benetauthor=K.+L.+Brouwerauthor=X.+Chuauthor=A.+Dahlinauthor=R.+Eversauthor=V.+Fischerauthor=K.+M.+Hillgrenauthor=K.+A.+Hoffmasterauthor=T.+Ishikawaauthor=D.+Kepplerauthor=R.+B.+Kimauthor=C.+A.+Leeauthor=M.+Niemiauthor=J.+W.+Polliauthor=Y.+Sugiyamaauthor=P.+W.+Swaanauthor=J.+A.+Wareauthor=S.+H.+Wrightauthor=S.+W.+Yeeauthor=M.+J.+Zamek-Gliszczynskiauthor=L.+Zhang&title=Membrane+Transporters+in+Drug+Development&doi=10.1038%2Fnrd3028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane transporters in drug development</span></div><div class="casAuthors">Giacomini, Kathleen M.; Huang, Shiew-Mei; Tweedie, Donald J.; Benet, Leslie Z.; Brouwer, Kim L. R.; Chu, Xiaoyan; Dahlin, Amber; Evers, Raymond; Fischer, Volker; Hillgren, Kathleen M.; Hoffmaster, Keith A.; Ishikawa, Toshihisa; Keppler, Dietrich; Kim, Richard B.; Lee, Caroline A.; Niemi, Mikko; Polli, Joseph W.; Sugiyama, Yuicchi; Swaan, Peter W.; Ware, Joseph A.; Wright, Stephen H.; Wah Yee, Sook; Zamek-Gliszczynski, Maciej J.; Zhang, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-236</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Membrane transporters can be major determinants of the pharmacokinetic, safety and efficacy profiles of drugs.  This presents several key questions for drug development, including which transporters are clin. important in drug absorption and disposition, and which in vitro methods are suitable for studying drug interactions with these transporters.  In addn., what criteria should trigger follow-up clin. studies, and which clin. studies should be conducted if needed.  In this article, we provide the recommendations of the International Transporter Consortium on these issues, and present decision trees that are intended to help guide clin. studies on the currently recognized most important drug transporter interactions.  The recommendations are generally intended to support clin. development and filing of a new drug application.  Overall, it is advised that the timing of transporter investigations should be driven by efficacy, safety and clin. trial enrollment questions (for example, exclusion and inclusion criteria), as well as a need for further understanding of the absorption, distribution, metab. and excretion properties of the drug mol., and information required for drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiBIf0gk93W7Vg90H21EOLACvtfcHk0lgGC_jiaN5BSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFelu74%253D&md5=89d9ce746284c1814fb01cd9b9a72027</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1038%2Fnrd3028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3028%26sid%3Dliteratum%253Aachs%26aulast%3DGiacomini%26aufirst%3DK.%2BM.%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DTweedie%26aufirst%3DD.%2BJ.%26aulast%3DBenet%26aufirst%3DL.%2BZ.%26aulast%3DBrouwer%26aufirst%3DK.%2BL.%26aulast%3DChu%26aufirst%3DX.%26aulast%3DDahlin%26aufirst%3DA.%26aulast%3DEvers%26aufirst%3DR.%26aulast%3DFischer%26aufirst%3DV.%26aulast%3DHillgren%26aufirst%3DK.%2BM.%26aulast%3DHoffmaster%26aufirst%3DK.%2BA.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DKeppler%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DC.%2BA.%26aulast%3DNiemi%26aufirst%3DM.%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DSwaan%26aufirst%3DP.%2BW.%26aulast%3DWare%26aufirst%3DJ.%2BA.%26aulast%3DWright%26aufirst%3DS.%2BH.%26aulast%3DYee%26aufirst%3DS.%2BW.%26aulast%3DZamek-Gliszczynski%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMembrane%2520Transporters%2520in%2520Drug%2520Development%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D215%26epage%3D236%26doi%3D10.1038%2Fnrd3028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalliokoski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemi, M.</span></span> <span> </span><span class="NLM_article-title">Impact of OATP Transporters on Pharmacokinetics</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>158</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">705</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2009.00430.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1111%2Fj.1476-5381.2009.00430.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19785645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2009&pages=693-705&author=A.+Kalliokoskiauthor=M.+Niemi&title=Impact+of+OATP+Transporters+on+Pharmacokinetics&doi=10.1111%2Fj.1476-5381.2009.00430.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of OATP transporters on pharmacokinetics</span></div><div class="casAuthors">Kalliokoski, A.; Niemi, M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-705</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Membrane transporters are now recognized as important determinants of the transmembrane passage of drugs.  Org. anion transporting polypeptides (OATP) form a family of influx transporters expressed in various tissues important for pharmacokinetics.  Of the 11 human OATP transporters, OATP1B1, OATP1B3 and OATP2B1 are expressed on the sinusoidal membrane of hepatocytes and can facilitate the liver uptake of their substrate drugs.  OATP1A2 is expressed on the luminal membrane of small intestinal enterocytes and at the blood-brain barrier, potentially mediating drug transport at these sites.  Several clin. used drugs have been identified as substrates of OATP transporters (e.g. many statins are substrates of OATP1B1).  Some drugs may inhibit OATP transporters (e.g. cyclosporine) causing pharmacokinetic drug-drug interactions.  Moreover, genetic variability in genes encoding OATP transporters can result in marked inter-individual differences in pharmacokinetics.  For example, a single nucleotide polymorphism (c.521T > C, p.Val174Ala) in the SLCO1B1 gene encoding OATP1B1 decreases the ability of OATP1B1 to transport active simvastatin acid from portal circulation into the liver, resulting in markedly increased plasma concns. of simvastatin acid and an enhanced risk of simvastatin-induced myopathy.  SLCO1B1 polymorphism also affects the pharmacokinetics of many other, but not all (fluvastatin), statins and that of the antidiabetic drug repaglinide, the antihistamine fexofenadine and the endothelin A receptor antagonist atrasentan.  This review compiles the current knowledge about the expression and function of human OATP transporters, their substrate and inhibitor specificities, as well as pharmacogenetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojTPf2q4a0OLVg90H21EOLACvtfcHk0lgGC_jiaN5BSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSks7rE&md5=0a07b22ca5cd25c31eebb7a557bca183</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00430.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00430.x%26sid%3Dliteratum%253Aachs%26aulast%3DKalliokoski%26aufirst%3DA.%26aulast%3DNiemi%26aufirst%3DM.%26atitle%3DImpact%2520of%2520OATP%2520Transporters%2520on%2520Pharmacokinetics%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D158%26spage%3D693%26epage%3D705%26doi%3D10.1111%2Fj.1476-5381.2009.00430.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karlgren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vildhede, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norinder, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisniewski, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haglund, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4740</span>– <span class="NLM_lpage">4763</span>, <span class="refDoi"> DOI: 10.1021/jm300212s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300212s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4740-4763&author=M.+Karlgrenauthor=A.+Vildhedeauthor=U.+Norinderauthor=J.+R.+Wisniewskiauthor=E.+Kimotoauthor=Y.+Laiauthor=U.+Haglundauthor=P.+Artursson&title=Classification+of+Inhibitors+of+Hepatic+Organic+Anion+Transporting+Polypeptides+%28OATPs%29%3A+Influence+of+Protein+Expression+on+Drug%E2%80%93Drug+Interactions&doi=10.1021%2Fjm300212s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug-Drug Interactions</span></div><div class="casAuthors">Karlgren, Maria; Vildhede, Anna; Norinder, Ulf; Wisniewski, Jacek R.; Kimoto, Emi; Lai, Yurong; Haglund, Ulf; Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4740-4763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatic org. anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clin. drug-drug interactions.  Predicting potential interactions with OATPs is, therefore, of value.  Here, we developed in vitro and in silico models for identification and prediction of specific and general inhibitors of OATP1B1, OATP1B3, and OATP2B1.  The maximal transport activity (MTA) of each OATP in human liver was predicted from transport kinetics and protein quantification.  We then used MTA to predict the effects of a subset of inhibitors on atorvastatin uptake in vivo.  Using a data set of 225 drug-like compds., 91 OATP inhibitors were identified.  In silico models indicated that lipophilicity and polar surface area are key mol. features of OATP inhibition.  MTA predictions identified OATP1B1 and OATP1B3 as major determinants of atorvastatin uptake in vivo.  The relative contributions to overall hepatic uptake varied with isoform specificities of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTZXuqAFWG7Vg90H21EOLACvtfcHk0lgGC_jiaN5BSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Oqur0%253D&md5=460b8f4ca6a399a16881f5fafd7f3b1e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm300212s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300212s%26sid%3Dliteratum%253Aachs%26aulast%3DKarlgren%26aufirst%3DM.%26aulast%3DVildhede%26aufirst%3DA.%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DWisniewski%26aufirst%3DJ.%2BR.%26aulast%3DKimoto%26aufirst%3DE.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DHaglund%26aufirst%3DU.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DClassification%2520of%2520Inhibitors%2520of%2520Hepatic%2520Organic%2520Anion%2520Transporting%2520Polypeptides%2520%2528OATPs%2529%253A%2520Influence%2520of%2520Protein%2520Expression%2520on%2520Drug%25E2%2580%2593Drug%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4740%26epage%3D4763%26doi%3D10.1021%2Fjm300212s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kotsampasakou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jäger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecker, G. F.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel Inhibitors of Arganic Anion Transporting Polypeptides 1B1 and 1B3 (PATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">4395</span>– <span class="NLM_lpage">4404</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.5b00583</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.5b00583" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Gks77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=4395-4404&author=E.+Kotsampasakouauthor=S.+Brennerauthor=S.+J%C3%A4gerauthor=G.+F.+Ecker&title=Identification+of+Novel+Inhibitors+of+Arganic+Anion+Transporting+Polypeptides+1B1+and+1B3+%28PATP1B1+and+OATP1B3%29+Using+a+Consensus+Vote+of+Six+Classification+Models&doi=10.1021%2Facs.molpharmaceut.5b00583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3 (OATP1B1 and OATP1B3) Using a Consensus Vote of Six Classification Models</span></div><div class="casAuthors">Kotsampasakou, Eleni; Brenner, Stefan; Jaeger, Walter; Ecker, Gerhard F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4395-4404</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Org. anion transporting polypeptides 1B1 and 1B3 are transporters selectively expressed on the basolateral membrane of the hepatocyte.  Several studies reveal that they are involved in drug-drug interactions, cancer, and hyperbilirubinemia.  In this study, we developed a set of classification models for OATP1B1 and 1B3 inhibition based on more than 1700 carefully curated compds. from literature, which were validated via cross-validation and by use of an external test set.  After combining several sets of descriptors and classifiers, the 6 best models were selected according to their statistical performance and were used for virtual screening of DrugBank.  Consensus scoring of the screened compds. resulted in the selection and purchase of nine compds. as potential dual inhibitors and of one compd. as potential selective OATP1B3 inhibitor.  Biol. testing of the compds. confirmed the validity of the models, yielding an accuracy of 90% for OATP1B1 and 80% for OATP1B3, resp.  Moreover, at least half of the new identified inhibitors are assocd. with hyperbilirubinemia or hepatotoxicity, implying a relationship between OATP inhibition and these severe side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQ9NCKeW4y7Vg90H21EOLACvtfcHk0ljHMEXeAztYFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Gks77E&md5=5809374e111405f7fbc161e45d77b800</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.5b00583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.5b00583%26sid%3Dliteratum%253Aachs%26aulast%3DKotsampasakou%26aufirst%3DE.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DS.%26aulast%3DEcker%26aufirst%3DG.%2BF.%26atitle%3DIdentification%2520of%2520Novel%2520Inhibitors%2520of%2520Arganic%2520Anion%2520Transporting%2520Polypeptides%25201B1%2520and%25201B3%2520%2528PATP1B1%2520and%2520OATP1B3%2529%2520Using%2520a%2520Consensus%2520Vote%2520of%2520Six%2520Classification%2520Models%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2015%26volume%3D12%26spage%3D4395%26epage%3D4404%26doi%3D10.1021%2Facs.molpharmaceut.5b00583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matter, H.</span>; <span class="NLM_string-name">Buning, C.</span>; <span class="NLM_string-name">Giegerich, C.</span></span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Matter%2C+H.%3B+Buning%2C+C.%3B+Giegerich%2C+C.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharom, F. J.</span></span> <span> </span><span class="NLM_article-title">ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance</span>. <i>Pharmacogenomics</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">127</span>, <span class="refDoi"> DOI: 10.2217/14622416.9.1.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.2217%2F14622416.9.1.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18154452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFOjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=105-127&author=F.+J.+Sharom&title=ABC+Multidrug+Transporters%3A+Structure%2C+Function+and+Role+in+Chemoresistance&doi=10.2217%2F14622416.9.1.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">ABC multidrug transporters: structure, function and role in chemoresistance</span></div><div class="casAuthors">Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacogenomics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">PARMFL</span>;
        ISSN:<span class="NLM_cas:issn">1462-2416</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Three ATP-binding cassette (ABC)-superfamily multidrug efflux pumps are known to be responsible for chemoresistance; P-glycoprotein (ABCB1), MRP1 (ABCC1) and ABCG2 (BCRP).  These transporters play an important role in normal physiol. by protecting tissues from toxic xenobiotics and endogenous metabolites.  Hydrophobic amphipathic compds., including many clin. used drugs, interact with the substrate-binding pocket of these proteins via flexible hydrophobic and H-bonding interactions.  These efflux pumps are expressed in many human tumors, where they likely contribute to resistance to chemotherapy treatment.  However, the use of efflux-pump modulators in clin. cancer treatment has proved disappointing.  Single nucleotide polymorphisms in ABC drug-efflux pumps may play a role in responses to drug therapy and disease susceptibility.  The effect of various genotypes and haplotypes on the expression and function of these proteins is not yet clear, and their true impact remains controversial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodtANKweyrPrVg90H21EOLACvtfcHk0ljHMEXeAztYFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFOjsg%253D%253D&md5=7594f33bc3a524c65d3622b00750dbe6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.2217%2F14622416.9.1.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14622416.9.1.105%26sid%3Dliteratum%253Aachs%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520Multidrug%2520Transporters%253A%2520Structure%252C%2520Function%2520and%2520Role%2520in%2520Chemoresistance%26jtitle%3DPharmacogenomics%26date%3D2008%26volume%3D9%26spage%3D105%26epage%3D127%26doi%3D10.2217%2F14622416.9.1.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aller, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittaboina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrell, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbatsch, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.</span></span> <span> </span><span class="NLM_article-title">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>323</i></span>,  <span class="NLM_fpage">1718</span>– <span class="NLM_lpage">1722</span>, <span class="refDoi"> DOI: 10.1126/science.1168750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1126%2Fscience.1168750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19325113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2009&pages=1718-1722&author=S.+G.+Allerauthor=J.+Yuauthor=A.+Wardauthor=Y.+Wengauthor=S.+Chittaboinaauthor=R.+Zhuoauthor=P.+M.+Harrellauthor=Y.+T.+Trinhauthor=Q.+Zhangauthor=I.+L.+Urbatschauthor=G.+Chang&title=Structure+of+P-Glycoprotein+Reveals+a+Molecular+Basis+for+Poly-Specific+Drug+Binding&doi=10.1126%2Fscience.1168750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding</span></div><div class="casAuthors">Aller, Stephen G.; Yu, Jodie; Ward, Andrew; Weng, Yue; Chittaboina, Srinivas; Zhuo, Rupeng; Harrell, Patina M.; Trinh, Yenphuong T.; Zhang, Qinghai; Urbatsch, Ina L.; Chang, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">5922</span>),
    <span class="NLM_cas:pages">1718-1722</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) detoxifies cells by exporting hundreds of chem. unrelated toxins but has been implicated in multidrug resistance (MDR) in the treatment of cancers.  Substrate promiscuity is a hallmark of P-gp activity, thus a structural description of poly-specific drug-binding is important for the rational design of anticancer drugs and MDR inhibitors.  The x-ray structure of apo P-gp at 3.8 angstroms reveals an internal cavity of ~6000 angstroms cubed with a 30 angstrom sepn. of the two nucleotide-binding domains.  Two addnl. P-gp structures with cyclic peptide inhibitors demonstrate distinct drug-binding sites in the internal cavity capable of stereoselectivity that is based on hydrophobic and arom. interactions.  Apo and drug-bound P-gp structures have portals open to the cytoplasm and the inner leaflet of the lipid bilayer for drug entry.  The inward-facing conformation represents an initial stage of the transport cycle that is competent for drug binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2EUmR-iQyaLVg90H21EOLACvtfcHk0ljHMEXeAztYFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1Kgtro%253D&md5=66c7398b0257e6c05161a1afbecdafb1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168750%26sid%3Dliteratum%253Aachs%26aulast%3DAller%26aufirst%3DS.%2BG.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DA.%26aulast%3DWeng%26aufirst%3DY.%26aulast%3DChittaboina%26aufirst%3DS.%26aulast%3DZhuo%26aufirst%3DR.%26aulast%3DHarrell%26aufirst%3DP.%2BM.%26aulast%3DTrinh%26aufirst%3DY.%2BT.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DUrbatsch%26aufirst%3DI.%2BL.%26aulast%3DChang%26aufirst%3DG.%26atitle%3DStructure%2520of%2520P-Glycoprotein%2520Reveals%2520a%2520Molecular%2520Basis%2520for%2520Poly-Specific%2520Drug%2520Binding%26jtitle%3DScience%26date%3D2009%26volume%3D323%26spage%3D1718%26epage%3D1722%26doi%3D10.1126%2Fscience.1168750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nies, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keppler, D.</span></span> <span> </span><span class="NLM_article-title">Interplay of Conjugating Enzymes with OATP Uptake Transporters and ABCC/MRP Efflux Pumps in the Elimination of Drugs</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">545</span>– <span class="NLM_lpage">568</span>, <span class="refDoi"> DOI: 10.1517/17425255.4.5.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1517%2F17425255.4.5.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=18484914" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVWrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=545-568&author=A.+T.+Niesauthor=M.+Schwabauthor=D.+Keppler&title=Interplay+of+Conjugating+Enzymes+with+OATP+Uptake+Transporters+and+ABCC%2FMRP+Efflux+Pumps+in+the+Elimination+of+Drugs&doi=10.1517%2F17425255.4.5.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs</span></div><div class="casAuthors">Nies, Anne T.; Schwab, Matthias; Keppler, Dietrich</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-568</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Biliary excretion is a major elimination route of many drugs and their metabolites.  Hepatobiliary elimination is a vectorial process involving uptake transporters in the basolateral hepatocyte membrane, possibly Phase I and Phase II metabolizing enzymes, and ATP-dependent efflux pumps in the apical hepatocyte membrane.  Because many drugs and their metabolites are anions, this review focuses on transporters involved in their hepatocellular uptake (members of the org. anion transporting polypeptide (OATP) family) and biliary elimination (apical conjugate efflux pump ABCC2/MRP2).  The mol. and functional characteristics of the human OATP and ABCC/MRP transporters are presented, including a detailed overview of endogenous and drug substrates.  Examples illustrate the interplay of transporters with Phase II conjugating enzymes.  Model systems to study the vectorial transport of org. anions are also discussed.  OATP uptake transporters, conjugating enzymes, and ABCC2/MRP2 work in concert to enable the hepatobiliary elimination of anionic drugs and their metabolites.  It is increasingly important to understand how genetic variants of these transporters and enzymes influence the interindividual variability of drug elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFQlXbU-NQPbVg90H21EOLACvtfcHk0ljHMEXeAztYFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVWrtrg%253D&md5=b7bf0bd75a0b09427bf5d8ac58fc5e53</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F17425255.4.5.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.4.5.545%26sid%3Dliteratum%253Aachs%26aulast%3DNies%26aufirst%3DA.%2BT.%26aulast%3DSchwab%26aufirst%3DM.%26aulast%3DKeppler%26aufirst%3DD.%26atitle%3DInterplay%2520of%2520Conjugating%2520Enzymes%2520with%2520OATP%2520Uptake%2520Transporters%2520and%2520ABCC%252FMRP%2520Efflux%2520Pumps%2520in%2520the%2520Elimination%2520of%2520Drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2008%26volume%3D4%26spage%3D545%26epage%3D568%26doi%3D10.1517%2F17425255.4.5.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imaoka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikkaichi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirouchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okudaira, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, T.</span></span> <span> </span><span class="NLM_article-title">Integrated Approach of in Vivo and in Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats using Rifampicin as an Inhibitor</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1442</span>– <span class="NLM_lpage">1449</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.051052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.113.051052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23640987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVajtr7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=1442-1449&author=T.+Imaokaauthor=T.+Mikkaichiauthor=K.+Abeauthor=M.+Hirouchiauthor=N.+Okudairaauthor=T.+Izumi&title=Integrated+Approach+of+in+Vivo+and+in+Vitro+Evaluation+of+the+Involvement+of+Hepatic+Uptake+Organic+Anion+Transporters+in+the+Drug+Disposition+in+Rats+using+Rifampicin+as+an+Inhibitor&doi=10.1124%2Fdmd.113.051052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor</span></div><div class="casAuthors">Imaoka, Tomoki; Mikkaichi, Tsuyoshi; Abe, Koji; Hirouchi, Masakazu; Okudaira, Noriko; Izumi, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1442-1449</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cumulative studies describe the importance of drug transporters as one of the key determinants of pharmacokinetics that necessitate investigation and assessment of the involvement of drug transporters in drug discovery and development.  The present study investigated an integrated in vivo and in vitro approach to det. the involvement of org. anion transporting polypeptides (Oatps) in the disposition of drugs in rats using rifampicin as an inhibitor.  When bromosulfophthalein (BSP) and HMG-CoA reductase inhibitors (statins), which were used as model substrates for Oatps, were administered i.v. (3 and 1 mg/kg, resp.) to rats pretreated with rifampicin orally (30 mg/kg), the total plasma clearance of BSP and statins was attenuated compared with that in control rats, suggesting the involvement of Oatps in the disposition of these drugs in vivo.  On the other hand, the pharmacokinetics of midazolam, used as a model substrate of cytochrome P 450 3a (Cyp3a), was unchanged between control rats and rifampicin-pretreated rats.  The involvement of Oatps in the disposition of statins obsd. in vivo was further clarified by employing an in vitro hepatic uptake study and media-loss assay in the presence or absence of 100 μM rifampicin.  Hepatic intrinsic clearance was reduced in the presence of rifampicin in both the media-loss assay and hepatocyte uptake study.  The present study suggests in vivo investigations in rats using rifampicin together with in vitro investigations with a media-loss assay and/or uptake assay using rat hepatocytes can help det. whether a clin. drug-drug interaction study is necessary in drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv3jdG9AtaNLVg90H21EOLACvtfcHk0ljhJ6UCqn7HIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVajtr7N&md5=7144466f633a54164000d0f5fdbfb6e1</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.051052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.051052%26sid%3Dliteratum%253Aachs%26aulast%3DImaoka%26aufirst%3DT.%26aulast%3DMikkaichi%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DHirouchi%26aufirst%3DM.%26aulast%3DOkudaira%26aufirst%3DN.%26aulast%3DIzumi%26aufirst%3DT.%26atitle%3DIntegrated%2520Approach%2520of%2520in%2520Vivo%2520and%2520in%2520Vitro%2520Evaluation%2520of%2520the%2520Involvement%2520of%2520Hepatic%2520Uptake%2520Organic%2520Anion%2520Transporters%2520in%2520the%2520Drug%2520Disposition%2520in%2520Rats%2520using%2520Rifampicin%2520as%2520an%2520Inhibitor%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D1442%26epage%3D1449%26doi%3D10.1124%2Fdmd.113.051052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shingaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takashima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijuin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katayama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashinaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, Y.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Oatp and Mrp2 Activities in Hepatobiliary Excretion Using Newly Developed Positron Emission Tomography Tracer [<sup>11</sup>C]Dehydropravastatin in Rats</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1124/jpet.113.206425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fjpet.113.206425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23926287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=193-202&author=T.+Shingakiauthor=T.+Takashimaauthor=R.+Ijuinauthor=X.+Zhangauthor=T.+Onoueauthor=Y.+Katayamaauthor=T.+Okauchiauthor=E.+Hayashinakaauthor=Y.+Cuiauthor=Y.+Wadaauthor=M.+Suzukiauthor=K.+Maedaauthor=H.+Kusuharaauthor=Y.+Sugiyamaauthor=Y.+Watanabe&title=Evaluation+of+Oatp+and+Mrp2+Activities+in+Hepatobiliary+Excretion+Using+Newly+Developed+Positron+Emission+Tomography+Tracer+%5B11C%5DDehydropravastatin+in+Rats&doi=10.1124%2Fjpet.113.206425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats</span></div><div class="casAuthors">Shingaki, Tomotaka; Takashima, Tadayuki; Ijuin, Ryosuke; Zhang, Xuan; Onoue, Tomohiro; Katayama, Yumiko; Okauchi, Takashi; Hayashinaka, Emi; Cui, Yilong; Wada, Yasuhiro; Suzuki, Masaaki; Maeda, Kazuya; Kusuhara, Hiroyuki; Sugiyama, Yuichi; Watanabe, Yasuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">193-202</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We developed a pravastatin deriv., sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S)-6-hydroxy-2-methyl-8-((1-[11C]-(E)-2-methyl-but-2-enoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate ([11C]DPV), as a positron emission tomog. (PET) probe for noninvasive measurement of hepatobiliary transport, and conducted pharmacokinetic anal. in rats as a feasibility study for future clin. study.  Transport activities of DPV in freshly isolated rat hepatocytes and rodent multidrug resistance-assocd. protein 2 (rMrp2; human, MRP2)-expressing membrane vesicles were similar to those of pravastatin.  Rifampicin diminished the uptake of DPV and pravastatin by the hepatocytes, with similar inhibition potency.  [11C]DPV underwent biotransformation to produce at least two metabolites in rat, but metab. of [11C]DPV occurred negligibly in human hepatocytes during a 90-min incubation.  After i.v. injection, [11C]DPV was mainly distributed to the liver and kidneys, where the tissue uptake clearances (CLuptake,liver and CLuptake,kidney) were blood-flow-limited (73.6 ± 4.8 and 24.6 ± 0.6 mL/min per kg, resp.).  Systemic elimination of [11C]DPV was delayed in rifampicin-treated rat and an Mrp2-deficient mutant rat, Eisai hyperbilirubinemic mutant rat (EHBR).  Rifampicin treatment decreased both CLuptake,liver and CLuptake,kidney of [11C]DPV by 30% (P < 0.05), whereas these parameters were unchanged in EHBR.  Meanwhile, the canalicular efflux clearance (CLint,bile) of [11C]DPV, which was 12.2 ± 1.5 mL/min per kg in the control rat, decreased by 60% and 89% in rifampicin-treated rat and EHBR (P < 0.05), resp.  These results indicate that [11C]DPV is taken up into the liver by org. anion-transporting polypeptides (rodent, Oatps; human, OATP) and excreted into bile by Mrp2 in rat, and that rifampicin may inhibit Mrp2 as well as Oatps, and consequently increase systemic exposure of [11C]DPV.  PET using [11C]DPV is feasible for studies prior to the future clin. investigation of OATP and MRP2 functionality, esp. for personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouxK1RXE4HfbVg90H21EOLACvtfcHk0ljhJ6UCqn7HIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jP&md5=3cfb24088a48bed605bb0155271d8c27</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.206425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.206425%26sid%3Dliteratum%253Aachs%26aulast%3DShingaki%26aufirst%3DT.%26aulast%3DTakashima%26aufirst%3DT.%26aulast%3DIjuin%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOnoue%26aufirst%3DT.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DHayashinaka%26aufirst%3DE.%26aulast%3DCui%26aufirst%3DY.%26aulast%3DWada%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DKusuhara%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DY.%26atitle%3DEvaluation%2520of%2520Oatp%2520and%2520Mrp2%2520Activities%2520in%2520Hepatobiliary%2520Excretion%2520Using%2520Newly%2520Developed%2520Positron%2520Emission%2520Tomography%2520Tracer%2520%255B11C%255DDehydropravastatin%2520in%2520Rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D193%26epage%3D202%26doi%3D10.1124%2Fjpet.113.206425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span> <span> </span><span class="NLM_article-title">Liver Uptake of Cefditoren is Mediated by OATP1B1 and OATP2B1 in Humans and Oatp1a1, Oatp1a4, and Oatp1b2 in Rats</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">30038</span>– <span class="NLM_lpage">30048</span>, <span class="refDoi"> DOI: 10.1039/C7RA03537C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1039%2FC7RA03537C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1GktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=30038-30048&author=H.+Wangauthor=P.+Sunauthor=C.+Wangauthor=Q.+Mengauthor=Z.+Liuauthor=X.+Huoauthor=H.+Sunauthor=X.+Maauthor=J.+Pengauthor=K.+Liu&title=Liver+Uptake+of+Cefditoren+is+Mediated+by+OATP1B1+and+OATP2B1+in+Humans+and+Oatp1a1%2C+Oatp1a4%2C+and+Oatp1b2+in+Rats&doi=10.1039%2FC7RA03537C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats</span></div><div class="casAuthors">Wang, Hepeng; Sun, Pengyuan; Wang, Changyuan; Meng, Qiang; Liu, Zhihao; Huo, Xiaokui; Sun, Huijun; Ma, Xiaodong; Peng, Jinyong; Liu, Kexin</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">30038-30048</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Cefditoren, a β-lactam antibiotic, is widely used in respiratory tract and skin infections in the clinic.  This study was aimed at investigating the mechanism underlying hepatic uptake of cefditoren in rats and humans.  Cmax of cefditoren plasma exposure was increased (0.80 ± 0.06 to 1.02 ± 0.16 μg mL-1) when co-administrated with rifampicin.  Extn. ratio of cefditoren was decreased (34.70% ± 4.61% to 18.30% ± 2.89%) by combining with rifampicin in perfused rat livers in situ.  Uptake of cefditoren by rat liver slices was temp.-dependent and significantly inhibited by Oatp modulators, such as ibuprofen, digoxin, cyclosporin A and glycyrrhizic acid, but not by tetraethylammonium or p-aminohippurate.  Uptake of cefditoren in hOATP1B1- and hOATP2B1-human embryonic kidney (HEK) 293 cells indicated a saturable process with a Km of 189.7 ± 60.4 μmol L-1 and 122.7 ± 37.37 μmol L-1, resp.  Sartans inhibited the transport of cefditoren in hOATP1B1- and hOATP2B1-HEK293 cells.  Moreover, cefditoren could increase the gene and protein expression levels of Oatp1a1 in rat liver, while Oatp1a4 and Oatp1b2 were unchanged.  These results indicated that OATP1B1 and OATP2B1 are involved in hepatic uptake of cefditoren in humans, and multiple Oatps (Oatp1a1, Oatp1a4 and Oatp1b2) might participate in this process in rats.  In addn., cefditoren could prompt the up-regulation of Oatp1a1 expression.  In the clinic, addnl. attention should be paid to the alternative exposure of cefditoren when co-administrated with sartans or other drugs that are substrates or inhibitors of OATP1B1 and/or OATP2B1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpQwcE7J7T07Vg90H21EOLACvtfcHk0lgsQnRE-SaC8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1GktL0%253D&md5=d4d9bbd28db205fc21326ccab9514123</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1039%2FC7RA03537C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7RA03537C%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DHuo%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26atitle%3DLiver%2520Uptake%2520of%2520Cefditoren%2520is%2520Mediated%2520by%2520OATP1B1%2520and%2520OATP2B1%2520in%2520Humans%2520and%2520Oatp1a1%252C%2520Oatp1a4%252C%2520and%2520Oatp1b2%2520in%2520Rats%26jtitle%3DRSC%2520Adv.%26date%3D2017%26volume%3D7%26spage%3D30038%26epage%3D30048%26doi%3D10.1039%2FC7RA03537C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.-T</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.-HJ.</span></span> <span> </span><span class="NLM_article-title">Influence of Rifampicin on the Pharmacokinetics of Salvianolic Acid B May Involve Inhibition of Organic Anion Transporting Polypeptide (Oatp) Mediated Influx</span>. <i>Phytother. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1002/ptr.3522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fptr.3522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=21567510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjsl2rsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=118-121&author=D.+Zhaoauthor=Z.-D.+Gaoauthor=D.+Hanauthor=N.+Liauthor=Y.-J.+Zhangauthor=Y.+Luauthor=T.-T+Liauthor=X.-HJ.+Chen&title=Influence+of+Rifampicin+on+the+Pharmacokinetics+of+Salvianolic+Acid+B+May+Involve+Inhibition+of+Organic+Anion+Transporting+Polypeptide+%28Oatp%29+Mediated+Influx&doi=10.1002%2Fptr.3522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of Rifampicin on the Pharmacokinetics of Salvianolic Acid B May Involve Inhibition of Organic Anion Transporting Polypeptide (Oatp) Mediated Influx</span></div><div class="casAuthors">Zhao, Di; Gao, Zi-dong; Han, De-en; Li, Ning; Zhang, Yong-jie; Lu, Yang; Li, Ting-ting; Chen, Xi-jing</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">118-121</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">This article studied the possible effect of rifampicin (RIF), an inhibitor of org. anion transporting polypeptide (Oatp), on the pharmacokinetics of salvianolic acid B (SAB) in rats.  Rifampicin was administered i.v. 15 min prior to SAB (5 mg/kg) in rats at doses of 0, 5.0, 10.0 and 20.0 mg/kg, resp.  The concns. of SAB in plasma and bile were detd. using a Shimadzu HPLC system coupled to a LC-MS-2010EV mass spectrometer.  Compared with the control group, the AUC0-t and Cmax values of SAB were increased significantly, while the CLtotal and CLbile were decreased significantly.  These results suggested that pretreatment with rifampicin prior to SAB administration could decrease significantly the total and bile elimination of SAB and alter its pharmacokinetic profiles.  The influence of rifampicin on the pharmacokinetics of SAB may be attributed to the inhibition of Oatp-mediated influx.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNlpCXeTDtX7Vg90H21EOLACvtfcHk0lgsQnRE-SaC8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjsl2rsw%253D%253D&md5=775a32600bfeb7ce71feb1154a965264</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fptr.3522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.3522%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DGao%26aufirst%3DZ.-D.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DY.-J.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DT.-T%26aulast%3DChen%26aufirst%3DX.-HJ.%26atitle%3DInfluence%2520of%2520Rifampicin%2520on%2520the%2520Pharmacokinetics%2520of%2520Salvianolic%2520Acid%2520B%2520May%2520Involve%2520Inhibition%2520of%2520Organic%2520Anion%2520Transporting%2520Polypeptide%2520%2528Oatp%2529%2520Mediated%2520Influx%26jtitle%3DPhytother.%2520Res.%26date%3D2012%26volume%3D26%26spage%3D118%26epage%3D121%26doi%3D10.1002%2Fptr.3522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lyons, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisfeld, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J.</span></span> <span> </span><span class="NLM_article-title">A Physiologically Based Pharmacokinetic Model of Rifampin in Mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1763</span>– <span class="NLM_lpage">1771</span>, <span class="refDoi"> DOI: 10.1128/AAC.01567-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1128%2FAAC.01567-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23357766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVKrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=1763-1771&author=M.+A.+Lyonsauthor=B.+Reisfeldauthor=R.+S.+H.+Yangauthor=A.+J.+Lenaerts&title=A+Physiologically+Based+Pharmacokinetic+Model+of+Rifampin+in+Mice&doi=10.1128%2FAAC.01567-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">A physiologically based pharmacokinetic model of rifampin in mice</span></div><div class="casAuthors">Lyons, Michael A.; Reisfeld, Brad; Yang, Raymond S. H.; Lenaerts, Anne J.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1763-1771</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">One problem assocd. with regimen-based development of antituberculosis (anti-TB) drugs is the difficulty of a systematic and thorough in vivo evaluation of the large no. of possible regimens that arise from consideration of multiple drugs tested together.  A math. model capable of simulating the pharmacokinetics and pharmacodynamics of exptl. combination chemotherapy of TB offers a way to mitigate this problem by extending the use of available data to investigate regimens that are not initially tested.  In order to increase the available math. tools needed to support such a model for preclin. anti-TB drug development, we constructed a preliminary whole-body physiol. based pharmacokinetic (PBPK) model of rifampin in mice, using data from the literature.  Interindividual variability was approximated using Monte Carlo (MC) simulation with assigned probability distributions for the model parameters.  An MC sensitivity anal. was also performed to det. correlations between model parameters and plasma concn. to inform future model development.  Model predictions for rifampin concns. in plasma, liver, kidneys, and lungs, following oral administration, were generally in agreement with published exptl. data from multiple studies.  Sensitive model parameters included those descriptive of oral absorption, total clearance, and partitioning of rifampin between blood and muscle.  This PBPK model can serve as a starting point for the integration of rifampin pharmacokinetics in mice into a larger math. framework, including the immune response to Mycobacterium tuberculosis infection, and pharmacokinetic models for other anti-TB drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGwB4sBkKejrVg90H21EOLACvtfcHk0lgsQnRE-SaC8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVKrsLw%253D&md5=f96b54a6378bf80f2f77aa347601784e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1128%2FAAC.01567-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01567-12%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DM.%2BA.%26aulast%3DReisfeld%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DR.%2BS.%2BH.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26atitle%3DA%2520Physiologically%2520Based%2520Pharmacokinetic%2520Model%2520of%2520Rifampin%2520in%2520Mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D1763%26epage%3D1771%26doi%3D10.1128%2FAAC.01567-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClean, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Harte, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gault, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harriott, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flatt, P. R.</span></span> <span> </span><span class="NLM_article-title">Comparison of the Anti-Diabetic Effects of GIP- and GLP1-Receptor Activation in Obese Diabetic (ob/ob) Mice: Studies with DPP IV resistant N-AcGIP and exendin(1- 39)amide</span>. <i>Diabetes/Metab. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1002/dmrr.729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fdmrr.729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=17315241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=572-579&author=N.+Irwinauthor=P.+L.+McCleanauthor=R.+S.+Cassidyauthor=F.+P.+O%E2%80%99Harteauthor=B.+D.+Greenauthor=V.+A.+Gaultauthor=P.+Harriottauthor=P.+R.+Flatt&title=Comparison+of+the+Anti-Diabetic+Effects+of+GIP-+and+GLP1-Receptor+Activation+in+Obese+Diabetic+%28ob%2Fob%29+Mice%3A+Studies+with+DPP+IV+resistant+N-AcGIP+and+exendin%281-+39%29amide&doi=10.1002%2Fdmrr.729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide</span></div><div class="casAuthors">Irwin, Nigel; McClean, Paula L.; Cassidy, Roslyn S.; O'Harte, Finbarr P. M.; Green, Brian D.; Gault, Victor A.; Harriott, Patrick; Flatt, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/Metabolism Research and Reviews</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">572-579</span>CODEN:
                <span class="NLM_cas:coden">DMRRFM</span>;
        ISSN:<span class="NLM_cas:issn">1520-7552</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Background: The two major incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are being actively explored as anti-diabetic agents because they lower blood glucose through multiple mechanisms.  The rapid inactivation of GIP and GLP-1 by the ubiquitous enzyme, dipeptidyl peptidase IV (DPP IV) makes their biol. actions short-lived, but stable agonists such as N-acetylated GIP (N-AcGIP) and exendin(1-39)amide have been advocated as stable and specific GIP and GLP-1 analogs.  Methods: The present study examd. the sub-chronic (14 days) anti-diabetic actions of single daily doses of N-AcGIP and exendin(1-39)amide given alone or in combination to obese diabetic (ob/ob) mice over a 14-day period.  Results: Initial expts. confirmed the potent anti-hyperglycemic and insulinotropic properties of N-AcGIP and exendin(1-39)amide.  Sub-chronic administration of N-AcGIP alone or in combination with exendin(1-39)amide significantly decreased non-fasting plasma glucose and improved glucose tolerance compared to control ob/ob mice.  This was assocd. with a significant enhancement of the insulin response to glucose and a notable improvement of insulin sensitivity.  Combined treatment with N-AcGIP and exendin(1-39)amide also significantly decreased glycated Hb.  Exendin(1-39)amide alone had no significant effect on any of the metabolic parameters monitored.  In addn., no significant effects were obsd. on body wt. and food intake in any of the treatment groups.  Conclusions: The results illustrate significant anti-diabetic potential of N-AcGIP alone and in combination with exendin(1-39)amide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoglOsyAPPrY7Vg90H21EOLACvtfcHk0lgsQnRE-SaC8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqs7nL&md5=4b1c5e2aa07e5268ee137264a04dfa61</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.729%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DN.%26aulast%3DMcClean%26aufirst%3DP.%2BL.%26aulast%3DCassidy%26aufirst%3DR.%2BS.%26aulast%3DO%25E2%2580%2599Harte%26aufirst%3DF.%2BP.%26aulast%3DGreen%26aufirst%3DB.%2BD.%26aulast%3DGault%26aufirst%3DV.%2BA.%26aulast%3DHarriott%26aufirst%3DP.%26aulast%3DFlatt%26aufirst%3DP.%2BR.%26atitle%3DComparison%2520of%2520the%2520Anti-Diabetic%2520Effects%2520of%2520GIP-%2520and%2520GLP1-Receptor%2520Activation%2520in%2520Obese%2520Diabetic%2520%2528ob%252Fob%2529%2520Mice%253A%2520Studies%2520with%2520DPP%2520IV%2520resistant%2520N-AcGIP%2520and%2520exendin%25281-%252039%2529amide%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2007%26volume%3D23%26spage%3D572%26epage%3D579%26doi%3D10.1002%2Fdmrr.729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamato, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikegami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamura, K.</span></span> <span> </span><span class="NLM_article-title">Establishment of a Pancreatic Beta Cell Line that Retains Glucose Inducible Insulin Secretion: Special Reference to Expression of Glucose Transporter Isoforms</span>. <i>Endocrinology</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1210/endo-127-1-126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1210%2Fendo-127-1-126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=2163307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3cXltV2lsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=1990&pages=126-132&author=J.+Miyazakiauthor=K.+Arakiauthor=E.+Yamatoauthor=H.+Ikegamiauthor=T.+Asanoauthor=Y.+Shibasakiauthor=Y.+Okaauthor=K.+Yamamura&title=Establishment+of+a+Pancreatic+Beta+Cell+Line+that+Retains+Glucose+Inducible+Insulin+Secretion%3A+Special+Reference+to+Expression+of+Glucose+Transporter+Isoforms&doi=10.1210%2Fendo-127-1-126"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion:  special reference to expression of glucose transporter isoforms</span></div><div class="casAuthors">Miyazaki, Junichi; Araki, Kimi; Yamato, Eiji; Ikegami, Hiroshi; Asano, Tomoichiro; Shibasaki, Yoshikazu; Oka, Yoshitomo; Yamamura, Kenichi</div><div class="citationInfo"><span class="NLM_cas:title">Endocrinology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-32</span>CODEN:
                <span class="NLM_cas:coden">ENDOAO</span>;
        ISSN:<span class="NLM_cas:issn">0013-7227</span>.
    </div><div class="casAbstract">Two cell lines have been established from insulinomas obtained by targeted expression of the simian virus 40 T antigen gene in transgenic mice.  These cell lines, designated MIN6 and MIN7, produce insulin and T antigen and have morphol. characteristics of pancreatic β cells.  MIN6 cells exhibit glucose-inducible insulin secretion comparable with cultured normal mouse islet cells, whereas MIN7 cells do not.  Both cell lines produce liver-type glucose transporter (GT) mRNA at high level.  Brain-type GT mRNA is also present at considerable level in MIN7 cells, but is barely detectable in MIN6 cells, suggesting that exclusive expression of the liver-type GT is related to glucose-inducible insulin secretion.  MIN6 cells do not express either major histocompatibility (MHC) class I or class II antigens on the cell surface.  However, treatment with interferon-γ induces high levels of MHC class I antigens, and a combination of interferon-γ and tumor necrosis factor-α induces a MHC class II antigen on the cell surface.  Apparently, the MIN6 cell line retains physiol. characteristics of normal β cells.  The MIN6 cell line will be esp. useful to analyze the mol. mechanisms by which β cells regulate insulin secretion in response to extracellular glucose concns.  A possible role of GT isoforms in glucose sensing by β cells is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzD14EusM_NLVg90H21EOLACvtfcHk0lie1AlD-Y30ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltV2lsbo%253D&md5=520dbbae9a050f75fa1d8fc7ada0198f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1210%2Fendo-127-1-126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-127-1-126%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DJ.%26aulast%3DAraki%26aufirst%3DK.%26aulast%3DYamato%26aufirst%3DE.%26aulast%3DIkegami%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DY.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DK.%26atitle%3DEstablishment%2520of%2520a%2520Pancreatic%2520Beta%2520Cell%2520Line%2520that%2520Retains%2520Glucose%2520Inducible%2520Insulin%2520Secretion%253A%2520Special%2520Reference%2520to%2520Expression%2520of%2520Glucose%2520Transporter%2520Isoforms%26jtitle%3DEndocrinology%26date%3D1990%26volume%3D127%26spage%3D126%26epage%3D132%26doi%3D10.1210%2Fendo-127-1-126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, J.</span></span> <span> </span><span class="NLM_article-title">Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(91)91647-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2F0006-291X%2891%2991647-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1673839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=1991&pages=880-885&author=P.+Arturssonauthor=J.+Karlsson&title=Correlation+between+Oral+Drug+Absorption+in+Humans+and+Apparent+Drug+Permeability+Coefficients+in+Human+Intestinal+Epithelial+%28Caco-2%29+Cells&doi=10.1016%2F0006-291X%2891%2991647-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells</span></div><div class="casAuthors">Artursson, P.; Karlsson, J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">880-5</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">Monolayers of a well differentiated human intestinal epithelial cell line, Caco-2, were used as a model to study passive drug absorption across the intestinal epithelium.  Absorption rate consts. (expressed as apparent permeability coeffs.) were detd. for 20 drugs and peptides with different structural properties.  The permeability coeffs. ranged from approx. 5 × 10-8 to 5 × 10-5 cm/s.  A good correlation was obtained between data on oral absorption in humans and the results in the Caco-2 model.  Drugs that are completely absorbed in humans had permeability coeffs. >1 × 10-6 cm/s.  Drugs that are absorbed to >1% but <100% had permeability coeffs. of 0.1-1.0 × 10-6 cm/s while drugs and peptides that are absorbed to <1% had permeability coeffs. of ≤1 × 10-7 cm/s.  The results indicate that Caco-2 monolayers can be used as a model for studies on intestinal drug absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdvsEluSXCILVg90H21EOLACvtfcHk0lie1AlD-Y30ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhslOrt7c%253D&md5=3b1e14cae3beb0345014284e3aa6a7c0</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2891%2991647-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252891%252991647-U%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCorrelation%2520between%2520Oral%2520Drug%2520Absorption%2520in%2520Humans%2520and%2520Apparent%2520Drug%2520Permeability%2520Coefficients%2520in%2520Human%2520Intestinal%2520Epithelial%2520%2528Caco-2%2529%2520Cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1991%26volume%3D175%26spage%3D880%26epage%3D885%26doi%3D10.1016%2F0006-291X%2891%2991647-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span>; <span class="NLM_string-name">Freidinger, R. M.</span>; <span class="NLM_string-name">Sawyer, T. K.</span></span> <i>Integration of Pharmaceutical Discovery and Development</i>; <span class="NLM_publisher-name">Plenum Press</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">1998</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2Fb114429" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=R.+T.+Borchardt&author=R.+M.+Freidinger&author=T.+K.+Sawyer&title=Integration+of+Pharmaceutical+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fb114429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252Fb114429%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26btitle%3DIntegration%2520of%2520Pharmaceutical%2520Discovery%2520and%2520Development%26pub%3DPlenum%2520Press%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hidalgo, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raub, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Characterization of the Human Colon Carcinoma Cell line (Caco-2) as a Model System for Intestinal Epithelial Permeability</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">736</span>– <span class="NLM_lpage">749</span>, <span class="refDoi"> DOI: 10.1016/0016-5085(89)90897-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS0016-5085%2889%2980072-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=2914637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADyaL1M7itFeqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1989&pages=736-749&author=I.+J.+Hidalgoauthor=T.+J.+Raubauthor=R.+T.+Borchardt&title=Characterization+of+the+Human+Colon+Carcinoma+Cell+line+%28Caco-2%29+as+a+Model+System+for+Intestinal+Epithelial+Permeability&doi=10.1016%2F0016-5085%2889%2990897-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability</span></div><div class="casAuthors">Hidalgo I J; Raub T J; Borchardt R T</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">736-49</span>
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    </div><div class="casAbstract">Caco-2 cells develop morphologic characteristics of normal enterocytes when grown on plastic dishes or nitrocellulose filters.  The purpose of this study was to determine whether Caco-2 cells undergo similar differentiation when grown on Transwell polycarbonate membranes, and to study the suitability of Caco-2 monolayers as an intestinal epithelial transport model system.  Transepithelial electrical resistance values after confluence were 173.5 omega.cm2 and remained unchanged through day 17.  Permeabilities to the water-soluble fluid-phase markers that do not permeate the membrane, Lucifer yellow CH, [14C]inulin, [14C]polyethylene glycol, and [3H] dextran were less than 0.25% of the administered amount per hour after day 10.  Qualitative evaluation of uptake and permeability to horseradish peroxidase confirmed the similarity in uptake and barrier properties between this cell system and the small intestinal epithelial layer.  We conclude that Caco-2 cells grown on collagen-coated polycarbonate membranes should represent a valuable transport model system for the small intestinal epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOn97989rzEIqdXsLcGTEUfW6udTcc2ebhH0YeiFTkQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M7itFeqsg%253D%253D&md5=59ffccc1dd4dccb01400c05df95ac1ff</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2889%2980072-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252889%252980072-1%26sid%3Dliteratum%253Aachs%26aulast%3DHidalgo%26aufirst%3DI.%2BJ.%26aulast%3DRaub%26aufirst%3DT.%2BJ.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DCharacterization%2520of%2520the%2520Human%2520Colon%2520Carcinoma%2520Cell%2520line%2520%2528Caco-2%2529%2520as%2520a%2520Model%2520System%2520for%2520Intestinal%2520Epithelial%2520Permeability%26jtitle%3DGastroenterology%26date%3D1989%26volume%3D96%26spage%3D736%26epage%3D749%26doi%3D10.1016%2F0016-5085%2889%2990897-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artursson, P.</span></span> <span> </span><span class="NLM_article-title">Epithelial Transport of Drug in Cell Culture. I: a Model for Studying the Passive Diffusion of Drugs over Intestinal Absorptive (Caco-2) cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">476</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1002/jps.2600790604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2Fjps.2600790604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1975619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1990&pages=476-82&author=P.+Artursson&title=Epithelial+Transport+of+Drug+in+Cell+Culture.+I%3A+a+Model+for+Studying+the+Passive+Diffusion+of+Drugs+over+Intestinal+Absorptive+%28Caco-2%29+cells&doi=10.1002%2Fjps.2600790604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial transport of drugs in cell culture.  I:  a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells</span></div><div class="casAuthors">Artursson, Per</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">476-82</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">A human intestinal cell line, Caco-2, was used as a model to study the passive diffusion of drugs across intestinal epithelium.  The cells formed continuous monolayers when grown on permeable filters of polycarbonate.  After 10 days in culture, the monolayers had a transmembrane resistance of ∼260 Ω.cm2 and a cell d. of 0.9 × 106 cells/cm2.  At this time the cells were impermeable to [14C]polyethyleneglycol (MW 4000).  These characteristics remained const. for 20 days (i.e., from day 10 to day 30).  Six β-blocking agents with a 2000-fold range of lipophilicity were studied for their transepithelial transport properties.  The transport parameters were independent of drug concn. and transport direction.  The apparent permeability coeffs. ranged from 41.91 × 10-6 cm/s for the most lipophilic drug, propranolol, to 0.203 × 10-6 cm/s for the most hydrophilic drug, atenolol.  The transport parameters were compared with those published for rat ileum.  The transport rates were similar for four out of five drugs.  Atenolol was transported at a slower rate in the Caco-2 model, which may be explained by the fact that the Caco-2 cells form a tighter epithelium than the rat ileal enterocytes.  Thus, Caco-2 cells may be used to model the intestinal absorption of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RIMzEBiAqrVg90H21EOLACvtfcHk0lhMJ05X_DWLyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXkvFSru74%253D&md5=68642fc4f08aaaa5a343822bea9ee95f</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600790604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600790604%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DEpithelial%2520Transport%2520of%2520Drug%2520in%2520Cell%2520Culture.%2520I%253A%2520a%2520Model%2520for%2520Studying%2520the%2520Passive%2520Diffusion%2520of%2520Drugs%2520over%2520Intestinal%2520Absorptive%2520%2528Caco-2%2529%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1990%26volume%3D79%26spage%3D476%26epage%3D82%26doi%3D10.1002%2Fjps.2600790604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dudda, A.</span>; <span class="NLM_string-name">Kürzel, G. U.</span></span> <span> </span><span class="NLM_article-title">Metabolism Studies in vitro and in vivo</span>. In  <i>Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, H. G.</span>, <span class="NLM_string-name">Hock, F. J.</span>, <span class="NLM_string-name">Maas, J.</span>, <span class="NLM_string-name">Mayer, D.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>, <span class="NLM_year">2006</span>; pp  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">520</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2F3-540-29804-5_25" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=493-520&author=A.+Dudda&author=G.+U.+K%C3%BCrzelauthor=H.+G.+Vogel&author=F.+J.+Hock&author=J.+Maas&author=D.+Mayer&title=Drug+Discovery+and+Evaluation%3A+Safety+and+Pharmacokinetic+Assays"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1007%2F3-540-29804-5_25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F3-540-29804-5_25%26sid%3Dliteratum%253Aachs%26aulast%3DDudda%26aufirst%3DA.%26atitle%3DMetabolism%2520Studies%2520in%2520vitro%2520and%2520in%2520vivo%26btitle%3DDrug%2520Discovery%2520and%2520Evaluation%253A%2520Safety%2520and%2520Pharmacokinetic%2520Assays%26aulast%3DVogel%26aufirst%3DH.%2BG.%26pub%3DSpringer%26date%3D2006%26spage%3D493%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span> <i>Guidance for industry:
Drug Interaction Studies—Study Design,
Data Analysis and Implications for Dosing and Labeling Recommendations,
Draft Guidance</i>; <span class="NLM_publisher-name">U.S. Department of Health
and Human Services, Food and Drug Administration, and Center for Drug
Evaluation and Research</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Guidance+for+industry%3A%0ADrug+Interaction+Studies%E2%80%94Study+Design%2C%0AData+Analysis+and+Implications+for+Dosing+and+Labeling+Recommendations%2C%0ADraft+Guidance%3B+U.S.+Department+of+Health%0Aand+Human+Services%2C+Food+and+Drug+Administration%2C+and+Center+for+Drug%0AEvaluation+and+Research%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuidance%2520for%2520industry%253A%250ADrug%2520Interaction%2520Studies%25E2%2580%2594Study%2520Design%252C%250AData%2520Analysis%2520and%2520Implications%2520for%2520Dosing%2520and%2520Labeling%2520Recommendations%252C%250ADraft%2520Guidance%26pub%3DU.S.%2520Department%2520of%2520Health%250Aand%2520Human%2520Services%252C%2520Food%2520and%2520Drug%2520Administration%252C%2520and%2520Center%2520for%2520Drug%250AEvaluation%2520and%2520Research%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>EMA,
Guideline
on the Investigation of Drug Interactions, Draft Guideline <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EMA%2C%0AGuideline%0Aon+the+Investigation+of+Drug+Interactions%2C+Draft+Guideline+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span> <i>Guideline on the Investigation of Drug Interactions</i>; <span class="NLM_publisher-name">European Medicines Agency</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Guideline+on+the+Investigation+of+Drug+Interactions%3B+European+Medicines+Agency%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGuideline%2520on%2520the%2520Investigation%2520of%2520Drug%2520Interactions%26pub%3DEuropean%2520Medicines%2520Agency%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guengerich, F. P.</span></span> <span> </span><span class="NLM_article-title">Cytochrome p450 and Chemical Toxicology</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1021/tx700079z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx700079z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=70-83&author=F.+P.+Guengerich&title=Cytochrome+p450+and+Chemical+Toxicology&doi=10.1021%2Ftx700079z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 and Chemical Toxicology</span></div><div class="casAuthors">Guengerich, F. Peter</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-83</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of cytochrome P 450 (P 450) research has developed considerably over the past 20 years, and many important papers on the roles of P450s in chem. toxicol. have appeared in Chem. Research in Toxicol.  Today, our basic understanding of many of the human P450s is relatively well-established, in terms of the details of the individual genes, sequences, and basic catalytic mechanisms.  Crystal structures of several of the major human P450s are now in hand.  The animal P450s are still important in the context of metab. and safety testing.  Many well-defined examples exist for roles of P450s in decreasing the adverse effects of drugs through biotransformation, and an equally interesting field of investigation is the bioactivation of chems., including drugs.  Unresolved problems include the characterization of the minor "orphan" P450s, ligand cooperativity and kinetic complexity of several P450s, the prediction of metab., the overall contribution of bioactivation to drug idiosyncratic problems, the extrapolation of animal test results to humans in drug development, and the contribution of genetic variation in human P450s to cancer incidence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQnvzpBM_I4LVg90H21EOLACvtfcHk0lhMJ05X_DWLyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlynurbF&md5=444b8d63bf07dc2449af6413fa7fff00</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Ftx700079z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700079z%26sid%3Dliteratum%253Aachs%26aulast%3DGuengerich%26aufirst%3DF.%2BP.%26atitle%3DCytochrome%2520p450%2520and%2520Chemical%2520Toxicology%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D70%26epage%3D83%26doi%3D10.1021%2Ftx700079z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaman, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremaine, L. M.</span></span> <span> </span><span class="NLM_article-title">The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.093229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fjpet.105.093229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=16192315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslCisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=336-348&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnanauthor=E.+A.+Gamanauthor=J.+B.+Houstonauthor=L.+M.+Tremaine&title=The+Utility+of+in+Vitro+Cytochrome+P450+Inhibition+Data+in+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fjpet.105.093229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik; Gaman, Emily A.; Houston, J. Brian; Tremaine, Larry M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">336-348</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The accuracy of in vitro inhibition parameters in scaling to in vivo drug-drug interactions (DDI) was examd. for over 40 drugs using seven human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, and fraction of the probe drug cleared by the inhibited enzyme) to predict increases in exposure to probe drugs, and the predictions were compared with in vivo DDI gathered from clin. studies reported in the scientific literature.  For drugs that had been tested as precipitants of drug interactions for more than one P 450 in vivo, the order of inhibitory potencies in vitro generally aligned with the magnitude of the in vivo interactions.  With the exception of many drugs known to be mechanism-based inactivators, the use of in vitro IC50, the fraction of the affected drug metabolized by the target enzyme [fm(CYP)] and an est. of free hepatic inlet Cmax, was generally successful in identifying those drugs that cause at least a 2-fold increase in the exposure to P 450 marker substrate drugs.  For CYP3A, incorporation of inhibition of both hepatic and intestinal metab. was needed for the prediction of DDI.  Many CYP3A inhibitors showed a different inhibitory potency for three different CYP3A marker activities; however, these differences generally did not alter the conclusions regarding whether a drug would cause a CYP3A DDI in vivo.  Overall, these findings support the conclusion that P 450 in vitro inhibition data are valuable in designing clin. DDI study strategies and can be used to predict the magnitudes of DDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUhOqooYvvbVg90H21EOLACvtfcHk0ljICHq8jIelHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslCisg%253D%253D&md5=988174eb3bb0d41655508395b1f982dd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.093229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.093229%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26aulast%3DGaman%26aufirst%3DE.%2BA.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26aulast%3DTremaine%26aufirst%3DL.%2BM.%26atitle%3DThe%2520Utility%2520of%2520in%2520Vitro%2520Cytochrome%2520P450%2520Inhibition%2520Data%2520in%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26spage%3D336%26epage%3D348%26doi%3D10.1124%2Fjpet.105.093229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsky, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, K.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inactivation of Human Cytochrome P450 Enzymes and the Prediction of Drug-Drug Interactions</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.012633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.106.012633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=17093004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=246-255&author=R.+S.+Obachauthor=R.+L.+Walskyauthor=K.+Venkatakrishnan&title=Mechanism-Based+Inactivation+of+Human+Cytochrome+P450+Enzymes+and+the+Prediction+of+Drug-Drug+Interactions&doi=10.1124%2Fdmd.106.012633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions</span></div><div class="casAuthors">Obach, R. Scott; Walsky, Robert L.; Venkatakrishnan, Karthik</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-255</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The ability to use vitro inactivation kinetic parameters in scaling to in vivo drug-drug interactions (DDIs) for mechanism-based inactivators of human cytochrome P 450 (P 450) enzymes was examd. using eight human P 450-selective marker activities in pooled human liver microsomes.  These data were combined with other parameters (systemic Cmax, estd. hepatic inlet Cmax, fraction unbound, in vivo P 450 enzyme degrdn. rate consts. estd. from clin. pharmacokinetic data, and fraction of the affected drug cleared by the inhibited enzyme) to predict increases in exposure to drugs, and the predictions were compared with in vivo DDIs gathered from clin. studies reported in the scientific literature.  In general, the use of unbound systemic Cmax as the inactivator concn. in vivo yielded the most accurate predictions of DDI with a mean -fold error of 1.64.  Abbreviated in vitro approaches to identifying mechanism-based inactivators were developed.  Testing potential inactivators at a single concn. (IC25) in a 30-min preincubation with human liver microsomes in the absence and presence of NADPH followed by assessment of P 450 marker activities readily identified those compds. known to be mechanism-based inactivators and represents an approach that can be used with greater throughput.  Measurement of decreases in IC50 occurring with a 30-min preincubation with liver microsomes and NADPH was also useful in identifying mechanism-based inactivators, and the IC50 measured after such a preincubation was highly correlated with the kinact/K1 ratio measured after a full characterization of inactivation.  Overall, these findings support the conclusion that P 450 in vitro inactivation data are valuable in predicting clin. DDIs that can occur via this mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPRf5ZGrW6LVg90H21EOLACvtfcHk0ljICHq8jIelHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVKrs7k%253D&md5=71733cfafba3b2c9cc6b47a46e7b3f40</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.012633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.012633%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DWalsky%26aufirst%3DR.%2BL.%26aulast%3DVenkatakrishnan%26aufirst%3DK.%26atitle%3DMechanism-Based%2520Inactivation%2520of%2520Human%2520Cytochrome%2520P450%2520Enzymes%2520and%2520the%2520Prediction%2520of%2520Drug-Drug%2520Interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D246%26epage%3D255%26doi%3D10.1124%2Fdmd.106.012633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-M.</span></span> <span> </span><span class="NLM_article-title">Predicting Drug–Drug Interactions: An FDA Perspective</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1208/s12248-009-9106-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1208%2Fs12248-009-9106-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19418230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=300-306&author=L.+Zhangauthor=Y.+D.+Zhangauthor=P.+Zhaoauthor=S.-M.+Huang&title=Predicting+Drug%E2%80%93Drug+Interactions%3A+An+FDA+Perspective&doi=10.1208%2Fs12248-009-9106-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting drug-drug interactions: an FDA perspective</span></div><div class="casAuthors">Zhang, Lei; Zhang, Yuanchao; Zhao, Ping; Huang, Shiew-Mei</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-306</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Pharmacokinetic drug interactions can lead to serious adverse events, and the evaluation of a new mol. entity's drug-drug interaction potential is an integral part of drug development and regulatory review prior to its market approval.  Alteration of enzyme and/or transporter activities involved in the absorption, distribution, metab., or excretion of a new mol. entity by other concomitant drugs may lead to a change in exposure leading to altered response (safety or efficacy).  Over the years, various in vitro methodologies have been developed to predict drug interaction potential in vivo.  In vitro study has become a crit. first step in the assessment of drug interactions.  Well-executed in vitro studies can be used as a screening tool for the need for further in vivo assessment and can provide the basis for the design of subsequent in vivo drug interaction studies.  Besides in vitro expts., in silico modeling and simulation may also assist in the prediction of drug interactions.  The recent FDA draft drug interaction guidance highlighted the in vitro models and criteria that may be used to guide further in vivo drug interaction studies and to construct informative labeling.  This report summarizes crit. elements in the in vitro evaluation of drug interaction potential during drug development and uses a case study to highlight the impact of in vitro information on drug labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX6hVDt5xvRrVg90H21EOLACvtfcHk0ljICHq8jIelHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqs7rL&md5=92e7b8a8607de8f39254ccd142d73a32</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1208%2Fs12248-009-9106-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-009-9106-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%2BD.%26aulast%3DZhao%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DS.-M.%26atitle%3DPredicting%2520Drug%25E2%2580%2593Drug%2520Interactions%253A%2520An%2520FDA%2520Perspective%26jtitle%3DAAPS%2520J.%26date%3D2009%26volume%3D11%26spage%3D300%26epage%3D306%26doi%3D10.1208%2Fs12248-009-9106-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimm, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Einolf, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skordos, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonn, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Horn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span> <span> </span><span class="NLM_article-title">The Conduct of in Vitro Studies to Address Time-Dpendent Inhibition of Drug Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1370</span>, <span class="refDoi"> DOI: 10.1124/dmd.109.026716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1124%2Fdmd.109.026716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19359406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFenu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=1355-1370&author=S.+W.+Grimmauthor=H.+J.+Einolfauthor=S.+D.+Hallauthor=K.+Heauthor=H.+K.+Limauthor=K.-H.+Lingauthor=C.+Luauthor=A.+A.+Nomeirauthor=E.+Seibertauthor=K.+W.+Skordosauthor=G.+R.+Tonnauthor=R.+Van+Hornauthor=R.+W.+Wangauthor=Y.+N.+Wongauthor=T.+J.+Yangauthor=R.+S.+Obach&title=The+Conduct+of+in+Vitro+Studies+to+Address+Time-Dpendent+Inhibition+of+Drug+Metabolizing+Enzymes%3A+A+Perspective+of+the+Pharmaceutical+Research+and+Manufacturers+of+America&doi=10.1124%2Fdmd.109.026716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The conduct of in vitro studies to address time-dependent inhibition of drug-metabolizing enzymes: a perspective of the Pharmaceutical Research and Manufacturers of America</span></div><div class="casAuthors">Grimm, Scott W.; Einolf, Heidi J.; Hall, Steven D.; He, Kan; Lim, Heng-Keang; Ling, Kah-Hiing John; Lu, Chuang; Nomeir, Amin A.; Seibert, Eleanore; Skordos, Konstantine W.; Tonn, George R.; Van Horn, Robert; Wang, Regina W.; Wong, Y. Nancy; Yang, Tian J.; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1355-1370</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Time-dependent inhibition (TDI) of cytochrome P 450 enzymes caused by new mol. entities (NMEs) is of concern because such compds. can be responsible for clin. relevant drug-drug interactions (DDI).  Although the biochem. underlying mechanism-based inactivation (MBI) of P 450 enzymes has been generally understood for several years, significant advances have been made only in the past few years regarding how in vitro time-dependent inhibition data can be used to understand and predict clin. DDI.  In this article, a team of scientists from 16 pharmaceutical research organizations that are member companies of the Pharmaceutical Research and Manufacturers of America offer a discussion of the phenomenon of TDI with emphasis on the lab. methods used in its measurement.  Results of an anonymous survey regarding pharmaceutical industry practices and strategies around TDI are reported.  Specific topics that still possess a high degree of uncertainty are raised, such as parameter ests. needed to make predictions of DDI magnitude from in vitro inactivation parameters.  A description of follow-up mechanistic expts. that can be done to characterize TDI are described.  A consensus recommendation regarding common practices to address TDI is included, the salient points of which include the use of a tiered approach wherein abbreviated assays are first used to det. whether NMEs demonstrate TDI or not, followed by more thorough inactivation studies for those that do to define the parameters needed for prediction of DDI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc57kHA3HAP7Vg90H21EOLACvtfcHk0ljICHq8jIelHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFenu7o%253D&md5=7f74567b5c9298806f8a5cc58355b867</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1124%2Fdmd.109.026716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.109.026716%26sid%3Dliteratum%253Aachs%26aulast%3DGrimm%26aufirst%3DS.%2BW.%26aulast%3DEinolf%26aufirst%3DH.%2BJ.%26aulast%3DHall%26aufirst%3DS.%2BD.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DH.%2BK.%26aulast%3DLing%26aufirst%3DK.-H.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSeibert%26aufirst%3DE.%26aulast%3DSkordos%26aufirst%3DK.%2BW.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DVan%2BHorn%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DR.%2BW.%26aulast%3DWong%26aufirst%3DY.%2BN.%26aulast%3DYang%26aufirst%3DT.%2BJ.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DThe%2520Conduct%2520of%2520in%2520Vitro%2520Studies%2520to%2520Address%2520Time-Dpendent%2520Inhibition%2520of%2520Drug%2520Metabolizing%2520Enzymes%253A%2520A%2520Perspective%2520of%2520the%2520Pharmaceutical%2520Research%2520and%2520Manufacturers%2520of%2520America%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D1355%26epage%3D1370%26doi%3D10.1124%2Fdmd.109.026716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grime, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, R. J.</span></span> <span> </span><span class="NLM_article-title">Mechanism-Based Inhibition of Cytochrome P450 Enzymes: an Evaluation of Early Decision Making <i>in vitro</i> Approaches and Drug–Drug Interaction Prediction Methods</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2008.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.ejps.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=19013237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=175-191&author=K.+H.+Grimeauthor=J.+Birdauthor=D.+Fergusonauthor=R.+J.+Riley&title=Mechanism-Based+Inhibition+of+Cytochrome+P450+Enzymes%3A+an+Evaluation+of+Early+Decision+Making+in+vitro+Approaches+and+Drug%E2%80%93Drug+Interaction+Prediction+Methods&doi=10.1016%2Fj.ejps.2008.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-based inhibition of cytochrome P450 enzymes: An evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods</span></div><div class="casAuthors">Grime, Kenneth H.; Bird, James; Ferguson, Douglas; Riley, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">175-191</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability to use in vitro human cytochrome P 450 (CYP) time-dependent inhibition (TDI) data for in vivo drug-drug interaction (DDI) predictions should be viewed as a prerequisite to generating the data.  Important terms in making such predictions are kinact and KI but first-line screening assays typically involve characterization of an IC50 value or a time dependent shift in IC50.  In the work presented here, two key screening methods from the scientific literature were appraised both in terms of practicality and quality of kinact/KI estn.  The utility of TDI screening data in DDI predictions was investigated and particular ref. given to a simple DDI simulation model based on a spreadsheet that calcs. the systemic exposure of unbound inhibitor drug following the input of human pharmacokinetic parameters.  Using several clin. mechanism-based CYP DDI examples, the effectiveness of the approach was assessed and compared to other widely available approaches (a simple algorithm that employs a single in vivo unbound inhibitor concn., a seven-compartment physiol. based pharmacokinetic (PBPK) model that defines the extent of interaction as a result of hepatic inhibitor concns. and the com. available software SimCYP).  All the methods gave predictions that compared favorably with the obsd. DDIs, but various advantages and disadvantages of each were also given full consideration.  The new model facilitates rapid sensitivity anal. (parameters can be easily input and altered to give a visual representation of the impact on the active enzyme concn.) and it was therefore used to derive "rules of thumb" demonstrating the relationship between extent of DDI, time-dependent IC50 and dose for typical acidic and basic drugs.  Addnl., a TDI decision tree linking into reactive metabolite investigations is proposed for use in a Drug Discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoM7p75JgXkwLVg90H21EOLACvtfcHk0li4fQsMo9bLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVWhtQ%253D%253D&md5=1621091a7cf8f8909e2e8d0c802fdfd0</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DGrime%26aufirst%3DK.%2BH.%26aulast%3DBird%26aufirst%3DJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DRiley%26aufirst%3DR.%2BJ.%26atitle%3DMechanism-Based%2520Inhibition%2520of%2520Cytochrome%2520P450%2520Enzymes%253A%2520an%2520Evaluation%2520of%2520Early%2520Decision%2520Making%2520in%2520vitro%2520Approaches%2520and%2520Drug%25E2%2580%2593Drug%2520Interaction%2520Prediction%2520Methods%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D36%26spage%3D175%26epage%3D191%26doi%3D10.1016%2Fj.ejps.2008.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mukadam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delarosa, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khojasteh, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halladay, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of Time-Dependent Cytochrome P450 Inhibition in a High-Throughput, Automated Assay: Introducing a Novel Area Under the Curve Shift Approach</span>. <i>Drug Metab. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">53</span>, <span class="refDoi"> DOI: 10.2174/187231212800229309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.2174%2F187231212800229309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22372554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsF2gsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&pages=43-53&author=S.+Mukadamauthor=S.+Tayauthor=D.+Tranauthor=L.+Wangauthor=E.+M.+Delarosaauthor=S.+C.+Khojastehauthor=J.+S.+Halladayauthor=J.+R.+Kenny&title=Evaluation+of+Time-Dependent+Cytochrome+P450+Inhibition+in+a+High-Throughput%2C+Automated+Assay%3A+Introducing+a+Novel+Area+Under+the+Curve+Shift+Approach&doi=10.2174%2F187231212800229309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of time-dependent cytochrome P450 inhibition in a high-throughput, automated assay: introducing a novel area under the curve shift approach</span></div><div class="casAuthors">Mukadam, Sophie; Tay, Suzanne; Tran, Daniel; Wang, Leslie; Delarosa, Erlie M.; Khojasteh, S. Cyrus; Halladay, Jason S.; Kenny, Jane R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-53</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Early in the drug discovery process, the identification of cytochrome P 450 (CYP) time-dependent inhibition (TDI) is an important step for compd. optimization.  Here we describe a high-throughput, automated method for the evaluation of TDI utilizing human liver microsomes and conventional CYP-specific mass spectrometer-based probes in a 384-well format.  One of the key differences from other published TDI assays is the use of a shift in area the under curve of the percent activity remaining vs. inhibitor concn. plot (AUC shift) rather than the traditional fold-shift in IC50, to det. the magnitude of TDI.  An AUC shift of <15% suggests neg. TDI and >15% suggests potential TDI.  This AUC shift was used to achieve quant. data reporting, even in the case of weak inhibitors for which IC50 values cannot be quantified.  An Agilent Technologies BioCel 1200 System was programmed such that the TDI liability of up to 77 test compds., incubated at four test concns., with and without NADPH in the pre-incubation, can be analyzed in a single run.  The detailed automated methodol., assay validation, data reporting and the novel TDI AUC shift approach to describe magnitude of TDI are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFMWd8ERjyqLVg90H21EOLACvtfcHk0li4fQsMo9bLvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsF2gsb0%253D&md5=fa66fc58babb575bcc03957ed430e6e9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.2174%2F187231212800229309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231212800229309%26sid%3Dliteratum%253Aachs%26aulast%3DMukadam%26aufirst%3DS.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DTran%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DDelarosa%26aufirst%3DE.%2BM.%26aulast%3DKhojasteh%26aufirst%3DS.%2BC.%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26atitle%3DEvaluation%2520of%2520Time-Dependent%2520Cytochrome%2520P450%2520Inhibition%2520in%2520a%2520High-Throughput%252C%2520Automated%2520Assay%253A%2520Introducing%2520a%2520Novel%2520Area%2520Under%2520the%2520Curve%2520Shift%2520Approach%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2012%26volume%3D6%26spage%3D43%26epage%3D53%26doi%3D10.2174%2F187231212800229309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, B. W.</span>; <span class="NLM_string-name">Usuki, E.</span>; <span class="NLM_string-name">Yerino, P.</span>; <span class="NLM_string-name">Parkinson, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro Approaches for Studying the Inhibition of Drug-Metabolizing Enzymes Responsible for the Metabolism of Drugs (Reaction Phenotyping) with Emphasis on Eytochrome P450</span>. In  <i>Drug-Drug Interactions</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, A. D.</span></span>, Ed.; Drugs and the Pharmaceutical Sciences, Vol. 179; <span class="NLM_publisher-name">Informa Healthcare</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">358</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=231-358&author=B.+W.+Ogilvie&author=E.+Usuki&author=P.+Yerino&author=A.+Parkinsonauthor=A.+D.+Rodrigues&title=Drug-Drug+Interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DOgilvie%26aufirst%3DB.%2BW.%26atitle%3DIn%2520Vitro%2520Approaches%2520for%2520Studying%2520the%2520Inhibition%2520of%2520Drug-Metabolizing%2520Enzymes%2520Responsible%2520for%2520the%2520Metabolism%2520of%2520Drugs%2520%2528Reaction%2520Phenotyping%2529%2520with%2520Emphasis%2520on%2520Eytochrome%2520P450%26btitle%3DDrug-Drug%2520Interactions%26aulast%3DRodrigues%26aufirst%3DA.%2BD.%26pub%3DInforma%2520Healthcare%26date%3D2011%26spage%3D231%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Urso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, G.</span></span> <span> </span><span class="NLM_article-title">A short introduction to pharmacokinetics</span>. <i>Eur. Rev. Med. Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=12708608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BD3s7ovFeitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=33-44&author=R.+Ursoauthor=P.+Blardiauthor=G.+Giorgi&title=A+short+introduction+to+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81aR"><div class="casContent"><span class="casTitleNuber">81a</span><div class="casTitle"><span class="NLM_cas:atitle">A short introduction to pharmacokinetics</span></div><div class="casAuthors">Urso R; Blardi P; Giorgi G</div><div class="citationInfo"><span class="NLM_cas:title">European review for medical and pharmacological sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">33-44</span>
        ISSN:<span class="NLM_cas:issn">1128-3602</span>.
    </div><div class="casAbstract">Phamacokinetics is proposed to study the absorption, the distribution, the biotransformations and the elimination of drugs in man and animals.  A single kinetic profile may be well summarized by Cmax, Tmax, t 1/2 and AUC and, having more than one profile, 8 parameters at least, the mean and standard deviation of these parameters, may well summarize the drug kinetics in the whole population.  A more carefull description of the data can be obtained interpolating and extrapolating the drug concentrations with some mathematical functions.  These functions may be used to reduce all the data in a small set of parameters, or to verify if the hypotheses incorporated in the functions are confirmed by the observations.  In the first case, we can say that the task is to get a simulation of the data, in the second to get a model.  The functions used to interpolate and reduce the pharmacokinetic data are the multiexponential functions and the reference models are the compartmental models whose solutions are just the multiexponential functions.  Using models, new meaningfull pharmacokinetic parameters may be defined which can be used to find relationships between the drug kinetic profile and the physiological process which drive the drug absorption, distribution and elimination.  For example, compartmental models allow to define easily the clearance which is dependent on the drug elimination process, or the volume of distribution which depends on the drug distribution in the tissues.  Models provide also an easy way to get an estimate of drug absorption after extravasculare drug administration (bioavailability).  Model building is a complex multistep process where, experiment by experiment and simulation by simulation, new hypothesis are proven and disproven through a continuous interaction between the experimenter and the computer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTPFsEkk26QzUEksK8CslK8fW6udTcc2eZ5cV1dM-sC_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7ovFeitg%253D%253D&md5=8c55add9ed575fc0e79b4a2068e1175c</span></div><a href="/servlet/linkout?suffix=cit81a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrso%26aufirst%3DR.%26aulast%3DBlardi%26aufirst%3DP.%26aulast%3DGiorgi%26aufirst%3DG.%26atitle%3DA%2520short%2520introduction%2520to%2520pharmacokinetics%26jtitle%3DEur.%2520Rev.%2520Med.%2520Pharmacol.%2520Sci.%26date%3D2002%26volume%3D6%26spage%3D33%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit81b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritschel, W. A.</span>; <span class="NLM_string-name">Kearns, G. L.</span></span> <i>Handbook of Basic Pharmacokinetics</i>, <span class="NLM_edition">6</span>th ed.; <span class="NLM_publisher-name">APhA</span>: <span class="NLM_publisher-loc">Washington, DC, U.S.</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+A.+Ritschel&author=G.+L.+Kearns&title=Handbook+of+Basic+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRitschel%26aufirst%3DW.%2BA.%26btitle%3DHandbook%2520of%2520Basic%2520Pharmacokinetics%26pub%3DAPhA%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit81c"><span><span class="NLM_label">(c) </span> Food and Drug
Administration. Additional Studies Part B. Metabolism and Pharmacokinetic
Studies, 1993 Draft “Redbook II”. Guidance for Industry
and Other Stakeholders Toxicological Principles for the Safety Assessment
of Food Ingredients. Redbook 2000 (Revised 2007). <a href="http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM078741.pdf" class="extLink">http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM078741.pdf</a> (accessed Feb 22, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Food+and+Drug%0AAdministration.+Additional+Studies+Part+B.+Metabolism+and+Pharmacokinetic%0AStudies%2C+1993+Draft+%E2%80%9CRedbook+II%E2%80%9D.+Guidance+for+Industry%0Aand+Other+Stakeholders+Toxicological+Principles+for+the+Safety+Assessment%0Aof+Food+Ingredients.+Redbook+2000+%28Revised+2007%29.+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FFood%2FGuidanceRegulation%2FUCM078741.pdf+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span> <i>Schrödinger
Molecular Modeling Suite</i>, release <span class="NLM_edition">2018-1</span>; <span class="NLM_publisher-name">Schrödinger LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger%0AMolecular+Modeling+Suite%2C+release+2018-1%3B+Schr%C3%B6dinger+LLC%3A+New+York%2C+NY%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%250AMolecular%2520Modeling%2520Suite%26pub%3DSchr%25C3%25B6dinger%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83a1"><span>PDB
files from RCSB Protein Database. <a href="http://www.rcsb.org/pdb" class="extLink">http://www.rcsb.org/pdb</a> (accessed Feb 22, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PDB%0Afiles+from+RCSB+Protein+Database.+http%3A%2F%2Fwww.rcsb.org%2Fpdb+%28accessed+Feb+22%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83a1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit83a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koetzle, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, G. J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brice, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennard, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanouchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasumi, M.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank: a Computer-Based Archival File for Macromolecular Structures</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">535</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/S0022-2836(77)80200-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FS0022-2836%2877%2980200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=875032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaE2sXkvVert7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=1977&pages=535-542&author=F.+C.+Bernsteinauthor=T.+F.+Koetzleauthor=G.+J.+B.+Williamsauthor=E.+F.+Meyerauthor=M.+D.+Briceauthor=J.+R.+Rodgersauthor=O.+Kennardauthor=T.+Shimanouchiauthor=M.+Tasumi&title=The+Protein+Data+Bank%3A+a+Computer-Based+Archival+File+for+Macromolecular+Structures&doi=10.1016%2FS0022-2836%2877%2980200-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83aR"><div class="casContent"><span class="casTitleNuber">83a</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank:  a computer-based archival file for macromolecular structures</span></div><div class="casAuthors">Bernstein, Frances C.; Koetzle, Thomas F.; Williams, Graheme J. B.; Meyer, Edgar F., Jr.; Brice, Michael D.; Rodgers, John R.; Kennard, Olga; Shimanouchi, Takehiko; Tasumi, Mitsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-42</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    </div><div class="casAbstract">The Protein Data Bank is a computer-based archival file for macromol. structures.  The Bank stores in a uniform format at. coordinates and partial bond connectivities, as derived from crystallog. studies.  Text included in each data entry gives pertinent information for the structure at hand (e.g., species from which the mol. was obtained, resoln. of diffraction data, literature citations, and specifications of secondary structure).  In addn., the Protein Data Bank stores structure factors and phases.  Input of data and general maintenance functions are at Brookhaven National Lab.  All data are available on magnetic tape for public distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9tv93dkDhxrVg90H21EOLACvtfcHk0liYCqJcwEym9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXkvVert7o%253D&md5=07736506e495f157c600cf51a253a0a0</span></div><a href="/servlet/linkout?suffix=cit83a&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2877%2980200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252877%252980200-3%26sid%3Dliteratum%253Aachs%26aulast%3DBernstein%26aufirst%3DF.%2BC.%26aulast%3DKoetzle%26aufirst%3DT.%2BF.%26aulast%3DWilliams%26aufirst%3DG.%2BJ.%2BB.%26aulast%3DMeyer%26aufirst%3DE.%2BF.%26aulast%3DBrice%26aufirst%3DM.%2BD.%26aulast%3DRodgers%26aufirst%3DJ.%2BR.%26aulast%3DKennard%26aufirst%3DO.%26aulast%3DShimanouchi%26aufirst%3DT.%26aulast%3DTasumi%26aufirst%3DM.%26atitle%3DThe%2520Protein%2520Data%2520Bank%253A%2520a%2520Computer-Based%2520Archival%2520File%2520for%2520Macromolecular%2520Structures%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1977%26volume%3D112%26spage%3D535%26epage%3D542%26doi%3D10.1016%2FS0022-2836%2877%2980200-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit83b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The Protein Data Bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=J.+W.+Bermanauthor=F.+Zukangauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+Protein+Data+Bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83bR"><div class="casContent"><span class="casTitleNuber">83b</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0liYCqJcwEym9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit83b&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DJ.%2BW.%26aulast%3DZukang%26aufirst%3DF.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Protein%2520Data%2520Bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+Ligand+Preparation%3A+Parameters%2C+Protocols%2C+and+Influence+on+Virtual+Screening+Enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eYVH8dm4_-2RLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520Ligand%2520Preparation%253A%2520Parameters%252C%2520Protocols%252C%2520and%2520Influence%2520on%2520Virtual%2520Screening%2520Enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">2558</span>, <span class="refDoi"> DOI: 10.1021/ct300203w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300203w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2553-2558&author=D.+Shivakumarauthor=E.+Harderauthor=W.+Dammauthor=R.+A.+Friesnerauthor=W.+Sherman&title=Improving+the+Prediction+of+Absolute+Solvation+Free+Energies+Using+the+Next+Generation+OPLS+Force+Field&doi=10.1021%2Fct300203w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Harder, Edward; Damm, Wolfgang; Friesner, Richard A.; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Explicit solvent mol. dynamics free energy perturbation simulations were performed to predict abs. solvation free energies of 239 diverse small mols.  We use OPLS2.0, the next generation OPLS force field, and compare the results with popular small mol. force fields-OPLS_2005, GAFF, and CHARMm-MSI.  OPLS2.0 produces the best correlation with exptl. data (R2 = 0.95, slope = 0.96) and the lowest av. unsigned errors (0.7 kcal/mol).  Important classes of compds. that performed suboptimally with OPLS_2005 show significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEngE5xV9Ev7Vg90H21EOLACvtfcHk0ljv2R1awDaO6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D&md5=eceb7dab3a8d0c6ac586c620848412d1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fct300203w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300203w%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DImproving%2520the%2520Prediction%2520of%2520Absolute%2520Solvation%2520Free%2520Energies%2520Using%2520the%2520Next%2520Generation%2520OPLS%2520Force%2520Field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D2553%26epage%3D2558%26doi%3D10.1021%2Fct300203w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maple, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboul, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupyan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerutti, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krilov, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span> <span> </span><span class="NLM_article-title">OPLS33: A Force Field Providing Broad Coverage of Drug-Like Small Molecules and Proteins</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1021/acs.jctc.5b00864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jctc.5b00864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=281-296&author=E.+Harderauthor=W.+Dammauthor=J.+Mapleauthor=C.+Wuauthor=M.+Reboulauthor=J.+Y.+Xiangauthor=L.+Wangauthor=D.+Lupyanauthor=M.+K.+Dahlgrenauthor=J.+L.+Knightauthor=J.+W.+Kausauthor=D.+S.+Ceruttiauthor=G.+Krilovauthor=W.+L.+Jorgensenauthor=R.+Abelauthor=R.+A.+Friesner&title=OPLS33%3A+A+Force+Field+Providing+Broad+Coverage+of+Drug-Like+Small+Molecules+and+Proteins&doi=10.1021%2Facs.jctc.5b00864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins</span></div><div class="casAuthors">Harder, Edward; Damm, Wolfgang; Maple, Jon; Wu, Chuanjie; Reboul, Mark; Xiang, Jin Yu; Wang, Lingle; Lupyan, Dmitry; Dahlgren, Markus K.; Knight, Jennifer L.; Kaus, Joseph W.; Cerutti, David S.; Krilov, Goran; Jorgensen, William L.; Abel, Robert; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">281-296</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The parametrization and validation of the OPLS3 force field for small mols. and proteins are reported.  Enhancements with respect to the previous version (OPLS2.1) include the addn. of off-atom charge sites to represent halogen bonding and aryl nitrogen lone pairs as well as a complete refit of peptide dihedral parameters to better model the native structure of proteins.  To adequately cover medicinal chem. space, OPLS3 employs over an order of magnitude more ref. data and assocd. parameter types relative to other commonly used small mol. force fields (e.g., MMFF and OPLS_2005).  As a consequence, OPLS3 achieves a high level of accuracy across performance benchmarks that assess small mol. conformational propensities and solvation.  The newly fitted peptide dihedrals lead to significant improvements in the representation of secondary structure elements in simulated peptides and native structure stability over a no. of proteins.  Together, the improvements made to both the small mol. and protein force field lead to a high level of accuracy in predicting protein-ligand binding measured over a wide range of targets and ligands (less than 1 kcal/mol RMS error) representing a 30% improvement over earlier variants of the OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_jrOhcBRgrVg90H21EOLACvtfcHk0ljv2R1awDaO6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCjtbfE&md5=42663f8cfa84b80a67132bbb13b9b7ce</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jctc.5b00864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jctc.5b00864%26sid%3Dliteratum%253Aachs%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DMaple%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DReboul%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLupyan%26aufirst%3DD.%26aulast%3DDahlgren%26aufirst%3DM.%2BK.%26aulast%3DKnight%26aufirst%3DJ.%2BL.%26aulast%3DKaus%26aufirst%3DJ.%2BW.%26aulast%3DCerutti%26aufirst%3DD.%2BS.%26aulast%3DKrilov%26aufirst%3DG.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DOPLS33%253A%2520A%2520Force%2520Field%2520Providing%2520Broad%2520Coverage%2520of%2520Drug-Like%2520Small%2520Molecules%2520and%2520Proteins%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2016%26volume%3D12%26spage%3D281%26epage%3D296%26doi%3D10.1021%2Facs.jctc.5b00864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K.-H.</span>; <span class="NLM_string-name">Hessler, G.</span>; <span class="NLM_string-name">Matter, H.</span>; <span class="NLM_string-name">Schmidt, F.</span></span> <span> </span><span class="NLM_article-title">Development and Applications of Global ADMET Models: In Silico Prediction of Human Microsomal Lability</span>. In  <i>Chemoinformatics for Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajorath, J.</span></span>, Ed.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">265</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=245-265&author=K.-H.+Baringhaus&author=G.+Hessler&author=H.+Matter&author=F.+Schmidtauthor=J.+Bajorath&title=Chemoinformatics+for+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBaringhaus%26aufirst%3DK.-H.%26atitle%3DDevelopment%2520and%2520Applications%2520of%2520Global%2520ADMET%2520Models%253A%2520In%2520Silico%2520Prediction%2520of%2520Human%2520Microsomal%2520Lability%26btitle%3DChemoinformatics%2520for%2520Drug%2520Discovery%26aulast%3DBajorath%26aufirst%3DJ.%26pub%3DWiley%26date%3D2014%26spage%3D245%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anger, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giegerich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Güssregen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K.-H.</span></span> <span> </span><span class="NLM_article-title">Development of in Silico Filters to Predict Activation of the Pregnane X Receptor (PXR) by Structurally Diverse Drug-Like Molecules</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5352</span>– <span class="NLM_lpage">5365</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2012.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2Fj.bmc.2012.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=22560839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms12rsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2012&pages=5352-5365&author=H.+Matterauthor=L.+T.+Angerauthor=C.+Giegerichauthor=S.+G%C3%BCssregenauthor=G.+Hesslerauthor=K.-H.+Baringhaus&title=Development+of+in+Silico+Filters+to+Predict+Activation+of+the+Pregnane+X+Receptor+%28PXR%29+by+Structurally+Diverse+Drug-Like+Molecules&doi=10.1016%2Fj.bmc.2012.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Development of in silico filters to predict activation of the pregnane X receptor (PXR) by structurally diverse drug-like molecules</span></div><div class="casAuthors">Matter, Hans; Anger, Lennart T.; Giegerich, Clemens; Guessregen, Stefan; Hessler, Gerhard; Baringhaus, Karl-Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5352-5365</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pregnane X receptor (PXR), a member of the nuclear hormone superfamily, regulates the expression of several enzymes and transporters involved in metabolically relevant processes.  The significant induction of CYP450 enzymes by PXR, in particular CYP3A4, might significantly alter the metab. of prescribed drugs.  In order to early identify mols. in drug discovery with a potential to activate PXR as antitarget, we developed fast and reliable in silico filters by ligand-based QSAR techniques.  Two classification models were established on a diverse dataset of 434 drug-like mols.  A second augmented set allowed focusing on interesting regions in chem. space.  These classifiers are based on decision trees combined with a genetic algorithm based variable selection to arrive at predictive models.  The classifier for the first dataset on 29 descriptors showed good performance on a test set with a correct classification of both 100% for PXR activators and non-activators plus 87% for activators and 83% for non-activators in an external dataset.  The second classifier then correctly predicts 97% activators and 91% non-activators in a test set and 94% for activators and 64% non-activators in an external set of 50 mols., which still qualifies for application as a filter focusing on PXR activators.  Finally a quant. model for PXR activation for a subset of these mols. was derived using a regression-tree approach combined with GA variable selection.  This final model shows a predictive r2 of 0.774 for the test set and 0.452 for an external set of 33 mols.  Thus, the combination of these filters consistently provide guidelines for lowering PXR activation in novel candidate mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFIMqHB3fyKbVg90H21EOLACvtfcHk0lis9GeYbDtm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms12rsr4%253D&md5=9f2ce599c60a3290670ce53eedab0ed7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DAnger%26aufirst%3DL.%2BT.%26aulast%3DGiegerich%26aufirst%3DC.%26aulast%3DG%25C3%25BCssregen%26aufirst%3DS.%26aulast%3DHessler%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.-H.%26atitle%3DDevelopment%2520of%2520in%2520Silico%2520Filters%2520to%2520Predict%2520Activation%2520of%2520the%2520Pregnane%2520X%2520Receptor%2520%2528PXR%2529%2520by%2520Structurally%2520Diverse%2520Drug-Like%2520Molecules%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2012%26volume%3D20%26spage%3D5352%26epage%3D5365%26doi%3D10.1016%2Fj.bmc.2012.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sadowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasteiger, J.</span></span> <span> </span><span class="NLM_article-title">The Generation of 3D-Models of Host-Guest Complexes</span>. <i>Anal. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>265</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1016/0003-2670(92)85029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2F0003-2670%2892%2985029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK38XlslSmsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1992&pages=233-241&author=J.+Sadowskiauthor=C.+Rudolphauthor=J.+Gasteiger&title=The+Generation+of+3D-Models+of+Host-Guest+Complexes&doi=10.1016%2F0003-2670%2892%2985029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The generation of 3D models of host-guest complexes</span></div><div class="casAuthors">Sadowski, Jens; Rudolph, Christine; Gasteiger, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Analytica Chimica Acta</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">265</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-41</span>CODEN:
                <span class="NLM_cas:coden">ACACAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2670</span>.
    </div><div class="casAbstract">A program has been developed for the completely automatic generation of 3D at. coordinates of org. mols.  This system has been extended also to process polymacrocyclic structures, allowing complex host mols. to be modelled.  A three-step approach has been developed for modeling the geometry and energies of host-guest complexes which avoids the problem of being trapped in local min.  Two examples are given that illustrate that fine exptl. details can be derived from this approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquF_ZvHvLOXrVg90H21EOLACvtfcHk0lis9GeYbDtm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlslSmsb0%253D&md5=8290558c7bc3ba649d41718a2c6c975b</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0003-2670%2892%2985029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2670%252892%252985029-6%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DC.%26aulast%3DGasteiger%26aufirst%3DJ.%26atitle%3DThe%2520Generation%2520of%25203D-Models%2520of%2520Host-Guest%2520Complexes%26jtitle%3DAnal.%2520Chim.%2520Acta%26date%3D1992%26volume%3D265%26spage%3D233%26epage%3D241%26doi%3D10.1016%2F0003-2670%2892%2985029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span> <i>Corina</i>, version <span class="NLM_edition">3.491</span>; <span class="NLM_publisher-name">Molecular Networks
Inc.</span>: <span class="NLM_publisher-loc">Erlangen,
Germany</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Corina%2C+version+3.491%3B+Molecular+Networks%0AInc.%3A+Erlangen%2C%0AGermany."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span> <i>MOE</i>,
version <span class="NLM_edition">2011</span>; <span class="NLM_publisher-name">Chemical Computing
Group (CCG)</span>: <span class="NLM_publisher-loc">Montreal,
Canada</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%2C%0Aversion+2011%3B+Chemical+Computing%0AGroup+%28CCG%29%3A+Montreal%2C%0ACanada."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%26pub%3DChemical%2520Computing%250AGroup%2520%2528CCG%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidhart, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, G.</span></span> <span> </span><span class="NLM_article-title">“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">2894</span>– <span class="NLM_lpage">2896</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADyaK1MXmslKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=2894-2896&author=G.+Schneiderauthor=W.+Neidhartauthor=T.+Gillerauthor=G.+Schmid&title=%E2%80%9CScaffold-Hopping%E2%80%9D+by+Topological+Pharmacophore+Search%3A+A+Contribution+to+Virtual+Screening&doi=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">"Scaffold-Hopping" by topological pharmacophore search: a contribution to virtual screening</span></div><div class="casAuthors">Schneider, Gisbert; Neidhart, Werner; Giller, Thomas; Schmid, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2894-2896</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">We present the successful application of a novel straightforward technique to "scaffold-hopping", i.e., identification of isofunctional mol. structures with significantly different mol. backbones.  The technique was applied to the prediction of novel cardiac T-type Ca2+ channel blocking agents using mibefradil as the seed structure.  The 12 highest-ranking mols. were tested using a cell culture assay for their ability to inhibit cellular Ca2+ influx.  One compd. (clopimozide) had an IC50 < 1 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgaa9cDF2whrVg90H21EOLACvtfcHk0lgf0pNwmGRdAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslKht78%253D&md5=460b2116abc32e54ba9eb3b712333eb9</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291521-3773%252819991004%252938%253A19%253C2894%253A%253AAID-ANIE2894%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DG.%26aulast%3DNeidhart%26aufirst%3DW.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DSchmid%26aufirst%3DG.%26atitle%3D%25E2%2580%259CScaffold-Hopping%25E2%2580%259D%2520by%2520Topological%2520Pharmacophore%2520Search%253A%2520A%2520Contribution%2520to%2520Virtual%2520Screening%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1999%26volume%3D38%26spage%3D2894%26epage%3D2896%26doi%3D10.1002%2F%28SICI%291521-3773%2819991004%2938%3A19%3C2894%3A%3AAID-ANIE2894%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crippen, G. M.</span></span> <span> </span><span class="NLM_article-title">Atomic Physicochemical Parameters for Three-Dimensional-Structure-Directed Quantitative Structure-Activity Relationships. 2. Modeling Dispersive and Hydrophobic Interactions</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">35</span>, <span class="refDoi"> DOI: 10.1021/ci00053a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci00053a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1987&pages=21-35&author=A.+K.+Ghoseauthor=G.+M.+Crippen&title=Atomic+Physicochemical+Parameters+for+Three-Dimensional-Structure-Directed+Quantitative+Structure-Activity+Relationships.+2.+Modeling+Dispersive+and+Hydrophobic+Interactions&doi=10.1021%2Fci00053a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fci00053a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00053a005%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DCrippen%26aufirst%3DG.%2BM.%26atitle%3DAtomic%2520Physicochemical%2520Parameters%2520for%2520Three-Dimensional-Structure-Directed%2520Quantitative%2520Structure-Activity%2520Relationships.%25202.%2520Modeling%2520Dispersive%2520and%2520Hydrophobic%2520Interactions%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D1987%26volume%3D27%26spage%3D21%26epage%3D35%26doi%3D10.1021%2Fci00053a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Improved Estimates for the Accuracy of Small Disjuncts</span>. <i>Machine Learn.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1007/BF00153762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1007%2FBF00153762" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=93-98&author=J.+R.+Quinlan&title=Improved+Estimates+for+the+Accuracy+of+Small+Disjuncts&doi=10.1007%2FBF00153762"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2FBF00153762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00153762%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DImproved%2520Estimates%2520for%2520the%2520Accuracy%2520of%2520Small%2520Disjuncts%26jtitle%3DMachine%2520Learn.%26date%3D1991%26volume%3D6%26spage%3D93%26epage%3D98%26doi%3D10.1007%2FBF00153762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Learning with Continuous Classes</span>.  <i>AI ’92: Proceedings of the 5th Australian Joint Conference on Artificial Intelligence</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, A.</span>, <span class="NLM_string-name">Sterling, L.</span></span>, Eds.; <span class="NLM_publisher-name">World Scientific</span>: <span class="NLM_publisher-loc">Singapore</span>, <span class="NLM_year">1992</span>; pp  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">348</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1992&pages=343-348&author=J.+R.+Quinlanauthor=A.+Adams&author=L.+Sterling&title=AI+%E2%80%9992%3A+Proceedings+of+the+5th+Australian+Joint+Conference+on+Artificial+Intelligence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DLearning%2520with%2520Continuous%2520Classes%26btitle%3DAI%2520%25E2%2580%259992%253A%2520Proceedings%2520of%2520the%25205th%2520Australian%2520Joint%2520Conference%2520on%2520Artificial%2520Intelligence%26aulast%3DAdams%26aufirst%3DA.%26pub%3DWorld%2520Scientific%26date%3D1992%26spage%3D343%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, J. R.</span></span> <span> </span><span class="NLM_article-title">Combining Instance-Based and Model-Based Learning</span>.  <i>Machine Learning Proceedings 1993</i>, Proceedings of the Tenth International Conference; <span class="NLM_contrib-group"><span class="NLM_string-name">Utgoff, P. E.</span></span>, Ed.; <span class="NLM_publisher-name">Morgan Kaufmann</span>: <span class="NLM_publisher-loc">Los Altos, CA</span>, <span class="NLM_year">1993</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=10.1016%2FB978-1-55860-307-3.50037-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&author=J.+R.+Quinlanauthor=P.+E.+Utgoff&title=Machine+Learning+Proceedings+1993"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2FB978-1-55860-307-3.50037-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-1-55860-307-3.50037-X%26sid%3Dliteratum%253Aachs%26aulast%3DQuinlan%26aufirst%3DJ.%2BR.%26atitle%3DCombining%2520Instance-Based%2520and%2520Model-Based%2520Learning%26btitle%3DMachine%2520Learning%2520Proceedings%25201993%26aulast%3DUtgoff%26aufirst%3DP.%2BE.%26pub%3DMorgan%2520Kaufmann%26date%3D1993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, A.</span></span> <span> </span><span class="NLM_article-title">P-glycoprotein Substrate Models using Support Vector Machines Based on a Comprehensive data set</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1447</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1021/ci2001583</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci2001583" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1447-1456&author=Z.+Wangauthor=Y.+Chenauthor=H.+Liangauthor=A.+Benderauthor=R.+C.+Glenauthor=A.+Yan&title=P-glycoprotein+Substrate+Models+using+Support+Vector+Machines+Based+on+a+Comprehensive+data+set&doi=10.1021%2Fci2001583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set</span></div><div class="casAuthors">Wang, Zhi; Chen, Yuanying; Liang, Hu; Bender, Andreas; Glen, Robert C.; Yan, Aixia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1447-1456</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is one of the major ABC transporters and involved in many essential processes such as lipid and steroid transport across cell membranes but also in the uptake of drugs such as HIV protease and reverse transcriptase inhibitors.  Despite its importance, reliable models predicting substrates of P-gp are scarce.  In this study, the authors have built several computational models to predict whether or not a compd. is a P-gp substrate, based on the largest data set yet published, employing 332 distinct structures.  Each mol. is represented by ADRIANA.Code, MOE, and ECFP_4 fingerprint descriptors.  The models are computed using a support vector machine based on a training set which includes 131 substrates and 81 nonsubstrates that were evaluated by 5-, 10-fold, and leave-one-out (LOO) cross-validation.  The best model gives a Matthews Correlation Coeff. of 0.73 and a prediction accuracy of 0.88 on the test set.  Examn. of the model based on ECFP_4 fingerprints revealed several substructures which could have significance in sepg. substrates and nonsubstrates of P-gp, such as the nitrile and sulfoxide functional groups which have a higher frequency in nonsubstrates than in substrates.  In addn. structural isomerism in sugars was found to result in remarkable differences regarding the likelihood of a compd. to be a substrate for P-gp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVTOVOdq4wKrVg90H21EOLACvtfcHk0lgf0pNwmGRdAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFSlur0%253D&md5=2cbbf22dfc3a7bd511e92c68c5a73f14</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fci2001583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci2001583%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DBender%26aufirst%3DA.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DYan%26aufirst%3DA.%26atitle%3DP-glycoprotein%2520Substrate%2520Models%2520using%2520Support%2520Vector%2520Machines%2520Based%2520on%2520a%2520Comprehensive%2520data%2520set%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1447%26epage%3D1456%26doi%3D10.1021%2Fci2001583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NX2','PDB','5NX2'); return false;">PDB: 5NX2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01071">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08166"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01071">10.1021/acs.jmedchem.9b01071</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Chemistry methods and general procedures; synthesis schemes and procedures for <b>9</b> and <b>14</b>; structure elucidation of <b>18</b>; results for selectivity testing for <b>9</b>, <b>14</b>. and <b>19</b>; pharmacokinetic data for <b>19</b>; in vitro data for literature reference compounds and/or close analogues; effect of ip administration of GLP1(9–36)NH<sub>2</sub> (9 mg/kg) on glucose excursion in C57BL/6 mice; in vivo effect of GLP1(9–36)NH<sub>2</sub> of <b>9</b> and BETP in combination with GLP1(9–36)NH<sub>2</sub>; effect of glucose concentration on insulin secretion in pancreatic rat islets (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings of all compounds and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_001.pdf">jm9b01071_si_001.pdf (1.53 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01071/suppl_file/jm9b01071_si_002.csv">jm9b01071_si_002.csv (0.43 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01071&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01071%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01071" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998d8e3d613c58","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
